Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,regulation of cell cycle (GO:0051726),-0.6584084563745023,-3.0243400884809915,0.0,0.0,0.0,45/159,12.96%,PCLAF;BIRC5;CKS1B;CENPF;FBXO5;CKS2;PLK1;CCNB1;DLGAP5;GMNN;KIF20B;RBBP4;MASTL;CCNB2;CDK4;BRCA1;FIGNL1;MYBL2;FOXM1;MIF;HNRNPU;CDKN3;BARD1;PRR11;CDKN2C;DDIAS;CDKN1A;DTL;MLF1;HSP90AB1;CDC25A;CDC123;CDKN2D;RAD23A;CDKN2A;LIN54;LIN9;ID2;TAF6;TARDBP;CHEK1;SKP2;EIF4G2;HRAS;GADD45GIP1
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),-0.7675406680572774,-3.0162165467598245,0.0,0.0,0.0,85/129,16.84%,CDK1;TUBB4B;UBE2S;UBE2C;CENPF;TPX2;FBXO5;CENPE;MAD2L1;PLK1;BUB3;CCNB1;HMMR;PLK4;BUB1B;CDC20;TUBG1;CKAP5;HSP90AA1;AURKA;NEK2;FZR1;ANLN;HAUS4;TUBA1A;TUBA4A;ANAPC5;UBB;KIF14;KNTC1;CDC6;PSMB6;HAUS5;ODF2;YWHAE;CNTRL;PCNT;NDE1;PSMB2;HAUS6;PSMB5;PSMA3;CEP57;HAUS1;ANAPC15;NEDD1;PSMC4;PSMA6;PSMD2;CDK2;PSMB7;PSMA4;ZW10;PSMD12;CCP110;ID2;PSMC2;CEP192;E2F1;HAUS7;PSMD1;PSMA5;PSMD7;PSMD14;CDC23;PSMD11;CENPJ;HAUS3;CEP72;CDK5RAP2;PSME3;CEP70;CDC27;PSMD6;PSMC1;HAUS8;PSMC5;PSMD3;PTPN6;DDB1;PSMC6;CEP135;CDC16;DCTN1;ACTR1A
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.6569244491779122,-3.0095521530168297,0.0,0.0,0.0,64/168,17.45%,CDK1;AURKB;UBE2S;UBE2C;FBXO5;MAD2L1;PLK1;BUB3;CCNB1;BUB1B;CDC20;CCNF;AURKA;FZR1;ANAPC5;UBB;KIF14;PSMB6;HSP90B1;STUB1;PSMB2;PSMB5;PSMA3;ANAPC15;RNF126;RAD23A;PSMC4;FAF1;RNF5;PSMA6;PSMD2;CDK2;PSMB7;PSMA4;TAF1;CDC34;PSMD12;DERL2;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;CDC23;PSMD11;NEDD4;SKP2;PSME3;CDC27;PSMD6;PSMC1;PSMC5;PSMD3;DDB1;EDEM1;MTA1;PSMC6;LTN1;CDC16;FBXO45;FBXL14;STT3B;ANAPC1;NSFL1C
gsea,mitotic cell cycle phase transition (GO:0044772),-0.7261996357037465,-3.001429994385595,0.0,0.0,0.0,70/139,13.57%,CCNA2;CDK1;TUBB4B;UBE2S;UBE2C;TACC3;PLK1;CCNB1;PLK4;TUBG1;MELK;MASTL;CCNB2;CCNF;CKAP5;HSP90AA1;CDC25B;AURKA;NEK2;NASP;HAUS4;CDK4;TUBA1A;TUBA4A;FOXM1;PKMYT1;DBF4;CDKN3;RCC1;CCNE1;CDKN2C;POLE;HAUS5;CDKN1A;ODF2;YWHAE;CDC25C;CNTRL;PCNT;NDE1;GSPT1;HAUS6;CDC25A;CDKN2D;BORA;CEP57;HAUS1;CDKN2A;CCNE2;NEDD1;CDK2;CDC7;CDC34;CCP110;CEP192;E2F1;HAUS7;EIF4E;CDC23;WEE1;CENPJ;HAUS3;CEP72;CCNG1;SKP2;CDK5RAP2;CEP70;CDC27;CHEK2;HAUS8
gsea,double-strand break repair (GO:0006302),-0.721404132032239,-2.9648494365224023,0.0,0.0,0.0,61/116,16.90%,HMGB2;HMGB1;KPNA2;CDCA5;RAD51;NUCKS1;RAD21;FEN1;RPA3;RAD51AP1;TRIP13;AUNIP;BRIP1;BRCA1;POLA1;NSD2;BARD1;HPF1;GEN1;RPA2;EME1;BLM;SMC6;RPA1;BAZ1B;RAD50;BRCA2;RFWD3;RAD54B;RBBP8;MCM8;TDP2;SMARCA5;MMS22L;NSMCE1;PRPF19;POLQ;PARP2;RNF168;RIF1;TDP1;SMC5;UBE2N;PARP1;DDX1;XRCC1;PAXIP1;SFPQ;PSMD14;PALB2;PPP5C;CHEK2;DNA2;BRCC3;SPIDR;RECQL4;MTA1;APLF;XRCC5;TONSL;XRCC2
gsea,regulation of mitotic cell cycle (GO:0007346),-0.7532470521383782,-2.9413750254914013,0.0,0.0,0.0,53/100,15.36%,CDK1;MKI67;UBE2S;UBE2C;CKS1B;FBXO5;CKS2;MAD2L1;PLK1;BUB3;CCNB1;DLGAP5;KIF20B;BUB1B;CDC20;CDC25B;NEK2;FZR1;ANAPC5;PKMYT1;HNRNPU;RCC1;PIN1;PSMB6;CDC25C;PSMB2;PSMB5;PSMA3;BORA;ANAPC15;PSMC4;ASNS;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;EIF4E;PSMD7;PSMD14;CDC23;PSMD11;PSME3;CDC27;PSMD6;PSMC1;PSMC5;PSMD3;DDB1;PSMC6
gsea,mitotic spindle organization (GO:0007052),-0.8344206581316224,-2.934808772645926,0.0,0.0,0.0,80/118,10.36%,BIRC5;AURKB;STMN1;KIF11;CDCA8;PRC1;SPC24;CENPF;TPX2;INCENP;KNL1;RAN;CENPE;MAD2L1;PLK1;SPC25;BUB3;CCNB1;NDC80;DLGAP5;BUB1;SKA1;KIFC1;KIF23;NUF2;SMC1A;BUB1B;CDC20;KIF2C;TUBG1;CENPA;NUDC;CKAP5;PMF1;AURKA;CENPM;SKA2;CENPP;STIL;CENPH;RANGAP1;SGO1;TTK;SPDL1;KNTC1;SMC3;ZWILCH;AAAS;NUP107;KIF18A;RCC1;NUP37;CENPN;NUP85;CENPK;CENPI;GPSM2;DSN1;PCNT;NDE1;NUP133;MIS12;CENPS;MAD1L1;ERCC6L;CENPL;NUP43;CENPU;CENPT;KPNB1;DYNLL2;NSL1;NUP160;RCC2;XPO1;ZWINT;ZW10;CENPQ;STAG1;CEP192
gsea,DNA repair (GO:0006281),-0.6766641837051437,-2.928615164531306,0.0,0.0,0.0,108/218,17.95%,CDK1;KPNA2;CDCA5;RAD51;NUCKS1;SMC1A;RAD21;FEN1;NEIL3;RFC4;RFC5;RPA3;RAD51AP1;USP1;TRIP13;LIG1;PCNA;BRIP1;UBB;BRCA1;POLA1;NSMCE4A;NSD2;RFC2;TICRR;UBE2T;BARD1;HPF1;TRAIP;RPA2;RAD18;EME1;BLM;FANCD2;TOPBP1;RPA1;POLE;BAZ1B;RAD54L;FAM111A;RAD50;BRCA2;POLD2;NPM1;EXO1;RFWD3;CENPS;RMI2;RFC3;RBBP8;POLD1;TRIM28;TDP2;CDKN2D;SMARCA5;RNASEH2A;NSMCE1;RHNO1;RAD23A;POLQ;POLD3;PARK7;PARP2;FANCF;POLH;WDHD1;FANCM;RNF168;FANCI;TDP1;UBE2N;PARP1;DDX1;XRCC1;TIMELESS;POLE2;MBD4;ZRANB3;CHEK1;PPP5C;PDS5A;NUDT1;FANCA;CHEK2;FANCG;PDS5B;DNA2;FANCB;FAAP24;BRCC3;RECQL4;DDB1;RAD9A;MTA1;ATR;APLF;TDG;APEX1;ASF1A;XRCC5;XRCC2;MLH1;WDR48;WRNIP1;MGME1;FANCL;ABRAXAS1;CHD1L
gsea,G2/M transition of mitotic cell cycle (GO:0000086),-0.7496288106336867,-2.918490478352959,0.0,0.0,0.0,47/88,13.57%,CCNA2;CDK1;TUBB4B;PLK1;CCNB1;PLK4;TUBG1;MELK;MASTL;CCNB2;CKAP5;HSP90AA1;CDC25B;AURKA;NEK2;HAUS4;TUBA1A;TUBA4A;FOXM1;PKMYT1;HAUS5;CDKN1A;ODF2;YWHAE;CDC25C;CNTRL;PCNT;NDE1;HAUS6;CDC25A;BORA;CEP57;HAUS1;NEDD1;CDK2;CCP110;CEP192;HAUS7;WEE1;CENPJ;HAUS3;CEP72;SKP2;CDK5RAP2;CEP70;CHEK2;HAUS8
gsea,regulation of cell cycle process (GO:0010564),-0.7928323501541501,-2.912823828407211,0.0,0.0,0.0,26/64,7.10%,MKI67;AURKB;KIF11;PRC1;FBXO5;RACGAP1;PLK1;BUB1;PLK4;CALM2;KIF20B;KIF20A;ECT2;TIPIN;AURKA;NEK2;SPAG5;PKMYT1;DBF4;KNSTRN;RCC1;PIN1;CDC25C;RMI2;MAD1L1;BORA
gsea,cell cycle G2/M phase transition (GO:0044839),-0.7485430827581502,-2.909636994452551,0.0,0.0,0.0,47/88,13.57%,CCNA2;CDK1;TUBB4B;PLK1;CCNB1;PLK4;TUBG1;MELK;MASTL;CCNB2;CKAP5;HSP90AA1;CDC25B;AURKA;NEK2;HAUS4;TUBA1A;TUBA4A;FOXM1;PKMYT1;HAUS5;CDKN1A;ODF2;YWHAE;CDC25C;CNTRL;PCNT;NDE1;HAUS6;CDC25A;BORA;CEP57;HAUS1;NEDD1;CDK2;CCP110;CEP192;HAUS7;WEE1;CENPJ;HAUS3;CEP72;SKP2;CDK5RAP2;CEP70;CHEK2;HAUS8
gsea,regulation of cytokinesis (GO:0032465),-0.8153452030897114,-2.9080013734342534,0.0,0.0,0.0,18/45,4.43%,AURKB;PRC1;RACGAP1;PLK1;KIF23;PLK4;CALM2;KIF20B;CIT;KIF20A;ECT2;CDC25B;AURKA;E2F8;KIF14;E2F7;CDC6;PIN1
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.8628474775221089,-2.901199161473314,0.0,0.0,0.0,72/100,8.62%,BIRC5;AURKB;STMN1;NUSAP1;KIF11;CDCA8;SPC24;CENPF;TACC3;INCENP;KNL1;RAN;CENPE;MAD2L1;PLK1;SPC25;BUB3;CCNB1;NDC80;DLGAP5;BUB1;SKA1;NUF2;BUB1B;CDC20;KIF2C;TUBG1;CENPA;NUDC;CKAP5;PMF1;AURKA;CENPM;SKA2;CENPP;STIL;CENPH;RANGAP1;SGO1;TTK;SPDL1;KNTC1;ESPL1;ZWILCH;NUP107;KIF18A;RCC1;NUP37;CENPN;NUP85;CENPK;CENPI;GPSM2;DSN1;PCNT;NDE1;NUP133;MIS12;CENPS;MAD1L1;ERCC6L;CENPL;NUP43;CENPU;CENPT;KPNB1;DYNLL2;NSL1;NUP160;RCC2;XPO1;ZWINT
gsea,DNA metabolic process (GO:0006259),-0.7242631750455267,-2.893842788928057,0.0,0.0,0.0,114/204,16.90%,TOP2A;HMGB2;CDK1;HMGB1;KPNA2;TYMS;RAN;RAD51;GMNN;SMC1A;RAD21;FEN1;NEIL3;RFC4;RFC5;RPA3;ORC6;RAD51AP1;DCTPP1;DNMT1;CDC45;LIG1;PTGES3;UHRF1;PCNA;MCM5;UBB;PRIM1;BRCA1;MCM7;POLA1;HMGB3;DBF4;NSMCE4A;RFC2;TICRR;UBE2T;BARD1;GEN1;RPA2;RAD18;PRIM2;CDC6;HELLS;BLM;MCM3;TINF2;TOPBP1;MCM10;RPA1;POLE;MCM4;RAD54L;RAD50;POLD2;NPM1;EXO1;CENPS;RMI2;RFC3;RBBP8;MCM8;POLE3;POLD1;TRIM28;RFC1;MCM6;TSN;CDT1;RNASEH2A;POLA2;CTC1;POLQ;POLD3;PARK7;PARP2;CDK2;POLH;WDHD1;CDC7;CDC34;RIF1;ORC1;TDP1;UBE2N;PARP1;XRCC1;TIMELESS;SMARCB1;POLE2;MCM2;ORC2;MBD4;ZRANB3;CHEK1;PDS5A;NUDT1;RTEL1;CNBP;FANCA;FANCG;LONP1;PDS5B;DNA2;RECQL4;DDB1;RAD9A;ATR;TDG;APEX1;ASF1A;XRCC5;HELB;XRCC2
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),-0.6260515021830464,-2.8881955672522333,0.0,0.0,0.0,58/168,17.45%,AURKB;UBE2S;UBE2C;MAD2L1;PLK1;BUB3;BUB1B;CDC20;AURKA;UHRF1;FZR1;ANAPC5;KIF14;PSMB6;STUB1;DTL;ELOC;PSMB2;PSMB5;PSMA3;ANAPC15;RNF126;RAD23A;PSMC4;FAF1;RNF5;PSMA6;PSMD2;PSMB7;PSMA4;TAF1;RNF168;CDC34;PSMD12;COPS3;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;CDC23;PSMD11;NEDD4;SKP2;PSME3;CDC27;PSMD6;PSMC1;PSMC5;PSMD3;DDB1;MTA1;PSMC6;CDC16;FBXO45;FBXL14;ANAPC1;NSFL1C
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),-0.7416863434182998,-2.8881000913951502,0.0,0.0,0.0,23/59,12.32%,CCNA2;INCENP;CCNB1;CALM2;EZH2;CCNB2;CCNF;PKMYT1;CDKN3;CDC6;BLM;CCNE1;CDKN2C;CDKN1A;CDC25C;CDC25A;PIH1D1;CDKN2D;ACTB;CCNE2;AKT1;ETAA1;CCNG1
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.7677527117213473,-2.8803341011964667,0.0,0.0,0.0,70/98,16.84%,CDK1;TUBB4B;CENPF;TPX2;FBXO5;PLK1;CCNB1;HMMR;PLK4;TUBG1;CKAP5;HSP90AA1;CDC25B;AURKA;NEK2;HAUS4;CDK4;TUBA1A;TUBA4A;KIF14;PSMB6;HAUS5;ODF2;YWHAE;DTL;CDC25C;CNTRL;PCNT;NDE1;PSMB2;HAUS6;PSMB5;CDC25A;PSMA3;CEP57;HAUS1;RCC2;NEDD1;PSMC4;PSMA6;PSMD2;CDK2;PSMB7;PSMA4;CDC7;PSMD12;CCP110;PSMC2;CEP192;HAUS7;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;CENPJ;HAUS3;CEP72;CDK5RAP2;PSME3;CEP70;PSMD6;PSMC1;HAUS8;PSMC5;PSMD3;PSMC6;CEP135;DCTN1;ACTR1A
gsea,modification-dependent protein catabolic process (GO:0019941),-0.6650296421500032,-2.870571983043003,0.0,0.0,0.0,37/99,17.40%,AURKB;UBE2S;UBE2C;MAD2L1;PLK1;BUB3;BUB1B;CDC20;AURKA;UHRF1;FZR1;ANAPC5;UBB;STUB1;DTL;ELOC;ANAPC15;RNF126;RNF5;TAF1;RNF168;CDC34;COPS3;PSMC2;PSMD14;CDC23;PSMD11;NEDD4;CDC27;LONP1;PSMD3;DDB1;PCYOX1L;CDC16;FBXO45;FBXL14;ANAPC1
gsea,positive regulation of cell cycle process (GO:0090068),-0.7951864570172272,-2.865893613441945,0.0,0.0,0.0,30/62,10.11%,AURKB;NUSAP1;RACGAP1;MAD2L1;CCNB1;NDC80;RANBP1;KIF23;PLK4;RAD21;KIF20B;CIT;FEN1;ECT2;CDC25B;AURKA;E2F8;SPAG5;KIF14;E2F7;DBF4;GEN1;CDC6;NUP62;GPSM2;RHNO1;CEP295;RCC2;CDC7;NUMA1
gsea,cilium assembly (GO:0060271),-0.6272313068860602,-2.858649257056587,0.0,0.0,0.0,61/145,23.46%,CDK1;TUBB4B;PLK1;PLK4;TUBG1;CKAP5;HSP90AA1;NEK2;HAUS4;TUBA1A;TUBA4A;HAUS5;ODF2;YWHAE;CNTRL;PCNT;NDE1;HAUS6;E2F4;DYNLL2;CEP83;CEP57;HAUS1;NEDD1;TMEM107;CCP110;IFT27;CEP192;HAUS7;SCLT1;KIF24;CENPJ;HAUS3;CEP72;CEP89;CDK5RAP2;EXOC4;CEP70;POC1B;HAUS8;WDR90;CFAP298;CEP135;DCTN1;ACTR1A;TMEM237;CEP76;HYLS1;CEP152;SSX2IP;TNPO1;PCM1;CLASP1;ALMS1;CEP78;OFD1;C2CD3;HAUS2;TMEM138;EHD4;FLNA
gsea,"mRNA splicing, via spliceosome (GO:0000398)",-0.7446405089210073,-2.851146681520146,0.0,0.0,0.0,129/171,19.91%,ALYREF;LSM2;LSM3;SNRPD1;SNRPE;HNRNPA3;SRSF3;YBX1;SRSF2;HNRNPD;LSM8;HNRNPA2B1;U2AF1;DDX39B;SNRPB;SNU13;SF3B2;HNRNPU;PCBP1;HNRNPF;EIF4A3;SNRPF;RNPS1;SRSF7;SNRPD3;NONO;RBMX2;RBM8A;PPIL1;MAGOH;PPIH;SNRNP70;SRRT;SNRNP40;SNRPA1;POLR2C;FUS;SRSF9;MAGOHB;PHF5A;SRRM1;SRSF10;GEMIN6;POLR2F;RBM17;DHX9;U2AF2;SF3A3;USP39;PRPF19;SNRNP25;HNRNPA1;EFTUD2;HNRNPR;HSPA8;SCAF11;SF3B4;RSRC1;WBP11;DDX20;SRSF4;SMU1;POLR2L;SRRM2;HNRNPA0;SF3A2;SRSF1;PRPF31;CCAR1;SYNCRIP;LSM7;CPSF2;DDX1;HNRNPK;U2SURP;HNRNPUL1;SART3;PRPF8;SFPQ;PRPF4;GEMIN2;HNRNPH1;SF3A1;SF3B3;HNRNPC;NCBP1;POLR2B;DBR1;DDX46;CLNS1A;PPWD1;PTBP1;SRPK1;MTREX;DDX42;HNRNPM;CPSF1;SRSF6;UPF3B;POLR2A;SNRNP200;STRAP;PRPF40A;RBMX;CPSF4;SART1;PPIE;PRPF3;ZCCHC8;RBM10;CACTIN;POLR2E;GTF2F1;BUD13;CSTF2;DHX15;GTF2F2;CWC27;CHERP;SNRPA;PRMT5;PRPF38A;POLR2H;RBM15;SMN1;SYMPK;RBM14;METTL14;CPSF3
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),-0.8997545568225884,-2.835740899336361,0.0,0.0,0.0,15/31,3.74%,AURKB;STMN1;NUSAP1;INCENP;RACGAP1;PLK1;KIF23;CEP55;CIT;KIF20A;CENPA;ECT2;ANLN;ESPL1;CKAP2
gsea,mitotic sister chromatid segregation (GO:0000070),-0.8538169388094378,-2.824620455188681,0.0,0.0,0.0,48/70,9.43%,SMC2;CDK1;NUSAP1;CDCA8;PRC1;SMC4;RAN;CENPE;NCAPG;PLK1;KIF22;NCAPH;CCNB1;CDCA5;NDC80;DLGAP5;KIFC1;KIF23;SMC1A;CEP55;NCAPD2;RAD21;KIF2C;SET;TUBG1;NCAPG2;NUDC;NCAPD3;KIF18B;SPAG5;SGO1;KIF14;SPDL1;NCAPH2;ESPL1;KNSTRN;KIF18A;NUP62;CENPK;DSN1;HASPIN;MIS12;KPNB1;KMT5A;NSL1;ZWINT;NAA50;ZW10
gsea,cellular response to DNA damage stimulus (GO:0006974),-0.6247341616017795,-2.8235255532124848,0.0,0.0,0.0,117/245,22.76%,TOP2A;PCLAF;CDK1;RAD51;SMC1A;FEN1;RFC4;RFC5;RAD51AP1;MASTL;LIG1;CBX5;BRCA1;MCM7;POLA1;NSMCE4A;SUV39H1;RFC2;TICRR;UBE2T;BARD1;HPF1;TRAIP;CBX1;CBX3;RAD18;BLM;SMC6;TOPBP1;MCM10;RPA1;CDKN1A;BAZ1B;RAD54L;FAM111A;DTL;RAD50;NPM1;EXO1;RFWD3;CENPS;RMI2;RFC3;RBBP8;MCM8;POLE3;POLD1;TRIM28;BAX;POLQ;PARK7;PARP2;FANCF;POLH;WDHD1;WDR76;TAF1;RNF168;RIF1;TDP1;SMC5;E2F1;CGAS;PARP1;TIMELESS;POLE2;ETAA1;MBD4;ZRANB3;CHEK1;ASH2L;PDS5A;NUDT1;RTEL1;FANCA;MTREX;CHEK2;FANCG;PDS5B;FMR1;SPIDR;RECQL4;MRNIP;DDB1;RAD9A;ATR;APLF;APEX1;ASF1A;XRCC5;FBXO45;HELB;XRCC2;WDR48;PIDD1;FANCL;CHD1L;SLF1;HTRA2;ZDHHC16;OARD1;PWWP3A;RECQL;DOT1L;RAD51C;BAK1;RAD1;TAF9;CUL4B;DDX11;SETX;MSH2;CHCHD6;MUTYH;NBN;KMT5C;RNF8
gsea,mRNA processing (GO:0006397),-0.7298531256269367,-2.821320462286881,0.0,0.0,0.0,129/181,19.91%,ALYREF;LSM2;LSM3;SNRPD1;SNRPE;HNRNPA3;SRSF3;YBX1;SRSF2;HNRNPD;LSM8;HNRNPA2B1;U2AF1;DDX39B;SNRPB;SNU13;SF3B2;HNRNPU;PCBP1;HNRNPF;EIF4A3;SNRPF;RNPS1;SRSF7;SNRPD3;NONO;RBMX2;RBM8A;PPIL1;MAGOH;PPIH;SNRNP70;SRRT;SNRNP40;SNRPA1;POLR2C;FUS;SRSF9;TCERG1;MAGOHB;PHF5A;SRRM1;SRSF10;GEMIN6;POLR2F;RBM17;DHX9;U2AF2;SF3A3;USP39;PRPF19;SNRNP25;HNRNPA1;EFTUD2;HNRNPR;HSPA8;SCAF11;SF3B4;RSRC1;WBP11;SRSF4;SMU1;POLR2L;SRRM2;HNRNPA0;SF3A2;SRSF1;PRPF31;CCAR1;SYNCRIP;LSM7;CPSF2;HNRNPK;U2SURP;HNRNPUL1;SART3;PRPF8;SFPQ;SARNP;PRPF4;GEMIN2;HNRNPH1;SF3A1;SF3B3;CPSF6;HNRNPC;THOC3;NCBP1;POLR2B;DBR1;DDX46;PPWD1;PTBP1;MTREX;DDX42;HNRNPM;CPSF1;SRSF6;UPF3B;POLR2A;SNRNP200;PRPF40A;RBMX;CPSF4;SART1;PPIE;RPRD1B;PRPF3;ZCCHC8;RBM10;CACTIN;POLR2E;GTF2F1;BUD13;CSTF2;DHX15;GTF2F2;CWC27;CHERP;THOC2;SNRPA;PRPF38A;THOC6;POLR2H;RBM15;SYMPK;RBM14;METTL14;CPSF3
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.7484085799427846,-2.8160984103676596,0.0,0.0,0.0,120/156,19.91%,ALYREF;LSM2;LSM3;SNRPD1;SNRPE;HNRNPA3;SRSF3;YBX1;SRSF2;HNRNPD;LSM8;HNRNPA2B1;U2AF1;DDX39B;SNRPB;SNU13;SF3B2;HNRNPU;PCBP1;HNRNPF;EIF4A3;SNRPF;RNPS1;SRSF7;SNRPD3;NONO;RBMX2;RBM8A;PPIL1;MAGOH;PPIH;SNRNP70;SRRT;SNRNP40;SNRPA1;POLR2C;FUS;SRSF9;MAGOHB;PHF5A;SRRM1;SRSF10;GEMIN6;POLR2F;RBM17;DHX9;U2AF2;SF3A3;USP39;PRPF19;SNRNP25;HNRNPA1;EFTUD2;HNRNPR;HSPA8;SF3B4;RSRC1;WBP11;SRSF4;SMU1;POLR2L;SRRM2;HNRNPA0;SF3A2;SRSF1;PRPF31;CCAR1;SYNCRIP;LSM7;CPSF2;HNRNPK;U2SURP;HNRNPUL1;SART3;PRPF8;SFPQ;PRPF4;HNRNPH1;SF3A1;SF3B3;HNRNPC;NCBP1;POLR2B;DBR1;DDX46;PPWD1;PTBP1;MTREX;DDX42;HNRNPM;CPSF1;SRSF6;UPF3B;POLR2A;SNRNP200;PRPF40A;RBMX;CPSF4;SART1;PPIE;PRPF3;ZCCHC8;RBM10;CACTIN;POLR2E;GTF2F1;BUD13;CSTF2;DHX15;GTF2F2;CWC27;CHERP;SNRPA;PRPF38A;POLR2H;RBM15;SYMPK;RBM14;METTL14;CPSF3
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),-0.7689358305323288,-2.7980842226205156,0.0,0.0,0.0,39/63,13.57%,CDK1;TUBB4B;CENPF;TPX2;PLK1;HMMR;PLK4;TUBG1;CKAP5;HSP90AA1;AURKA;NEK2;HAUS4;TUBA1A;TUBA4A;KIF14;GTSE1;ATAD5;HAUS5;ODF2;YWHAE;CNTRL;PCNT;NDE1;NPM1;HAUS6;CEP57;HAUS1;NEDD1;CDK2;CCP110;CEP192;HAUS7;CENPJ;HAUS3;CEP72;CDK5RAP2;CEP70;HAUS8
gsea,regulation of cell division (GO:0051302),-0.7882785102438319,-2.7873962799039704,0.0,0.0,0.0,11/38,4.43%,AURKB;PRC1;PLK1;PLK4;CALM2;ORC6;KIF20A;AURKA;KIF18B;BLM;PIN1
gsea,double-strand break repair via homologous recombination (GO:0000724),-0.7694928976825743,-2.7852161901513925,0.0,0.0,0.0,44/70,14.61%,RAD51;NUCKS1;RAD21;FEN1;RPA3;RAD51AP1;CDC45;AUNIP;MCM5;BRCA1;MCM7;GINS2;GEN1;RPA2;BLM;MCM3;SMC6;RPA1;MCM4;RAD54L;RAD50;BRCA2;GINS4;RFWD3;RAD54B;RBBP8;MCM8;MCM6;MMS22L;NSMCE1;POLQ;FANCM;CDC7;SMC5;UBE2N;PARP1;XRCC1;SFPQ;PSMD14;MCM2;PALB2;FANCB;SPIDR;RECQL4
gsea,regulation of cell cycle phase transition (GO:1901987),-0.8037636040370066,-2.7805354715774357,0.0,0.0,0.0,42/59,15.36%,CDK1;UBE2S;UBE2C;FBXO5;MAD2L1;PLK1;BUB3;CCNB1;BUB1B;CDC20;FZR1;ANAPC5;GTSE1;DBF4;PSMB6;CDKN1A;PSMB2;PSMB5;PSMA3;ANAPC15;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;TAF1;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;CDC23;PSMD11;PSME3;CDC27;PSMD6;PSMC1;PSMC5;PSMD3;DDB1;PSMC6
gsea,ciliary basal body-plasma membrane docking (GO:0097711),-0.7238127461351032,-2.778729065367882,0.0,0.0,0.0,45/67,22.12%,CDK1;TUBB4B;PLK1;PLK4;TUBG1;CKAP5;HSP90AA1;NEK2;HAUS4;TUBA1A;TUBA4A;HAUS5;ODF2;YWHAE;CNTRL;PCNT;NDE1;HAUS6;CEP83;CEP57;HAUS1;NEDD1;CCP110;CEP192;HAUS7;SCLT1;KIF24;CENPJ;HAUS3;CEP72;CEP89;CDK5RAP2;CEP70;HAUS8;CEP135;DCTN1;ACTR1A;CEP76;CEP152;PCM1;CLASP1;ALMS1;CEP78;OFD1;C2CD3
gsea,mitotic cytokinesis (GO:0000281),-0.8842639325784943,-2.7782612770960755,0.0,0.0,0.0,14/29,3.74%,STMN1;NUSAP1;INCENP;RACGAP1;PLK1;KIF23;CEP55;CIT;KIF20A;CENPA;ECT2;ANLN;ESPL1;CKAP2
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),-0.6871975332817033,-2.774371881858462,0.0,0.0,0.0,64/99,23.87%,CDK1;AURKB;TPX2;RFC4;RBBP7;RFC5;RPA3;RBBP4;AURKA;BRIP1;SSRP1;BRCA1;RFC2;BARD1;RPA2;BLM;PIN1;TOPBP1;RPA1;RAD50;EXO1;RMI2;RFC3;RBBP8;HDAC1;KMT5A;RHNO1;CDK2;MBD3;TAF15;TAF1;TAF6;AKT1;CHEK1;CCNG1;HDAC2;NOC2L;RPS15;CHEK2;SMYD2;DNA2;RAD9A;ATR;TAF5;BRD7;TOP3A;PRMT5;EHMT2;CSNK2A2;TBP;MDM2;RPF2;RAD1;TAF9;TAF3;NBN;ING5;BOP1;PDPK1;MTOR;PRR5;MTA2;BRPF1;RAD17
gsea,protein polyubiquitination (GO:0000209),-0.6093402414976247,-2.77336256257236,0.0,0.0,0.0,52/139,17.40%,UBE2S;UBE2C;CCNF;FZR1;ANAPC5;UBB;BRCA1;UBE2T;BARD1;PSMB6;STUB1;DTL;PSMB2;DCAF15;PSMB5;PSMA3;RNF126;PSMC4;PRPF19;RNF5;PSMA6;PSMD2;PSMB7;PSMA4;TAF1;RNF168;CDC34;PSMD12;PSMC2;UBE2N;PSMD1;PSMA5;PSMD7;PSMD14;ZFP91;CDC23;PSMD11;NEDD4;SKP2;PSME3;CDC27;PSMD6;PSMC1;THOP1;PSMC5;UBE2E3;TRAF2;PSMD3;PSMC6;CDC16;FBXL14;ANAPC1
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.7517122346577407,-2.7659052166542133,0.0,0.0,0.0,19/45,7.93%,CCNA2;PLK1;CCNB1;CCNB2;CCNF;PKMYT1;CDKN3;CDC6;BLM;CCNE1;CDKN2C;CDKN1A;CDC25C;IPO5;CDC25A;CDKN2D;ACTB;CDKN2A;CCNE2
gsea,recombinational repair (GO:0000725),-0.7396941087978921,-2.756716688309475,0.0,0.0,0.0,33/56,16.90%,RAD51;NUCKS1;FEN1;RPA3;RAD51AP1;AUNIP;BRCA1;GEN1;RPA2;BLM;SMC6;RPA1;RAD50;BRCA2;RFWD3;RAD54B;RBBP8;MCM8;MMS22L;NSMCE1;RHNO1;POLQ;SMC5;UBE2N;PARP1;XRCC1;SFPQ;PSMD14;PALB2;SPIDR;RECQL4;TONSL;XRCC2
gsea,mitotic nuclear division (GO:0140014),-0.8129863366771781,-2.748155540084603,0.0,0.0,0.0,33/54,10.36%,NUSAP1;KIF11;CDCA8;UBE2S;UBE2C;TPX2;SMC4;RAN;PLK1;NDC80;KIFC1;SMC1A;TUBG1;NCAPG2;KIF18B;SPAG5;SGO1;ESPL1;KNSTRN;SMC3;AAAS;KIF18A;NUP62;CENPK;DSN1;NDE1;MIS12;KPNB1;NSL1;ZWINT;ZW10;STAG1;CEP192
gsea,positive regulation of cellular protein localization (GO:1903829),-0.7338172859746642,-2.747775694020016,0.0,0.0,0.0,12/39,11.06%,CDK1;PLK1;NDC80;GTSE1;NUP62;HSP90AB1;TFRC;CDT1;PARK7;CENPQ;NUMA1;AKT1
gsea,cellular macromolecule biosynthetic process (GO:0034645),-0.7109793205562626,-2.738148406879122,0.0,0.0,0.0,103/183,16.88%,PCLAF;CDK1;PTMA;TYMS;DUT;CLSPN;NAP1L1;FEN1;SET;RFC4;RFC5;RPA3;ORC6;CDC45;TIPIN;MRPL18;MCM5;BRIP1;BRCA1;MCM7;POLA1;DBF4;RFC2;TICRR;BARD1;RPA2;CDC6;RNPS1;BLM;MCM3;MRPL51;TOPBP1;MCM10;MRPL42;RPA1;POLE;MCM4;FAM111A;MRPL28;RAD50;POLD2;EXO1;GSPT1;RMI2;RFC3;RBBP8;MCM8;POLE3;POLD1;POLR2C;MLF1;MCM6;POLR2F;RPS17;RNASEH2A;RHNO1;POLA2;MRPL13;POLD3;CDK2;RPS2;EIF4G1;POLR2L;CDC7;ORC1;MRPS12;PIF1;E2F1;MRPL55;EEF1D;TSFM;MRPL35;RPL14;TIMELESS;POLE2;MCM2;ORC2;ABCF1;CHEK1;PPP5C;POLR2B;COPS5;EIF4G2;SRBD1;RPS15;FARSB;MRPS5;MRPS7;DNA2;DRG1;POLR2A;RECQL4;EEF1G;RPS25;EEFSEC;RAD9A;ATR;MRPS18A;MRPL37;TUFM;RPL23A;HELB;POLR2E
gsea,DNA synthesis involved in DNA repair (GO:0000731),-0.826370444516756,-2.7275579867271933,0.0,0.0,0.0,19/35,8.88%,PCLAF;RFC4;RFC5;RPA3;PCNA;UBB;POLA1;RFC2;RPA2;RPA1;POLE;DTL;POLD2;RFC3;POLD1;RFC1;CDKN2D;POLD3;POLH
gsea,DNA-dependent DNA replication (GO:0006261),-0.7800260387760778,-2.722622759104343,0.0,0.0,0.0,75/96,17.17%,RAD51;GMNN;RFC4;RFC5;RPA3;ORC6;CDC45;MCM5;UBB;PRIM1;MCM7;POLA1;DBF4;GINS2;RFC2;RPA2;PRIM2;CDC6;BLM;GINS3;PSMB6;MCM3;TOPBP1;MCM10;RPA1;POLE;MCM4;POLD2;GINS4;RFC3;PSMB2;MCM8;POLE3;POLD1;PSMB5;RFC1;MCM6;PSMA3;CDT1;PSMC4;POLA2;POLD3;PSMA6;PSMD2;CDK2;PSMB7;WDHD1;PSMA4;GINS1;CDC7;CDC34;ORC1;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;POLE2;MCM2;ORC2;PSMD11;CDK2AP1;PSME3;PSMD6;PSMC1;DNA2;PSMC5;RECQL4;PSMD3;PSMC6;MCMBP;HELB;WRNIP1;MGME1
gsea,G1/S transition of mitotic cell cycle (GO:0000082),-0.7584445861903055,-2.722376678875361,0.0,0.0,0.0,30/60,10.94%,RRM2;FBXO5;TYMS;CDC45;NASP;PCNA;CDK4;POLA1;DBF4;DHFR;CDKN3;CDC6;TFDP1;RCC1;CCNE1;CDKN2C;POLE;CDKN1A;GSPT1;CDC25A;CDKN2D;CDT1;CDKN2A;CCNE2;CDK2;CDC7;CDC34;ORC1;E2F1;EIF4E
gsea,chromosome organization (GO:0051276),-0.707264255086109,-2.717910635325587,0.0,0.0,0.0,40/70,22.14%,TOP2A;HMGB2;CDCA8;HMGN2;NDC80;NUCKS1;NUF2;EZH2;CENPW;UBB;CENPH;SUV39H1;NUP133;RFWD3;HDAC1;POLE3;CENPT;CDT1;NUP155;COPS3;SMARCA4;PARP1;COPS4;COPS5;HDAC2;MTF2;GPS1;SAFB;DDB1;HMGN1;CENPV;LRWD1;PHF19;RAE1;PWWP3A;RAD23B;DOT1L;COPS7A;CUL4B;MSH2
gsea,peptidyl-lysine modification (GO:0018205),-0.6754976789401789,-2.714594441177753,0.0,0.0,0.0,32/65,21.92%,SUMO2;RANGAP1;NDUFAB1;SAE1;NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;UBA2;NUP133;TRIM28;NUP43;NUP93;NUP205;NUP160;NUP35;PARK7;NUP88;NUP155;POM121;NUP54;SEH1L;RANBP2;SUMO3;NUP214;ATPSCKMT;RAE1;PIAS4;NUP210;NUP188
gsea,positive regulation of binding (GO:0051099),-0.7057453870818322,-2.714118714267767,0.0,0.0,0.0,10/49,9.44%,HMGB2;STMN1;HMGB1;RAN;GMNN;PIN1;NME1;DHX9;CDT1;TAF1
gsea,protein modification by small protein conjugation (GO:0032446),-0.5859189620286774,-2.7136847342936528,0.0,0.0,0.0,76/180,26.23%,UBE2S;UBE2C;PLK1;SUMO2;CCNF;UHRF1;PCNA;UBB;RANGAP1;BRCA1;SAE1;UBE2T;BARD1;NDC1;TRAIP;AAAS;NUP107;RAD18;NUP37;NUP62;NUP85;UBE2M;STUB1;UBA2;NUP133;RFWD3;ELOC;TRIM28;UCHL3;DCAF15;NUP43;NUP93;NUP205;NUP160;NUP35;NUP88;RNF168;CDC34;NUP155;UBE2N;CDC23;NEDD4;CDC27;POM121;NUP54;USP5;UBE2E3;NAE1;DDB1;SEH1L;RANBP2;SUMO3;CDC16;NUP214;FBXO45;LEO1;RAE1;PIAS4;BSPRY;MDM2;NUP210;TMEM129;UBA3;KCTD13;CUL4B;NUP188;RNF8;HLTF;ANAPC7;BIRC6;NUP153;UBE2V2;UBA1;TNFAIP1;NFX1;CUL3
gsea,RNA processing (GO:0006396),-0.7125084067878646,-2.7096643448266815,0.0,0.0,0.0,57/108,13.35%,LSM3;SNRPD1;SRSF2;HNRNPD;HNRNPA2B1;U2AF1;DDX39B;SNRPB;SF3B2;HNRNPU;HNRNPF;SNRPF;RNPS1;SRSF7;SNRPD3;NONO;RBM8A;MAGOH;SNRNP40;SNRPA1;FUS;SRSF9;TCERG1;MAGOHB;SRRM1;U2AF2;PPIG;SF3A3;USP39;SNRNP25;HNRNPR;SCAF11;SF3B4;RSRC1;DDX20;SRSF4;SMU1;HNRNPA0;SF3A2;SRSF1;SYNCRIP;HNRNPK;HNRNPUL1;TARDBP;KHSRP;PRPF8;SFPQ;PRPF4;GEMIN2;HNRNPH1;SF3A1;SF3B3;CPSF6;HNRNPC;NCBP1;PTBP1;SRPK1
gsea,protein deubiquitination (GO:0016579),-0.5954835543377224,-2.698286474216419,0.0,0.0,0.0,57/144,21.22%,CCNA2;CDK1;CLSPN;CDC20;USP1;UBB;BRCA1;UCHL5;BARD1;PSMB6;SHMT2;PSMB2;UCHL3;PSMB5;USP14;CDC25A;PSMA3;ACTB;ACTL6A;RAD23A;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;CCP110;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;RUVBL1;SKP2;PSME3;COPS5;PSMD6;PSMC1;BRCC3;USP5;PSMC5;ASXL1;TRAF2;PSMD3;PSMC6;INO80E;HCFC1;WDR48;ABRAXAS1;USP15;MCRS1;RAD23B;ADRM1;MDM2;USP37;PSME2
gsea,protein-DNA complex assembly (GO:0065004),-0.7543712292216473,-2.69825799747329,0.0,0.0,0.0,53/82,15.36%,HMGB2;ANP32B;RAD51;GMNN;NAP1L1;RPA3;ORC6;MCM5;UBB;MCM7;RPA2;CDC6;PSMB6;MCM3;RPA1;MCM4;NPM1;CHAF1A;PSMB2;MCM8;PSMB5;MCM6;PSMA3;SMARCA5;CDT1;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;CHAF1B;ORC1;PSMD12;PSMC2;PARP1;PSMD1;PSMA5;SART3;PSMD7;PSMD14;MCM2;ORC2;PSMD11;BRD2;PSME3;NAP1L4;ATRX;PSMD6;PSMC1;PSMC5;PSMD3;DDB1;PSMC6
gsea,organelle assembly (GO:0070925),-0.5781560485319908,-2.69756742239068,0.0,0.0,0.0,66/166,26.83%,CENPF;CENPE;DLGAP5;PLK4;LSM3;CENPW;CENPA;NEK2;ANLN;HAUS4;RCC1;NUP62;G3BP1;HAUS5;PCNT;NPM1;MIS12;HAUS6;CENPT;E2F4;DYNLL2;CEP83;HAUS1;EIF2S1;TMEM107;TUBGCP2;HAUS7;SCLT1;KIF24;CORO1A;CENPJ;SAC3D1;HAUS3;CEP89;EXOC4;POC1B;HAUS8;CCDC61;WDR90;ATXN2L;CFAP298;MRPL22;UBAP2L;SQLE;ATP2A2;NSFL1C;TMEM237;HYLS1;SSX2IP;RBM14;FLII;PCM1;OFD1;HAUS2;TMEM138;EHD4;TUBGCP3;FLNA;UBQLN1;DYNC1H1;HDAC6;CEP290;CEP162;PRRC2C;IFT74;ACTR2
gsea,gene expression (GO:0010467),-0.6486602051440739,-2.6946747965543847,0.0,0.0,0.0,128/203,25.06%,PTMA;ALYREF;SRSF3;SRSF2;MRPL18;HNRNPD;SLBP;HNRNPA2B1;U2AF1;DDX39B;HNRNPU;NDC1;HNRNPF;AAAS;NUP107;EIF4A3;RNPS1;NUP37;SRSF7;NUP62;MRPL51;RBM8A;NUP85;MAGOH;MRPL42;STUB1;HSPD1;MRPL28;NUP133;SNRNP40;GSPT1;POLR2C;MLF1;SRSF9;MAGOHB;NUP43;SRRM1;NXT1;POLR2F;NUP93;RPS17;NUP205;U2AF2;NUP160;NUP35;MRPL13;GLE1;NUP88;RPS2;DDX20;EIF4G1;SRSF4;POLR2L;NUP155;MRPS12;LMF2;SRSF1;SYNCRIP;E2F1;MRPL55;CPSF2;HNRNPK;DNAJB11;MRPL35;EIF4E;RPL14;HNRNPUL1;SARNP;PRPF4;HNRNPH1;ABCF1;PPP5C;THOC3;NCBP1;POLR2B;COPS5;SRBD1;POM121;RPS15;FARSB;MRPS5;MRPS7;NUP54;CPSF1;SRSF6;DRG1;UPF3B;POLR2A;RPS25;CPSF4;SEH1L;RANBP2;DKC1;MRPS18A;MRPL37;RPL23A;NUP214;POLR2E;MRPL11;THOC2;THOC6;RPL31;POLR2H;RAE1;SYMPK;CPSF3;RRBP1;NUP210;NXF1;RPS6;RPL4;HNRNPH3;CASC3;SETX;NUP188;MRPS18B;CELF2;RBM6;DHPS;MRPL3;PABPC4;ALKBH5;MMS19;NUP153;NCBP2;TESC;MRPL44;THOC5
gsea,DNA replication (GO:0006260),-0.787268303914048,-2.6913989205644344,0.0,0.0,0.0,57/89,11.92%,PCLAF;CDK1;DUT;CLSPN;NAP1L1;FEN1;SET;RFC4;RFC5;RPA3;ORC6;CDC45;TIPIN;MCM5;BRIP1;BRCA1;MCM7;POLA1;DBF4;RFC2;TICRR;BARD1;RPA2;CDC6;BLM;MCM3;TOPBP1;MCM10;RPA1;POLE;MCM4;FAM111A;RAD50;POLD2;EXO1;RMI2;RFC3;RBBP8;MCM8;POLE3;POLD1;RFC1;MCM6;RNASEH2A;RHNO1;POLA2;CDK2;WDHD1;CDC7;ORC1;PIF1;TIMELESS;POLE2;MCM2;ORC2;CDK2AP1;CHEK1
gsea,response to UV (GO:0009411),-0.6728367895233279,-2.690258182379565,0.0,0.0,0.0,22/65,15.47%,PCLAF;AURKB;FEN1;USP1;PCNA;DTL;NPM1;POLD1;CDC25A;CDKN2D;RUVBL2;RHNO1;EIF2S1;POLH;TAF1;PARP1;AKT1;ZRANB3;NEDD4;NOC2L;FMR1;ATR
gsea,positive regulation of cell population proliferation (GO:0008284),-0.545870943467358,-2.6798168072410617,0.0,0.0,0.0,57/205,23.53%,BIRC5;PRC1;FBXO5;EZH2;NAP1L1;KIF20B;TIPIN;CDC25B;SAPCD2;CDK4;KIF14;TTK;FOXM1;MIF;SLC25A5;HNRNPU;PRMT1;NME1;CDKN1A;NPM1;HDAC1;CDC123;NME2;DHX9;FXN;CDK2;CDC7;HMGN5;DERL2;ID2;CCAR1;MAZ;E2F1;AKT1;SAAL1;ASH2L;SINHCAF;FAM98B;HRAS;HDAC2;CNBP;PHB;PTPN6;RPRD1B;CALR;PHIP;DNAJA2;SHC1;DOT1L;MDM2;RPS6;CDCA7L;TBRG4;COX17;CIAO1;DHPS;PRDX3
gsea,regulation of mRNA stability (GO:0043488),-0.6718814926484015,-2.6785937637784287,0.0,0.0,0.0,58/94,21.67%,SET;EXOSC8;YBX1;HNRNPD;UBB;HNRNPU;PSMB6;THRAP3;NPM1;SERBP1;PSMB2;FUS;PSMB5;PSMA3;EXOSC3;PSMC4;XPO1;PSMA6;PSMD2;HSPA8;PSMB7;TAF15;PSMA4;EIF4G1;EXOSC7;PSMD12;PSMC2;E2F1;PSMD1;PSMA5;KHSRP;AKT1;PSMD7;PSMD14;PSMD11;EXOSC9;PSME3;PSMD6;DIS3;PSMC1;EXOSC4;FMR1;PSMC5;PSMD3;PSMC6;VIM;EXOSC1;EXOSC5;EXOSC2;APEX1;NUP214;ROCK2;TNPO1;METTL14;ROCK1;METTL16;PSME2;TBRG4
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.8016661465712761,-2.675523248450361,0.0,0.0,0.0,42/54,15.36%,CDK1;AURKB;UBE2S;UBE2C;FBXO5;MAD2L1;PLK1;BUB3;CCNB1;BUB1B;CDC20;AURKA;FZR1;ANAPC5;UBB;PSMB6;PSMB2;PSMB5;PSMA3;ANAPC15;PSMC4;PSMA6;PSMD2;CDK2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;CDC23;PSMD11;SKP2;PSME3;CDC27;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,regulation of intracellular signal transduction (GO:1902531),-0.5395286450160408,-2.6736300760196317,0.0,0.0,0.0,85/234,25.44%,CDK1;AURKB;TPX2;RACGAP1;RFC4;RBBP7;RFC5;RPA3;RBBP4;FAM83D;ECT2;AURKA;BRIP1;ARHGAP11A;SSRP1;BRCA1;RFC2;BARD1;DEPDC1B;RPA2;ARHGAP19;BLM;PIN1;TOPBP1;RPA1;RAD50;EXO1;RMI2;RFC3;RBBP8;HDAC1;ARHGDIA;KMT5A;RHNO1;CDK2;MBD3;TAF15;TAF1;TAF6;AKT1;EZR;CHEK1;CCNG1;HDAC2;NOC2L;CHEK2;SMYD2;DNA2;TRAF2;RAD9A;ATR;TAF5;PIDD1;BRD7;TOP3A;PRMT5;EHMT2;CPNE1;OPTN;CSNK2A2;SRGAP2;TBP;MDM2;RPF2;ARHGAP10;RAD1;TAF9;TAF3;NBN;ING5;BOP1;PDPK1;MTOR;PRR5;MTA2;NET1;INPP5B;BRPF1;TTI1;RAD17;RHOT2;HUS1;ENTPD5;BIRC3;MDM4
gsea,postreplication repair (GO:0006301),-0.8165160841140556,-2.673063064641307,0.0,0.0,0.0,20/35,10.30%,PCLAF;RFC4;RFC5;RPA3;PCNA;UBB;BRCA1;RFC2;RPA2;RAD18;RPA1;DTL;POLD2;RFC3;POLD1;RFC1;NSMCE1;POLD3;POLH;UBE2N
gsea,positive regulation of transferase activity (GO:0051347),-0.6857180537776794,-2.669170535585617,0.0,0.0,0.0,22/68,10.30%,AURKB;PLK1;RFC4;RFC5;HSP90AA1;PTGES3;HNRNPD;NEK2;PCNA;HNRNPA2B1;RFC2;TCP1;PIN1;DBI;CHTF18;RAD50;RFC3;HSP90AB1;DSCC1;RPS2;CCT2;UBE2N
gsea,protein modification by small protein removal (GO:0070646),-0.5867306790284107,-2.665426172532749,0.0,0.0,0.0,64/152,23.05%,CCNA2;CDK1;CLSPN;CDC20;USP1;UBB;BRCA1;UCHL5;BARD1;PSMB6;PSMB2;UCHL3;PSMB5;USP14;CDC25A;PSMA3;ACTB;ACTL6A;RAD23A;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;CCP110;COPS3;PSMC2;PSMD1;PSMA5;COPS4;PSMD7;PSMD14;PSMD11;RUVBL1;SKP2;PSME3;COPS5;PSMD6;PSMC1;GPS1;BRCC3;USP5;PSMC5;ASXL1;TRAF2;PSMD3;PSMC6;INO80E;HCFC1;WDR48;ABRAXAS1;USP15;MCRS1;RAD23B;ADRM1;MDM2;USP37;COPS7A;PSME2;DESI1;TOMM20;USP34;USP10
gsea,mRNA export from nucleus (GO:0006406),-0.7293760741618611,-2.6588485870293326,0.0,0.0,0.0,59/77,21.92%,ALYREF;SRSF3;SRSF2;SLBP;HNRNPA2B1;U2AF1;DDX39B;NDC1;AAAS;NUP107;EIF4A3;RNPS1;NUP37;SRSF7;NUP62;RBM8A;NUP85;MAGOH;NUP133;SRSF9;MAGOHB;NUP43;SRRM1;NXT1;NUP93;NUP205;U2AF2;NUP160;NUP35;GLE1;NUP88;SRSF4;NUP155;SRSF1;CPSF2;IWS1;EIF4E;SARNP;THOC3;NCBP1;POM121;NUP54;CPSF1;SRSF6;UPF3B;CPSF4;SEH1L;RANBP2;NUP214;DDX19A;THOC2;THOC6;RAE1;SYMPK;CPSF3;NUP210;NXF1;CASC3;NUP188
gsea,regulation of mitotic nuclear division (GO:0007088),-0.8057471205409592,-2.655266111100218,0.0,0.0,0.0,14/31,7.44%,MKI67;NUSAP1;FBXO5;CCNB1;KIF20B;AURKA;NEK2;PKMYT1;RCC1;PIN1;NUP62;CDC25C;BORA;ANAPC15
gsea,regulation of primary metabolic process (GO:0080090),-0.682436498014104,-2.6548124138631355,0.0,0.0,0.0,41/71,19.15%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;NFYB;PSMD12;ID2;PSMC2;PSMD1;PSMA5;FDFT1;PSMD7;PSMD14;SP1;PSMD11;PSME3;PSMD6;FDPS;PSMC1;PSMC5;HMGCS1;PSMD3;PSMC6;SIN3A;AZIN1;NCOR2;HMGCR;OPA3;ROCK2;SQLE;NFYC;IDI1;ODC1;SC5D;SREBF2;NFYA
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.7333422453190003,-2.6448458308869154,0.0,0.0,0.0,57/74,21.92%,ALYREF;SRSF3;SRSF2;SLBP;HNRNPA2B1;U2AF1;DDX39B;NDC1;AAAS;NUP107;EIF4A3;RNPS1;NUP37;SRSF7;NUP62;RBM8A;NUP85;MAGOH;NUP133;SRSF9;MAGOHB;NUP43;SRRM1;NXT1;NUP93;NUP205;U2AF2;NUP160;NUP35;GLE1;NUP88;SRSF4;NUP155;SRSF1;CPSF2;EIF4E;SARNP;THOC3;NCBP1;POM121;NUP54;CPSF1;SRSF6;UPF3B;CPSF4;SEH1L;RANBP2;NUP214;THOC2;THOC6;RAE1;SYMPK;CPSF3;NUP210;NXF1;CASC3;NUP188
gsea,mRNA transport (GO:0051028),-0.7137578943808093,-2.6425446613562986,0.0,0.0,0.0,58/79,21.92%,ALYREF;SRSF3;SRSF2;SLBP;HNRNPA2B1;U2AF1;DDX39B;NDC1;AAAS;NUP107;EIF4A3;RNPS1;NUP37;SRSF7;NUP62;RBM8A;NUP85;MAGOH;NUP133;SRSF9;MAGOHB;NUP43;SRRM1;NXT1;NUP93;NUP205;U2AF2;NUP160;NUP35;GLE1;NUP88;SRSF4;NUP155;SRSF1;CPSF2;EIF4E;SARNP;THOC3;NCBP1;POM121;NUP54;FMR1;CPSF1;SRSF6;UPF3B;CPSF4;SEH1L;RANBP2;NUP214;THOC2;THOC6;RAE1;SYMPK;CPSF3;NUP210;NXF1;CASC3;NUP188
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.6804896585960284,-2.642273844917938,0.0,0.0,0.0,23/54,17.54%,CDK1;CCNB1;AURKA;E2F8;PCNA;RPS27L;E2F7;GTSE1;FOXM1;TFDP1;PRMT1;CDKN1A;CDC25C;E2F4;BAX;E2F1;PAXIP1;ATRX;CHEK2;CNOT9;CNOT10;TFDP2;PIDD1
gsea,regulation of establishment of planar polarity (GO:0090175),-0.7555503220207304,-2.641965877876417,0.0,0.0,0.0,24/42,15.36%,SAPCD2;PSMB6;PFN1;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.7173367700437977,-2.6366444251809154,0.0,0.0,0.0,23/46,17.54%,CDK1;CCNB1;AURKA;E2F8;PCNA;RPS27L;E2F7;GTSE1;RPA2;TFDP1;PRMT1;CDKN1A;CDC25C;RFWD3;E2F4;BAX;CDK2;E2F1;CHEK2;CNOT9;CNOT10;TFDP2;PIDD1
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.8005709385685847,-2.6347274623927537,0.0,0.0,0.0,17/31,7.93%,CCNA2;CCNB1;CCNB2;CCNF;PKMYT1;CDKN3;CDC6;BLM;CCNE1;CDKN2C;CDKN1A;CDC25C;HSP90AB1;CDC25A;CDKN2D;ACTB;CCNE2
gsea,positive regulation of protein kinase activity (GO:0045860),-0.6185581432798262,-2.6328186931404156,0.0,0.0,0.0,15/74,11.89%,TPX2;INCENP;CENPE;CLSPN;CALM2;EZH2;ECT2;HSP90AA1;KIF14;CDKN1A;HSP90AB1;PIH1D1;BORA;ETAA1;MAP2K3
gsea,positive regulation of cellular process (GO:0048522),-0.5265916442124415,-2.632382309442262,0.0,0.0,0.0,94/277,28.94%,BIRC5;PRC1;FBXO5;EZH2;NAP1L1;KIF20B;PA2G4;TIPIN;CDC25B;SAPCD2;CDK4;SPAG5;KIF14;TTK;FOXM1;NSMCE4A;SLC25A5;RAD18;CDC6;ACTN4;SMC6;PRMT1;LYAR;ANKLE1;NPM1;HDAC1;HSP90AB1;CDC123;HDGFL2;C1QBP;FXN;NSMCE1;RAD23A;FAF1;CDK2;EIF4G1;CDC7;HMGN5;DERL2;NUMA1;P4HB;SMC5;CCAR1;MAZ;LMAN2;AKT1;CHEK1;EXOSC9;ASH2L;NCBP1;SINHCAF;EIF4G2;FAM98B;HRAS;HDAC2;BCLAF1;CNBP;PHB;EXOSC4;FMR1;PTPN6;RPRD1B;CALR;HCFC1;PHIP;EXOSC2;DNAJA2;SHC1;MT3;DOT1L;MDM2;RPS6;CDCA7L;TBRG4;COX17;CIAO1;DHPS;PRDX3;IFNG;TPM1;RAB27A;DYNC1H1;HSF1;CUL3;TCIRG1;TSPAN31;FXR2;DOCK2;CSPP1;ADAM17;ACACA;DDX49;ACLY;LMNA
gsea,cell cycle G1/S phase transition (GO:0044843),-0.7306457831825105,-2.6292488973300743,0.0,0.0,0.0,20/44,10.94%,CCNA2;NASP;CDK4;DBF4;CDKN3;RCC1;CCNE1;CDKN2C;POLE;CDKN1A;GSPT1;CDC25A;CDKN2D;CDKN2A;CCNE2;CDK2;CDC7;CDC34;E2F1;EIF4E
gsea,regulation of mRNA catabolic process (GO:0061013),-0.6831772661714466,-2.6271716591114647,0.0,0.0,0.0,44/75,16.75%,SET;EXOSC8;HNRNPD;UBB;PSMB6;SERBP1;PSMB2;PSMB5;PSMA3;EXOSC3;PSMC4;XPO1;PSMA6;PSMD2;HSPA8;PSMB7;PSMA4;EIF4G1;EXOSC7;PSMD12;PSMC2;PSMD1;PSMA5;KHSRP;AKT1;PSMD7;PSMD14;PSMD11;EXOSC9;PSME3;PSMD6;DIS3;PSMC1;EXOSC4;FMR1;PSMC5;PSMD3;PSMC6;VIM;EXOSC1;EXOSC5;EXOSC2;APEX1;NUP214
gsea,mitotic metaphase plate congression (GO:0007080),-0.8467611243177428,-2.624466843378238,0.0,0.0,0.0,20/30,9.43%,CDCA8;CENPE;KIF22;CCNB1;CDCA5;NDC80;KIFC1;NUF2;CEP55;KIF2C;NUDC;KIF14;SPDL1;KIF18A;NUP62;MIS12;MAD1L1;KPNB1;CDT1;ZW10
gsea,RNA export from nucleus (GO:0006405),-0.7322417439197261,-2.621079006636032,0.0,0.0,0.0,59/77,21.92%,ALYREF;RAN;SRSF3;SRSF2;SLBP;HNRNPA2B1;U2AF1;DDX39B;NDC1;AAAS;NUP107;EIF4A3;RNPS1;NUP37;SRSF7;NUP62;RBM8A;NUP85;MAGOH;NUP133;SRSF9;MAGOHB;NUP43;SRRM1;NXT1;NUP93;NUP205;U2AF2;NUP160;NUP35;HNRNPA1;GLE1;NUP88;SRSF4;NUP155;SRSF1;CPSF2;EIF4E;SARNP;THOC3;NCBP1;POM121;NUP54;CPSF1;SRSF6;UPF3B;CPSF4;SEH1L;RANBP2;NUP214;THOC2;THOC6;RAE1;SYMPK;CPSF3;NUP210;NXF1;CASC3;NUP188
gsea,regulation of stem cell differentiation (GO:2000736),-0.7273813291867359,-2.620821332377067,0.0,0.0,0.0,25/48,17.01%,HNRNPU;PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;TCF3;PSMC6;NSUN2
gsea,regulation of apoptotic process (GO:0042981),-0.5023608599936276,-2.6170717956125378,0.0,0.0,0.0,107/379,24.78%,TOP2A;BIRC5;CDK1;PTMA;HMGB1;PPIA;MAD2L1;PLK1;ARL6IP1;ANP32B;ANP32E;MELK;ECT2;HSP90AA1;PA2G4;STIL;UBB;KIF14;FIGNL1;MIF;BARD1;RNPS1;ACTN4;NUP62;HSP90B1;NME1;HSPD1;NPM1;HDAC1;CFL1;NME2;ARHGDIA;TFRC;C1QBP;BAX;FXN;SERPINB9;FAF1;MTCH2;ASNS;PARK7;PHB2;PRELID1;DDX20;VDAC1;HIGD1A;HMGN5;CCAR1;E2F1;HNRNPK;CASP3;TARDBP;AKT1;HSPA9;SKP2;COPS5;HDAC2;PPIF;BCLAF1;PHB;AIFM1;APIP;DDX42;NAE1;TRAF2;MYDGF;PPID;PTPN6;CALR;RSL1D1;PHIP;APEX1;MTDH;RBM25;UTP11;HAX1;NAA16;PIDD1;RRP1B;HTRA2;THOC6;SHC1;API5;EEF1E1;MT3;PHLDA3;NAA15;FADD;ATAD3A;ARHGAP10;BAK1;BAG4;AVEN;NAA35;RPS6;TAF9;SETX;ING5;NET1;FLNA;PRDX3;PCID2;LRP8;BIRC6;SIGMAR1;SLK;RABGGTB
gsea,RNA splicing (GO:0008380),-0.7690278692747196,-2.6158680959078033,0.0,0.0,0.0,42/60,13.35%,SNRPD1;SRSF2;U2AF1;DDX39B;SNRPB;SF3B2;SNRPF;RNPS1;SRSF7;SNRPD3;NONO;RBM8A;MAGOH;SNRNP40;SNRPA1;FUS;TCERG1;MAGOHB;SRRM1;SRSF10;PPIG;SF3A3;USP39;SNRNP25;SCAF11;SF3B4;RSRC1;SRSF4;SMU1;SYNCRIP;TARDBP;KHSRP;PRPF8;SFPQ;PRPF4;GEMIN2;SF3B3;HNRNPC;NCBP1;DBR1;PTBP1;SRPK1
gsea,regulation of phosphorylation (GO:0042325),-0.649248135319171,-2.613588842536605,0.0,0.0,0.0,39/74,21.92%,PTGES3;MCM7;MIF;BARD1;NDC1;AAAS;NUP107;NUP37;PIN1;NUP62;NUP85;CDKN2C;CDKN1A;NUP133;NUP43;CDKN2D;NUP93;NUP205;NUP160;NUP35;CDKN2A;PGAM1;NUP88;NUP155;CORO1C;EIF6;POM121;NUP54;SEH1L;RANBP2;PRKRIP1;PHIP;NUP214;KCTD20;RAE1;ROCK1;GLMN;NUP210;NUP188
gsea,mRNA metabolic process (GO:0016071),-0.7409572547193322,-2.610972755409374,0.0,0.0,0.0,37/59,15.63%,LSM2;LSM3;SNRPE;SRSF2;SLBP;HNRNPA2B1;U2AF1;SNRPB;SF3B2;SNRPF;SRSF7;SNRPD3;NONO;SRSF9;TCERG1;U2AF2;SF3A3;SSB;USP39;HNRNPR;SCAF11;SF3B4;SRSF4;HNRNPA0;SF3A2;SRSF1;PRPF8;SFPQ;GEMIN2;SF3A1;CPSF6;NCBP1;PTBP1;LSM11;CNOT10;DXO;PRPF3
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.7184840845142275,-2.607579828407966,0.0,0.0,0.0,32/55,15.36%,FBXO5;AURKA;CDK4;E2F7;PSMB6;CDKN2C;CDKN1A;RBL1;PSMB2;PSMB5;PSMA3;CDKN2D;CDKN2A;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;WEE1;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,protein ubiquitination (GO:0016567),-0.5380647760280866,-2.60416843759068,0.0,0.0,0.0,88/216,29.55%,UBE2S;UBE2C;PLK1;CCNF;UHRF1;PCNA;UBB;BRCA1;UBE2T;BARD1;TRAIP;RAD18;PSMB6;STUB1;DTL;RFWD3;ELOC;PSMB2;UCHL3;DCAF15;PSMB5;PSMA3;RNF126;PSMC4;PRPF19;PSMA6;PSMD2;PSMB7;PSMA4;TAF1;RNF168;CDC34;PSMD12;PSMC2;UBE2N;PSMD1;PSMA5;PSMD7;PSMD14;CDC23;PSMD11;NEDD4;SKP2;PSME3;CDC27;PSMD6;PSMC1;THOP1;USP5;PSMC5;UBE2E3;TRAF2;PSMD3;DDB1;PSMC6;TRIM37;CDC16;FBXO45;FBXL14;LEO1;FANCL;BSPRY;MDM2;PSME2;TMEM129;KCTD13;CUL4B;BLMH;RNF8;HLTF;ANAPC7;BIRC6;UBE2V2;UBA1;TNFAIP1;RBBP6;NFX1;CUL3;DZIP3;USP7;IRF2BP1;DDB2;KEAP1;CUL1;ANKRD9;VCP;UBA6;HUWE1
gsea,histone exchange (GO:0043486),-0.8412435061909743,-2.603932001994273,0.0,0.0,0.0,23/32,7.49%,KNL1;ANP32E;CENPW;HJURP;MIS18BP1;RBBP7;RBBP4;CENPA;MIS18A;NASP;CENPM;CENPP;CENPH;OIP5;CENPN;CENPK;CENPI;NPM1;CENPS;CENPL;CENPU;CENPT;SMARCA5
gsea,regulation of cellular response to stress (GO:0080135),-0.6457374305214515,-2.5997591601635177,0.0,0.0,0.0,45/87,22.80%,RPA3;HSP90AA1;PTGES3;NDC1;AAAS;RPA2;NUP107;NUP37;NUP62;NUP85;FKBP4;RPA1;YWHAE;DNAJC2;MANF;NPM1;NUP133;NUP43;HSP90AB1;NUP93;NUP205;NUP160;NUP35;HIKESHI;HSPA8;NUP88;EIF4G1;NUP155;POM121;NUP54;SEH1L;RANBP2;ATR;RSL1D1;NUP214;DNAJB1;ROCK2;CEBPB;DNAJC7;RAE1;BAG4;NUP210;NUP188;HSPH1;MTOR
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.7423646353321928,-2.5906298438105493,0.0,0.0,0.0,23/42,15.36%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;TCF3;PSMC6
gsea,translesion synthesis (GO:0019985),-0.79678141441727,-2.5902003361599752,0.0,0.0,0.0,16/33,8.88%,PCLAF;RFC4;RFC5;RPA3;PCNA;UBB;RFC2;RPA2;RPA1;DTL;POLD2;RFC3;POLD1;RFC1;POLD3;POLH
gsea,histone modification (GO:0016570),-0.6518408894917554,-2.5866183524822555,0.0,0.0,0.0,28/68,20.24%,CCNA2;AURKB;INCENP;EZH2;UHRF1;PRMT1;BAZ1B;HDAC1;BRD8;RUVBL2;PARK7;PARP2;CDK2;NAA50;UBE2N;TAF6;RUVBL1;HDAC2;PHB;SGF29;MTA1;SIN3A;MORF4L2;EHMT2;MT3;RBM14;RPS6KA5;TAF6L
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.5140506323551752,-2.5856694471982955,0.0,0.0,0.0,94/277,27.85%,HMGB2;BIRC5;CENPF;TYMS;GMNN;EZH2;SET;YBX1;PA2G4;CBX5;BRCA1;FOXM1;DHFR;SUV39H1;NCL;CTCF;CBX3;EIF4A3;CDC6;NONO;DBI;CDKN1A;GAPDH;HDAC1;TRIM28;GZMB;ENO1;KMT5A;CDKN2A;SUV39H2;MRPL13;PHB2;HSPA8;SHMT1;ID2;SMARCA4;SYNCRIP;E2F1;SFPQ;SMARCC2;TIMELESS;PDS5A;EED;HDAC2;PASK;BCLAF1;PHB;FMR1;CAPRIN1;CNOT9;CNOT10;ATR;CALR;SIN3A;NAB1;NCOR2;ILF3;XRCC5;MYBBP1A;TFDP2;BRD7;SHC1;SAMD1;L3MBTL2;MT3;CBY1;RBM15;SETDB2;KAT7;PIAS4;RPS6KA5;POU2F1;MDM2;XRCC6;KDM8;RB1;RAD17;CNOT1;IFNG;PHF10;FOXK2;TLE5;ELK3;MYB;HDAC6;DMAP1;LARP1;SFMBT1;HMGA1;CCAR2;LANCL2;LBH;PSPC1;FXR2
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.5370035098673608,-2.5849819680584902,0.0,0.0,0.0,76/208,27.84%,CCNA2;FBXO5;ESCO2;GMNN;NUCKS1;EZH2;HINT1;YBX1;HNRNPD;MYBL2;NSD2;SMC3;NUP107;NONO;SRRT;BRCA2;FUS;MLF1;SRSF10;SAP30;NUP35;LIN54;DSCC1;TCOF1;NOLC1;NFYB;ZNHIT3;HMGN5;CCAR1;E2F1;EIF4E;SFPQ;SP1;ATRX;CNBP;MTF2;HP1BP3;PHB;CHEK2;POLR2A;TCF3;PPIE;MYBL1;CALR;HCFC1;TAF5;NAB1;MYBBP1A;NFYC;MYCBP;CEBPB;PRMT5;EHMT2;NFYA;PHF19;KAT7;RPS6KA5;TAF6L;USP37;ORC3;UTP4;RB1;PTP4A3;PUM3;OGG1;FOXK2;MYB;RBBP6;ATF4;NFX1;RUNX3;NFKB2;RABL3;HMGA1;CCAR2;PSPC1
gsea,negative regulation of cell cycle process (GO:0010948),-0.7861931274876356,-2.582196719716663,0.0,0.0,0.0,22/41,12.63%,AURKB;RRM2;FBXO5;RAD51;EZH2;RBBP7;RBBP4;NEK2;E2F8;SUZ12;CBX5;BRCA1;E2F7;ESPL1;CBX3;TFDP1;RBBP8;CDC7;CCP110;E2F1;CHEK1;EED
gsea,sister chromatid segregation (GO:0000819),-0.8890282530447843,-2.577420873363386,0.0,0.0,0.0,23/29,9.43%,TOP2A;NUSAP1;CDCA8;SMC4;RAN;PLK1;NDC80;KIFC1;SMC1A;TUBG1;NCAPG2;KIF18B;SPAG5;SGO1;ESPL1;KNSTRN;KIF18A;CENPK;DSN1;MIS12;NSL1;ZWINT;ZW10
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.61777625275742,-2.5740533712862526,0.0,0.0,0.0,25/72,16.55%,PSMB6;PSMB2;HDAC1;PSMB5;PSMA3;RUVBL2;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;FRMD8
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.7368609789221339,-2.5729551091678995,0.0,0.0,0.0,24/42,17.57%,PSMB6;PFN1;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;CLTC
gsea,negative regulation of programmed cell death (GO:0043069),-0.538064201645558,-2.571264053627755,0.0,0.0,0.0,58/188,21.86%,BIRC5;CDK1;PTMA;MAD2L1;PLK1;ARL6IP1;PA2G4;STIL;UBB;KIF14;FIGNL1;MIF;BARD1;NUP62;HSP90B1;HSPD1;NPM1;HDAC1;CFL1;NME2;ARHGDIA;TFRC;FXN;SERPINB9;ASNS;PARK7;PHB2;PRELID1;VDAC1;HIGD1A;HMGN5;HNRNPK;CASP3;AKT1;HSPA9;COPS5;HDAC2;PPIF;APIP;PSMC5;MYDGF;PHIP;MTDH;HAX1;NAA16;PIDD1;THOC6;SHC1;API5;MT3;NAA15;ATAD3A;ARHGAP10;BAG4;AVEN;NAA35;TAF9;SETX
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.7294390017779919,-2.5708430391463035,0.0,0.0,0.0,25/41,15.36%,UBB;PSMB6;ELOC;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;HIGD1A;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,post-translational protein modification (GO:0043687),-0.5511704002863463,-2.5701495827223297,0.0,0.0,0.0,52/168,22.29%,ESCO2;RBBP7;CCNF;LRR1;PSMB6;HSP90B1;UBE2M;DTL;ELOC;PSMB2;UCHL3;PSMB5;PSMA3;PSMC4;DSCC1;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;COPS3;P4HB;PSMC2;PSMD1;PSMA5;PDIA6;COPS4;PSMD7;PSMD14;DCAF7;PSMD11;SKP2;PSME3;COPS5;PSMD6;PSMC1;GPS1;WDR5;PSMC5;NAE1;PSMD3;DDB1;PSMC6;FBXL14;STT3B;PRKCSH;STT3A;COPS7A;PSME2;UBA3;CUL4B;DCAF13
gsea,centromere complex assembly (GO:0034508),-0.8716785202873655,-2.568785114311566,0.0,0.0,0.0,27/32,7.49%,CENPF;KNL1;CENPE;DLGAP5;CENPW;HJURP;MIS18BP1;RBBP7;RBBP4;CENPA;MIS18A;NASP;CENPM;CENPP;CENPH;OIP5;HELLS;CENPN;CENPK;CENPI;NPM1;MIS12;CENPS;CENPL;CENPU;CENPT;SMARCA5
gsea,non-canonical Wnt signaling pathway (GO:0035567),-0.6665799080360492,-2.5665340522158395,0.0,0.0,0.0,25/59,17.57%,PSMB6;PFN1;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;PPP3CB;CLTC
gsea,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.7602344558037616,-2.5652990685619526,0.0,0.0,0.0,23/40,14.09%,CDK1;UBE2C;FBXO5;CCNB1;CDCA5;DLGAP5;CDC25B;CDK4;ANAPC5;ESPL1;TFDP1;DTL;CDC25C;CDC25A;RCC2;PHB2;EIF4G1;CDC7;AKT1;CDC23;CDC27;RDX;LSM11
gsea,spindle assembly (GO:0051225),-0.7195972314275729,-2.564571500495802,0.0,0.0,0.0,35/46,24.50%,KIF11;TPX2;KIFC1;SMC1A;NEK2;HAUS4;SMC3;AAAS;RCC1;HAUS5;HAUS6;KPNB1;HAUS1;TUBGCP2;STAG1;NUMA1;CEP192;HAUS7;SAC3D1;HAUS3;STAG2;CHEK2;HAUS8;CCDC61;ABRAXAS1;CLASP2;WRAP73;CLASP1;OFD1;KIF2A;HAUS2;TUBGCP3;FLNA;MAP9;BCCIP
gsea,protein import (GO:0017038),-0.6904118154477117,-2.5630605693056565,0.0,0.0,0.0,26/52,18.49%,RAN;HSP90AA1;NUTF2;NUP107;NUP62;NUP85;CSE1L;NUP133;IPO5;NXT1;KPNB1;NUP93;HIKESHI;PHB2;NUP88;NUP155;AKT1;HSPA4;POM121;IPO9;SAMM50;NUP214;IPO7;E2F3;IPO11;TNPO1
gsea,nucleic acid metabolic process (GO:0090304),-0.7618842852641573,-2.5627355389664346,0.0,0.0,0.0,37/49,19.90%,KPNA2;RAN;FEN1;HNRNPA3;HNRNPD;LSM8;HNRNPA2B1;HNRNPU;PCBP1;HNRNPF;TOPBP1;RAD50;ANKLE1;POLR2C;POLR2F;HNRNPA1;HNRNPR;POLR2L;HNRNPA0;DDX1;HNRNPK;HNRNPH1;HNRNPC;NCBP1;POLR2B;PTBP1;DNA2;HNRNPM;POLR2A;RBMX;DXO;POLR2E;GTF2F1;GTF2F2;WDR74;POLR2H;METTL14
gsea,cellular protein-containing complex assembly (GO:0034622),-0.63493105852764,-2.556397348836488,0.0,0.0,0.0,31/79,15.19%,CENPF;CENPE;DLGAP5;CENPW;CENPA;HSP90AA1;PTGES3;ANLN;NDC1;TCP1;NUP107;HSPD1;MIS12;PFDN6;HSP90AB1;CENPT;DNAAF2;NUP93;DHX9;NUP205;CLTB;HIGD1A;PSMG2;CCT2;EIF4H;PSMD11;HSPA4;LONP1;AIFM1;TRAF2;SAMM50
gsea,nucleotide-excision repair (GO:0006289),-0.6706822416002708,-2.5452102124426377,0.0,0.0,0.0,36/72,17.95%,RFC4;RFC5;RPA3;LIG1;PCNA;BRIP1;UBB;POLA1;RFC2;RPA2;RPA1;POLE;BRCA2;POLD2;RFC3;POLD1;POLR2C;RFC1;POLR2F;RAD23A;PRPF19;POLD3;POLR2L;COPS3;PARP1;XRCC1;COPS4;POLR2B;COPS5;GPS1;POLR2A;DDB1;PPIE;POLR2E;HMGN1;CHD1L
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.7200405204398621,-2.54448717124759,0.0,0.0,0.0,23/43,15.36%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;TCF3;PSMC6
gsea,interstrand cross-link repair (GO:0036297),-0.7250608973561239,-2.543461958935407,0.0,0.0,0.0,26/41,17.67%,RAD51;NUCKS1;NEIL3;RPA3;RAD51AP1;USP1;UBB;UBE2T;RPA2;EME1;FANCD2;RPA1;RFWD3;CENPS;MCM8;FANCF;FANCM;RNF168;FANCI;FANCA;FANCG;FANCB;FAAP24;ATR;WDR48;FANCL
gsea,DNA recombination (GO:0006310),-0.7526149182096874,-2.5405502289866364,0.0,0.0,0.0,13/32,7.75%,HMGB1;RAD51;RAD21;HMGB3;GEN1;BLM;RPA1;RAD54L;RAD50;EXO1;RAD54B;TSN;RHNO1
gsea,positive regulation of DNA biosynthetic process (GO:2000573),-0.7533670902094807,-2.5368640142568895,0.0,0.0,0.0,25/42,16.61%,AURKB;RFC4;RFC5;HSP90AA1;PTGES3;NEK2;PCNA;RFC2;TCP1;CHTF18;RFC3;CCT8;HSP90AB1;CCT6A;HNRNPA1;DSCC1;CCT7;CCT3;CCT2;CCT5;CCT4;CHTF8;ATR;DKC1;XRCC5
gsea,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.7382866169298145,-2.5364622508618155,0.0,0.0,0.0,20/33,17.06%,RAD51;RAD51AP1;PARPBP;SMCHD1;FIGNL1;RPA2;RMI2;FUS;POLQ;RIF1;CGAS;PARP1;TIMELESS;CHEK1;RTEL1;FANCB;SPIDR;MRNIP;HELB;WDR48
gsea,protein import into nucleus (GO:0006606),-0.7130983129440139,-2.5352225401591575,0.0,0.0,0.0,28/47,18.49%,KPNA2;RAN;NUTF2;NUP107;NUP62;NUP85;CSE1L;NUP133;IPO5;NXT1;KPNB1;NUP93;NUP35;HIKESHI;PHB2;NUP88;NUP155;AKT1;POM121;NUP54;IPO9;RANBP2;KPNA3;NUP214;IPO7;E2F3;IPO11;TNPO1
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.7612752189596428,-2.534306320056282,0.0,0.0,0.0,25/38,15.56%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;IFI30;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PDIA3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;CALR
gsea,RNA metabolic process (GO:0016070),-0.6525863574283888,-2.53358206096375,0.0,0.0,0.0,52/83,25.03%,HNRNPA3;HNRNPD;LSM8;HNRNPA2B1;DDX39B;HNRNPU;PCBP1;HNRNPF;RNASEH2B;SNRNP40;POLR2C;POLR2F;DHX9;RNASEH2A;HNRNPA1;HNRNPR;DDX20;EXOSC7;POLR2L;HNRNPA0;SYNCRIP;HNRNPK;HNRNPUL1;PRPF4;HNRNPH1;HNRNPC;NCBP1;POLR2B;PTBP1;MTREX;HNRNPM;POLR2A;SND1;RBMX;DKC1;POLR2E;GTF2F1;GTF2F2;WDR74;POLR2H;METTL14;RNASEH1;TBRG4;HNRNPH3;SETX;CELF2;RBM6;PABPC4;PPP1R8;NCBP2;PARN;MRPL44
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),-0.7535328051971425,-2.533310513932765,0.0,0.0,0.0,22/39,15.27%,CDK1;PLK1;CLSPN;TIPIN;FZR1;RPS27L;BRCA1;TICRR;RPA2;EME1;BLM;FANCD2;TOPBP1;CDKN1A;DTL;RFWD3;CDK2;CHEK1;CHEK2;BRCC3;MRNIP;RAD9A
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),-0.7031511483748532,-2.5331278202933345,0.0,0.0,0.0,29/53,17.29%,RFC4;RFC5;RPA3;LIG1;PCNA;UBB;RFC2;RPA2;RPA1;POLD2;RFC3;POLD1;POLR2C;RFC1;POLR2F;PRPF19;POLD3;POLR2L;COPS3;XRCC1;COPS4;POLR2B;COPS5;GPS1;POLR2A;DDB1;PPIE;POLR2E;HMGN1
gsea,nucleosome organization (GO:0034728),-0.7517819810664889,-2.528553107469105,0.0,0.0,0.0,21/39,12.65%,HMGB2;ANP32B;ANP32E;NAP1L1;SET;NASP;CTCF;SMARCC1;NPM1;CHAF1A;POLE3;SMARCA5;LIN54;CHAF1B;SMARCA4;SART3;SMARCC2;SMARCB1;BRD2;NAP1L4;ATRX
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.6694894619347985,-2.527850658224106,0.0,0.0,0.0,27/53,17.14%,UBB;PSMB6;ELOC;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;HIGD1A;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;CHEK1;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;DNAJB1
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.7114144825531866,-2.52557308922428,0.0,0.0,0.0,19/39,17.54%,CDK1;CCNB1;AURKA;E2F8;PCNA;E2F7;GTSE1;TFDP1;PRMT1;CDKN1A;CDC25C;E2F4;BAX;E2F1;CHEK2;CNOT9;CNOT10;TFDP2;PIDD1
gsea,response to ionizing radiation (GO:0010212),-0.6576334194983137,-2.525242703652221,0.0,0.0,0.0,20/51,15.33%,RAD51;RAD51AP1;ECT2;BRCA1;FIGNL1;TICRR;BLM;FANCD2;TOPBP1;CDKN1A;RFWD3;RHNO1;RNF168;EEF1D;PAXIP1;BRCC3;SPIDR;MRNIP;RAD9A;MTA1
gsea,DNA replication-independent nucleosome assembly (GO:0006336),-0.8409827913517185,-2.52383239421328,0.0,0.0,0.0,24/32,7.49%,KNL1;ASF1B;CENPW;HJURP;MIS18BP1;RBBP7;RBBP4;CENPA;MIS18A;NASP;CENPM;CENPP;CENPH;OIP5;HAT1;CENPN;CENPK;CENPI;NPM1;CENPS;CENPL;CENPU;CENPT;SMARCA5
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),-0.7057129101283282,-2.523209750619255,0.0,0.0,0.0,24/40,23.33%,HMGB2;HMGB1;BRCA1;POLA1;NSD2;BARD1;RAD50;PRPF19;POLQ;RNF168;RIF1;SMC5;UBE2N;PAXIP1;PSMD14;BRCC3;XRCC5;ABRAXAS1;PIAS4;DCLRE1B;NBN;RNF8;XRCC6;MDC1
gsea,regulation of cell population proliferation (GO:0042127),-0.4862359795129298,-2.520560448039546,0.0,0.0,0.0,91/339,27.62%,HMGB2;BIRC5;PRC1;FBXO5;SHCBP1;EZH2;NAP1L1;KIF20B;RBBP4;TIPIN;CDC25B;SAPCD2;UHRF1;CDK4;KIF14;TTK;E2F7;FOXM1;SLC25A5;CDKN3;CTCF;CDC6;NUP62;PRMT1;CDKN2C;NME1;CDKN1A;NPM1;HDAC1;CDC123;CDKN2D;TFRC;RNF126;FXN;CDKN2A;PBRM1;CDK2;CDC7;HMGN5;DERL2;ID2;CCAR1;MAZ;AKT1;TIMELESS;ASH2L;SINHCAF;FAM98B;HRAS;HDAC2;CNBP;HP1BP3;PHB;PDS5B;SMYD2;PTPN6;RPRD1B;CALR;PHIP;XRCC5;DNAJA2;SQLE;BRD7;CHERP;SHC1;EEF1E1;GLMN;DOT1L;MDM2;RPS6;CDCA7L;TBRG4;ING5;COX17;XRCC6;CIAO1;DHPS;PRDX3;UTP20;BIRC6;IFNG;TESC;MDM4;HSF1;CUL3;TNFRSF9;TCIRG1;DNAJA3;TSPAN31;HMGA1;CDK6
gsea,"transcription, DNA-templated (GO:0006351)",-0.5821167359028265,-2.5197828813114045,0.0,0.0,0.0,62/124,27.09%,PTMA;DEK;TRIP13;PMF1;SSRP1;TFDP1;RNPS1;TTF2;ELOC;POLR2C;NELFE;MLF1;MRPL12;POLR3K;POLR2F;SMARCA5;TAF15;POLR2L;TAF1;E2F1;PARP1;IWS1;MED4;TAF6;PPP5C;NCBP1;POLR2B;GTF3A;NELFCD;DRG1;POLR2A;TFAM;GTF2E2;GTF3C2;RBMX;TAF5;POLR3H;POLR2E;LEO1;GTF2F1;GTF2F2;PRMT5;NFYA;POLR2H;GTF3C5;SMN1;TBP;TAF9;SETX;TAF3;DDX21;MMS19;PKNOX1;NCBP2;IVNS1ABP;GTF2H4;ATF4;NFX1;HSF1;PWP1;CCNK;CTDP1
gsea,chromatin remodeling at centromere (GO:0031055),-0.8565241661649028,-2.5196205313293882,0.0,0.0,0.0,23/28,7.49%,KNL1;CENPW;HJURP;MIS18BP1;RBBP7;RBBP4;CENPA;MIS18A;NASP;CENPM;CENPP;CENPH;OIP5;HELLS;CENPN;CENPK;CENPI;NPM1;CENPS;CENPL;CENPU;CENPT;SMARCA5
gsea,transcription by RNA polymerase II (GO:0006366),-0.5368528394196619,-2.51861592707389,0.0,0.0,0.0,88/172,31.58%,DEK;SNRPE;TRIP13;PMF1;SLBP;SSRP1;SNRPB;SNRPF;TFDP1;SNRPD3;SRRT;TTF2;ELOC;HDAC1;ELOF1;POLR2C;NELFE;POLR2F;TAF15;E2F2;POLR2L;TAF1;INTS11;MAZ;PARP1;CPSF2;IWS1;MED4;TAF6;SP1;NCBP1;POLR2B;NELFCD;CPSF1;LSM11;POLR2A;GTF2E2;RBMX;CPSF4;RPRD1B;TAF5;NCOR2;POLR2E;E2F3;LEO1;GTF2F1;CSTF2;GTF2F2;NFYA;ELP2;POLR2H;SYMPK;CPSF3;TBP;POU2F1;ADRM1;ELP4;TAF9;SETX;TAF3;MED7;INTS10;INTS1;DDX21;PCID2;PKNOX1;NCBP2;CSTF1;GTF2H4;INTS3;ATF4;NFX1;CCNK;INTS5;CTDP1;INTS7;INTS8;MED16;GTF2H3;RPAP1;COPS2;INTS14;INTS4;CSTF3;ELOA;TAF2;GMEB2;SETD2
gsea,pre-replicative complex assembly (GO:0036388),-0.8087748904532426,-2.517999843091681,0.0,0.0,0.0,36/42,15.36%,GMNN;ORC6;MCM5;UBB;MCM7;CDC6;PSMB6;MCM3;MCM4;PSMB2;MCM8;PSMB5;MCM6;PSMA3;CDT1;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;ORC1;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;MCM2;ORC2;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,cellular response to UV (GO:0034644),-0.6809423655443011,-2.515744974044792,0.0,0.0,0.0,18/45,15.47%,AURKB;PCNA;CDKN1A;NPM1;POLD1;CDC25A;RUVBL2;RHNO1;EIF2S1;TAF1;PARP1;CHEK1;NEDD4;NOC2L;FMR1;PPID;DDB1;ATR
gsea,protein localization to nucleus (GO:0034504),-0.6356573341100695,-2.5141137371631945,0.0,0.0,0.0,35/69,24.63%,RAN;PLK1;NUTF2;HNRNPU;NUP107;NUP62;NUP85;CSE1L;YWHAE;NUP133;IPO5;NXT1;KPNB1;NUP93;HIKESHI;PHB2;NUP88;CHCHD10;NUP155;AKT1;POM121;IPO9;CALR;NUP214;IPO7;E2F3;IPO11;TNPO1;MDM2;RPF2;NUP188;TAF3;ARL2;NUP153;RPAIN
gsea,CENP-A containing chromatin organization (GO:0061641),-0.8656917094370058,-2.5121812779796575,0.0,0.0,0.0,22/26,7.49%,KNL1;CENPW;HJURP;MIS18BP1;RBBP7;RBBP4;CENPA;MIS18A;NASP;CENPM;CENPP;CENPH;OIP5;CENPN;CENPK;CENPI;NPM1;CENPS;CENPL;CENPU;CENPT;SMARCA5
gsea,CENP-A containing nucleosome assembly (GO:0034080),-0.8656917094370058,-2.5121812779796575,0.0,0.0,0.0,22/26,7.49%,KNL1;CENPW;HJURP;MIS18BP1;RBBP7;RBBP4;CENPA;MIS18A;NASP;CENPM;CENPP;CENPH;OIP5;CENPN;CENPK;CENPI;NPM1;CENPS;CENPL;CENPU;CENPT;SMARCA5
gsea,mRNA 3'-end processing (GO:0031124),-0.7182206656280908,-2.512062801198371,0.0,0.0,0.0,34/51,19.91%,ALYREF;SRSF3;SRSF2;SLBP;U2AF1;DDX39B;EIF4A3;RNPS1;SRSF7;RBM8A;MAGOH;SRSF9;MAGOHB;SRRM1;U2AF2;SRSF4;SRSF1;CPSF2;SARNP;CPSF6;THOC3;NCBP1;CPSF1;SRSF6;LSM11;UPF3B;CPSF4;RPRD1B;LEO1;CSTF2;THOC2;THOC6;SYMPK;CPSF3
gsea,protein phosphorylation (GO:0006468),-0.5131549669822699,-2.5105449611085757,0.0,0.0,0.0,56/229,24.55%,CCNA2;BIRC5;CDK1;AURKB;INCENP;PLK1;CLSPN;PLK4;CIT;MELK;MASTL;CDC25B;AURKA;NEK2;CDK4;TTK;CCNE1;BAZ1B;HASPIN;STK39;BCKDK;CDK2;TAF1;CDC7;AKT1;BRD2;CHEK1;CAD;PASK;SRPK1;CHEK2;PRDX4;VRK1;PTPN6;ATR;ILF3;PPP3CB;ROCK2;MAST2;BMP2K;USP15;CSNK2A2;VRK3;ROCK1;RPS6KA5;PRKCE;GMFB;MAP4K1;CDK19;CREB1;PDPK1;MTOR;MAPK6;BIRC6;SLK;DYRK3
gsea,nuclear export (GO:0051168),-0.7176627179397749,-2.5060637284029372,0.0,0.0,0.0,48/59,25.27%,ALYREF;RAN;SRSF3;SRSF2;U2AF1;DDX39B;NUTF2;EIF4A3;RNPS1;SRSF7;NUP62;RBM8A;MAGOH;CSE1L;ANKLE1;SRSF9;MAGOHB;SRRM1;U2AF2;HNRNPA1;XPO1;SRSF4;NUP155;SRSF1;EIF4E;SARNP;THOC3;NCBP1;POM121;SRSF6;UPF3B;CALR;NUP214;THOC2;THOC6;CCHCR1;RANBP3;RAE1;XPO4;NXF1;DESI1;CASC3;NUP188;NUP153;XPO7;NCBP2;THOC5;XPO5
gsea,proteasomal protein catabolic process (GO:0010498),-0.5790885827919876,-2.5043799035186214,0.0,0.0,0.0,41/102,21.68%,KIF14;PSMB6;STUB1;PSMB2;PSMB5;PSMA3;RNF126;RAD23A;PSMC4;PRPF19;FAF1;RNF5;PSMA6;PSMD2;PSMB7;PSMA4;CDC34;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;NEDD4;SKP2;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;DDB1;MTA1;PSMC6;FBXO45;NSFL1C;RAD23B;MDM2;PSME2;KCTD13;CUL4B
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.6990151070422892,-2.504134406331681,0.0,0.0,0.0,16/40,17.57%,KIF11;CENPE;RACGAP1;KIF22;KIF15;KIF23;KIF2C;KIF18A;AP1M1;DYNLL2;CANX;IFI30;CAPZA2;DCTN1;ACTR1A;CLTC
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.6990151070422892,-2.504134406331681,0.0,0.0,0.0,16/40,17.57%,KIF11;CENPE;RACGAP1;KIF22;KIF15;KIF23;KIF2C;KIF18A;AP1M1;DYNLL2;CANX;IFI30;CAPZA2;DCTN1;ACTR1A;CLTC
gsea,positive regulation of cell division (GO:0051781),-0.8476810555317934,-2.5038385922808266,0.0,0.0,0.0,9/19,4.26%,AURKB;RACGAP1;KIF23;KIF20B;CIT;ECT2;CDC25B;KIF14;CDC6
gsea,positive regulation of cytokinesis (GO:0032467),-0.8476810555317934,-2.5038385922808266,0.0,0.0,0.0,9/19,4.26%,AURKB;RACGAP1;KIF23;KIF20B;CIT;ECT2;CDC25B;KIF14;CDC6
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.6941199970059538,-2.5011386597573653,0.0,0.0,0.0,16/41,17.57%,KIF11;CENPE;RACGAP1;KIF22;KIF15;KIF23;KIF2C;KIF18A;AP1M1;DYNLL2;CANX;IFI30;CAPZA2;DCTN1;ACTR1A;CLTC
gsea,protein sumoylation (GO:0016925),-0.7557995005132111,-2.498439144079544,0.0,0.0,0.0,29/36,21.92%,SUMO2;RANGAP1;SAE1;NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;UBA2;NUP133;TRIM28;NUP43;NUP93;NUP205;NUP160;NUP35;NUP88;NUP155;POM121;NUP54;SEH1L;RANBP2;SUMO3;NUP214;RAE1;PIAS4;NUP210;NUP188
gsea,chromatin organization (GO:0006325),-0.602005325744217,-2.4976499882819914,0.0,0.0,0.0,42/90,23.22%,HMGB2;HMGN2;NUCKS1;EZH2;RBBP4;SUV39H1;CBX3;HIRIP3;SMARCC1;BAZ1B;NPM1;NUDT5;HDAC1;NPM3;PIH1D1;ACTL6A;RUVBL2;SMARCA5;SUV39H2;PBRM1;SMARCA4;SMARCC2;SMARCB1;RUVBL1;ATRX;HDAC2;MTF2;HP1BP3;SAFB;HCFC1;HMGN1;CHD1L;LRWD1;ARID1A;PHF19;SETDB2;PWWP3A;TAF6L;DDX11;MTA2;RB1;SETDB1
gsea,negative regulation of apoptotic process (GO:0043066),-0.5074232567589605,-2.4937558257836523,0.0,0.0,0.0,69/228,24.31%,BIRC5;CDK1;PTMA;MAD2L1;PLK1;ARL6IP1;SET;PA2G4;STIL;UBB;KIF14;FIGNL1;MIF;BARD1;NUP62;HSP90B1;HSPD1;YWHAE;NPM1;HDAC1;CFL1;CDKN2D;NME2;ARHGDIA;TFRC;FXN;SERPINB9;ASNS;PARK7;PHB2;PRELID1;VDAC1;HIGD1A;HMGN5;MAZ;HNRNPK;CASP3;AKT1;SFPQ;HSPA9;COPS5;HDAC2;PPIF;APIP;MYDGF;PHIP;MTDH;HAX1;NAA16;PIDD1;THOC6;SHC1;API5;MT3;NAA15;CSNK2A2;ATAD3A;ARHGAP10;BAG4;AVEN;NAA35;TAF9;SETX;MSH2;RB1;FLNA;PRDX3;PCID2;BIRC6
gsea,regulation of G0 to G1 transition (GO:0070316),-0.7780129318786936,-2.4936567992242074,0.0,0.0,0.0,16/32,12.63%,RRM2;RAD51;EZH2;RBBP7;RBBP4;SUZ12;CBX5;BRCA1;CBX3;TFDP1;RBBP8;RHNO1;CDC7;E2F1;CHEK1;EED
gsea,import into nucleus (GO:0051170),-0.7077555121919045,-2.4921176098105806,0.0,0.0,0.0,33/54,19.58%,RAN;SNRPD1;SNRPE;SNRPB;NUTF2;NUP107;SNRPF;SNRPD3;NUP62;NUP85;CSE1L;NUP133;IPO5;NXT1;KPNB1;GEMIN6;NUP93;HIKESHI;HNRNPA1;PHB2;NUP88;DDX20;NUP155;AKT1;GEMIN2;POM121;IPO9;NUP214;IPO7;E2F3;IPO11;TNPO1;SMN1
gsea,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.7799034258027034,-2.4920941011451574,0.0,0.0,0.0,21/32,13.04%,ALYREF;RAD51;NUCKS1;TIPIN;PCNA;TRAIP;GEN1;EME1;BLM;POLE;FAM111A;RFWD3;CENPS;POLD1;MMS22L;FANCM;TIMELESS;ETAA1;ZRANB3;ATRX;RTEL1
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.7685802842290808,-2.4918971572196567,0.0,0.0,0.0,24/35,15.56%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PDIA3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;CALR
gsea,cytoskeleton-dependent intracellular transport (GO:0030705),-0.8470904259578946,-2.4901984430510025,0.0,0.0,0.0,3/17,2.89%,TUBA1B;TUBA1C;TUBA1A
gsea,regulation of cellular response to heat (GO:1900034),-0.67825175881165,-2.488388370080484,0.0,0.0,0.0,39/62,22.80%,RPA3;HSP90AA1;PTGES3;NDC1;AAAS;RPA2;NUP107;NUP37;NUP62;NUP85;FKBP4;RPA1;YWHAE;DNAJC2;NUP133;NUP43;HSP90AB1;NUP93;NUP205;NUP160;NUP35;HIKESHI;HSPA8;NUP88;NUP155;POM121;NUP54;SEH1L;RANBP2;ATR;NUP214;DNAJB1;DNAJC7;RAE1;BAG4;NUP210;NUP188;HSPH1;MTOR
gsea,regulation of gene silencing by miRNA (GO:0060964),-0.7148196662589928,-2.4878675746496475,0.0,0.0,0.0,32/43,21.92%,NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NUP133;POLR2C;NUP43;POLR2F;NUP93;DHX9;NUP205;NUP160;NUP35;NUP88;EIF4G1;POLR2L;NUP155;POLR2B;POM121;NUP54;FMR1;POLR2A;SEH1L;RANBP2;NUP214;POLR2E;POLR2H;RAE1;NUP210;NUP188
gsea,regulation of response to DNA damage stimulus (GO:2001020),-0.7822999648508983,-2.486883778284398,0.0,0.0,0.0,15/24,13.97%,FBXO5;USP1;NSMCE4A;RPA2;ANKLE1;RFWD3;KMT5A;NSMCE1;POLH;WDR76;UBE2N;ETAA1;BCLAF1;SMYD2;FMR1
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.6840347696558067,-2.485483754367904,0.0,0.0,0.0,27/48,18.45%,CCNF;KIF14;PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;SKP2;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;FBXL14;FBXO48
gsea,replication fork processing (GO:0031297),-0.7753801506933982,-2.484332355300738,0.0,0.0,0.0,22/29,16.86%,ALYREF;RAD51;NUCKS1;PCNA;TRAIP;GEN1;EME1;BLM;FAM111A;BRCA2;RFWD3;CENPS;MMS22L;FANCM;ETAA1;ZRANB3;ZGRF1;ATRX;RTEL1;DNA2;ATR;TONSL
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.7032681182216579,-2.4812375434632816,0.0,0.0,0.0,12/41,11.09%,KIF11;CENPE;RACGAP1;KIF22;KIF15;KIF23;KIF2C;KIF18A;KDELR2;ZW10;LMAN2;TMED2
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6852350458266251,-2.4738510627027854,0.0,0.0,0.0,21/46,15.61%,FEN1;RFC4;RFC5;RPA3;PCNA;UBB;RFC2;RPA2;RPA1;RAD50;POLD2;ANKLE1;RFC3;POLD1;RFC1;POLD3;PARP1;DDX1;DNA2;DDB1;DXO
gsea,chromosome condensation (GO:0030261),-0.9084366340467059,-2.473574056258712,0.0,0.0,0.0,17/26,3.28%,TOP2A;SMC2;CDK1;NUSAP1;INCENP;SMC4;NCAPG;PLK1;NCAPH;CCNB1;CDCA5;BANF1;NCAPD2;SET;NCAPG2;NCAPD3;NCAPH2
gsea,telomere maintenance (GO:0000723),-0.7161871465097343,-2.4733831041501486,0.0,0.0,0.0,23/40,16.61%,RAD51;RPA3;PTGES3;PCNA;RPA2;BLM;TINF2;SMC6;RPA1;RAD50;POLD2;POLD1;CTC1;POLD3;RIF1;SMC5;PARP1;RTEL1;DNA2;RECQL4;ATR;APEX1;XRCC5
gsea,positive regulation of protein localization to nucleus (GO:1900182),-0.6938055007387995,-2.4715017136215844,0.0,0.0,0.0,17/45,11.50%,CDK1;RAN;PLK1;ECT2;GTSE1;TCP1;TRIM28;CCT8;IPO5;TFRC;CCT6A;PARK7;CCT7;CCT3;CCT2;AKT1;CCT5
gsea,cellular response to light stimulus (GO:0071482),-0.6927351130096855,-2.469004557605844,0.0,0.0,0.0,14/36,15.47%,AURKB;PCNA;NPM1;POLD1;CDC25A;RUVBL2;RHNO1;EIF2S1;TAF1;PARP1;NEDD4;NOC2L;FMR1;ATR
gsea,regulation of translation (GO:0006417),-0.6008400530424052,-2.4647091614611423,0.0,0.0,0.0,55/115,25.11%,TYMS;YBX1;HNRNPD;RPS27L;DHFR;NCL;EIF4A3;SHMT2;GAPDH;NPM1;GSPT1;GZMB;EIF3B;EIF3C;DHX9;MRPL13;GLE1;TCOF1;NOLC1;SHMT1;EIF4G1;EIF6;EIF4H;SYNCRIP;DDX1;TSFM;EIF4E;TRAP1;NCBP1;EIF4G2;PASK;FMR1;UPF3B;EIF3D;CAPRIN1;CNOT9;CNOT10;CALR;ETF1;VIM;LTN1;EIF5;ILF3;MIF4GD;LARP4B;METTL14;EIF5B;MTG1;NSUN5;MTOR;PUM3;CNOT1;METTL5;NCBP2;EIF4G3
gsea,negative regulation of cellular amide metabolic process (GO:0034249),-0.6516881948850298,-2.45972365275644,0.0,0.0,0.0,18/49,16.47%,TYMS;YBX1;DHFR;NCL;EIF4A3;PIN1;GAPDH;GZMB;MRPL13;RTN3;SHMT1;SYNCRIP;FMR1;CAPRIN1;CNOT9;CNOT10;CALR;ILF3
gsea,RNA transport (GO:0050658),-0.7093077947730141,-2.459043008890039,0.0,0.0,0.0,31/53,14.32%,ALYREF;CKAP5;SRSF3;YBX1;SRSF2;SLBP;HNRNPA2B1;U2AF1;DDX39B;EIF4A3;RNPS1;SRSF7;NUP62;RBM8A;MAGOH;SRSF9;MAGOHB;SRRM1;U2AF2;HNRNPA1;SRSF4;NUP155;SRSF1;EIF4E;SARNP;THOC3;NCBP1;POM121;FMR1;SRSF6;UPF3B
gsea,RNA 3'-end processing (GO:0031123),-0.7184026193817201,-2.458235533580794,0.0,0.0,0.0,30/45,19.91%,ALYREF;SRSF3;SRSF2;U2AF1;DDX39B;EIF4A3;RNPS1;SRSF7;RBM8A;MAGOH;SRSF9;MAGOHB;SRRM1;U2AF2;SRSF4;SRSF1;CPSF2;SARNP;THOC3;NCBP1;CPSF1;SRSF6;UPF3B;CPSF4;RPRD1B;CSTF2;THOC2;THOC6;SYMPK;CPSF3
gsea,epithelial cell differentiation (GO:0030855),-0.6515317297919963,-2.4519627377586692,0.0,0.0,0.0,13/44,12.85%,CDK1;TAGLN2;E2F8;PCNA;E2F7;HDAC1;PIH1D1;E2F4;PGK1;VDAC1;PCK2;AKT1;HDAC2
gsea,response to light stimulus (GO:0009416),-0.6888097462351604,-2.4493204347359305,0.0,0.0,0.0,7/32,11.84%,PCLAF;USP1;DTL;POLD1;CDKN2D;COPS3;ZRANB3
gsea,translational termination (GO:0006415),-0.7042960171156041,-2.448380076281706,0.0,0.0,0.0,44/55,25.83%,MRPL18;MRPL51;MRPL42;MRPL28;GSPT1;MRPL12;CHCHD1;MRPL13;MRPL17;MRPL49;MRPL20;MRPL40;MRPS12;MRPL15;MRPL53;MRPL55;MRPL35;MRPL39;GADD45GIP1;MRPS28;MRPS5;MRPS7;MRPL2;MRPS10;ETF1;MRPS18A;MRPL37;MRPL22;MRPS25;MRPL16;MRPL11;MRPS22;MRPL1;MRPS31;MRPL45;MRPS35;ABCE1;MRPS18B;DAP3;MRPL3;MRPS27;MRPL44;MRPS2;PTCD3
gsea,nuclear membrane reassembly (GO:0031468),-0.8062721907626443,-2.447018815987233,0.0,0.0,0.0,21/32,9.63%,CDK1;RAN;CCNB1;BANF1;REEP4;CCNB2;RANGAP1;NDC1;NUP107;LBR;RCC1;NUP37;NUP85;NUP133;NUP43;KPNB1;NUP93;NUP205;NUP160;NUP35;NUP155
gsea,NIK/NF-kappaB signaling (GO:0038061),-0.7128619208389569,-2.4442244247299576,0.0,0.0,0.0,25/42,15.36%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;AKT1;PSMD7;PSMD14;ZFP91;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;TRAF2;PSMD3;PSMC6
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.6648822160500234,-2.443070118619657,0.0,0.0,0.0,13/37,18.02%,CDK1;CCNB1;CDK4;MED30;CDKN1A;TRIM28;BAX;CDKN2A;MED4;BCLAF1;MED14;MED8;CEBPB
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.7677210715642897,-2.4416955224850136,0.0,0.0,0.0,25/35,15.36%,AURKB;AURKA;PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;CHEK1;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.7245688564888008,-2.441694439979877,0.0,0.0,0.0,27/44,16.58%,SRSF3;NCL;HNRNPU;RNPS1;SRSF7;RBM8A;MAGOH;THRAP3;SRSF9;DAZAP1;SRSF10;C1QBP;U2AF2;HNRNPA1;SF3B4;SRSF4;SMU1;HNRNPK;MBNL3;NCBP1;PTBP1;SRPK1;FMR1;SRSF6;RBMX;RBMXL1;RBM25
gsea,regulation of neurogenesis (GO:0050767),-0.7175850451345893,-2.4403016229220595,0.0,0.0,0.0,2/26,1.44%,HMGB2;NAP1L1
gsea,mitotic nuclear membrane organization (GO:0101024),-0.8218084047638327,-2.438602188350951,0.0,0.0,0.0,21/30,9.63%,CDK1;RAN;CCNB1;BANF1;REEP4;CCNB2;RANGAP1;NDC1;NUP107;LBR;RCC1;NUP37;NUP85;NUP133;NUP43;KPNB1;NUP93;NUP205;NUP160;NUP35;NUP155
gsea,mitotic nuclear membrane reassembly (GO:0007084),-0.8218084047638327,-2.438602188350951,0.0,0.0,0.0,21/30,9.63%,CDK1;RAN;CCNB1;BANF1;REEP4;CCNB2;RANGAP1;NDC1;NUP107;LBR;RCC1;NUP37;NUP85;NUP133;NUP43;KPNB1;NUP93;NUP205;NUP160;NUP35;NUP155
gsea,cellular protein modification process (GO:0006464),-0.4579047034837288,-2.436317473827367,0.0,0.0,0.0,181/480,36.68%,BIRC5;CDK1;AURKB;UBE2S;PLK1;PLK4;RBBP7;MELK;CCNF;LRR1;CDC25B;AURKA;NEK2;CDK4;PSMB6;CCNE1;HSP90B1;UBE2M;PPM1G;DTL;TIMM50;HASPIN;DDOST;ELOC;PSMB2;STK39;BCKDK;UCHL3;PSMB5;METAP2;RPN2;PSMA3;PSMC4;PARK7;PARP2;ADPRH;PSMA6;PSMD2;CDK2;SEPHS1;PSMB7;PSMA4;TAF1;CDC34;PSMD12;COPS3;P4HB;PSMC2;PARP1;RPN1;PSMD1;PSMA5;AKT1;PDIA6;COPS4;PSMD7;PSMD14;DCAF7;PSMD11;BRD2;CHEK1;PPP5C;SKP2;PSME3;COPS5;PASK;PSMD6;SRPK1;PSMC1;TRIOBP;CHEK2;GPS1;WDR5;PPP2CB;VRK1;PSMC5;NAE1;PSMD3;PTPN6;DDB1;PPP2R5D;PSMC6;ILF3;PPP3CB;FBXL14;ROCK2;STT3B;MAST2;PRKCSH;BMP2K;OARD1;PTPN7;MT3;MCRS1;ROCK1;RPS6KA5;PRKCE;ZDHHC6;STT3A;PIGU;GMFB;COPS7A;PSME2;UBA3;MAP4K1;CUL4B;CDK19;CREB1;DCAF13;PDPK1;MTOR;MAPK6;PHKA2;BIRC6;ALG3;DYRK3;RABGGTB;ST3GAL4;RUNX3;CUL3;RBBP5;CTDP1;CAMKK2;CDK6;DDB2;CTDSP1;LGALS1;OXSR1;SPP1;RYK;PDXP;FNTB;KEAP1;CUL1;ANKRD9;STK3;PDP1;SIRT6;COPS7B;MEN1;COPS2;CALU;GRK2;MAPKAPK2;FBXL8;UBLCP1;TAB1;CAND1;ST3GAL5;SLC35A1;GLRX;CLK2;STRADA;UFL1;ERCC8;TBCK;DUSP12;KLHL20;BAP1;SUMF2;PRKDC;PTPN12;DYRK1A;PRKAA1;CDK14;NEK1;MPI;EPAS1;PRKAG2;PLOD2;TAOK2;MTMR4;TLK2;PAK4;CUL4A;GOLGA2;CTH;GSK3B;CDK8;AGA;CUL5
gsea,negative regulation of gene expression (GO:0010629),-0.5116341029518217,-2.4347553857727373,0.0,0.0,0.0,47/176,20.74%,TYMS;LSM2;EZH2;RBBP7;RBBP4;DNMT1;YBX1;AURKA;SUZ12;DHFR;MIF;NCL;EIF4A3;HELLS;RBL1;GAPDH;HDAC1;GZMB;MRPL13;PARK7;SHMT1;TAF1;ID2;SYNCRIP;SLC7A5;TARDBP;EED;HRAS;MTF2;PTBP1;FMR1;CAPRIN1;CNOT9;CNOT10;CALR;DXO;NCOR2;ILF3;ROCK2;CENPV;PPHLN1;CPNE1;PHF19;SETDB2;FLOT2;RPS6KA5;METTL16
gsea,regulation of gene silencing by RNA (GO:0060966),-0.7346673852736462,-2.4342190146184075,0.0,0.0,0.0,31/38,21.92%,NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NUP133;POLR2C;NUP43;POLR2F;NUP93;NUP205;NUP160;NUP35;NUP88;EIF4G1;POLR2L;NUP155;POLR2B;POM121;NUP54;FMR1;POLR2A;SEH1L;RANBP2;NUP214;POLR2E;POLR2H;RAE1;NUP210;NUP188
gsea,regulation of posttranscriptional gene silencing (GO:0060147),-0.7346673852736462,-2.4342190146184075,0.0,0.0,0.0,31/38,21.92%,NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NUP133;POLR2C;NUP43;POLR2F;NUP93;NUP205;NUP160;NUP35;NUP88;EIF4G1;POLR2L;NUP155;POLR2B;POM121;NUP54;FMR1;POLR2A;SEH1L;RANBP2;NUP214;POLR2E;POLR2H;RAE1;NUP210;NUP188
gsea,cellular response to hypoxia (GO:0071456),-0.6056286530508256,-2.4328541907142243,0.0,0.0,0.0,35/77,21.22%,UBB;SUV39H1;PSMB6;STUB1;ELOC;PSMB2;PSMB5;PSMA3;SUV39H2;PSMC4;PGK1;PSMA6;PSMD2;PSMB7;PSMA4;HIGD1A;PSMD12;P4HB;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;HP1BP3;PSMC1;PSMC5;PSMD3;PSMC6;MT3;EGLN1;MDM2;PSME2
gsea,mitotic chromosome condensation (GO:0007076),-0.9041051078078739,-2.42776798043688,0.0,0.0,0.0,14/22,3.28%,SMC2;CDK1;NUSAP1;SMC4;NCAPG;PLK1;NCAPH;CCNB1;CDCA5;NCAPD2;SET;NCAPG2;NCAPD3;NCAPH2
gsea,peptidyl-serine modification (GO:0018209),-0.563539545807122,-2.426455107678902,0.0,0.0,0.0,28/89,22.80%,CDK1;PLK1;CLSPN;MASTL;AURKA;TTK;HPF1;STK39;PARP2;CDK2;TAF1;CDC7;PARP1;AKT1;VRK1;NAA10;ATR;GALNT1;ROCK2;MAST2;CSNK2A2;VRK3;ROCK1;RPS6KA5;PRKCE;MAP4K1;PDPK1;MTOR
gsea,negative regulation of Wnt signaling pathway (GO:0030178),-0.5592343551743423,-2.425255275492587,0.0,0.0,0.0,26/89,16.55%,PSMB6;PSMB2;HDAC1;PSMB5;PSMA3;RUVBL2;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;HMGXB4;FRMD8
gsea,cellular response to lectin (GO:1990858),-0.6371991502810374,-2.4250136585958963,0.0,0.0,0.0,23/56,15.36%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;HRAS;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.6371991502810374,-2.4250136585958963,0.0,0.0,0.0,23/56,15.36%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;HRAS;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.6371991502810374,-2.4250136585958963,0.0,0.0,0.0,23/56,15.36%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;HRAS;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,mitotic spindle assembly (GO:0090307),-0.7542847772307685,-2.4240661387717863,0.0,0.0,0.0,16/31,13.79%,AURKB;KIF11;PRC1;TPX2;RACGAP1;KIFC1;KIF23;SMC1A;SMC3;AAAS;KPNB1;STAG1;CEP192;STAG2;CHEK2;CCDC61
gsea,regulation of exit from mitosis (GO:0007096),-0.8100795577813953,-2.4217522245289014,0.0,0.0,0.0,17/25,12.92%,UBE2S;UBE2C;MAD2L1;BUB3;CDCA5;BUB1B;CDC20;NEK2;ANLN;ANAPC5;UBB;KNTC1;ANAPC15;PHB2;ZW10;CDC23;CDC27
gsea,regulation of DNA replication (GO:0006275),-0.751692830081378,-2.4194381432440166,0.0,0.0,0.0,15/35,8.23%,CCNA2;FBXO5;ESCO2;GMNN;NUCKS1;PCNA;ATAD5;SMC3;CDC6;BLM;DHX9;CDT1;CTC1;DSCC1;FAF1
gsea,mitochondrial translational elongation (GO:0070125),-0.7092459961850379,-2.418974216073381,0.0,0.0,0.0,44/52,25.83%,MRPL18;MRPL51;MRPL42;MRPL28;MRPL12;CHCHD1;MRPL13;MRPL17;MRPL49;MRPL20;MRPL40;MRPS12;MRPL15;MRPL53;MRPL55;TSFM;MRPL35;MRPL39;GADD45GIP1;MRPS28;MRPS5;MRPS7;MRPL2;MRPS10;MRPS18A;MRPL37;TUFM;MRPL22;MRPS25;MRPL16;MRPL11;MRPS22;GFM1;MRPL1;MRPS31;MRPL45;MRPS35;MRPS18B;DAP3;MRPL3;MRPS27;MRPL44;MRPS2;PTCD3
gsea,negative regulation of cellular protein metabolic process (GO:0032269),-0.6315275685359556,-2.418168237084993,0.0,0.0,0.0,18/51,16.47%,TYMS;YBX1;DHFR;NCL;EIF4A3;GAPDH;GZMB;MRPL13;SHMT1;SYNCRIP;AKT1;SERPINE2;FMR1;CAPRIN1;CNOT9;CNOT10;CALR;ILF3
gsea,regulation of cell cycle G1/S phase transition (GO:1902806),-0.7826650778837895,-2.414737407673357,0.0,0.0,0.0,10/20,14.92%,EZH2;FAM83D;KIF14;CDKN1A;PHB2;TAF1;ID2;E2F1;PSME3;PTPN6
gsea,negative regulation of DNA recombination (GO:0045910),-0.7024146220432425,-2.4142045767020703,0.0,0.0,0.0,19/31,16.88%,PARPBP;SMCHD1;BLM;TINF2;RMI2;POLR2C;POLR2F;POLQ;POLR2L;RIF1;CGAS;ZRANB3;POLR2B;ATRX;RTEL1;FANCB;POLR2A;HELB;POLR2E
gsea,mitochondrial translational termination (GO:0070126),-0.7030815053916344,-2.4129301037590962,0.0,0.0,0.0,41/50,25.83%,MRPL18;MRPL51;MRPL42;MRPL28;MRPL12;CHCHD1;MRPL13;MRPL17;MRPL49;MRPL20;MRPL40;MRPS12;MRPL15;MRPL53;MRPL55;MRPL35;MRPL39;GADD45GIP1;MRPS28;MRPS5;MRPS7;MRPL2;MRPS10;MRPS18A;MRPL37;MRPL22;MRPS25;MRPL16;MRPL11;MRPS22;MRPL1;MRPS31;MRPL45;MRPS35;MRPS18B;DAP3;MRPL3;MRPS27;MRPL44;MRPS2;PTCD3
gsea,mitotic G2/M transition checkpoint (GO:0044818),-0.7533829366399366,-2.410891540705154,0.0,0.0,0.0,16/29,14.68%,CDK1;PLK1;CLSPN;FZR1;BRCA1;TICRR;CDC6;BLM;TOPBP1;CDKN1A;DTL;ORC1;CHEK1;BRCC3;NAE1;MRNIP
gsea,regulation of cellular amino acid metabolic process (GO:0006521),-0.7940826872071335,-2.410658680261425,0.0,0.0,0.0,25/29,18.21%,PSMB6;PSMB2;BCKDK;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;AZIN1;ODC1
gsea,base-excision repair (GO:0006284),-0.7573731677674124,-2.4105827051872577,0.0,0.0,0.0,23/37,16.39%,FEN1;NEIL3;RFC4;RFC5;RPA3;LIG1;PCNA;RFC2;RPA2;RPA1;POLE;POLD2;RFC3;POLD1;RFC1;POLQ;POLD3;PARP1;XRCC1;MBD4;DNA2;TDG;APEX1
gsea,regulation of protein binding (GO:0043393),-0.5861411338863847,-2.4064974014875276,0.0,0.0,0.0,20/64,25.90%,AURKB;RAN;PLK1;AURKA;PIN1;CDKN1A;ACTB;BAX;PARK7;TAF1;AKT1;GTF2F1;SYMPK;ROCK1;DDX11;NVL;PRMT7;TLE5;TFIP11;ADD1
gsea,chromatin assembly (GO:0031497),-0.79950965374589,-2.4057146308603925,0.0,0.0,0.0,16/25,12.91%,HMGB2;ANP32B;NAP1L1;RBBP4;CTCF;NPM1;CHAF1A;POLE3;SMARCA5;LIN54;CHAF1B;SART3;BRD2;NAP1L4;ATRX;NOC2L
gsea,negative regulation of G0 to G1 transition (GO:0070317),-0.7770697669489024,-2.4042373863123614,0.0,0.0,0.0,15/29,12.63%,RRM2;RAD51;EZH2;RBBP7;RBBP4;SUZ12;CBX5;BRCA1;CBX3;TFDP1;RBBP8;CDC7;E2F1;CHEK1;EED
gsea,positive regulation of DNA repair (GO:0045739),-0.7017352506285353,-2.4039780430481272,0.0,0.0,0.0,20/31,23.70%,HMGB1;PCNA;SMCHD1;BRCA1;FOXM1;TRIM28;DHX9;RNF168;UBE2N;PARP1;XRCC1;TIMELESS;BRCC3;SPIDR;ABRAXAS1;SLF1;DDX11;ZCWPW1;RNF8;WRAP53
gsea,regulation of cellular ketone metabolic process (GO:0010565),-0.7589038627753357,-2.4039114692687966,0.0,0.0,0.0,25/32,18.21%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;AZIN1;NCOR2;ODC1
gsea,"regulation of gene expression, epigenetic (GO:0040029)",-0.657054878727957,-2.4034801729391275,0.0,0.0,0.0,23/52,20.35%,DEK;EZH2;RBBP7;RBBP4;DNMT1;SUZ12;CTCF;BAZ1B;ACTB;POLR2F;SMARCA5;POLR2L;EED;MTF2;MTA1;TDG;POLR2E;MYBBP1A;PPHLN1;POLR2H;PHF19;TBP;GLMN
gsea,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.8758340540129947,-2.399575376153638,0.0,0.0,0.0,16/20,10.63%,RFC4;RFC5;RPA3;LIG1;PCNA;UBB;RFC2;RPA2;RPA1;POLE;POLD2;RFC3;POLD1;RFC1;POLD3;XRCC1
gsea,cellular response to ionizing radiation (GO:0071479),-0.6649880194721289,-2.3991249301300566,0.0,0.0,0.0,21/37,26.07%,RAD51;NUCKS1;RAD51AP1;ECT2;FIGNL1;BLM;CDKN1A;TMEM109;RHNO1;EEF1D;HRAS;SPIDR;RAD9A;ATR;XRCC5;MDM2;RAD1;XRCC6;NET1;HUS1;HSF1
gsea,DNA replication initiation (GO:0006270),-0.8580372937333547,-2.398036492990258,0.0,0.0,0.0,30/34,11.46%,GMNN;RPA3;ORC6;CDC45;MCM5;PRIM1;MCM7;POLA1;DBF4;RPA2;PRIM2;CDC6;MCM3;TOPBP1;MCM10;RPA1;POLE;MCM4;MCM8;POLE3;MCM6;CDT1;POLA2;CDK2;CDC7;CDC34;ORC1;POLE2;MCM2;ORC2
gsea,Ras protein signal transduction (GO:0007265),-0.5615597980119789,-2.397688972623813,0.0,0.0,0.0,18/75,19.92%,CCNA2;DNMT1;G3BP1;GPSM2;CDKN1A;TRIM28;CFL1;KPNB1;ARHGDIA;CDKN2A;PARK7;CDK2;HRAS;ELMO1;ROCK2;SHC1;RALA;ROCK1
gsea,nucleocytoplasmic transport (GO:0006913),-0.7502263115906679,-2.396870776288154,0.0,0.0,0.0,17/31,12.42%,SNRPD1;SNRPE;SNRPB;NUTF2;AAAS;SNRPF;SNRPD3;NPM1;NXT1;GEMIN6;NUP205;HNRNPA1;XPO1;RSRC1;DDX20;GEMIN2;NCBP1
gsea,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.7987640593437682,-2.394470023853538,0.0,0.0,0.0,8/20,10.30%,UBE2S;UBE2C;PLK1;CDC20;FZR1;PIN1;RPS2;UBE2N
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.7724806833263341,-2.3914192358819815,0.0,0.0,0.0,23/31,15.36%,AURKA;PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,positive regulation of Wnt signaling pathway (GO:0030177),-0.596208895829059,-2.3905271428744173,0.0,0.0,0.0,26/67,15.36%,DEPDC1B;PIN1;PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;SMARCA4;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;RUVBL1;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,regulation of ATP metabolic process (GO:1903578),-0.6869532735181038,-2.389966519297442,0.0,0.0,0.0,25/38,21.92%,NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;SHMT2;NUP133;NUP43;NUP93;NUP205;NUP160;NUP35;PGAM1;NUP88;NUP155;EIF6;POM121;NUP54;SEH1L;RANBP2;NUP214;RAE1;NUP210;NUP188
gsea,protein polymerization (GO:0051258),-0.7335293255442067,-2.388763433162108,0.0,0.0,0.0,5/24,4.43%,UBE2S;UBE2C;DIAPH3;CKAP5;PIN1
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.6727633695339967,-2.3880787052194883,0.0,0.0,0.0,13/35,18.02%,CDK1;CCNB1;CDK4;MED30;CDKN1A;TRIM28;BAX;CDKN2A;PAXIP1;MED4;MED14;MED8;CEBPB
gsea,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.8991428301969187,-2.3839034564685853,0.0,0.0,0.0,14/17,9.43%,CENPF;FBXO5;MAD2L1;PLK1;BUB3;BUB1;BUB1B;CDC20;TRIP13;TTK;KNTC1;MAD1L1;ZWINT;ZW10
gsea,positive regulation of cellular protein metabolic process (GO:0032270),-0.6217132927590996,-2.382711408205356,0.0,0.0,0.0,30/56,24.60%,PLK1;HSP90AA1;HNRNPD;UHRF1;RPS27L;EIF4A3;STUB1;NPM1;EIF3C;FAF1;EIF4G1;EIF6;AKT1;EZR;HDAC2;PASK;RDX;FMR1;UPF3B;EIF3D;VPS35;VIM;LARP4B;FADD;METTL14;BAK1;NSUN5;MTOR;CLN6;METTL5
gsea,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.8137949499462459,-2.380496819056195,0.0,0.0,0.0,15/25,10.43%,RRM2;FBXO5;TYMS;CDC45;PCNA;E2F7;POLA1;DHFR;CDC6;TFDP1;CCNE1;CDT1;ORC1;ID2;E2F1
gsea,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.7960338025259039,-2.3789419250763113,0.0,0.0,0.0,10/22,5.42%,CDK1;PLK1;CLSPN;FZR1;BRCA1;TICRR;BLM;TOPBP1;CDKN1A;DTL
gsea,organelle organization (GO:0006996),-0.4872646118385254,-2.375775678450666,0.0,0.0,0.0,97/211,39.07%,CDCA8;PPIA;DIAPH3;CEP55;CENPW;CYCS;MTFR2;MNS1;ODF2;STOML2;CFL1;CENPT;PARK7;PHB2;ZW10;CHCHD10;NUMA1;PARP1;LMAN2;TMED2;LNPK;LMAN1;PHB;FANCG;LONP1;MTX2;TFAM;PRPF40A;PPID;NRF1;MTX1;HCFC1;PHIP;PITPNB;HAX1;MAST2;NSFL1C;CLASP2;SYNE3;ATP8B4;GABPA;FMNL3;PI4K2B;OPTN;PEX7;DIAPH1;TFB1M;ATAD3A;ARHGAP10;CLASP1;CEP78;PRDX3;ARL1;ATL2;AGTPBP1;DYRK3;RHOT2;PACSIN2;TPM1;TMED1;MTFR1;NPLOC4;DNAJA3;DYM;GABPB1;BAG5;HUWE1;GORASP2;YME1L1;BNIP1;SMPD4;EPS15;PEX3;GAK;CLUH;KLHL20;DPYSL2;POLRMT;SEC23IP;ARHGAP21;UBXN2B;ZMYM3;HACE1;PAK4;GOLGA2;SPRYD3;DYNC2H1;OPA1;BCS1L;CCL3;PTCD2;HTT;GBF1;FBXW8;LARP4;RAB3GAP1;WDR73
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.47613589182945165,-2.3752422236347526,0.0,0.0,0.0,70/228,27.84%,HMGB2;BIRC5;CENPF;GMNN;EZH2;SET;PA2G4;CBX5;BRCA1;FOXM1;SUV39H1;CTCF;CBX3;NONO;HDAC1;TRIM28;ENO1;KMT5A;CDKN2A;SUV39H2;PHB2;HSPA8;ID2;SMARCA4;E2F1;SFPQ;SMARCC2;TIMELESS;EED;HDAC2;BCLAF1;PHB;CALR;SIN3A;NAB1;NCOR2;ILF3;XRCC5;MYBBP1A;TFDP2;BRD7;SHC1;SAMD1;L3MBTL2;MT3;CBY1;RBM15;SETDB2;KAT7;PIAS4;RPS6KA5;POU2F1;MDM2;XRCC6;KDM8;RB1;IFNG;PHF10;FOXK2;TLE5;ELK3;MYB;HDAC6;DMAP1;SFMBT1;HMGA1;CCAR2;LANCL2;LBH;PSPC1
gsea,nucleobase-containing small molecule interconversion (GO:0015949),-0.8437639243451701,-2.3733272935635035,0.0,0.0,0.0,10/18,10.67%,RRM2;RRM1;TYMS;DUT;DTYMK;NME1;NME2;AK6;AK2;GSR
gsea,error-prone translesion synthesis (GO:0042276),-0.8423452266862317,-2.3725881508908677,0.0,0.0,0.0,12/18,11.42%,RFC4;RFC5;RPA3;PCNA;UBB;RFC2;RPA2;RPA1;RFC3;RFC1;POLH;POLE2
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.6133979319187031,-2.3683895140007603,0.0,0.0,0.0,24/59,15.36%,PIN1;PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;RUVBL1;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,regulation of telomere maintenance via telomerase (GO:0032210),-0.705818900447284,-2.3654874695730768,0.0,0.0,0.0,18/34,16.61%,AURKB;NEK2;HNRNPU;TCP1;TINF2;CCT8;CCT6A;CTC1;HNRNPA1;CCT7;CCT3;CCT2;PIF1;CCT5;HNRNPC;CCT4;ATR;XRCC5
gsea,mitotic spindle checkpoint signaling (GO:0071174),-0.8980116193086258,-2.3607689138822376,0.0,0.0,0.0,13/16,9.43%,CENPF;MAD2L1;PLK1;BUB3;BUB1;BUB1B;CDC20;TRIP13;TTK;KNTC1;MAD1L1;ZWINT;ZW10
gsea,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.8980116193086258,-2.3607689138822376,0.0,0.0,0.0,13/16,9.43%,CENPF;MAD2L1;PLK1;BUB3;BUB1;BUB1B;CDC20;TRIP13;TTK;KNTC1;MAD1L1;ZWINT;ZW10
gsea,spindle assembly checkpoint signaling (GO:0071173),-0.8980116193086258,-2.3607689138822376,0.0,0.0,0.0,13/16,9.43%,CENPF;MAD2L1;PLK1;BUB3;BUB1;BUB1B;CDC20;TRIP13;TTK;KNTC1;MAD1L1;ZWINT;ZW10
gsea,regulation of cellular amine metabolic process (GO:0033238),-0.7933732474710281,-2.358730381857127,0.0,0.0,0.0,24/27,18.21%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;AZIN1;ODC1
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.44703780417967426,-2.356562560147369,0.0,0.0,0.0,134/427,29.35%,HMGB2;BIRC5;AURKB;HMGB1;CENPF;PLK1;GMNN;EZH2;SET;PA2G4;UHRF1;E2F8;CBX5;UBB;BRCA1;HDGF;E2F7;FOXM1;SUV39H1;HNRNPU;CTCF;CBX3;NONO;LYAR;HDAC1;TRIM28;ENO1;TCERG1;KMT5A;C1QBP;SAP30;CDKN2A;SUV39H2;PHB2;HSPA8;DDX20;TAF1;RIF1;ID2;SMARCA4;MAZ;E2F1;PARP1;SFPQ;SMARCC2;TIMELESS;ORC2;EZR;EED;HDAC2;NOC2L;BCLAF1;CNBP;MTF2;PHB;SMYD2;MCPH1;PPID;TCF3;SP2;MTA1;CALR;IRF8;SIN3A;HCFC1;TRIM37;NAB1;MTDH;NCOR2;ILF3;XRCC5;MYBBP1A;DNAJB1;TFDP2;BRD7;CEBPB;DCAF1;EHMT2;SHC1;SAMD1;SREBF2;L3MBTL2;MT3;CBY1;RBM15;SETDB2;KAT7;PIAS4;URI1;RPS6KA5;POU2F1;MDM2;LARP7;CREB1;TAF3;SAP130;XRCC6;KDM8;MTA2;RB1;GLIS1;FLNA;CNOT1;IFNG;PHF10;FOXK2;TLE5;GATAD2B;ELK3;MDM4;MYB;HDAC6;ATF4;WWOX;NFX1;E2F6;DMAP1;HSF1;RUNX3;SFMBT1;IRF2BP1;DNAJA3;RIPPLY3;HMGA1;CCAR2;LANCL2;LBH;PSPC1;PRDM1;BPTF;HINFP;SIRT6;YY1;USP47
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.6807947050923636,2.3562383902118165,0.0,0.0,0.0,19/37,18.38%,S1PR4;PTGER2;ADGRG1;S1PR1;RAMP3;RAMP1;TBXA2R;PTGER4;CALCB;CALCA;ADORA2A;ADRB2;ADM;LPAR3;S1PR2;ADGRG3;CXCL9;GLP1R;ADGRE5
gsea,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.7458738259411772,-2.354501678231201,0.0,0.0,0.0,14/29,10.47%,RFC4;RFC5;RPA3;PCNA;UBB;RFC2;RPA2;RPA1;POLD2;RFC3;POLD1;RFC1;POLD3;PARP1
gsea,protein K63-linked ubiquitination (GO:0070534),-0.7233547328777202,-2.351656356954698,0.0,0.0,0.0,12/23,14.69%,UBE2S;UBE2T;STUB1;RNF126;PRPF19;RNF5;RNF168;UBE2N;ZFP91;NEDD4;UBE2E3;TRAF2
gsea,positive regulation of response to DNA damage stimulus (GO:2001022),-0.6693006858635429,-2.34879127269658,0.0,6.976568403948379e-06,0.001,16/34,18.71%,PCNA;SMCHD1;BRCA1;NSMCE4A;ANKLE1;TRIM28;DHX9;NSMCE1;RNF168;UBE2N;BCLAF1;FMR1;BRCC3;ATR;ABRAXAS1;EEF1E1
gsea,ribonucleoprotein complex assembly (GO:0022618),-0.6551826257360256,-2.3464029425873654,0.0,6.946235497844255e-06,0.001,48/87,19.58%,SNRPD1;SNRPE;HSP90AA1;PTGES3;RPS27L;DDX39B;SNRPB;SNRPF;SNRPD3;SRSF9;HSP90AB1;SRSF10;GEMIN6;DHX9;USP39;PRPF19;SCAF11;DDX20;MRPL20;SF3A2;SRSF1;EIF6;EIF4H;DDX1;SART3;GEMIN2;CPSF6;NCBP1;DENR;CLNS1A;EIF3A;RPS15;SRPK1;MRPS7;SRSF6;SNRNP200;STRAP;SART1;BRIX1;EIF2D;EIF5;RPL23A;XRCC5;EIF2S2;LUC7L;PRMT5;TARBP2;SMN1
gsea,mitochondrial translation (GO:0032543),-0.651848056405165,-2.344794397897475,0.0,6.916165214303804e-06,0.001,45/63,26.32%,MRPL18;MRPL51;MRPL42;MRPL28;MRPL12;CHCHD1;MRPL13;MRPL17;MRPL49;MRPL20;MRPL40;MRPS12;MRPL15;MRPL53;MRPL55;TSFM;MRPL35;MRPL39;GADD45GIP1;MRPS28;MRPS5;MRPS7;MRPL2;MRPS10;MRPS18A;MRPL37;TUFM;MRPL22;MRPS25;MRPL16;MRPL11;MRPS22;GFM1;MRPL1;MRPS31;MRPL45;MRPS35;MRPS18B;DAP3;MRPL3;MRPS27;MRPL44;MRPS2;PTCD3;QRSL1
gsea,ATP-dependent chromatin remodeling (GO:0043044),-0.7155243043128533,-2.3444350669029697,0.0,6.886354157345597e-06,0.001,15/30,12.85%,ANP32E;RBBP4;NASP;SMARCC1;HDAC1;ACTB;ACTL6A;SMARCA5;PBRM1;MBD3;SMARCA4;SMARCC2;SMARCB1;HNRNPC;HDAC2
gsea,Fc receptor signaling pathway (GO:0038093),-0.583269022328438,-2.342878412161828,0.0,6.8567989892883205e-06,0.001,26/64,22.77%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;PPP3CB;SHC1;PSME2;PDPK1
gsea,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.6291810658126825,-2.3426995757518263,0.0,6.8274964295050365e-06,0.001,18/46,14.92%,CDK4;KIF14;E2F7;TFDP1;CDKN2C;CDKN1A;RBL1;CDKN2D;CDKN2A;EIF4G1;ID2;E2F1;AKT1;WEE1;PSME3;RDX;LSM11;PTPN6
gsea,error-free translesion synthesis (GO:0070987),-0.8442297792365473,-2.3424941933563246,0.0,6.798443253209271e-06,0.001,12/18,8.88%,RFC4;RFC5;RPA3;PCNA;UBB;RFC2;RPA2;RPA1;RFC3;POLD1;RFC1;POLH
gsea,regulation of programmed cell death (GO:0043067),-0.5218919856698347,-2.3389381167780594,0.0,6.769636290271943e-06,0.001,25/101,17.54%,BIRC5;ANP32B;ANP32E;HSP90AA1;ACTN4;NUP62;NME1;NME2;BAX;PRELID1;TARDBP;AKT1;SKP2;PHB;DDX42;PSMC5;NAE1;TRAF2;PTPN6;CALR;RSL1D1;APEX1;RBM25;HAX1;PIDD1
gsea,peptidyl-serine phosphorylation (GO:0018105),-0.5483554373157938,-2.338562984415457,0.0,6.741072424068264e-06,0.001,23/81,22.80%,CDK1;PLK1;CLSPN;MASTL;AURKA;TTK;STK39;CDK2;TAF1;CDC7;AKT1;VRK1;ATR;ROCK2;MAST2;CSNK2A2;VRK3;ROCK1;RPS6KA5;PRKCE;MAP4K1;PDPK1;MTOR
gsea,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.7340432400788732,-2.338369719185148,0.0,6.712748590353692e-06,0.001,14/30,10.47%,RFC4;RFC5;RPA3;PCNA;UBB;RFC2;RPA2;RPA1;POLD2;RFC3;POLD1;RFC1;POLD3;PARP1
gsea,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.7878321182500397,-2.3381621840578837,0.0,6.6846617761681114e-06,0.001,13/22,12.92%,UBE2C;FBXO5;CENPE;PLK1;CCNB1;DLGAP5;ANAPC5;ESPL1;CDC6;ANAPC15;CDC23;CDK5RAP2;CDC27
gsea,nucleosome assembly (GO:0006334),-0.809944714619064,-2.336851577131741,0.0,6.656809018767411e-06,0.001,15/23,12.65%,HMGB2;ASF1B;ANP32B;NAP1L1;RBBP4;NASP;HAT1;NPM1;CHAF1A;SMARCA5;CHAF1B;SART3;BRD2;NAP1L4;ATRX
gsea,interleukin-1-mediated signaling pathway (GO:0070498),-0.6434622345867476,-2.3360699697596985,0.0,6.629187404581654e-06,0.001,24/48,15.36%,UBB;PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;UBE2N;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6
gsea,regulation of glycolytic process (GO:0006110),-0.6517742563207808,-2.334421194631842,0.0,6.601794068199085e-06,0.001,27/44,25.32%,NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NUP133;NUP43;NUP93;NUP205;NUP160;NUP35;PGAM1;NUP88;NUP155;EIF6;POM121;NUP54;SEH1L;RANBP2;NUP214;RAE1;NUP210;NUP188;NUP153;IFNG;ENTPD5
gsea,regulation of cellular component organization (GO:0051128),-0.5551477656483992,-2.3307605018907127,0.0,6.574626191375221e-06,0.001,25/75,25.71%,MKI67;HJURP;HSP90AA1;AURKA;SSRP1;KIF14;HNRNPU;TMEM97;NUBP1;TFRC;PARK7;HSPA8;NEDD4;TRAF2;HCFC1;ROCK2;NCLN;ROCK1;URI1;ATAD3A;MTOR;NET1;PACSIN2;METTL4;SETD1A
gsea,telomere organization (GO:0032200),-0.6879128860369556,-2.3300970015748255,0.0,6.547681002066306e-06,0.001,26/35,25.53%,RPA3;PTGES3;PCNA;RPA2;BLM;TINF2;RPA1;RAD50;POLD2;POLD1;CTC1;POLD3;RIF1;PARP1;RTEL1;DNA2;RECQL4;ATR;APEX1;XRCC5;DOT1L;DCLRE1B;NBN;XRCC6;HUS1;TERF2
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.45892819307004123,-2.325546788859869,0.0,6.520955773486443e-06,0.001,80/258,28.05%,HMGB2;HNRNPAB;ATAD2;HNRNPD;BRCA1;MED30;FOXM1;CTCF;BLM;NUP62;NUP85;SMARCC1;DNAJC2;BRCA2;ILF2;THRAP3;NPM1;HDAC1;TRIM28;PHF5A;MRPL12;NME2;TAF15;HMGN5;ID2;SMARCA4;MAZ;E2F1;MED4;AKT1;SMARCC2;SP1;MAP2K3;CDK5RAP2;ING1;HDAC2;CNBP;PHB;CHEK2;SNX5;PSMC5;TFAM;TCF3;MYBL1;MED14;HCFC1;PHIP;ILF3;PPP3CB;NAA16;BRD7;CEBPB;SHC1;NFYA;ARID1A;MT3;NAA15;NPAT;CREB1;ING5;XRCC6;KDM8;PSRC1;BRPF1;MMS19;PCID2;KLF6;TESC;FOXK2;MYB;ATF4;CEP290;RUNX3;PITHD1;TADA3;CAMKK2;HMGA1;LBH;QRICH1;SPP1
gsea,cellular component assembly (GO:0022607),-0.5140985757503076,-2.3250606851215614,0.0,6.494447823187718e-06,0.001,38/110,27.26%,ARL6IP1;RAD21;RBBP4;TRIP13;KNTC1;TINF2;PPIH;CHAF1A;SYCE2;ACTG1;ACTB;RTN3;ZW10;CHCHD10;CHAF1B;TUBGCP2;EZR;NOC2L;FANCA;CAPZA2;LCP1;TRAF2;PPID;KPNA3;LPXN;NEFH;ST13;SPG7;MDM2;SH3BP1;FLNA;MDM4;TSPAN4;ADD1;CEP290;SLC2A1;FANCC;SPTBN1
gsea,translational elongation (GO:0006414),-0.6508891467770486,-2.3247739899238935,0.0,6.468154512162666e-06,0.001,48/62,25.83%,MRPL18;MRPL51;MRPL42;MRPL28;MRPL12;CHCHD1;MRPL13;MRPL17;MRPL49;MRPL20;MRPL40;MRPS12;MRPL15;MRPL53;MRPL55;EEF1D;TSFM;MRPL35;MRPL39;GADD45GIP1;MRPS28;MRPS5;MRPS7;MRPL2;EEF1G;EEFSEC;MRPS10;LTN1;MRPS18A;MRPL37;TUFM;MRPL22;MRPS25;MRPL16;MRPL11;MRPS22;GFM1;MRPL1;MRPS31;MRPL45;MRPS35;MRPS18B;DAP3;MRPL3;MRPS27;MRPL44;MRPS2;PTCD3
gsea,establishment of protein localization to organelle (GO:0072594),-0.6372781236863161,-2.3204253275473024,0.0,6.442073243968463e-06,0.001,24/48,19.84%,RAN;NUTF2;NUP107;NUP62;NUP85;CSE1L;NUP133;IPO5;NXT1;KPNB1;NUP93;HIKESHI;PHB2;NUP88;NUP155;AKT1;POM121;IPO9;NUP214;IPO7;E2F3;IPO11;TNPO1;RALA
gsea,positive regulation of intracellular protein transport (GO:0090316),-0.5543011324492999,-2.3201731537446157,0.0,6.416201463872203e-06,0.001,27/71,26.04%,RAN;ANP32B;KIF20B;ECT2;GTSE1;SAE1;TFDP1;YWHAE;PCNT;TRIM28;GZMB;IPO5;E2F1;ZDHHC2;HRAS;TFDP2;HTRA2;NMT1;SREBF2;CSNK2A2;XPO4;PCM1;FLNA;C2CD5;IFNG;DMAP1;CEP290
gsea,regulation of nervous system development (GO:0051960),-0.7824221746117063,-2.3200384363561213,0.0,6.390536658016715e-06,0.001,2/16,3.12%,HMGB2;KIF14
gsea,nucleus organization (GO:0006997),-0.7457171340785426,-2.3193913189105095,0.0,6.365076352606289e-06,0.001,13/21,18.34%,CEP55;REEP4;NDC1;NUP133;NUP93;NUP205;NUP35;NUP155;NUMA1;NUP54;SEH1L;PITPNB;SUN2
gsea,regulation of nucleic acid-templated transcription (GO:1903506),-0.4830063637292838,-2.314750543164731,0.0,6.33981811311182e-06,0.001,61/177,27.84%,EZH2;HINT1;YBX1;HNRNPD;MYBL2;NSD2;NUP107;ACTN4;NONO;SRRT;BRCA2;FUS;MLF1;SRSF10;SAP30;NUP35;LIN54;NFYB;ZNHIT3;HMGN5;CCAR1;E2F1;SFPQ;SP1;ATRX;CNBP;MTF2;HP1BP3;PHB;CHEK2;POLR2A;TCF3;PPIE;MYBL1;CALR;HCFC1;TAF5;NAB1;MYBBP1A;NFYC;MYCBP;CEBPB;PRMT5;NFYA;PHF19;KAT7;RPS6KA5;TAF6L;UTP4;RB1;PTP4A3;OGG1;FOXK2;MYB;ATF4;NFX1;RUNX3;NFKB2;HMGA1;CCAR2;PSPC1
gsea,small GTPase mediated signal transduction (GO:0007264),-0.5748758717258136,-2.3141184602314233,0.0,6.314759543494777e-06,0.001,15/56,24.77%,CCNA2;DNMT1;G3BP1;CDKN1A;TRIM28;CDKN2A;PARK7;CDK2;HRAS;SHC1;RALA;RB1;SETDB1;RHEBL1;SHOC2
gsea,regulation of purine nucleotide metabolic process (GO:1900542),-0.7116332026952388,-2.3125212165429256,0.0,6.289898285449522e-06,0.001,24/31,21.92%,NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NUP133;NUP43;NUP93;NUP205;NUP160;NUP35;PGAM1;NUP88;NUP155;EIF6;POM121;NUP54;SEH1L;RANBP2;NUP214;RAE1;NUP210;NUP188
gsea,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.8709910623268697,-2.311844305839538,0.0,6.2652320176634455e-06,0.001,12/15,9.51%,CDK1;FBXO5;CCNB1;CDC25B;CDK4;ATAD5;DTL;CDC25C;NPM1;CDC25A;RCC2;CDC7
gsea,DNA geometric change (GO:0032392),-0.7685994842680801,-2.311593692861878,0.0,6.240758455094448e-06,0.001,13/21,14.61%,HMGB2;HMGB1;HNRNPA2B1;HMGB3;BLM;RAD50;DHX9;PIF1;DDX1;ZRANB3;RTEL1;DNA2;RECQL4
gsea,regulation of generation of precursor metabolites and energy (GO:0043467),-0.6878976075981155,-2.310409892458344,0.0,6.216475348265286e-06,0.001,24/35,21.92%,NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NUP133;NUP43;NUP93;NUP205;NUP160;NUP35;PGAM1;NUP88;NUP155;EIF6;POM121;NUP54;SEH1L;RANBP2;NUP214;RAE1;NUP210;NUP188
gsea,peptidyl-proline modification (GO:0018208),-0.774469353316628,-2.3077912681990975,0.0,6.192380482574335e-06,0.001,12/18,17.98%,PPIA;PIN1;PPIL1;FKBP4;PPIH;PPIG;PPIF;PPWD1;PPID;PPIE;FKBP5;CWC27
gsea,establishment of mitotic spindle localization (GO:0040001),-0.7809539250997738,-2.306512410693011,0.0,6.168471677622312e-06,0.001,14/22,12.48%,NUSAP1;MAD2L1;PLK1;NDC80;CENPA;SAPCD2;SPDL1;ESPL1;GPSM2;NDE1;KPNB1;ZW10;NUMA1;CDK5RAP2
gsea,positive regulation of viral process (GO:0048524),-0.6726131404237073,-2.3064661827658117,0.0,6.144746786554533e-06,0.001,21/35,19.28%,KPNA2;PPIA;PPIH;POLR2C;NELFE;POLR2F;DHX9;RAD23A;POLR2L;POLR2B;NELFCD;SRPK1;POLR2A;PPID;DDB1;PPIE;POLR2E;GTF2F1;GTF2F2;TARBP2;POLR2H
gsea,positive regulation of developmental process (GO:0051094),-0.5413440241373267,-2.305623480300116,0.0,6.121203695418309e-06,0.001,22/73,24.52%,FBXO5;CDC20;PA2G4;AURKA;HSP90AB1;CFL1;TFRC;C1QBP;RIF1;CORO1C;NUMA1;PAXIP1;FMR1;VPS35;CEBPB;CLASP2;RALA;ZDHHC6;CLASP1;KMT5C;LRP8;ZBED3
gsea,ncRNA export from nucleus (GO:0097064),-0.7438614763289946,-2.3036989274880297,0.0,6.097840322535032e-06,0.001,22/31,16.75%,RAN;NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NPM1;NUP133;NUP43;NUP93;NUP205;NUP160;NUP35;SSB;NUP88;NUP155;POM121;NUP54;SEH1L;RANBP2;NUP214
gsea,"DNA-templated transcription, termination (GO:0006353)",-0.6411061950766925,-2.2982700913299134,0.0,6.074654617886611e-06,0.001,28/47,25.65%,SNRPE;SLBP;SNRPB;SNRPF;SNRPD3;TTF2;POLR3K;POLR2F;POLR2L;MAZ;CPSF2;NCBP1;CPSF1;LSM11;POLR2A;CPSF4;POLR2E;CSTF2;PRMT5;POLR2H;SMN1;SYMPK;CPSF3;TBP;SETX;NCBP2;CSTF1;GTF2H4
gsea,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.7540630868291939,-2.2976875597490776,0.0,6.028808167940297e-06,0.001,21/28,16.75%,RAN;NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NUP133;NUP43;NUP93;NUP205;NUP160;NUP35;SSB;NUP88;NUP155;POM121;NUP54;SEH1L;RANBP2;NUP214
gsea,tRNA export from nucleus (GO:0006409),-0.7540630868291939,-2.2976875597490776,0.0,6.028808167940297e-06,0.001,21/28,16.75%,RAN;NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NUP133;NUP43;NUP93;NUP205;NUP160;NUP35;SSB;NUP88;NUP155;POM121;NUP54;SEH1L;RANBP2;NUP214
gsea,neuron projection development (GO:0031175),-0.5451904326786302,-2.2972626785693406,0.0,6.006143475579619e-06,0.001,11/75,20.07%,STMN1;HMGB1;KIF20B;UBB;PRMT1;MANF;NEDD4;MAP4;NEFH;ROCK1;SRGAP2
gsea,ncRNA processing (GO:0034470),-0.5861069026836607,-2.293441104341592,0.0,5.983648556195426e-06,0.001,90/138,28.92%,EXOSC8;HNRNPA2B1;SNU13;LYAR;RPP30;SRRT;PIH1D1;RPS17;FBL;EXOSC3;SSB;NOP56;POP4;DDX27;NOLC1;NOP58;RPS2;EXOSC7;EMG1;INTS11;MRTO4;RPL14;WDR18;PELP1;POP5;EXOSC9;DGCR8;EBNA1BP2;RPS15;DIS3;NOC4L;MTREX;TBL3;UTP3;EXOSC4;RRP1;RPS25;NOL11;DKC1;ZCCHC8;EXOSC1;EXOSC5;EXOSC2;RPL23A;UTP11;RRP1B;UTP18;TARBP2;WDR74;RPL31;IMP4;UTP6;WDR36;WDR75;MPHOSPH6;UTP4;RPS6;WDR46;UTP15;DDX47;RPL4;NVL;WDR43;DCAF13;HEATR1;EXOSC10;BOP1;INTS10;BMS1;INTS1;UTP20;MRPL44;DDX52;NOP14;FCF1;ESF1;RPF1;INTS3;PES1;LAS1L;INTS5;DROSHA;PDCD11;INTS7;WDR12;HELQ;DDX49;INTS8;DDX10;THG1L
gsea,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.6923597976391217,-2.2911572879490056,0.0,1.1922643018687899e-05,0.002,6/23,10.30%,FBXO5;PLK1;PIN1;PARK7;RPS2;UBE2N
gsea,regulation of microtubule cytoskeleton organization (GO:0070507),-0.7625454312488594,-2.290257922145035,0.0,1.1878320925681626e-05,0.002,4/18,3.59%,STMN1;SKA1;SKA2;SKA3
gsea,chromatin remodeling (GO:0006338),-0.5753663624383909,-2.289778302158995,0.0,1.1834327144475396e-05,0.002,33/70,25.59%,RBBP4;CBX3;SMARCC1;BAZ1B;NPM1;NUDT5;HDAC1;POLE3;NPM3;PIH1D1;ACTB;ACTL6A;RUVBL2;SMARCA5;SUV39H2;PBRM1;MBD3;SMARCA4;SMARCC2;SMARCB1;HNRNPC;RUVBL1;ATRX;HDAC2;HCFC1;CHD1L;ARID1A;TAF6L;MTA2;RB1;TADA2A;GATAD2B;MYB
gsea,tRNA transport (GO:0051031),-0.747404255115635,-2.289225104334671,0.0,1.1790658040621244e-05,0.002,22/30,16.75%,RAN;YBX1;NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NUP133;NUP43;NUP93;NUP205;NUP160;NUP35;SSB;NUP88;NUP155;POM121;NUP54;SEH1L;RANBP2;NUP214
gsea,negative regulation of supramolecular fiber organization (GO:1902904),-0.6273751372861563,-2.289022464646472,0.0,1.174731003311896e-05,0.002,13/34,23.37%,STMN1;TPX2;PFN1;PFDN6;HSPA8;CORO1A;MID1IP1;KATNB1;CLASP2;VBP1;CLASP1;FGF13;PFDN4
gsea,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.7667464862614775,-2.2859312982656705,0.0,1.1704279593437207e-05,0.002,15/23,16.61%,AURKB;NEK2;HNRNPA2B1;TCP1;CCT8;CCT6A;HNRNPA1;CCT7;CCT3;CCT2;CCT5;RTEL1;CCT4;ATR;XRCC5
gsea,"protein localization to chromosome, centromeric region (GO:0071459)",-0.8923837971662878,-2.285727613432643,0.0,1.1661563244556048e-05,0.002,13/15,9.43%,CDK1;AURKB;KNL1;BUB3;CENPA;TTK;SPDL1;ZWILCH;CTCF;HASPIN;MIS12;MTBP;ZW10
gsea,regulation of carbohydrate catabolic process (GO:0043470),-0.7169936156551074,-2.2827672982009775,0.0,1.1619157560030391e-05,0.002,24/30,21.92%,NDC1;AAAS;NUP107;NUP37;NUP62;NUP85;NUP133;NUP43;NUP93;NUP205;NUP160;NUP35;PGAM1;NUP88;NUP155;EIF6;POM121;NUP54;SEH1L;RANBP2;NUP214;RAE1;NUP210;NUP188
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),-0.569092185606677,-2.2816960829511252,0.0,1.1577059163073759e-05,0.002,26/64,22.77%,PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;PPP3CB;SHC1;PSME2;PDPK1
gsea,regulation of proteasomal protein catabolic process (GO:0061136),-0.683838452820144,-2.281185824870384,0.0,1.153526472566194e-05,0.002,17/28,21.79%,UBB;UCHL5;USP14;HSP90AB1;RAD23A;XPO1;ALAD;PSMC2;PSMD14;PSME3;FMR1;PSMC5;PSMC6;RAD23B;GLMN;PSME2;DESI1
gsea,negative regulation of translation (GO:0017148),-0.6083658126382641,-2.2803096727556946,0.0,1.1493770967655961e-05,0.002,20/50,20.74%,TYMS;YBX1;DHFR;NCL;EIF4A3;GAPDH;GZMB;MRPL13;SHMT1;SYNCRIP;FMR1;CAPRIN1;CNOT9;CNOT10;CALR;ILF3;ROCK2;METTL14;ROCK1;METTL16
gsea,regulation of cell growth (GO:0001558),-0.508023131577011,-2.279612143413115,0.0,1.71788619839159e-05,0.003,41/104,31.49%,RBBP7;KIF14;CDKN2C;TMEM97;NUBP1;CDKN1A;ENO1;CDKN2D;HDGFL2;TFRC;FXN;CDKN2A;EIF4G1;DERL2;SMARCA4;AKT1;EXOSC9;NCBP1;ING1;EIF4G2;PHB;EXOSC4;EXOSC2;MT3;URI1;ATAD3A;NME6;MTOR;JADE1;RB1;PSRC1;NET1;EI24;DCBLD2;CCAR2;ADAM17;DDX49;USP47;DDX3X;HSPA1B;DNPH1
gsea,protein depolymerization (GO:0051261),-0.7692950522402449,-2.2782035728694687,0.0,2.2823345207202553e-05,0.004,8/18,11.07%,STMN1;KIF2C;CKAP5;KIF18B;KIF14;KIF18A;CFL1;KIF24
gsea,cellular response to radiation (GO:0071478),-0.6987352998720782,-2.2735251913193397,0.0,2.842765417267222e-05,0.005,10/24,15.27%,RAD51;RAD51AP1;ECT2;FIGNL1;BLM;CDKN1A;RHNO1;EEF1D;SPIDR;RAD9A
gsea,intracellular protein transport (GO:0006886),-0.4904764840952218,-2.27349812141754,0.0,2.832684688837196e-05,0.005,55/158,27.39%,RAN;NUTF2;NUP107;NUP62;NUP85;CSE1L;ANKLE1;NPM1;NUP133;IPO5;NXT1;KPNB1;NUP93;HIKESHI;XPO1;ADPRH;PHB2;NUP88;NUP155;IFT27;AKT1;TMED2;POM121;LMAN1;TBC1D10B;VPS35;IPO9;EIF2D;CALR;NUP214;IPO7;E2F3;CLTC;KATNB1;IPO11;TNPO1;CCHCR1;RANBP3;XPO4;COX18;ARCN1;DESI1;NUP188;GIPC1;ARL1;C2CD5;NUP153;RPAIN;XPO7;TMED1;XPO5;HDAC6;AP3D1;SIL1;RABL3
gsea,plasma membrane bounded cell projection organization (GO:0120036),-0.5701808443470192,-2.269591042363001,0.0,2.8226752023042025e-05,0.005,13/59,25.14%,STMN1;HMGB1;MNS1;PRMT1;ODF2;MANF;NEDD4;MAP4;ROCK1;CEP78;PLEK;RB1;TPM1
gsea,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.787782777694227,-2.263593363558192,0.0,3.375283446135589e-05,0.006,5/16,4.81%,STMN1;SKA1;SKA2;SKA3;FKBP4
gsea,positive regulation of cellular biosynthetic process (GO:0031328),-0.5261654238918907,-2.262294185248811,0.0,3.363440346324586e-05,0.006,37/95,26.14%,HSP90AA1;HNRNPD;PCNA;RPS27L;ATAD5;EIF4A3;PRMT1;NPM1;HSP90AB1;EIF3C;DHX9;CDT1;CTC1;FAF1;PARK7;EIF6;AKT1;SP1;PASK;DNA2;FMR1;UPF3B;EIF3D;DDB1;VIM;STARD4;MID1IP1;LARP4B;KAT7;METTL14;NSUN5;GIPC1;MTOR;METTL5;IFNG;PAOX;LDLR
gsea,positive regulation of DNA metabolic process (GO:0051054),-0.6306411792081571,-2.2615532741158955,0.0,3.351680065393382e-05,0.006,19/39,23.70%,HMGB1;RAD51;PCNA;SMCHD1;BRCA1;RAD50;TRIM28;DHX9;RNF168;UBE2N;ATRX;RTEL1;BRCC3;APLF;ABRAXAS1;ZCWPW1;NBN;RNF8;WRAP53
gsea,mRNA stabilization (GO:0048255),-0.7520166294477004,-2.2611853200494334,0.0,3.3400017376393976e-05,0.006,12/22,11.74%,YBX1;HNRNPU;THRAP3;FUS;DHX9;TAF15;YBX3;HNRNPA0;SYNCRIP;E2F1;TARDBP;HNRNPC
gsea,termination of RNA polymerase II transcription (GO:0006369),-0.731792647982015,-2.2611725240523035,0.0,3.328404509383705e-05,0.006,18/21,24.82%,SNRPE;SLBP;SNRPB;SNRPF;SNRPD3;TTF2;MAZ;CPSF2;NCBP1;CPSF1;LSM11;CPSF4;CSTF2;SYMPK;CPSF3;SETX;NCBP2;CSTF1
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),-0.49982582588000146,-2.2568159895103235,0.0,3.3168875387630004e-05,0.006,40/108,30.23%,PIN1;PSMB6;PSMB2;HDAC1;PSMB5;PSMA3;RUVBL2;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;RUVBL1;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;FRMD8;PSME2;USP34;JADE1;ZBED3;TLE5;CUL3;CCAR2;STK3;VCP;USP47;DDX3X;USP8;UBR5
gsea,regulation of protein localization to nucleus (GO:1900180),-0.6740946406272955,-2.256684607826399,0.0,3.3054499955258866e-05,0.006,9/27,16.20%,CDK1;PLK1;GTSE1;PIN1;TFRC;PARK7;AKT1;SIN3A;SUMO3
gsea,protein stabilization (GO:0050821),-0.5136047352377369,-2.253525100520551,0.0,3.8431062376389175e-05,0.007,44/99,29.40%,HSP90AA1;PTGES3;GTSE1;TCP1;PIN1;CDKN1A;HSPD1;GAPDH;PFN1;MCM8;CCT8;HSP90AB1;CCT6A;PARK7;PHB2;CCT7;CCT3;TAF1;CCT2;CCT5;PHB;CHEK2;CCT4;CALR;HCFC1;NCLN;NAA16;MT3;NAA15;FLOT2;BAG4;TAF9;CREB1;FLNA;ZBED3;TESC;MDM4;USP7;RABL3;IFT46;BAG5;STK3;GTPBP4;WIZ
gsea,positive regulation of mitotic nuclear division (GO:0045840),-0.7303854929975064,-2.2502450281160815,0.0,3.829944914907278e-05,0.007,10/21,16.62%,NUSAP1;DLGAP5;AURKA;ANAPC5;ESPL1;NUP62;CDC23;CDC27;PHIP;CDC16
gsea,regulation of DNA metabolic process (GO:0051052),-0.6814934132537707,-2.2483355448166424,0.0,3.816873430556058e-05,0.007,20/28,25.53%,ALYREF;KPNA2;NUCKS1;USP1;HNRNPD;TICRR;CDT1;POLH;PIF1;UBE2N;WDR18;XRCC5;HELB;WRNIP1;KAT7;NBN;YLPM1;SUB1;UBE2V2;TERF2
gsea,"base-excision repair, gap-filling (GO:0006287)",-0.7940714111846263,-2.245402280272129,0.0,4.8907168301148325e-05,0.008,18/26,11.67%,FEN1;RFC4;RFC5;RPA3;LIG1;PCNA;RFC2;RPA2;RPA1;POLE;POLD2;RFC3;POLD1;RFC1;POLD3;PARP1;XRCC1;MBD4
gsea,regulation of DNA recombination (GO:0000018),-0.7297673832900419,-2.245053883869287,0.0,4.8741381289957994e-05,0.008,12/24,14.44%,ALYREF;KPNA2;RAD51;RAD51AP1;FIGNL1;RPA2;BLM;RAD50;ZRANB3;CHEK1;RTEL1;SPIDR
gsea,establishment of spindle orientation (GO:0051294),-0.7644489731771926,-2.244800882054255,0.0,4.85767144612757e-05,0.008,14/20,17.45%,MAD2L1;PLK1;NDC80;CENPA;SAPCD2;SPDL1;GPSM2;NDE1;ZW10;NUMA1;CDK5RAP2;MAP4;DCTN1;NSFL1C
gsea,snRNA transcription by RNA polymerase II (GO:0042795),-0.5897856496985209,-2.244612853069889,0.0,4.8413156500126625e-05,0.008,30/47,30.35%,SRRT;POLR2C;POLR2F;POLR2L;INTS11;TAF6;SP1;NCBP1;POLR2B;POLR2A;GTF2E2;RPRD1B;TAF5;POLR2E;GTF2F1;GTF2F2;POLR2H;TBP;POU2F1;TAF9;INTS10;INTS1;NCBP2;INTS3;CCNK;INTS5;INTS7;INTS8;INTS14;INTS4
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.6951431947027459,-2.2445923643920307,0.0,4.825069624341479e-05,0.008,20/30,24.77%,SHCBP1;HNRNPF;POLR2C;POLR2F;CEP57;HNRNPA1;POLR2L;HNRNPH1;NCBP1;POLR2B;PTBP1;HNRNPM;POLR2A;POLR2E;GTF2F1;GTF2F2;POLR2H;SETX;NCBP2;SHOC2
gsea,epithelium development (GO:0060429),-0.5993754011683353,-2.243369560088345,0.0,4.808932267738331e-05,0.008,9/44,11.31%,CDK1;TAGLN2;PCNA;STIL;PIH1D1;MTHFD1;PGK1;VDAC1;TIMELESS
gsea,calcium ion transport (GO:0006816),0.6273839595327603,2.2387473158671742,0.0,0.0018567210542706554,0.006,19/41,12.03%,TPT1;CCL5;ORAI1;ATP2A3;ORAI2;ATP2B2;P2RX4;TRPV2;CCR5;RAMP3;RAMP1;TRPM1;STIM2;PSEN2;MCOLN2;RYR1;TRPA1;CRACR2A;ITPR1
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.6973471310749568,-2.2355606108939776,0.0,6.923081379518108e-05,0.012,14/25,16.30%,LSM2;LSM3;EXOSC8;EXOSC3;EXOSC7;LSM7;EXOSC9;DIS3;EXOSC4;CNOT9;CNOT10;EXOSC1;EXOSC5;EXOSC2
gsea,microtubule polymerization or depolymerization (GO:0031109),-0.7947413498981344,-2.2350023434715247,0.0,6.90008110915426e-05,0.012,9/16,11.76%,STMN1;KIF2C;CKAP5;KIF18B;KIF14;KIF18A;PIN1;KIF24;CENPJ
gsea,signal transduction in response to DNA damage (GO:0042770),-0.6311135264383658,-2.2347779760638637,0.0,6.877233158461695e-05,0.012,21/36,27.46%,CLSPN;BRIP1;E2F7;RHNO1;PRPF19;E2F1;PAXIP1;CHEK1;ATRX;CHEK2;RAD9A;ATR;DOT1L;RAD1;NBN;USP10;RAD17;HUS1;MDM4;DONSON;INTS7
gsea,DNA strand elongation involved in DNA replication (GO:0006271),-0.9068357275534372,-2.2330127912212716,0.0,7.909080022297915e-05,0.013,16/17,9.29%,RFC4;LIG1;PCNA;MCM7;POLA1;GINS2;GINS3;MCM3;POLE;MCM4;POLD2;GINS4;RFC3;POLE3;POLD3;GINS1
gsea,spliceosomal complex assembly (GO:0000245),-0.7033727912321273,-2.23181817734743,0.0,7.883063311698251e-05,0.013,17/29,14.43%,SNRPD1;SNRPE;DDX39B;SRSF9;SRSF10;SF3A3;USP39;PRPF19;SCAF11;SF3A2;SRSF1;DDX1;SF3A1;NCBP1;SRPK1;SRSF6;SNRNP200
gsea,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.6548068642190359,-2.227881020421781,0.0,7.857217202479567e-05,0.013,10/32,12.00%,RAN;ANP32B;ECT2;GTSE1;YWHAE;TRIM28;IPO5;DHX9;CPSF6;NEDD4
gsea,activation of protein kinase activity (GO:0032147),-0.561653917523273,-2.2261920512720415,0.0,7.831540022079307e-05,0.013,12/54,14.69%,TPX2;PPIA;CLSPN;ECT2;KIF14;BORA;PARK7;PHB2;AKT1;ZFP91;PHB;TRAF2
gsea,phosphorylation (GO:0016310),-0.4536251543520846,-2.2257106694793376,0.0,7.806030119727256e-05,0.013,69/196,35.67%,BIRC5;CDK1;AURKB;PLK1;PLK4;MELK;CDC25B;AURKA;NEK2;CDK4;CCNE1;HASPIN;STK39;BCKDK;PGK1;CDK2;TAF1;AKT1;BRD2;CHEK1;PASK;SRPK1;CHEK2;VRK1;ILF3;PPP3CB;ROCK2;MAST2;BMP2K;GK;ROCK1;RPS6KA5;PRKCE;GMFB;MAP4K1;CDK19;CREB1;PDPK1;MTOR;GNPTAB;PIK3CG;MAPK6;BIRC6;DYRK3;RUNX3;CAMKK2;CDK6;OXSR1;RYK;STK3;COPS2;GRK2;MAPKAPK2;AGK;PI4KA;CLK2;STRADA;HK1;TBCK;PRKDC;CERKL;DYRK1A;PRKAA1;CDK14;NEK1;PRKAG2;TAOK2;TLK2;PAK4
gsea,DNA duplex unwinding (GO:0032508),-0.6428492875411708,-2.224105161632493,0.0,7.780685866091779e-05,0.013,22/38,22.57%,RAD51;UBB;MCM7;BLM;RPA1;MCM4;RAD50;MCM6;DHX9;PIF1;PARP1;DDX1;MCM2;RTEL1;RECQL4;DDB1;CHD1L;RECQL;RAD23B;CUL4B;DDX11;NBN
gsea,neuron development (GO:0048666),-0.5497354411128937,-2.223515241071701,0.0,7.755505652932905e-05,0.013,13/60,28.22%,STMN1;HMGB1;PRMT1;MANF;TDP2;NEDD4;MAP4;THOC2;ROCK1;RB1;RUNX3;PBX2;RYK
gsea,regulation of gene expression (GO:0010468),-0.42437803806361646,-2.221735769815965,0.0,7.730487892762154e-05,0.013,156/453,32.69%,HNRNPAB;EZH2;HINT1;DNMT1;YBX1;HNRNPD;AURKA;CDK4;BRCA1;MYBL2;MIF;NSD2;TCF19;PCBP1;HNRNPF;CTCF;NUP107;PIN1;NONO;SNRNP70;RBL1;SRRT;BRCA2;HDAC1;FUS;MLF1;HNRNPDL;SRSF10;ACTG1;TFRC;SAP30;NUP35;SERPINB9;LIN54;PARK7;COQ7;CDK2;NFYB;YBX3;ZNHIT3;TAF1;HMGN5;ID2;CCAR1;MAZ;E2F1;HNRNPK;SLC7A5;TARDBP;SART3;KHSRP;AKT1;SFPQ;SP1;HNRNPH1;MBNL3;EZR;UBAP2;ATRX;FAM98B;HRAS;CNBP;MTF2;HP1BP3;PTBP1;PHB;CHEK2;RDX;POLR2A;FUBP1;VPS35;TCF3;CPSF4;PPIE;MYBL1;MTA1;CALR;TDG;HCFC1;TAF5;NAB1;CACTIN;MYBBP1A;ROCK2;NFYC;MYCBP;HMG20B;CEBPB;RRP1B;PRMT5;NFYA;GABPA;CPNE1;MT3;PHF19;SETDB2;FLOT2;KAT7;NPAT;ROCK1;RPS6KA5;TAF6L;GLMN;METTL16;HNRNPLL;UTP4;RBM38;HNRNPH3;MTOR;RB1;SETDB1;PTP4A3;OGG1;IFNG;TESC;FOXK2;TLE5;RAB27A;METTL4;TERF2;MYB;HDAC6;ATF4;NFX1;RUNX3;LARP1;TADA3;RBL2;NFKB2;PUM2;HMGA1;CDK6;CCAR2;PSPC1;PRDM1;HINFP;GRSF1;YY1;GON4L;DDX3X;UBR5;XDH;TNRC6A;ASCC2;HSPA1B;PRDM10;GCFC2;RPL5;CARM1;HGS;ZPR1;ERC1;CLK2;NANOS1;FADS1;TBX21
gsea,snRNA transcription (GO:0009301),-0.5846015529994166,-2.21874432206872,0.0,7.705631018508899e-05,0.013,30/48,30.35%,SRRT;POLR2C;POLR2F;POLR2L;INTS11;TAF6;SP1;NCBP1;POLR2B;POLR2A;GTF2E2;RPRD1B;TAF5;POLR2E;GTF2F1;GTF2F2;POLR2H;TBP;POU2F1;TAF9;INTS10;INTS1;NCBP2;INTS3;CCNK;INTS5;INTS7;INTS8;INTS14;INTS4
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.6227498188144585,-2.2162974472184858,0.0,7.680933483193167e-05,0.013,25/40,27.09%,SSRP1;ELOC;ELOF1;POLR2C;NELFE;POLR2F;POLR2L;IWS1;NCBP1;POLR2B;NELFCD;POLR2A;POLR2E;LEO1;GTF2F1;GTF2F2;ELP2;POLR2H;ADRM1;ELP4;PCID2;NCBP2;GTF2H4;CCNK;CTDP1
gsea,establishment of mitotic spindle orientation (GO:0000132),-0.7868354427379064,-2.2134891983601284,0.0,8.166820010245002e-05,0.014,13/17,17.45%,MAD2L1;PLK1;NDC80;CENPA;SAPCD2;SPDL1;GPSM2;NDE1;ZW10;NUMA1;CDK5RAP2;DCTN1;NSFL1C
gsea,protein localization to chromosome (GO:0034502),-0.7140058770569649,-2.211055750572307,0.0,8.140811029320655e-05,0.014,14/22,18.10%,PLK1;RAD21;CENPA;CTCF;RPA2;TINF2;RPA1;HASPIN;MCM8;ATRX;MRNIP;ATR;XRCC5;SLF1
gsea,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.7573438426751866,-2.2083568811873495,0.0,8.622152633832075e-05,0.015,13/21,16.61%,AURKB;NEK2;TCP1;CCT8;CCT6A;HNRNPA1;CCT7;CCT3;CCT2;CCT5;CCT4;ATR;XRCC5
gsea,regulation of double-strand break repair (GO:2000779),-0.6674733802036962,-2.2068854784848155,0.0,8.594867340687037e-05,0.015,11/28,14.68%,RAD51;DEK;RAD51AP1;FIGNL1;FOXM1;RPA2;TIMELESS;CHEK1;RTEL1;SPIDR;MRNIP
gsea,positive regulation of protein ubiquitination (GO:0031398),-0.6013805663291665,-2.2067921782250663,0.0,8.567754194501904e-05,0.015,13/37,15.71%,PLK1;UBB;BRCA1;PIN1;STUB1;CENPS;RPS2;FANCM;FANCI;UBE2N;PAXIP1;MTA1;HSPBP1
gsea,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.6421634798541463,-2.2062620176492196,0.0,8.540811571248753e-05,0.015,16/36,20.34%,DEK;ATAD2;CDCA4;BAZ1B;ELOF1;ACTB;POLR2F;SMARCA5;POLR2L;CHEK1;ASF1A;POLR2E;MYBBP1A;POLR2H;ARID1A;TBP
gsea,"DNA-templated transcription, elongation (GO:0006354)",-0.6163209160671065,-2.203807819636684,0.0,9.014863624161509e-05,0.016,25/41,27.09%,SSRP1;ELOC;ELOF1;POLR2C;NELFE;POLR2F;POLR2L;IWS1;NCBP1;POLR2B;NELFCD;POLR2A;POLR2E;LEO1;GTF2F1;GTF2F2;ELP2;POLR2H;ADRM1;ELP4;PCID2;NCBP2;GTF2H4;CCNK;CTDP1
gsea,regulation of cell development (GO:0060284),-0.6956208861923505,-2.2035185739381244,0.0,8.986692175336005e-05,0.016,2/21,11.06%,HMGB2;AKT1
gsea,protein modification process (GO:0036211),-0.6345258752536763,-2.2014141125930466,0.0,8.958696249556142e-05,0.016,8/34,10.55%,UBE2S;UBE2M;RPN2;ADPRH;SEPHS1;CDC34;PARP1;RPN1
gsea,monocyte chemotaxis (GO:0002548),0.7951496339304339,2.2013574565558387,0.0,0.002750697858178749,0.012,10/19,11.59%,LGALS3;CCL5;XCL1;TNFSF11;CCL1;ANXA1;CCL4;CALCA;FLT1;PDGFB
gsea,spliceosomal snRNP assembly (GO:0000387),-0.7414705520919234,-2.2012295871915013,0.0,8.930874211514042e-05,0.016,18/27,15.63%,LSM2;SNRPD1;SNRPE;SNRPB;SNRPF;SNRPD3;SRSF10;GEMIN6;PRPF19;DDX20;PRPF31;SART3;PRPF8;GEMIN2;CLNS1A;STRAP;SART1;PRPF3
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.43035674759696746,-2.200713410844717,0.0,8.903224446153317e-05,0.016,87/295,29.27%,AURKB;HMGB1;PLK1;EZH2;UHRF1;E2F8;CBX5;UBB;HDGF;E2F7;FOXM1;SUV39H1;HNRNPU;CTCF;LYAR;HDAC1;ENO1;TCERG1;KMT5A;C1QBP;SAP30;SUV39H2;DDX20;TAF1;RIF1;ID2;SMARCA4;MAZ;E2F1;PARP1;SFPQ;ORC2;EZR;NEDD4;EED;ATRX;HDAC2;NOC2L;CNBP;MTF2;PHB;SMYD2;MCPH1;PPID;TCF3;SP2;MTA1;CALR;IRF8;SIN3A;HCFC1;TRIM37;MTDH;NCOR2;DNAJB1;CEBPB;DCAF1;EHMT2;SREBF2;URI1;MDM2;LARP7;TAF3;SAP130;MTA2;RB1;GLIS1;CNOT1;IFNG;TLE5;GATAD2B;MDM4;MYB;ATF4;WWOX;NFX1;E2F6;DMAP1;HSF1;RUNX3;IRF2BP1;DNAJA3;RIPPLY3;PRDM1;BPTF;SIRT6;YY1
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.6097948511291769,2.1972065538539542,0.0,0.0023724769026791707,0.014,24/46,20.13%,S1PR4;GNA15;RGS1;PTGER2;ADGRG1;GABBR1;S1PR1;RAMP3;RAMP1;TBXA2R;PTGER4;CALCB;AKAP12;CALCA;ADORA2A;ADRB2;ADM;LPAR3;S1PR2;ADGRG3;CXCL9;GLP1R;ADGRE5;GNAT1
gsea,supramolecular fiber organization (GO:0097435),-0.47214946755395115,-2.196708835431771,0.0,9.36884232270969e-05,0.016,38/149,25.26%,STMN1;KIF2C;CKAP5;KIF18B;UBB;KIF14;FIGNL1;KIF18A;PIN1;TPM3;TPM4;HSP90AB1;TUBGCP2;CORO1C;P4HB;KIF24;CORO1A;CENPJ;TRIOBP;MYO5A;ALDOA;VIM;ELMO1;DCTN1;MPRIP;KATNB1;FLII;PCM1;MDM2;FGF13;KIF2A;SH3BP1;TUBGCP3;SLK;ZBED3;COLGALT1;TPM1;DYNC1H1
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.5362736347646873,-2.1949852666602347,0.0,9.340015115562891e-05,0.016,28/73,24.69%,HNRNPD;PCNA;RPS27L;ATAD5;EIF4A3;PRMT1;NPM1;EIF3C;DHX9;CDT1;CTC1;FAF1;EIF6;AKT1;PASK;DNA2;FMR1;UPF3B;EIF3D;VIM;LARP4B;KAT7;METTL14;NSUN5;HSPH1;MTOR;METTL5;IFNG
gsea,histone acetylation (GO:0016573),-0.5812953778155929,-2.1944293143092244,0.0,9.311364762447667e-05,0.016,24/46,26.70%,HAT1;BRCA2;POLE3;ACTL6A;BRD8;RUVBL2;NAA50;NAA40;TAF6;RUVBL1;SGF29;WDR5;TAF5;MORF4L2;KAT7;TAF6L;TAF9;ING5;JADE1;BRPF1;EP400;TADA2A;DMAP1;TADA3
gsea,T cell receptor signaling pathway (GO:0050852),-0.5342171464875836,-2.1942850485815093,0.0,9.282889640849967e-05,0.016,25/74,16.53%,PSMB6;STOML2;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;UBE2N;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;EIF2B1
gsea,regulation of mitotic spindle organization (GO:0060236),-0.705402624254541,-2.1927869753007743,0.0,9.254588148042499e-05,0.016,12/21,17.57%,TPX2;TACC3;PLK1;HNRNPU;NUP62;GPSM2;BORA;CCSAP;NUMA1;DRG1;DCTN1;CLTC
gsea,histone mRNA metabolic process (GO:0008334),-0.7494428666760153,-2.191383952691204,0.0,9.22645870078401e-05,0.016,11/19,14.09%,SNRPE;SLBP;SNRPB;SNRPF;SNRPD3;ERI1;SSB;CPSF2;NCBP1;EXOSC4;LSM11
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.767002178407825,-2.1909179143222848,0.0,9.19849973502406e-05,0.016,12/18,16.30%,LSM2;LSM3;EXOSC8;EXOSC3;EXOSC7;LSM7;EXOSC9;DIS3;EXOSC4;EXOSC1;EXOSC5;EXOSC2
gsea,telomere maintenance via telomere lengthening (GO:0010833),-0.7045918242826775,-2.189548850329309,0.0,9.17070970561311e-05,0.016,18/27,21.36%,RAD51;HSP90AA1;PTGES3;TINF2;RPA1;NHP2;RAD50;HSP90AB1;RFC1;CTC1;GAR1;CDK2;PIF1;RTEL1;DKC1;NOP10;DCLRE1B;PPP6R3
gsea,carbohydrate derivative biosynthetic process (GO:1901137),-0.7696315434082804,-2.1879277125832908,0.0,9.143087086017889e-05,0.016,6/15,12.13%,RRM2;RRM1;TPI1;TKT;ALG8;ALG6
gsea,cellular response to type I interferon (GO:0071357),0.6944721905731561,2.187752933709238,0.0,0.0015816512684527807,0.014,21/31,15.36%,SAMHD1;IRF7;IFI27;IFNAR2;STAT1;SP100;ISG20;IFITM2;IRF4;RNASEL;IFITM1;IFIT1;ISG15;GBP2;XAF1;IRF1;RSAD2;IFITM3;IRF9;OAS3;IRF5
gsea,type I interferon signaling pathway (GO:0060337),0.6944721905731561,2.187752933709238,0.0,0.0015816512684527807,0.014,21/31,15.36%,SAMHD1;IRF7;IFI27;IFNAR2;STAT1;SP100;ISG20;IFITM2;IRF4;RNASEL;IFITM1;IFIT1;ISG15;GBP2;XAF1;IRF1;RSAD2;IFITM3;IRF9;OAS3;IRF5
gsea,RNA-dependent DNA biosynthetic process (GO:0006278),-0.7209701084488963,-2.1870206156017646,0.0,9.11563036804186e-05,0.016,14/24,15.76%,PPIA;HSP90AA1;PTGES3;TINF2;RPA1;NHP2;RAD50;HSP90AB1;RFC1;GAR1;CDK2;PIF1;RTEL1;DKC1
gsea,ribosome biogenesis (GO:0042254),-0.5844651344253935,-2.1833866731979596,0.0,0.00010045005225924477,0.017,101/134,34.26%,RAN;EXOSC8;SNU13;LYAR;NPM1;PIH1D1;RPS17;FBL;EXOSC3;NOP56;XPO1;POP4;DDX27;NOLC1;NOP58;RPS2;EXOSC7;EMG1;EIF6;MRTO4;RPL14;WDR18;PELP1;POP5;EXOSC9;EBNA1BP2;GTF3A;NOC2L;RPS15;DIS3;NOC4L;MTREX;TBL3;UTP3;EXOSC4;RRP1;RPS25;NOL11;DKC1;EXOSC1;EXOSC5;EXOSC2;MRPL22;RPL23A;UTP11;RRP1B;UTP18;WDR74;RPL31;IMP4;UTP6;WDR36;RPF2;WDR75;MPHOSPH6;UTP4;RPS6;WDR46;UTP15;ABCE1;CUL4B;DDX47;RPL4;NVL;WDR43;NIP7;DCAF13;HEATR1;EXOSC10;BOP1;BMS1;UTP20;NOP16;DDX52;NOP14;FCF1;ESF1;RPF1;PES1;LAS1L;PDCD11;WDR12;HELQ;DDX49;DDX10;SDAD1;WDR55;WDR3;NAF1;MPHOSPH10;RPL5;BYSL;RIOK2;RRP9;LTV1;SENP3;KRR1;RRS1;DHX29;LSG1;RRP12
gsea,cilium organization (GO:0044782),-0.4993836157380344,-2.182730827844731,0.0,0.00010491925856445352,0.017,49/92,40.00%,PLK4;MNS1;ODF2;PCNT;DYNLL2;CEP83;TMEM107;CCP110;SCLT1;KIF24;CENPJ;CEP89;EXOC4;POC1B;RTTN;WDR90;CFAP298;TMEM237;HYLS1;SSX2IP;PCM1;CEP78;OFD1;TMEM138;EHD4;FLNA;HDAC6;CEP290;CEP162;IFT74;ACTR2;CEP164;IFT46;RP2;CCDC66;IFT140;SNX10;NEK1;PDE6D;TRAF3IP1;DYNC2H1;TCTN3;IQCB1;AHI1;RAB23;GBF1;CEP41;ARL13B;IFT88
gsea,regulation of calcium ion transport (GO:0051924),0.6976042362188819,2.1811060971566074,0.0,0.0014146446127776423,0.015,12/23,15.05%,CCL5;BCL2;ORAI1;IL16;P2RX4;STIM2;CCL4;CRACR2A;CD33;HOMER1;CD4;F2R
gsea,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.7286916183822091,-2.180780528731693,0.0,0.00010936186245117889,0.018,8/17,21.09%,STMN1;TPX2;FKBP4;MID1IP1;KATNB1;CLASP2;CLASP1;FGF13
gsea,regulation of protein export from nucleus (GO:0046825),-0.7657496845864916,-2.179930198019145,0.0,0.00010903734653886086,0.018,6/15,8.45%,ANP32B;RANGAP1;GTSE1;BARD1;YWHAE;PARK7
gsea,regulation of telomerase activity (GO:0051972),-0.67494252771892,-2.1793172930358016,0.0,0.00011344147913639138,0.019,11/27,16.61%,AURKB;HSP90AA1;PTGES3;NEK2;TCP1;HSP90AB1;CCT2;PIF1;CCT4;DKC1;XRCC5
gsea,regulation of DNA repair (GO:0006282),-0.6799227556550629,-2.173464922885408,0.0,0.00014138355438090075,0.025,17/26,25.05%,DEK;USP1;PCNA;SMCHD1;BRCA1;TRIM28;DHX9;POLH;RNF168;UBE2N;BRCC3;WRNIP1;ABRAXAS1;KAT7;RNF8;WRAP53;UBE2V2
gsea,regulation of DNA binding (GO:0051101),-0.6665272698828109,-2.1724283829059003,0.0,0.0001503655684239227,0.026,9/24,20.39%,HMGB2;HMGB1;HJURP;NME1;CDT1;E2F1;SUMO3;CPNE1;DOT1L
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.7746716984522135,-2.171832386643644,0.0,0.00014992461367781149,0.026,12/17,16.30%,LSM2;LSM3;EXOSC8;EXOSC3;EXOSC7;LSM7;EXOSC9;DIS3;EXOSC4;EXOSC1;EXOSC5;EXOSC2
gsea,positive regulation of fibroblast proliferation (GO:0048146),-0.7050903642195786,-2.171653635950191,0.0,0.00014948623761442607,0.026,5/18,10.43%,CDK4;MIF;CDKN1A;DHX9;E2F1
gsea,mismatch repair (GO:0006298),-0.7164898586057871,-2.167363054737202,0.0,0.00015836606878467076,0.026,10/24,8.33%,RPA3;LIG1;PCNA;RPA2;RPA1;POLD2;EXO1;POLD1;RNASEH2A;POLD3
gsea,nucleic acid-templated transcription (GO:0097659),-0.6732545698743617,-2.1653613249868733,0.0,0.0001718385583914378,0.029,13/25,19.28%,PTMA;RNPS1;POLR2C;MLF1;POLR2F;POLR2L;E2F1;PPP5C;POLR2B;DRG1;POLR2A;POLR2E;POLR2H
gsea,positive regulation of cell-cell adhesion (GO:0022409),0.6857089573560045,2.1638073221058645,0.0,0.00201144780879321,0.025,12/22,18.93%,CCL5;TNFSF11;CITED2;PLAUR;FLOT1;CD44;SMAD7;IL1B;TNF;CXCL13;BMP7;GCNT2
gsea,regulation of histone acetylation (GO:0035065),-0.6692576231026862,-2.163785775565167,0.0,0.00017597129927872114,0.03,10/21,20.19%,SET;BRCA1;RUVBL2;PARK7;PAXIP1;IWS1;CHEK1;NOC2L;BRD7;RPS6KA5
gsea,mitochondrion organization (GO:0007005),-0.5122054115675798,-2.1611999075701447,0.0,0.00018469759127215938,0.031,54/102,34.86%,CYCS;MTFR2;HSPD1;TIMM50;STOML2;BAX;TIMM17A;PARK7;TOMM40;PHB2;TIMM23;HIGD1A;CHCHD10;PARP1;TIMM13;PHB;FANCG;LONP1;AIFM1;MTX2;TFAM;NRF1;SAMM50;MTX1;HCFC1;MGME1;HAX1;GABPA;PITRM1;SPG7;TFB1M;ATAD3A;CHCHD4;TOMM20;PRDX3;AGTPBP1;RHOT2;NUBPL;MTFR1;TMEM70;DNAJA3;NDUFS1;GABPB1;THG1L;TIMM8B;YME1L1;PNPT1;TIMM10;SUPV3L1;CLUH;MTFP1;POLRMT;BIK;TIMM44
gsea,negative regulation of protein binding (GO:0032091),-0.5773541662917615,-2.156364037427483,0.0,0.00018416532155667766,0.031,15/43,25.79%,AURKB;AURKA;PIN1;CDKN1A;ACTB;BAX;PARK7;AKT1;ATP2A2;GTF2F1;SYMPK;ROCK1;DDX11;TLE5;TFIP11
gsea,aerobic electron transport chain (GO:0019646),-0.7895163933337808,-2.1562937187369564,0.0,0.00018310993289446175,0.031,9/15,10.32%,CYCS;NDUFAB1;CYC1;NDUFA5;NDUFV1;NDUFA4;SDHD;UQCRC1;NDUFA12
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7895163933337808,-2.1562937187369564,0.0,0.00018310993289446175,0.031,9/15,10.32%,CYCS;NDUFAB1;CYC1;NDUFA5;NDUFV1;NDUFA4;SDHD;UQCRC1;NDUFA12
gsea,positive regulation of telomere maintenance (GO:0032206),-0.7186775528221321,-2.1559406597248403,0.0,0.00018258676165762043,0.031,7/19,13.04%,AURKB;HNRNPD;NEK2;HNRNPA2B1;RAD50;ATRX;RTEL1
gsea,regulation of fibroblast proliferation (GO:0048145),-0.6330134428680116,-2.155735401970832,0.0,0.00018206657145346765,0.031,5/27,10.43%,CDK4;MIF;CDKN1A;DHX9;E2F1
gsea,rRNA metabolic process (GO:0016072),-0.5926274040492208,-2.154671584345439,0.0,0.0001860880702973617,0.031,74/108,28.49%,EXOSC8;SNU13;LYAR;PIH1D1;RPS17;FBL;EXOSC3;NOP56;POP4;DDX27;NOLC1;NOP58;RPS2;EXOSC7;EMG1;MRTO4;RPL14;WDR18;PELP1;POP5;EXOSC9;EBNA1BP2;RPS15;DIS3;NOC4L;MTREX;TBL3;UTP3;EXOSC4;RRP1;RPS25;NOL11;DKC1;EXOSC1;EXOSC5;EXOSC2;RPL23A;UTP11;RRP1B;UTP18;WDR74;RPL31;IMP4;UTP6;WDR36;WDR75;MPHOSPH6;UTP4;RPS6;WDR46;UTP15;DDX47;RPL4;NVL;WDR43;DCAF13;HEATR1;EXOSC10;BOP1;BMS1;UTP20;DDX52;NOP14;FCF1;ESF1;RPF1;PES1;LAS1L;PDCD11;WDR12;HELQ;DDX49;XRN1;DDX10
gsea,"RNA splicing, via transesterification reactions (GO:0000375)",-0.7580903561174316,-2.1545405176546333,0.0,0.00018556090862513122,0.031,14/18,15.63%,SNRNP40;SRRM1;SRSF10;SF3A3;SCAF11;SF3B4;SRSF4;KHSRP;PRPF8;PRPF4;GEMIN2;SF3B3;DBR1;PRPF3
gsea,regulation of cellular component biogenesis (GO:0044087),-0.6411715718483765,-2.15275176005473,0.0,0.00018954981612761442,0.031,10/26,19.92%,HJURP;HSP90AA1;HSPA8;EZR;RDX;TRAF2;HCFC1;ROCK2;NCLN;ROCK1
gsea,rRNA processing (GO:0006364),-0.5888909510947076,-2.152511388663218,0.0019455252918287938,0.00018901587298359297,0.031,90/121,32.35%,EXOSC8;SNU13;ERI1;LYAR;NHP2;PIH1D1;RPS17;FBL;EXOSC3;NOP56;POP4;DDX27;NOLC1;NOP58;RPS2;EXOSC7;EMG1;EIF6;MRTO4;RPL14;WDR18;PELP1;POP5;EXOSC9;EBNA1BP2;RPS15;DIS3;NOC4L;MTREX;TBL3;UTP3;EXOSC4;RRP1;RPS25;NOL11;SART1;DKC1;RSL1D1;EXOSC1;EXOSC5;EXOSC2;RPL23A;UTP11;RRP1B;UTP18;WDR74;RPL31;IMP4;UTP6;WDR36;TFB1M;WDR75;MPHOSPH6;MRPL1;UTP4;RPS6;WDR46;UTP15;DDX47;RPL4;NVL;WDR43;DCAF13;HEATR1;EXOSC10;BOP1;BMS1;UTP20;DDX52;NOP14;FCF1;ESF1;RPF1;PES1;LAS1L;PDCD11;WDR12;HELQ;TSR3;DDX49;DDX10;WDR55;WDR3;MPHOSPH10;RPL5;BYSL;RIOK2;NAT10;MAK16;RRP9
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.5633624996017145,-2.151932219420845,0.0,0.0001884849295201559,0.031,11/42,15.71%,PLK1;SUMO2;STUB1;RAD23A;TAF1;PSMC2;FMR1;USP5;PSMC5;PSMC6;HSPBP1
gsea,DNA integrity checkpoint signaling (GO:0031570),-0.6891159781913614,-2.15059108630132,0.0,0.00019690729198370828,0.032,21/28,26.05%,CLSPN;CDC45;TIPIN;BRIP1;CDC6;CDT1;RHNO1;PRPF19;E2F1;TIMELESS;CHEK1;CHEK2;DNA2;RAD9A;ATR;DOT1L;RAD1;NBN;RAD17;HUS1;DONSON
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.7059432359382936,-2.1505431881924166,0.0,0.00019635727161503873,0.032,14/23,19.50%,HNRNPU;RNPS1;RBM8A;MAGOH;THRAP3;HNRNPA1;SMU1;MBNL3;PTBP1;FMR1;SRSF6;RBMX;RBM25;RBM15
gsea,DNA strand elongation (GO:0022616),-0.8658061649648486,-2.1496612397814454,0.0,0.000195810315426696,0.032,13/15,9.29%,RFC4;MCM7;POLA1;GINS2;GINS3;MCM3;MCM4;RAD50;POLD2;GINS4;RFC3;POLD3;GINS1
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),-0.5130463998563687,-2.1490134772162297,0.0,0.00019526639788384405,0.032,16/68,28.73%,RACGAP1;ECT2;ARHGAP11A;FOXM1;DEPDC1B;ARHGAP19;NUP62;ARHGDIA;SRGAP2;ARHGAP10;SH3BP1;NET1;INPP5B;RHOT2;RABL3;MYO9B
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.4081859456590719,-2.14607244490834,0.0,0.00020357665254069866,0.033,131/442,31.29%,HMGB2;HMGB1;DLGAP5;YBX1;ATAD2;UHRF1;E2F8;EIF5A;UBB;BRCA1;E2F7;MED30;MYBL2;FOXM1;HNRNPU;CKAP2;PCBP1;TFDP1;PIN1;RBL1;THRAP3;NPM1;HDAC1;TCERG1;E2F4;NME2;BRD8;RUVBL2;DHX9;SMARCA5;NFATC2IP;PARK7;NFYB;E2F2;SMARCA4;E2F1;PARP1;PAXIP1;MED4;TAF6;SFPQ;ATF1;SMARCB1;SP1;PELP1;ATRX;COPS5;HRAS;HDAC2;BCLAF1;CNBP;MTF2;ASXL1;MYDGF;TCF3;RBMX;NRF1;RPRD1B;MYBL1;IRF8;MED14;SIN3A;HCFC1;PHIP;APEX1;PPP3CB;HAX1;TFDP2;E2F3;LEO1;GTF2F1;CEBPB;RRP1B;GABPB2;SREBF2;GABPA;KAT7;NPAT;FADD;RBM14;PLAC8;MCRS1;RPS6KA5;BCLAF3;TAF6L;DOT1L;POU2F1;TAF9;SETX;LARP7;CREB1;ETV4;XRCC6;SSBP3;GCN1;GLIS1;SUB1;AKIRIN2;ZBED3;KLF6;PHF10;FOXK2;SS18L2;ELK3;MYB;PRPF6;ATF4;WWOX;HSF1;PBX2;ACTR2;CCNK;NFKB2;HMGA1;ATF6;BPTF;GABPB1;MED16;HINFP;YY1;PAXBP1;ZBED4;SENP1;NCOA7;MEN1;DDX3X;AATF;E2F5;NUFIP1;ECD;PRDM10
gsea,negative regulation of mitotic cell cycle (GO:0045930),-0.6652829476810287,-2.1442024282223957,0.0,0.0002074276401428077,0.033,8/24,11.92%,MAD2L1;BUB1;BUB1B;ZWILCH;ZWINT;ZW10;WEE1;CHEK1
gsea,heterotypic cell-cell adhesion (GO:0034113),0.7381404583881122,2.141126297632164,0.0,0.0020630233936340617,0.028,11/17,18.46%,CD200;ITGAX;ITGB1;NINJ1;ITGB3;JUP;ITGB7;ITGA4;VCAM1;ITGA7;ITGA5
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5773721823456055,-2.1389959854549323,0.0,0.00021125741018237072,0.034,9/38,19.41%,HMGB1;ARL6IP1;CYCS;YWHAE;CDKN2D;AKT1;DELE1;HTRA2;MT3
gsea,negative regulation of cellular process (GO:0048523),-0.41890849839542327,-2.1384702654560397,0.0,0.0002106770326818697,0.034,71/250,30.07%,FBXO5;ANP32B;GMNN;RBBP7;ORC6;RBBP4;SUZ12;E2F7;FOXM1;MIF;CDKN3;CTCF;RAD18;CDC6;BLM;NUP62;CDKN2C;NME1;CDKN1A;NPM1;TMEM109;ENO1;CDKN2D;ARHGDIA;CDKN2A;PARK7;PBRM1;SMARCA4;TAF6;SINHCAF;ING1;HRAS;PHB;PDS5B;SMYD2;SRSF6;VPS35;PTPN6;MYBL1;LPXN;BRD7;CHERP;HTRA2;EEF1E1;MT3;SRGAP2;GLMN;NME6;MYH9;ING5;SPN;JADE1;RB1;PSRC1;EI24;UTP20;VAMP8;TESC;MDM4;RUNX3;DCBLD2;DSCAM;DNAJA3;HMGA1;CDK6;CCAR2;LMNA;GTPBP4;MEN1;DDX3X;GSDME
gsea,cellular protein metabolic process (GO:0044267),-0.4876798638974785,-2.1363279728044002,0.0,0.0002144769152348075,0.034,57/171,24.78%,UBE2S;MRPL18;MRPL51;HSP90B1;UBE2M;MRPL42;MRPL28;STOML2;GSPT1;RPN2;RPS17;MRPL13;ADPRH;RNF5;SEPHS1;RPS2;EIF4G1;CDC34;MRPS12;P4HB;MRPL55;RPN1;MRPL35;RPL14;PDIA6;FDX1;ABCF1;ZDHHC2;COPS5;SRBD1;RPS15;FARSB;MRPS5;MRPS7;CHEK2;RPS25;MRPS18A;MRPL37;RPL23A;MRPL11;PRKCSH;HTRA2;RPL31;SPCS3;SPG7;MCRS1;RRBP1;PARL;UBA3;RPS6;RPL4;MRPS18B;DHPS;MRPL3;PABPC4;PHKA2;RABGGTB
gsea,histone lysine methylation (GO:0034968),-0.6836310001090582,-2.1349339022148683,0.0,0.0002182560334022102,0.035,14/22,23.52%,EZH2;DPY30;SUV39H1;SUV39H2;PAXIP1;ASH2L;SMYD2;WDR5;EHMT2;SETDB2;DOT1L;SETDB1;SETD6;SMYD3
gsea,RNA biosynthetic process (GO:0032774),-0.7572944380057993,-2.1337938273691583,0.0,0.0002220145569201992,0.035,14/17,21.86%,PRIM1;POLA1;PRIM2;TTF2;SMARCA5;POLA2;TAF6;POLR2A;TAF5;HELB;PRMT5;SMN1;TBP;SETX
gsea,positive regulation of protein-containing complex assembly (GO:0031334),-0.5092102505670564,-2.1308328158836334,0.0,0.0002257526536799383,0.036,33/74,29.89%,RPA3;HSP90AA1;RPA2;STUB1;RPA1;PIH1D1;TFRC;CDT1;BAX;PSMC4;FAF1;PARK7;EIF4G1;PSMC2;PARP1;LCP1;PSMC5;SPIDR;DDB1;PSMC6;ATR;CHD1L;SLF1;BAK1;CUL4B;PLEK;IFNG;GTF2H4;DDB2;SLF2;GTF2H3;VCP;DDX3X
gsea,regulation of macromolecule metabolic process (GO:0060255),-0.49755405357858284,-2.1235329170226662,0.0,0.0002511186491632584,0.039,22/83,19.67%,HNRNPAB;YBX1;HNRNPD;CDK4;TCF19;PCBP1;CTCF;PIN1;HNRNPDL;COQ7;CDK2;YBX3;HNRNPK;TARDBP;SART3;KHSRP;UBAP2;FUBP1;CACTIN;ROCK2;HMG20B;NPAT
gsea,defense response to Gram-negative bacterium (GO:0050829),-0.7415965395639282,-2.1176969750287067,0.0,0.0002720296009831439,0.042,1/15,0.12%,HMGB2
gsea,chordate embryonic development (GO:0043009),-0.6822154118616754,-2.1173233657670396,0.0020491803278688526,0.00027129636755731333,0.042,2/19,3.08%,STIL;BRCA1
gsea,telomere maintenance via telomerase (GO:0007004),-0.6992141644633083,-2.1165704450469693,0.0,0.0002748617917426544,0.043,14/23,18.46%,HSP90AA1;PTGES3;TINF2;RPA1;NHP2;RAD50;HSP90AB1;RFC1;GAR1;CDK2;PIF1;RTEL1;DKC1;NOP10
gsea,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.7343770252162635,-2.1158669843527957,0.0,0.0002741248968586258,0.043,9/17,19.44%,EZH2;RBBP7;RBBP4;DNMT1;SUZ12;EED;MTF2;PPHLN1;PHF19
gsea,negative regulation of response to stimulus (GO:0048585),-0.6198684220056639,-2.1123776658608664,0.0019801980198019802,0.0002819354407948551,0.044,3/26,5.44%,FBXO5;YBX1;RBL1
gsea,cellular macromolecule catabolic process (GO:0044265),-0.6200761640700893,-2.1121317368981494,0.0,0.00028118361295273545,0.044,14/26,24.27%,HNRNPD;RNASEH2B;RNASEH2A;RNF5;EXOSC7;NCBP1;MTREX;CHEK2;SND1;STT3B;HTRA2;RNASEH1;PABPC4;PPP1R8
gsea,response to unfolded protein (GO:0006986),-0.6321675691497362,-2.1117213039539657,0.0,0.0002804357841948824,0.044,16/35,22.21%,HSP90AA1;HSPD1;HSP90AB1;BAX;HSPA8;HSPE1;HSPA14;HSPA9;HSPA4;DNAJB1;STT3B;OPTN;BAK1;HSPA13;HSPA4L;HSPH1
gsea,positive regulation of double-strand break repair (GO:2000781),-0.6063938313642171,-2.1085130484475796,0.0,0.0003008807047209461,0.046,17/32,24.07%,RAD51AP1;SMCHD1;FOXM1;FUS;RIF1;PARP1;TIMELESS;FANCB;SPIDR;MRNIP;WDR48;SLF1;DDX11;ZCWPW1;KMT5C;WRAP53;MMS19
gsea,negative regulation of double-strand break repair (GO:2000780),-0.6869575593811375,-2.1083212409433236,0.0,0.0003000847240206261,0.046,9/20,16.87%,AUNIP;PARPBP;SMCHD1;RMI2;POLQ;RIF1;CGAS;FANCB;HELB
gsea,histone H4 acetylation (GO:0043967),-0.6062762372183277,-2.1073735800135633,0.0,0.00030350833732005505,0.046,17/32,26.70%,HAT1;BRCA2;ACTL6A;BRD8;RUVBL2;NAA40;RUVBL1;WDR5;HCFC1;MORF4L2;KAT7;MCRS1;ING5;JADE1;EP400;DMAP1;TADA3
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.5552737846250493,-2.1068655779189056,0.0,0.0003069139316021185,0.046,9/42,15.71%,PLK1;SUMO2;CDC20;FZR1;STUB1;RAD23A;TAF1;USP5;HSPBP1
gsea,microtubule polymerization (GO:0046785),-0.7054702966101863,-2.1026414644029012,0.0,0.00032707471084337516,0.048,7/18,11.76%,TPX2;TUBG1;CKAP5;PIN1;NDE1;TUBGCP2;CENPJ
gsea,dicarboxylic acid metabolic process (GO:0043648),-0.6024617195045949,-2.1020296896977815,0.0,0.0003304007827115971,0.048,9/35,11.55%,MTHFD2;DHFR;SHMT2;MDH2;ME2;MTHFD1;SHMT1;GOT2;MTHFD1L
gsea,protein homooligomerization (GO:0051260),-0.525903863721487,-2.1017963017473678,0.0,0.00032953811748258517,0.048,21/57,25.66%,TK1;ECT2;MIF;BLM;PRMT1;SHMT2;FUS;POLQ;ALAD;SHMT1;APIP;RBMX;ALDOA;ALDH9A1;LETM1;MLKL;CBY1;EHD4;ATL2;SIGMAR1;GLS
gsea,cellular response to interleukin-12 (GO:0071349),-0.6762151718227368,-2.1000927209623272,0.0,0.0003411614622118298,0.051,16/28,21.22%,PPIA;LMNB1;HNRNPA2B1;MIF;HNRNPF;TCP1;SNRPA1;HNRNPDL;CFL1;P4HB;HSPA9;LCP1;GSTO1;MTAP;RALA;PSME2
gsea,generation of neurons (GO:0048699),-0.5247179225148125,-2.09815484926145,0.0,0.0003444250276723294,0.051,6/65,10.69%,HMGB2;RACGAP1;CIT;PIN1;TUBGCP2;CASP3
gsea,heterochromatin assembly (GO:0031507),-0.742242573933134,-2.098110456608463,0.0,0.0003435327348545254,0.051,6/15,7.89%,SMCHD1;SUV39H1;HELLS;HDAC1;POLE3;CDKN2A
gsea,membrane organization (GO:0061024),-0.47509855303230025,-2.0976415762478453,0.0,0.0003467733070241628,0.052,46/101,39.76%,CEP55;REEP4;KIF20A;UBB;TIMM50;ACTG1;ACTB;TFRC;NUP93;CLTB;HSPA8;NUP155;CORO1C;NEMP1;TMEM43;M6PR;NSFL1C;CLTC;SUN2;COX18;VAMP8;PACSIN2;LDLR;AP3D1;ACTR2;SPTBN1;HUWE1;HGS;STAM2;EPS15;GCA;CPTP;EPS15L1;GAK;UBXN2B;HACE1;PICALM;SNX9;AP2B1;OPA1;SPAG4;HIP1R;AP2A2;GAPVD1;FZD4;TMEM33
gsea,protein-containing complex subunit organization (GO:0043933),-0.5286685946946842,-2.097238242358588,0.0,0.0003458795613875026,0.052,24/58,26.92%,KNTC1;NDC1;PPIH;NUP133;NUP205;NUP35;ZW10;CHCHD10;TUBGCP2;FANCA;CAPZA2;NUP54;TRAF2;PPID;SEH1L;KPNA3;LPXN;ST13;SPG7;MDM2;MDM4;TSPAN4;SLC2A1;FANCC
gsea,positive regulation of telomerase activity (GO:0051973),-0.7040091372323294,-2.097194544952383,0.0,0.00034499041084408997,0.052,10/21,16.61%,AURKB;HSP90AA1;PTGES3;NEK2;TCP1;HSP90AB1;CCT2;CCT4;DKC1;XRCC5
gsea,positive regulation of gene expression (GO:0010628),-0.4250886196167204,-2.0956898204748797,0.0,0.00034820231790475687,0.052,80/227,31.98%,DEK;DNMT1;HNRNPD;RPS27L;BRCA1;MIF;CTCF;EIF4A3;BAZ1B;GAPDH;NPM1;ACTG1;ACTB;EIF3C;TFRC;POLR2F;SMARCA5;U2AF2;SERPINB9;PARK7;POLR2L;HMGN5;ID2;EIF6;MAZ;E2F1;AKT1;SP1;EZR;FAM98B;PASK;PHB;RDX;FMR1;UPF3B;POLR2A;EIF3D;FUBP1;VPS35;VIM;HCFC1;POLR2E;MYBBP1A;ROCK2;LARP4B;GABPA;POLR2H;MT3;METTL14;ROCK1;TBP;GLMN;HNRNPLL;SETX;NSUN5;MTOR;PIK3CG;DDX21;METTL5;IFNG;TESC;RAB27A;TERF2;ATF4;TADA3;FXR2;HINFP;TAF1D;PHF2;TENT4A;DDX3X;UBR5;TAF1B;TNRC6A;HSPA1B;PYM1;RPL5;HGS;NAT10;ZPR1
gsea,positive regulation of viral genome replication (GO:0045070),-0.6825464849841115,-2.0947379833559885,0.0,0.0003513977957732976,0.053,8/19,15.11%,TOP2A;PPIA;PPIH;RAD23A;SRPK1;PPID;DDB1;PPIE
gsea,positive regulation of DNA recombination (GO:0045911),-0.6708066825481594,-2.094644871709338,0.0,0.00035050137282489636,0.053,14/21,24.07%,RAD51AP1;FUS;TFRC;RIF1;PARP1;PAXIP1;TIMELESS;FANCB;MRNIP;WDR48;ZCWPW1;KMT5C;WRAP53;MMS19
gsea,neutrophil degranulation (GO:0043312),-0.4420559699044654,-2.092216423844548,0.0,0.000365870419352102,0.056,70/219,29.89%,TUBB4B;HMGB1;PPIA;HSP90AA1;PA2G4;IMPDH2;FABP5;MIF;GLIPR1;DSN1;ILF2;DDOST;PKM;CCT8;HSP90AB1;KPNB1;NME2;AP1M1;PDAP1;PGAM1;PSMD2;HSPA8;ALAD;PSMB7;PSMD12;CCT2;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;IQGAP2;ARSB;PSMD6;APRT;PRDX4;PSMD3;PTPN6;PPIE;ALDOA;MAGT1;XRCC5;ATP8B4;CPNE1;MLEC;PLAC8;ROCK1;DIAPH1;PGRMC1;XRCC6;PFKL;VAMP8;RAB27A;DYNC1H1;DGAT1;CEP290;ACTR2;TCIRG1;GUSB;PTGES2;NRAS;PGM1;DOCK2;UBR4;ACLY;VCP;HUWE1;OSTF1;DDX3X
gsea,negative regulation of binding (GO:0051100),-0.5345484934559388,-2.091692043634448,0.0,0.0003649418142268428,0.056,17/50,25.79%,AURKB;AURKA;PIN1;CDKN1A;ACTB;BAX;PARK7;E2F1;AKT1;SUMO3;GTF2F1;CPNE1;SYMPK;ROCK1;DDX11;TLE5;TFIP11
gsea,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.7112577069403025,2.0901895785081157,0.0,0.0037959630442866736,0.063,7/16,11.59%,CCR7;PIK3R1;PIK3IP1;WDR81;KIT;FLT1;PDGFB
gsea,second-messenger-mediated signaling (GO:0019932),0.5498806055967889,2.0892178863269377,0.0,0.0034508754948060667,0.063,18/48,15.60%,CCR7;CXCR6;CCR6;CCR8;TNFSF11;CXCR3;GUCY1A1;P2RX4;CCR2;CCR5;CXCR5;PLCG1;MCTP1;LRRK2;DGKD;PPP1R9B;NDNF;KSR2
gsea,neutrophil mediated immunity (GO:0002446),-0.44011100754297455,-2.087262469876006,0.0,0.0003842411281718911,0.059,71/220,29.89%,TUBB4B;HMGB1;PPIA;HSP90AA1;PA2G4;IMPDH2;FABP5;MIF;GLIPR1;DSN1;ILF2;DDOST;PKM;CCT8;HSP90AB1;KPNB1;NME2;AP1M1;PDAP1;PGAM1;PSMD2;HSPA8;ALAD;PSMB7;PSMD12;CCT2;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;IQGAP2;ARSB;PSMD6;APRT;PRDX4;PSMD3;PTPN6;PPIE;ALDOA;MAGT1;XRCC5;ATP8B4;CPNE1;MLEC;PLAC8;ROCK1;DIAPH1;PGRMC1;XRCC6;PFKL;VAMP8;RAB27A;DYNC1H1;DGAT1;CEP290;ACTR2;TCIRG1;GUSB;PTGES2;NRAS;PGM1;DOCK2;ADAM17;UBR4;ACLY;VCP;HUWE1;OSTF1;DDX3X
gsea,neutrophil activation involved in immune response (GO:0002283),-0.43917288179774866,-2.0866505600922927,0.0,0.0003913396817093569,0.06,70/221,29.89%,TUBB4B;HMGB1;PPIA;HSP90AA1;PA2G4;IMPDH2;FABP5;MIF;GLIPR1;DSN1;ILF2;DDOST;PKM;CCT8;HSP90AB1;KPNB1;NME2;AP1M1;PDAP1;PGAM1;PSMD2;HSPA8;ALAD;PSMB7;PSMD12;CCT2;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;IQGAP2;ARSB;PSMD6;APRT;PRDX4;PSMD3;PTPN6;PPIE;ALDOA;MAGT1;XRCC5;ATP8B4;CPNE1;MLEC;PLAC8;ROCK1;DIAPH1;PGRMC1;XRCC6;PFKL;VAMP8;RAB27A;DYNC1H1;DGAT1;CEP290;ACTR2;TCIRG1;GUSB;PTGES2;NRAS;PGM1;DOCK2;UBR4;ACLY;VCP;HUWE1;OSTF1;DDX3X
gsea,positive regulation of translation (GO:0045727),-0.5622022835679581,-2.083559378150347,0.0,0.00040242674168870996,0.062,33/52,31.84%,HNRNPD;EIF5A;RPS27L;EIF4A3;NPM1;PKM;CDC123;EIF3C;DHX9;C1QBP;YBX3;EIF6;PASK;CNBP;FMR1;UPF3B;EIF3D;VIM;LARP4B;METTL14;NSUN5;MTOR;EIF2B5;MRPS27;METTL5;LARP1;FXR2;RPUSD3;DDX3X;EIF5A2;PYM1;RPL5;NAT10
gsea,interleukin-12-mediated signaling pathway (GO:0035722),-0.6817717863281337,-2.0834266750171726,0.0,0.0004014156192221554,0.062,16/27,21.22%,PPIA;LMNB1;HNRNPA2B1;MIF;HNRNPF;TCP1;SNRPA1;HNRNPDL;CFL1;P4HB;HSPA9;LCP1;GSTO1;MTAP;RALA;PSME2
gsea,regulation of centriole replication (GO:0046599),-0.7310357185769533,-2.0833030171923457,0.0,0.0004004095650386412,0.062,13/17,21.28%,PLK4;STIL;BRCA1;NUP62;NPM1;CEP295;MDM1;CENPJ;CDK5RAP2;TRIM37;CEP76;RBM14;ALMS1
gsea,DNA damage checkpoint signaling (GO:0000077),-0.6695112621153037,-2.082782496555225,0.0,0.00039940854112604466,0.062,17/22,29.05%,CLSPN;BRIP1;RHNO1;PRPF19;E2F1;CHEK1;CHEK2;RAD9A;ATR;DOT1L;RAD1;NBN;RAD17;HUS1;DONSON;INTS7;HINFP
gsea,cellular amide metabolic process (GO:0043603),-0.5287319988794503,-2.082432621389653,0.0,0.0004103648851469586,0.065,9/51,13.40%,MTHFD2;DHFR;DBI;SHMT2;MTHFD1;SHMT1;PDZD11;MTHFD1L;THOP1
gsea,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.6647504425311197,-2.0808528948221787,0.0,0.0004133182913145139,0.066,13/22,27.62%,CDK4;E2F7;CDKN2C;CDKN1A;RBL1;CDKN2D;CDKN2A;WEE1;BRD7;JADE1;RB1;RBL2;CDK6
gsea,protein autophosphorylation (GO:0046777),-0.4896853391606414,-2.078863029053597,0.0,0.00043607880420709584,0.07,24/76,35.21%,AURKB;MELK;AURKA;NEK2;STK39;TAF1;AKT1;CAD;PASK;CHEK2;VRK1;ATR;MAP4K1;PDPK1;MTOR;SLK;CAMKK2;OXSR1;MAPKAPK2;RIOK2;CLK2;DYRK1A;MAP3K3;TAOK2
gsea,positive regulation of cellular amide metabolic process (GO:0034250),-0.5492599656498205,-2.0786289820737442,0.0,0.0004389539412375342,0.071,20/47,24.69%,HNRNPD;RPS27L;EIF4A3;NPM1;EIF3C;EIF6;CASP3;SP1;PASK;FMR1;UPF3B;EIF3D;VIM;ROCK2;LARP4B;METTL14;NSUN5;MTOR;METTL5;IFNG
gsea,RNA catabolic process (GO:0006401),-0.6063727989731896,-2.077445771785521,0.0,0.0004497044314900651,0.074,16/31,24.27%,LSM2;FEN1;HNRNPD;RNASEH2B;RNASEH2A;EXOSC7;NCBP1;MTREX;DNA2;SND1;CNOT10;DXO;RNASEH1;METTL16;PABPC4;PPP1R8
gsea,regulation of megakaryocyte differentiation (GO:0045652),-0.5869176184103271,-2.075645930077123,0.0,0.0004643370231810174,0.077,13/32,26.67%,HMGB2;DPY30;PRMT1;HDAC1;EIF6;ASH2L;WDR5;SIN3A;RBM15;TESC;SETD1A;PITHD1;RBBP5
gsea,regulation of organelle organization (GO:0033043),-0.5649458872590094,-2.0755488959697157,0.0,0.00046712153704176227,0.078,12/34,24.61%,ARL6IP1;CDT1;EZR;LMAN1;RDX;VPS35;MYO5A;CENPV;CLIC4;DIAPH1;PARL;RHOT2
gsea,positive regulation of programmed cell death (GO:0043068),-0.4291243220902894,-2.072878363896498,0.0,0.00047380817133579813,0.08,40/154,29.89%,TOP2A;HMGB1;MELK;ECT2;UBB;BARD1;RNPS1;HSPD1;C1QBP;BAX;FAF1;MTCH2;DDX20;CCAR1;E2F1;CASP3;BCLAF1;AIFM1;PPID;UTP11;PIDD1;RRP1B;HTRA2;EEF1E1;PHLDA3;FADD;BAK1;RPS6;ING5;NET1;IFNG;HDAC6;ATF4;ITGB3BP;CCAR2;QRICH1;ATF6;STK3;SCRIB;DDX3X
gsea,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.6663239076311047,-2.070071742952379,0.0,0.0005038992841590197,0.084,13/22,27.62%,CDK4;E2F7;CDKN2C;CDKN1A;RBL1;CDKN2D;CDKN2A;WEE1;BRD7;JADE1;RB1;RBL2;CDK6
gsea,negative regulation of growth (GO:0045926),-0.5055539212331369,-2.0682417071153325,0.0,0.0005182569362903799,0.088,21/55,31.14%,RBBP7;CDKN2C;CDKN1A;ENO1;CDKN2D;CDKN2A;SMARCA4;ING1;PHB;MT3;NME6;ING5;JADE1;RB1;PSRC1;EI24;DCBLD2;CCAR2;DDX3X;PNPT1;HSPA1B
gsea,protein catabolic process (GO:0030163),-0.5800929536026682,-2.0654871156937977,0.0,0.0005286575337532075,0.089,12/32,24.00%,HSP90AA1;UCHL3;PRPF19;RNF5;HSPA8;CHEK2;DDB1;STT3B;HTRA2;CUL4B;MTOR;CLN6
gsea,regulation of viral transcription (GO:0046782),-0.6570671151633598,-2.0654609457670237,0.0,0.0005273743843994377,0.089,14/22,21.99%,POLR2C;NELFE;POLR2F;DHX9;POLR2L;POLR2B;NELFCD;POLR2A;POLR2E;GTF2F1;GTF2F2;TARBP2;POLR2H;LARP7
gsea,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.6771673944197779,-2.0638587613161135,0.0,0.0005415709032217555,0.092,14/20,26.34%,NCL;LYAR;PIH1D1;SMARCA4;SMARCB1;NOL11;WDR75;UTP15;DDX11;WDR43;HEATR1;MTOR;ATF4;PWP1
gsea,antigen receptor-mediated signaling pathway (GO:0050851),-0.4802853014344664,-2.0598402239108844,0.0,0.0005595578595485649,0.093,25/90,16.53%,PSMB6;STOML2;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;UBE2N;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;PSMC6;EIF2B1
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.5259221812163434,-2.0583029563448276,0.0,0.0005659089691135283,0.095,25/67,15.36%,EIF5A;ACTN4;PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;TRAF2;PSMD3;PSMC6
gsea,negative regulation of protein metabolic process (GO:0051248),-0.6227528694311372,-2.0561366008295052,0.002004008016032064,0.0005837509447226807,0.098,15/24,26.14%,MAD2L1;PIN1;PFDN6;HSP90AB1;SF3B3;PHB;AZIN1;HMGCR;FLOT2;VBP1;ROCK1;PFDN4;FLNA;MDM4;LDLR
gsea,negative regulation of cell-substrate adhesion (GO:0010812),-0.6709446272387322,-2.055720763593487,0.0,0.0005861823193504539,0.099,4/18,10.08%,ACTN4;CDKN2A;RCC2;CORO1C
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6002691069965527,2.0549247526082635,0.0,0.005157558484085154,0.106,16/36,16.11%,EMB;SELL;CRTAM;JAML;ITGB1;ICAM1;PECAM1;CLDN10;ITGAM;SELP;PVR;PTPRS;CEACAM1;CDH1;MPZL2;VCAM1
gsea,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.6478537308544292,-2.0525264736614712,0.0,0.0006268229736332184,0.107,3/19,9.26%,PLK1;CALM2;EIF4G1
gsea,Golgi organization (GO:0007030),-0.5085797131142619,-2.052189206895372,0.0,0.0006253269760827811,0.107,32/58,38.81%,CDK1;ZW10;LMAN2;TMED2;LMAN1;VRK1;NSFL1C;CLASP2;PRMT5;ATP8B4;PI4K2B;OPTN;CLASP1;ARL1;ATL2;TMED1;NPLOC4;DYM;BAG5;HUWE1;GORASP2;GCC2;GAK;SEC23IP;ARHGAP21;UBXN2B;HACE1;GOLGA2;DYNC2H1;HTT;GBF1;FBXW8
gsea,positive regulation of ATPase activity (GO:0032781),-0.6804407107010453,-2.052101526721674,0.0,0.0006238381023302032,0.107,13/19,25.14%,UHRF1;DNAJC9;HNRNPU;PFN1;DYNLL2;DHX9;AHSA1;DNAJB11;DNAJB1;DNAJC10;MSH2;MSH6;TPM1
gsea,defense response to Gram-positive bacterium (GO:0050830),-0.7064268788050662,-2.0506586426585875,0.0,0.0006299460126073484,0.109,1/15,0.12%,HMGB2
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.5163774782818902,-2.050516374172918,0.0,0.0006360249754424218,0.11,30/53,36.38%,PLK1;SUMO2;UCHL5;STUB1;HSP90AB1;RAD23A;PARK7;XPO1;TAF1;USP5;HSPBP1;RAD23B;GLMN;MDM2;TAF9;DESI1;GIPC1;USP7;CCAR2;KEAP1;BAG5;VCP;HSPA1B;HERPUD1;UFL1;TRIB3;HSPA1A;MAP1A;TLK2;GSK3B
gsea,cellular response to interleukin-1 (GO:0071347),-0.5231652174169072,-2.049974275385419,0.0,0.0006458521090548807,0.111,30/75,23.05%,UBB;PSMB6;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;UBE2N;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;PSMD3;RBMX;PSMC6;GBP3;CACTIN;RPS6KA5;PSME2;USP10
gsea,positive regulation of endothelial cell proliferation (GO:0001938),-0.5549246171235303,-2.0494164066650047,0.0,0.0006518648831585445,0.113,11/37,29.25%,HMGB2;HMGB1;AKT1;SP1;MYDGF;VEGFB;PDPK1;EGFL7;NRAS;ADAM17;SIRT6
gsea,regulation of interleukin-1 beta production (GO:0032651),0.6199439259448604,2.0486389360893806,0.0,0.005173427894805417,0.115,14/33,15.27%,CCR7;TNFAIP3;RIPK2;JAK2;ZC3H12A;TYROBP;F2RL1;FOXP1;MALT1;TNF;SIRPA;CD33;F2R;APP
gsea,purine-containing compound biosynthetic process (GO:0072522),-0.7270063770761053,-2.0485604849614534,0.0,0.0006578493618546617,0.114,11/18,13.99%,DCK;SHMT2;PAICS;MTHFD1;SHMT1;ADSL;GART;GMPS;PPAT;PRPS1;APRT
gsea,protein acetylation (GO:0006473),-0.6733115048868078,-2.0483401625940836,0.0,0.0006638057444066657,0.115,10/20,22.62%,ESCO2;HAT1;DSCC1;NAA50;NAA40;NAA10;NAA16;NAA15;NAA35;ING5
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.5667727383224532,-2.0468767442486446,0.0,0.0006847003562160765,0.121,20/41,24.77%,SHCBP1;HNRNPF;POLR2C;POLR2F;CEP57;HNRNPA1;POLR2L;HNRNPH1;NCBP1;POLR2B;PTBP1;HNRNPM;POLR2A;POLR2E;GTF2F1;GTF2F2;POLR2H;SETX;NCBP2;SHOC2
gsea,positive regulation of apoptotic process (GO:0043065),-0.42255314056625637,-2.0468339878533737,0.0,0.0006831005890286557,0.121,40/160,29.89%,TOP2A;HMGB1;MELK;ECT2;UBB;BARD1;RNPS1;HSPD1;C1QBP;BAX;FAF1;MTCH2;DDX20;CCAR1;E2F1;CASP3;BCLAF1;AIFM1;PPID;MYBBP1A;UTP11;PIDD1;RRP1B;HTRA2;EEF1E1;PHLDA3;FADD;BAK1;RPS6;ING5;NET1;TLE5;ATF4;ITGB3BP;CCAR2;QRICH1;ATF6;STK3;SCRIB;DDX3X
gsea,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.6808937894276264,-2.0456138809448157,0.0,0.0006926805468479657,0.123,1/18,0.41%,HMGB1
gsea,ncRNA catabolic process (GO:0034661),-0.6699070072088467,-2.0437207670570117,0.0,0.0007096468033030188,0.126,11/19,16.30%,EXOSC8;EXOSC3;EXOSC7;EXOSC9;DIS3;MTREX;EXOSC4;SND1;ZCCHC8;EXOSC5;EXOSC2
gsea,protein complex oligomerization (GO:0051259),-0.5407345213975971,-2.0433815092712138,0.0,0.0007080002909983714,0.126,11/43,17.10%,ECT2;BLM;PRMT1;SHMT2;STOML2;FUS;POLQ;ALAD;CPSF6;RBMX;LETM1
gsea,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.6774855019858111,2.0431093669411355,0.001941747572815534,0.005216502009617556,0.121,10/20,12.47%,SLAMF6;XCL1;CD160;CRTAM;LAMP1;TYROBP;CD226;SPI1;ITGAM;PVR
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.4308227277891835,-2.042440054581934,0.0,0.0007063614014358752,0.126,42/162,28.22%,STMN1;SHCBP1;HSP90AA1;HNRNPF;POLR2C;ACTG1;ACTB;POLR2F;CEP57;HNRNPA1;POLR2L;CASP3;AKT1;HNRNPH1;NCBP1;POLR2B;HRAS;PTBP1;HNRNPM;POLR2A;ELMO1;PHIP;POLR2E;ROCK2;GTF2F1;GTF2F2;VEGFB;SHC1;POLR2H;ROCK1;AP3S1;SETX;NCBP2;SHOC2;SIPA1L1;ACTR2;ATP6V0A2;TCIRG1;DDIT4;ELMO2;KIF16B;RYK
gsea,regulation of telomere maintenance (GO:0032204),-0.6523086864076639,-2.042119158362973,0.0,0.000712109454386389,0.127,14/20,30.22%,HNRNPD;TINF2;RAD50;PIF1;ATRX;RTEL1;XRCC5;NBN;YLPM1;TERF2;USP7;SIRT6;PPP1R10;SMG6
gsea,peptidyl-threonine modification (GO:0018210),-0.5924208243153959,-2.041357677115562,0.0019342359767891683,0.0007178310186136287,0.127,13/32,24.55%,CDK1;CIT;STK39;TAF1;AKT1;CHEK1;CAD;GALNT1;ROCK2;CSNK2A2;ROCK1;PDPK1;DYRK3
gsea,positive regulation of organelle assembly (GO:1902117),-0.6019525008114834,-2.039599395804914,0.0,0.000727198999015695,0.129,8/28,14.13%,PLK4;SPAG5;NUP62;G3BP1;GPSM2;CCP110;NUMA1;LCP1
gsea,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.6553817642492772,-2.0376279309053063,0.0,0.0007438526041154776,0.131,8/21,14.09%,EZH2;FAM83D;TFDP1;PHB2;EIF4G1;AKT1;RDX;LSM11
gsea,positive regulation of establishment of protein localization (GO:1904951),-0.7502590907061931,-2.0356960726393107,0.0,0.0007604299913429501,0.133,12/16,16.02%,TCP1;CCT8;CCT6A;CEP295;CCT7;CCT3;CCT2;CCT5;CENPJ;CCT4;DKC1;CEP135
gsea,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.7080777003427853,-2.0326652568968924,0.0,0.0008024646488377152,0.142,9/15,22.76%,HNRNPU;NELFE;TCERG1;RNF168;NELFCD;LEO1;WDR43;LARP7;RNF8
gsea,microtubule bundle formation (GO:0001578),-0.6630006605089864,-2.0321127997226878,0.003937007874015748,0.0008042759689189601,0.142,5/19,12.48%,PLK1;KIF20A;AAAS;NUMA1;CDK5RAP2
gsea,positive regulation of intracellular transport (GO:0032388),-0.6569329601731957,-2.0303112679547337,0.0,0.0008097100424646177,0.144,5/18,12.00%,KIF20B;SPAG5;PCNT;NUMA1;NEDD4
gsea,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.7051546271295646,-2.0289787304051536,0.0018975332068311196,0.0008151194716858054,0.146,8/15,15.80%,MED30;PSMC4;PSMC2;PAXIP1;MED4;PSMC5;PSMC6;MED14
gsea,peptidyl-threonine phosphorylation (GO:0018107),-0.5899534117304606,-2.026618563899827,0.0,0.0008494208793178326,0.153,12/30,24.55%,CDK1;CIT;STK39;TAF1;AKT1;CHEK1;CAD;ROCK2;CSNK2A2;ROCK1;PDPK1;DYRK3
gsea,Notch signaling pathway (GO:0007219),-0.5913013360426315,-2.0249676720854963,0.0,0.0008583226436839605,0.156,3/26,8.73%,DLGAP5;YBX1;GMDS
gsea,MAPK cascade (GO:0000165),-0.4363767188071189,-2.0234872624024494,0.0,0.0008635860348671236,0.157,44/142,29.75%,CDK1;UBB;PSMB6;YWHAE;PSMB2;PSMB5;PSMA3;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;PSMD12;PSMC2;PSMD1;PSMA5;PSMD7;PSMD14;PSMD11;PPP5C;PSME3;HRAS;PSMD6;PEBP1;PSMC1;PSMC5;PSMD3;PSMC6;SHC1;PTPN7;MT3;FGF13;PSME2;SETX;ARL2;SHOC2;HSF1;CUL3;SPTBN1;CAMKK2;NRAS;FNTB;CUL1;MEN1
gsea,negative regulation of DNA biosynthetic process (GO:2000279),-0.6761194212269965,-2.0232991511409115,0.0,0.0008688257703595759,0.158,7/17,11.74%,HNRNPU;TINF2;CDKN1A;CTC1;HNRNPA1;PIF1;HNRNPC
gsea,positive regulation of erythrocyte differentiation (GO:0045648),-0.6968636313149544,-2.018867817410738,0.0,0.0009170276818678694,0.166,2/15,4.73%,HMGB2;PRMT1
gsea,positive regulation of protein phosphorylation (GO:0001934),-0.4238057510612162,-2.0166395046054943,0.0,0.0009435691709823337,0.17,41/159,31.47%,CENPE;PPIA;PLK1;CALM2;HSP90AA1;TTK;MIF;PIN1;CDKN1A;RAD50;HSP90AB1;TFRC;PARK7;EIF4G1;AKT1;CDK2AP1;MAP2K3;HRAS;FMR1;CNOT9;MRNIP;MYDGF;XRCC5;ROCK2;HAX1;VEGFB;MT3;RPS6KA5;NBN;XRCC6;MMD;LRP8;IFNG;HDAC6;CAMKK2;FXR2;ADAM17;DDX3X;PTPN11;AXIN1;DUSP19
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6185504293974151,-2.015722629209922,0.0,0.0009592937282402323,0.174,6/24,11.06%,ARL6IP1;YWHAE;PIH1D1;CDKN2D;PARK7;AKT1
gsea,negative regulation of endothelial cell migration (GO:0010596),-0.6682729591697217,-2.0148155805118857,0.0,0.0009607154218622009,0.175,1/19,0.41%,HMGB1
gsea,regulation of cellular localization (GO:0060341),-0.6058626120496479,-2.0123662637911144,0.0019723865877712033,0.000986982883849248,0.18,6/23,10.47%,HSP90AA1;SPAG5;MAD1L1;HSP90AB1;NUMA1;PARP1
gsea,regulation of immune response (GO:0050776),0.5391405790739295,2.0114969217815157,0.0,0.007619433067155134,0.185,39/70,18.73%,SLAMF6;SELL;CD160;CRTAM;CLEC2D;CD200;JAML;ITGB1;SLAMF7;BCL6;SAMHD1;IRF7;CD81;ICAM1;TYROBP;IRF4;CD226;IL4I1;IFITM1;FOXP1;DHX58;IRF1;ITGB7;ITGA4;CD40LG;AHR;RSAD2;CD300A;PVR;CD33;CD40;CD300LF;FCGR2B;VCAM1;COL1A1;CXCL13;FOXP3;TREML2;SYK
gsea,positive regulation of RNA splicing (GO:0033120),-0.6447478413962261,-2.0106539939591674,0.002008032128514056,0.0009918793039050333,0.181,11/20,21.86%,NCL;THRAP3;DAZAP1;U2AF2;SF3B4;NCBP1;POLR2A;RBMX;RBMXL1;HNRNPLL;SETX
gsea,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.6420222067833815,-2.0098021601663985,0.0,0.001000288647244873,0.182,7/20,16.44%,BRCA1;HDAC1;SMARCA4;PHB;CNOT9;CALR;NCOR2
gsea,mRNA splice site selection (GO:0006376),-0.6934811358975073,-2.0097494709462644,0.001893939393939394,0.000998080504535723,0.182,11/17,22.91%,PSIP1;SRSF9;SRSF10;SF3A3;SF3A2;SRSF1;SF3A1;SRSF6;LUC7L;SETX;CELF2
gsea,regulation of organelle assembly (GO:1902115),-0.5474651900173559,-2.0092041381325547,0.0018552875695732839,0.0010064391432779627,0.184,11/36,21.28%,STIL;NPM1;CEP295;ADPRH;CENPJ;EZR;RDX;TBC1D10B;ATXN2L;CEP76;ALMS1
gsea,external encapsulating structure organization (GO:0045229),0.5304500781279873,2.007984038564378,0.0,0.007349520839821344,0.188,43/68,25.97%,ITGAX;ITGB1;FURIN;ICAM1;ITGA1;ITGB3;PECAM1;ITGB8;CD44;COLQ;ITGB7;ADAMTS6;SPOCK2;ITGA4;SERPINE1;ITGAM;ITGA6;PDGFB;TGFBI;APLP1;CDH1;NDNF;APP;VCAM1;COL1A1;THBS1;ITGA7;DAG1;ITGAE;FN1;ITGA5;LAMC2;SH3PXD2A;JAM2;FGF2;MADCAM1;COL27A1;ADAM19;MMP14;ITGA3;PDGFA;COL7A1;NID1
gsea,regulation of cellular protein localization (GO:1903827),-0.5943510290807222,-2.0049608159273,0.0,0.001060407731165411,0.195,8/27,16.20%,HSP90AA1;PIN1;HSP90AB1;PARP1;CEP72;LCP1;SPIDR;SUMO3
gsea,extracellular matrix organization (GO:0030198),0.47808628009486287,2.003476341227006,0.0,0.007354071626719067,0.197,59/105,25.97%,CTSS;CAPG;GPM6B;GSN;ITGAX;ITGB1;FURIN;TIMP2;ICAM1;FLOT1;CTSL;ITGA1;ITGB3;PECAM1;P4HA2;ITGB8;CD44;COLQ;PRSS2;ITGB7;ADAMTS6;SPOCK2;ITGA4;SERPINE1;CREB3L1;ITGAM;ITGA6;PDGFB;TGFBI;ADAM8;APLP1;CDH1;NDNF;APP;PLOD1;VCAM1;COL1A1;THBS1;ITGA7;DAG1;ITGAE;FN1;ITGA5;LAMC2;P3H1;SH3PXD2A;JAM2;P3H2;FGF2;SH3PXD2B;MADCAM1;COL27A1;ADAM19;MMP14;ITGA3;PDGFA;TGFB2;COL7A1;NID1
gsea,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5935230485043063,2.001186296475228,0.0,0.0071976593955677265,0.201,17/32,20.80%,CCL5;TNFRSF18;JAK2;CLCF1;SH2B3;KIT;INPP5F;CSF2;IL6ST;TNF;CD40;PARP14;LIF;PIBF1;IL2;SOCS3;IL23A
gsea,positive regulation of protein transport (GO:0051222),-0.5353722182131977,-2.000682596215758,0.0,0.0010966216962495787,0.203,6/39,20.31%,PPIA;KIF20B;PCNT;EZR;PPID;PCM1
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.6522928950267932,-1.9996609951062607,0.0,0.0011012139208289196,0.203,7/19,15.56%,ACTN4;C1QBP;RCC2;CORO1C;P4HB;TRIOBP;CALR
gsea,regulation of embryonic development (GO:0045995),-0.7099443438378411,-1.997723730758537,0.00202020202020202,0.0011197392288337148,0.205,7/15,20.83%,CDK1;RACGAP1;CFL1;CCSAP;TDG;CLASP2;CLASP1
gsea,negative regulation of cell growth (GO:0030308),-0.4844599232615489,-1.9974831216136826,0.0,0.0011172997098166477,0.205,20/58,31.14%,RBBP7;CDKN2C;CDKN1A;ENO1;CDKN2D;CDKN2A;SMARCA4;ING1;PHB;MT3;FGF13;NME6;JADE1;RB1;PSRC1;EI24;DCBLD2;CCAR2;DDX3X;HSPA1B
gsea,regulation of protein kinase activity (GO:0045859),-0.48458526710773375,-1.9941490513931996,0.0,0.001170440681386757,0.213,16/59,23.01%,CENPE;PPIA;ECT2;CDKN1A;PARK7;AKT1;MAP2K3;MRNIP;CEP85;PRKRIP1;XRCC5;TARBP2;PDPK1;XRCC6;MMD;RB1
gsea,protein targeting to mitochondrion (GO:0006626),-0.6459348916900899,-1.9926046059093925,0.0020242914979757085,0.0011921608516039857,0.214,17/29,22.56%,HSP90AA1;HSPD1;TIMM50;TIMM17A;TOMM40;TIMM23;TIMM13;HSPA4;PMPCA;GRPEL1;AIFM1;SAMM50;PITRM1;MIPEP;CHCHD4;PMPCB;TOMM20
gsea,lymphocyte migration (GO:0072676),0.6808081230786622,1.992255762346452,0.0,0.007405168181360158,0.215,8/21,12.37%,CCL5;XCL1;CCR6;CRTAM;S1PR1;CCL1;CCL4;ADAM8
gsea,protein export from nucleus (GO:0006611),-0.6920833011118612,-1.9897580368058674,0.0,0.0012483678211818365,0.225,13/17,25.27%,RAN;NUTF2;CSE1L;ANKLE1;XPO1;CALR;NUP214;CCHCR1;RANBP3;XPO4;DESI1;XPO7;XPO5
gsea,regulation of neuron differentiation (GO:0045664),-0.574932451007027,-1.9892716826171557,0.002061855670103093,0.0012525727898812459,0.226,9/28,22.88%,ECT2;ID2;CDK5RAP2;TCF3;CALR;SIN3A;CPNE1;ROCK1;MMD
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.47404008689725524,-1.9879131427653227,0.0,0.0012636459878729172,0.227,23/68,22.63%,HDAC1;POLR2C;POLR2F;TAF15;E2F2;POLR2L;TAF1;MAZ;TAF6;POLR2B;POLR2A;GTF2E2;TAF5;NCOR2;POLR2E;E2F3;GTF2F1;GTF2F2;POLR2H;TBP;TAF9;TAF3;MED7
gsea,extracellular structure organization (GO:0043062),0.5235058892294524,1.9875871991096956,0.0,0.007674447024318709,0.234,43/69,25.97%,ITGAX;ITGB1;FURIN;ICAM1;ITGA1;ITGB3;PECAM1;ITGB8;CD44;COLQ;ITGB7;ADAMTS6;SPOCK2;ITGA4;SERPINE1;ITGAM;ITGA6;PDGFB;TGFBI;APLP1;CDH1;NDNF;APP;VCAM1;COL1A1;THBS1;ITGA7;DAG1;ITGAE;FN1;ITGA5;LAMC2;SH3PXD2A;JAM2;FGF2;MADCAM1;COL27A1;ADAM19;MMP14;ITGA3;PDGFA;COL7A1;NID1
gsea,regulation of RNA splicing (GO:0043484),-0.5761193215857007,-1.987578215323183,0.00199203187250996,0.001260928469619427,0.227,19/37,21.99%,SRSF3;HNRNPF;SNRNP70;FUS;SRSF10;U2AF2;HNRNPK;HNRNPH1;MBNL3;PTBP1;SRPK1;POLR2A;RRP1B;METTL16;HNRNPLL;RBM38;HNRNPH3;SETX;LARP7
gsea,protein maturation (GO:0051604),-0.5266496949089138,-1.987450494452598,0.0,0.001261651014029051,0.227,19/46,24.89%,NDUFAB1;STUB1;HSPD1;METAP2;NAA50;NAA40;LMF2;DNAJB11;GLRX3;NAA10;NAA16;PITRM1;NAA15;TYSND1;NAA35;CIAO1;GCSH;MMS19;TESC
gsea,protein methylation (GO:0006479),-0.6414685361334025,-1.9847814585061776,0.0,0.0013102652783835128,0.235,10/23,18.54%,EZH2;SNRPB;SNRPD3;PRMT1;GSPT1;FAM98B;ETF1;ATPSCKMT;PRMT5;EHMT2
gsea,cytokine-mediated signaling pathway (GO:0019221),-0.4053512789964844,-1.9843048805628438,0.0,0.0013108793144649671,0.235,63/311,21.22%,BIRC5;PPIA;LMNB1;HSP90AA1;EIF5A;HNRNPA2B1;UBB;MIF;HNRNPF;TCP1;ACTN4;PSMB6;HSP90B1;CDKN1A;PLP2;SNRPA1;PSMB2;PSMB5;HNRNPDL;CFL1;PSMA3;PSMC4;PSMA6;PSMD2;HSPA8;PSMB7;PSMA4;CANX;PSMD12;P4HB;PSMC2;UBE2N;SMARCA4;IFI30;PSMD1;PSMA5;CASP3;AKT1;PSMD7;PSMD14;PSMD11;HSPA9;PSME3;PSMD6;PSMC1;LCP1;PSMC5;GSTO1;TRAF2;PSMD3;PTPN6;TXLNA;PSMC6;IRF8;VIM;MTAP;SHC1;MT3;RALA;RPS6KA5;POU2F1;BAG4;PSME2
gsea,purine ribonucleotide metabolic process (GO:0009150),-0.5683147883098791,-1.9806261569775359,0.0,0.0013728071818660636,0.246,3/29,5.12%,RAN;HINT1;DBI
gsea,pattern recognition receptor signaling pathway (GO:0002221),-0.5952293659873845,-1.9789477592664901,0.0,0.0013936808669079005,0.25,3/27,4.75%,HMGB1;UBB;HSP90B1
gsea,"DNA-templated transcription, initiation (GO:0006352)",-0.4499877328256856,-1.9777548276803296,0.0,0.0014144659163444638,0.255,46/86,40.06%,HDAC1;POLR2C;POLR2F;SMARCA5;TAF15;E2F2;POLR2L;TAF1;MAZ;TAF6;POLR2B;POLR2A;TFAM;GTF2E2;TAF5;POLR3H;NCOR2;POLR2E;E2F3;GTF2F1;GTF2F2;POLR2H;TBP;TFB1M;TAF9;TAF3;MED7;GTF2H4;GTF2H3;TAF1D;TAF1B;TAF2;TBL1XR1;GTF2H2;GTF2H1;POLRMT;GTF3C1;RRN3;UBTF;TBL1X;POLR1A;ERCC3;BRF2;GTF2A1;POLR1E;POLR1C
gsea,cellular response to heat (GO:0034605),-0.6607296639171328,-1.9759399634248966,0.002061855670103093,0.001438547711682788,0.257,6/19,8.04%,RBBP7;HSP90AA1;STUB1;YWHAE;HSP90AB1;HIKESHI
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5171722954681643,-1.9738507886693857,0.0,0.0014996819641434572,0.264,7/47,12.84%,INCENP;CALM2;EZH2;PIH1D1;AKT1;ETAA1;HRAS
gsea,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.634616892521461,-1.9736008153889546,0.0039603960396039604,0.001510000222991291,0.266,9/19,20.78%,TFDP1;YWHAE;GZMB;BAX;CHCHD10;E2F1;TFDP2;NMT1;BAK1
gsea,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.672196362671205,-1.972304285971892,0.0019880715705765406,0.0015370922382703363,0.269,15/19,27.76%,EXOSC8;ERI1;EXOSC3;EXOSC7;NOP9;EXOSC9;ERI2;EXOSC2;FTSJ3;EXOSC10;UTP20;NOP14;RPP40;PES1;WDR12
gsea,positive regulation of myeloid cell differentiation (GO:0045639),-0.6098469318702833,-1.9700609189215785,0.0,0.0015942777902090018,0.279,2/21,4.73%,HMGB2;PRMT1
gsea,regulation of protein dephosphorylation (GO:0035304),-0.6291516403277871,-1.9688965350812295,0.0019646365422396855,0.0016143808538595682,0.284,7/21,13.30%,PPIA;CALM2;CDCA2;PIN1;HSP90B1;PPP1R7;PTBP1
gsea,toll-like receptor signaling pathway (GO:0002224),-0.516916690105104,-1.9688124664229625,0.0,0.0016110034880565146,0.284,4/44,5.32%,HMGB1;UBB;HSP90B1;HSPD1
gsea,tRNA processing (GO:0008033),-0.5489503573420759,-1.9682567174862973,0.0,0.0016176462834750036,0.286,26/42,35.32%,RPP30;SSB;DDX1;POP5;FAM98B;CPSF1;TRMT6;ELP5;CPSF4;NSUN2;CSTF2;CTU2;TSEN15;FTSJ1;WDR4;TSEN34;RPP40;TRDMT1;THG1L;TRMT10A;METTL1;TSEN54;ADAT2;TRUB1;POP1;THUMPD1
gsea,inorganic anion transport (GO:0015698),-0.6328895084503795,-1.968033761253327,0.0,0.0016176045915604809,0.286,2/21,6.19%,RACGAP1;SLC25A10
gsea,mitochondrial membrane organization (GO:0007006),-0.6351453874867243,-1.9670990676772937,0.0,0.0016474564357465127,0.292,13/21,22.17%,SLC25A5;TIMM50;IMMT;APOO;HSPA9;PPIF;MTX2;SAMM50;MTX1;DNAJC11;SPG7;BAK1;CHCHD6
gsea,prostaglandin metabolic process (GO:0006693),-0.6815332862098389,-1.9664745853086245,0.0,0.0016506676637408316,0.293,2/15,3.54%,PTGES3;MIF
gsea,regulation of chromosome organization (GO:0033044),-0.6944732907691691,-1.9656837576498398,0.002061855670103093,0.0016637887882931717,0.296,10/15,25.53%,BUB1;HNRNPD;RMI2;CDT1;PIF1;XRCC5;CENPV;YLPM1;RB1;TERF2
gsea,positive regulation of cellular metabolic process (GO:0031325),-0.5060229140978246,-1.9630001058554314,0.0,0.0017131655606976626,0.302,10/49,19.41%,CDK1;CCNB1;UHRF1;CDKN1A;PRELID1;EIF4G1;AKT1;FMR1;STARD4;MT3
gsea,cytoplasmic microtubule organization (GO:0031122),-0.5800106149728419,-1.9615652997175037,0.0,0.0017359859890591796,0.304,15/29,31.40%,FIGNL1;KPNB1;TUBGCP2;NUMA1;EZR;DCTN1;PCM1;CLASP1;TUBGCP3;SLK;DYNC1H1;HOOK1;CLIP1;TUBGCP6;TUBGCP4
gsea,negative regulation of cell cycle (GO:0045786),-0.5275076919808721,-1.9588993371894705,0.0,0.0017915856371497475,0.313,13/39,29.75%,MAD2L1;PLK1;GMNN;IPO5;CDKN2A;TAF6;IPO7;HTRA2;RB1;RUNX3;CDK6;SCRIB;MEN1
gsea,liver development (GO:0001889),-0.6396757194777982,-1.9580760860827664,0.0,0.0017977485054379671,0.314,7/18,18.02%,AURKA;E2F8;E2F7;PCK2;GFER;PRKCSH;CEBPB
gsea,positive regulation of histone acetylation (GO:0035066),-0.6341038521668602,-1.957765911481206,0.0,0.001800612275568234,0.314,9/18,24.35%,BRCA1;PIH1D1;RUVBL2;PAXIP1;SMARCB1;BRD7;KAT7;RPS6KA5;TADA2A
gsea,epidermis development (GO:0008544),-0.6148456947861458,-1.956594613482037,0.0,0.0018198000605906491,0.316,6/22,19.60%,YBX1;FABP5;HDAC1;HDAC2;ATP2A2;FLOT2
gsea,endomembrane system organization (GO:0010256),-0.43820983871705127,-1.95130585195008,0.0,0.0019139005195182711,0.323,41/97,38.81%,REEP4;NUP93;ZW10;NUP155;LMAN2;TMED2;LNPK;LMAN1;NSFL1C;CLASP2;SUN2;ATP8B4;PI4K2B;OPTN;CLASP1;ARL1;ATL2;TMED1;AP3D1;NPLOC4;HOOK1;SPTBN1;DYM;BAG5;HUWE1;GORASP2;USP8;BNIP1;SMPD4;GAK;SNX10;SEC23IP;ARHGAP21;UBXN2B;HACE1;GOLGA2;DYNC2H1;SPAG4;HTT;GBF1;FBXW8
gsea,water-soluble vitamin metabolic process (GO:0006767),-0.5239363085570671,-1.9490941229686256,0.0,0.001949048603947053,0.327,8/40,14.57%,MTHFD2;DHFR;SHMT2;MTHFD1;SHMT1;PDZD11;MTHFD1L;GSTO1
gsea,extracellular matrix disassembly (GO:0022617),0.6090792464230969,1.9484605524586052,0.0,0.011258213376688737,0.33,10/22,12.37%,CTSS;CAPG;GSN;FURIN;TIMP2;FLOT1;CTSL;CD44;PRSS2;ADAM8
gsea,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.6714175850536406,-1.9436393485350696,0.0,0.0020684816316852883,0.338,7/16,11.74%,HNRNPU;TINF2;CTC1;HNRNPA1;PIF1;PARP1;HNRNPC
gsea,protein K48-linked ubiquitination (GO:0070936),-0.6058961280055134,-1.9416462417997313,0.002053388090349076,0.002106414212835124,0.341,7/21,14.50%,UBE2C;UBE2T;RNF126;RNF5;CDC34;SKP2;UBE2E3
gsea,mesenchymal cell differentiation (GO:0048762),-0.6038678208763317,-1.9414773879376728,0.0,0.002105384293708948,0.341,5/22,19.92%,HNRNPAB;FAM83D;TRIM28;ROCK2;ROCK1
gsea,negative regulation of mRNA catabolic process (GO:1902373),-0.6673095238444913,-1.940144905791957,0.002028397565922921,0.0021398615173055966,0.344,7/17,13.97%,YBX1;HNRNPU;THRAP3;FUS;TAF15;E2F1;FMR1
gsea,regulation of T cell receptor signaling pathway (GO:0050856),0.6195079293764325,1.939596046758766,0.0,0.012040554715573342,0.357,11/20,15.56%,LGALS3;CD160;TESPA1;CD81;TRAT1;CD226;PRNP;CD300A;CEACAM1;CARD11;PVRIG
gsea,cellular senescence (GO:0090398),-0.636895649690563,-1.9385323891588018,0.0,0.00219996801281523,0.352,7/18,15.56%,SMC6;CDKN1A;CDKN2A;ID2;SMC5;HRAS;CALR
gsea,cellular response to tumor necrosis factor (GO:0071356),-0.4595199970588979,-1.9378974923239933,0.0,0.002201970629145598,0.353,31/104,16.77%,EIF5A;BRCA1;ACTN4;PSMB6;PSMB2;PSMB5;PSMA3;DHX9;PSMC4;PSMA6;PSMD2;PSMB7;PSMA4;YBX3;PSMD12;PSMC2;PSMD1;PSMA5;AKT1;PSMD7;PSMD14;PSMD11;PSME3;PSMD6;PSMC1;PSMC5;TRAF2;PSMD3;PSMC6;GBP3;CACTIN
gsea,positive regulation of protein import (GO:1904591),-0.6362045256216109,-1.9370779177639532,0.0,0.002220005706499782,0.357,4/19,6.71%,RAN;ECT2;TRIM28;IPO5
gsea,negative regulation of phosphorylation (GO:0042326),-0.4845200163890184,-1.936064980390028,0.0,0.0022347668273024384,0.36,19/52,30.92%,PPIA;HNRNPU;CDKN2C;CDKN1A;CDKN2D;CDKN2A;PARK7;CORO1C;TARDBP;PRKRIP1;CACTIN;DNAJC10;ROCK1;PRDX3;ZBED3;MEN1;XDH;PFKFB1;ANKLE2
gsea,internal peptidyl-lysine acetylation (GO:0018393),-0.6456961282904208,-1.9359166577470723,0.0018975332068311196,0.002233492561976842,0.361,9/18,20.24%,BRD8;RUVBL2;NAA50;TAF6;RUVBL1;SGF29;MORF4L2;KAT7;TAF6L
gsea,positive regulation of hydrolase activity (GO:0051345),-0.4540646903274317,-1.933362410127602,0.0,0.0022800567417574605,0.368,27/81,40.73%,HMGB2;CALM2;EZH2;ECT2;ARHGAP11A;PIN1;HRAS;RGS16;SRGAP2;TBC1D7;SH3BP1;NET1;DOCK11;PKP4;DOCK8;WRN;RAP1GDS1;GSK3B;RASGRP2;PICALM;SNX9;CCL3;RAB3GAP1;AFDN;SGSM3;RSU1;RIPK3
gsea,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.599556119646006,1.9329840226786752,0.0,0.012521655032665871,0.379,15/27,20.80%,CCL5;TNFRSF18;JAK2;CLCF1;KIT;CSF2;IL6ST;TNF;CD40;PARP14;LIF;PIBF1;IL2;SOCS3;IL23A
gsea,histone methylation (GO:0016571),-0.6472721541233911,-1.931988571821744,0.00199203187250996,0.0022946100251145674,0.368,11/18,24.97%,EZH2;SUV39H1;PRMT1;FBL;SUV39H2;SMYD2;PRMT5;EHMT2;SETD6;SMYD3;PRMT7
gsea,positive regulation of chemotaxis (GO:0050921),0.643247782050721,1.931515088219848,0.001851851851851852,0.012326564776963518,0.387,10/20,17.29%,XCL1;NTRK3;TMSB4X;P2RX4;NRP1;CCR2;F2RL1;PDGFB;AIF1;THBS1
gsea,regulation of protein ubiquitination (GO:0031396),-0.4934035215192431,-1.9309259355906652,0.0,0.0023027530204086074,0.369,26/51,32.32%,HSP90AA1;UBB;BRCA1;STUB1;CENPS;HSP90AB1;U2AF2;PARK7;FANCI;UBE2N;PAXIP1;AKT1;HSPBP1;TBC1D7;UBQLN1;BIRC3;IVNS1ABP;CUL3;NXN;BAG5;GTPBP4;PHF23;HUWE1;HSPA1B;AXIN1;UFL1
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.5215061862161281,-1.9303881666177198,0.0,0.002326713247512038,0.37,18/38,31.32%,UBB;BRCA1;SAE1;STUB1;UBA2;CENPS;FANCI;PAXIP1;HSPBP1;WDR48;PIAS4;TBC1D7;UBQLN1;BIRC3;CUL3;PHF23;HUWE1;AXIN1
gsea,protein N-linked glycosylation (GO:0006487),-0.5448535484844585,-1.9296703516055573,0.0,0.0023474149506180204,0.373,16/36,25.32%,DDOST;RPN2;ALG8;MOGS;RPN1;DPAGT1;MPDU1;ALG6;LMAN1;MAGT1;ALG13;STT3B;STT3A;ALG3;PMM1;ENTPD5
gsea,positive regulation of osteoblast differentiation (GO:0045669),-0.6347669274951295,-1.9274659604370001,0.0,0.0024185529051585,0.38,1/18,0.56%,FBXO5
gsea,positive regulation of protein modification process (GO:0031401),-0.4354449107308504,-1.9266598892235227,0.0,0.002429538344837715,0.381,19/98,19.74%,PPIA;CALM2;CDCA2;HSP90AA1;PIN1;TFRC;CEP295;UBE2N;AKT1;PPP1R7;CDK2AP1;HRAS;PTBP1;FMR1;MYDGF;ROCK2;VEGFB;MT3;SYMPK
gsea,maturation of SSU-rRNA (GO:0030490),-0.6194875706172088,-1.9261343603324708,0.0078125,0.0024436254838971394,0.382,18/24,31.84%,SNU13;UTP3;NOL11;HELB;NOL10;UTP6;UTP4;WDR46;DCAF13;HEATR1;BMS1;DDX52;NOP14;TSR3;WDR3;TSR2;RIOK2;NAT10
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.47774624233505314,-1.9258517145650373,0.0,0.002451379729818789,0.383,13/59,19.71%,HMGB1;ANP32B;CYCS;RPS27L;HSPD1;BAX;CASP8AP2;HSPE1;AIFM1;TRAF2;PIDD1;HTRA2;FADD
gsea,snRNA 3'-end processing (GO:0034472),-0.6595036649128333,-1.924635029516188,0.0019880715705765406,0.002484164495003556,0.388,13/17,30.12%,EXOSC8;EXOSC3;EXOSC7;EXOSC9;EXOSC4;EXOSC5;EXOSC2;TOE1;INTS1;INTS5;INTS7;INTS8;INTS14
gsea,negative regulation of cell death (GO:0060548),-0.5171133421728535,-1.9238852147577954,0.0,0.0024980620302129915,0.39,13/38,20.07%,RAD18;NUP62;TMEM109;PARK7;EIF4G1;AKT1;SRSF6;PSMC5;TRAF2;VPS35;HTRA2;MT3;SRGAP2
gsea,'de novo' posttranslational protein folding (GO:0051084),-0.6175716462092284,-1.9233127032513515,0.0,0.0025275071743132514,0.392,12/24,21.39%,PTGES3;SDF2L1;HSPA8;CCT2;HSPE1;HSPA14;HSPA9;DNAJB1;DNAJC7;ST13;HSPA13;CHCHD4
gsea,regulation of lipid metabolic process (GO:0019216),-0.5079694666980172,-1.9200101819305717,0.0,0.0026502664210390956,0.411,17/45,19.15%,NFYB;ID2;FDFT1;SP1;FDPS;HMGCS1;SIN3A;NCOR2;HMGCR;OPA3;MID1IP1;SQLE;NFYC;IDI1;SC5D;SREBF2;NFYA
gsea,intracellular protein transmembrane transport (GO:0065002),-0.6342358702826697,-1.9189356534986444,0.0,0.0026699761620799403,0.415,12/22,25.49%,HSPD1;TIMM50;TIMM17A;TOMM40;TIMM23;GRPEL1;AIFM1;PEX7;CHCHD4;TOMM20;C2CD5;DNAJC15
gsea,negative regulation of DNA metabolic process (GO:0051053),-0.660556420114224,-1.918752610434259,0.0,0.002683404955914785,0.417,9/15,25.53%,BLM;CDKN1A;ZRANB3;RTEL1;XRCC5;MSH2;SUB1;MSH6;TERF2
gsea,positive regulation of protein import into nucleus (GO:0042307),-0.6371955421175408,-1.9163286583007964,0.002004008016032064,0.0027772826464345893,0.426,4/18,6.71%,RAN;ECT2;TRIM28;IPO5
gsea,positive regulation of histone methylation (GO:0031062),-0.6770407939975287,-1.9153768239755058,0.003883495145631068,0.0028213539500818474,0.429,7/15,19.44%,DNMT1;BRCA1;RIF1;PAXIP1;MTF2;WDR5;PHF19
gsea,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.6044066637383984,-1.9150625541740562,0.008130081300813009,0.0028189915566733965,0.43,6/18,20.57%,MIF;KMT5A;SMYD2;ATR;EEF1E1;MDM2
gsea,ribonucleoprotein complex biogenesis (GO:0022613),-0.5881505930747736,-1.9117859464432814,0.0039603960396039604,0.0029490048739788115,0.448,30/40,33.98%,NPM1;RPS17;XPO1;EMG1;MRTO4;RPL14;EBNA1BP2;GTF3A;NOC2L;RPS15;RPS25;WDR74;RPF2;RPS6;CUL4B;NVL;NIP7;BOP1;NOP16;NOP14;PES1;WDR12;SDAD1;NAF1;RPL5;BYSL;RIOK2;LTV1;SHQ1;RRS1
gsea,epithelial to mesenchymal transition (GO:0001837),-0.597229940130875,-1.9115377634117587,0.0,0.0029464060841528986,0.448,5/23,19.92%,HNRNPAB;FAM83D;TRIM28;ROCK2;ROCK1
gsea,cellular respiration (GO:0045333),-0.6282603591319768,-1.9109590505473109,0.0,0.002956083175781244,0.449,6/18,9.45%,CYCS;MTFR2;MDH2;NDUFA5;ETFB;UQCRC1
gsea,negative regulation of response to DNA damage stimulus (GO:2001021),-0.6295886634567205,-1.910353933612026,0.00404040404040404,0.002977965597821007,0.454,6/17,13.04%,FBXO5;DDX39B;MIF;DDIAS;CDKN2D;RTEL1
gsea,actomyosin structure organization (GO:0031032),-0.5764526660703757,-1.9096952054543952,0.0019267822736030828,0.003008928588980145,0.459,12/27,26.23%,CIT;CSRP1;CSRP2;EPB41L2;ROCK2;ROCK1;FLII;MYH9;KCTD13;TPM1;TNFAIP1;CUL3
gsea,negative regulation of protein catabolic process (GO:0042177),-0.6323714456611214,-1.9096519465929893,0.0,0.0030031863588485036,0.459,10/19,25.44%,MAD2L1;PIN1;SNRNP70;SF3B3;PHB;AZIN1;HMGCR;ROCK1;FLNA;MDM4
gsea,RNA methylation (GO:0001510),-0.5126818833538305,-1.9085232298266968,0.0,0.0030400695815993796,0.462,29/45,41.10%,FBL;TRMT6;BUD23;VIRMA;NSUN2;FTSJ3;RBM15;METTL14;TFB1M;METTL16;NSUN5;CMTR1;FTSJ1;DIMT1;METTL5;TRDMT1;TRMO;GTPBP3;TRMT10A;METTL1;ZC3H13;MTO1;TYW3;RBM15B;METTL3;NOP2;ZCCHC4;TRMT61A;TRMT5
gsea,regulation of translational initiation (GO:0006446),-0.5440980533029282,-1.905983914448727,0.003976143141153081,0.003125409800902661,0.47,21/34,29.89%,NPM1;EIF3B;CDC123;GLE1;EIF4G1;EIF4H;DDX1;NCBP1;EIF4G2;FMR1;EIF5;CEBPB;MIF4GD;EIF5B;EIF2B5;NCBP2;EIF4G3;ATF4;LARP1;EIF4B;DDX3X
gsea,receptor signaling pathway via STAT (GO:0097696),0.6590627919206102,1.9053909445023824,0.00404040404040404,0.016702237394861364,0.476,6/17,5.18%,STAT4;JAK2;CLCF1;IFNAR2;STAT1;CCR2
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.6385013764668713,-1.9024411476925225,0.0,0.003255899606598648,0.484,4/16,6.69%,CALM2;MASTL;HSP90B1;HSP90AB1
gsea,positive regulation of growth (GO:0045927),-0.528249822810707,-1.901374470161461,0.0,0.0032799913528835786,0.486,17/35,32.54%,HDGFL2;FXN;EIF4G1;DERL2;AKT1;EXOSC9;NCBP1;EIF4G2;EXOSC4;EXOSC2;ADAM17;DDX49;USP47;DDX3X;DNPH1;ZPR1;SUPV3L1
gsea,regulation of mRNA processing (GO:0050684),-0.6617888673648179,-1.9007053333304087,0.0,0.0032979518102808376,0.487,14/18,24.14%,SRSF3;SRSF10;DHX9;HNRNPK;IWS1;NCBP1;SRPK1;SAFB;CPSF4;SLTM;METTL16;LARP7;AHCYL1;SAFB2
gsea,chaperone cofactor-dependent protein refolding (GO:0051085),-0.6406636166550169,-1.9003253189287572,0.0,0.0033007724719473124,0.488,10/20,20.89%,PTGES3;SDF2L1;HSPA8;HSPE1;HSPA14;HSPA9;DNAJB1;DNAJC7;ST13;HSPA13
gsea,DNA modification (GO:0006304),-0.6368718245509786,-1.8996588222704995,0.002066115702479339,0.0033306610548137962,0.491,12/17,25.53%,NEIL3;TINF2;EXOSC3;PARP2;PARP1;MBD4;EXOSC4;TDG;EXOSC5;MUTYH;OGG1;TERF2
gsea,regulation of protein catabolic process (GO:0042176),-0.5034787163580173,-1.898431918119937,0.0,0.0033784557050135352,0.499,29/45,36.38%,MAD2L1;FAM83D;FZR1;BARD1;PIN1;DTL;FAF1;SF3B3;NEDD4;ZDHHC2;PHB;CHEK2;DDB1;AZIN1;HMGCR;ODC1;MDM2;FLNA;MDM4;BANP;VCP;HUWE1;AXIN1;HGS;NSF;WWP1;IDE;HACE1;GSK3B
gsea,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.780619203498342,-1.8980380664812686,0.0,0.003387104326247133,0.499,13/15,18.46%,TCP1;NHP2;CCT8;RUVBL2;CCT6A;CCT7;CCT3;CCT2;CCT5;RUVBL1;CCT4;DKC1;NOP10
gsea,positive regulation of cell cycle (GO:0045787),-0.5097660712145954,-1.8937118157346102,0.002053388090349076,0.0035333444724333987,0.511,14/39,28.23%,CCNB1;CDC25B;CDK4;RAD23A;ASNS;EIF4E;AKT1;CHEK1;CALR;HCFC1;MDM2;PSRC1;HSF1;ADAM17
gsea,regulation of microtubule polymerization (GO:0031113),-0.6009583804022676,-1.893405965599069,0.0019305019305019305,0.003532712554408305,0.512,8/21,23.16%,STMN1;NUMA1;CDK5RAP2;DRG1;DCTN1;CLASP1;PSRC1;ARL2
gsea,regulation of protein import into nucleus (GO:0042306),-0.6152678938646775,-1.8928548059669472,0.0,0.003552947619568994,0.516,4/20,6.71%,RAN;ECT2;TRIM28;IPO5
gsea,translation (GO:0006412),-0.5293718878363741,-1.8914049598894316,0.003883495145631068,0.003576082431534493,0.516,58/102,27.15%,MRPL18;MRPL51;MRPL42;MRPL28;GSPT1;RPS17;MRPL13;PPA1;RPS2;EIF4G1;MRPS12;MRPL55;EEF1D;TSFM;MRPL35;RPL14;ABCF1;COPS5;AIMP2;SRBD1;MRPS28;RPS15;FARSB;MRPS5;MRPS7;MRPL2;DRG1;EEF1G;RPS25;EEFSEC;ETF1;MRPS18A;MRPL37;TUFM;RPL23A;MRPL16;MRPL11;EEF1E1;RPL31;DARS2;RRBP1;FARSA;SARS2;RPS6;ABCE1;RPL4;MRPS18B;PPA2;FTSJ1;DRG2;RPL22L1;DHPS;MRPL3;PABPC4;MRPS2;PTCD3;QRSL1;HBS1L
gsea,inner mitochondrial membrane organization (GO:0007007),-0.637325375023203,-1.8906923408619447,0.005859375,0.003602100820712953,0.519,11/19,22.17%,IMMT;APOO;HSPA9;TIMM13;MTX2;SAMM50;MTX1;LETM1;DNAJC11;SPG7;CHCHD6
gsea,positive regulation of epithelial cell proliferation (GO:0050679),-0.5002778056117021,-1.8895138363398993,0.0,0.0036369148791217574,0.52,8/46,18.11%,HMGB2;NME1;NME2;AKT1;HRAS;SRSF6;MYDGF;VEGFB
gsea,7-methylguanosine RNA capping (GO:0009452),-0.6363499767832794,-1.8877355213716376,0.0019305019305019305,0.003706156888082706,0.53,13/20,25.65%,POLR2C;POLR2F;POLR2L;NCBP1;POLR2B;POLR2A;POLR2E;GTF2F1;GTF2F2;POLR2H;CMTR1;NCBP2;GTF2H4
gsea,7-methylguanosine mRNA capping (GO:0006370),-0.6363499767832794,-1.8877355213716376,0.0019305019305019305,0.003706156888082706,0.53,13/20,25.65%,POLR2C;POLR2F;POLR2L;NCBP1;POLR2B;POLR2A;POLR2E;GTF2F1;GTF2F2;POLR2H;CMTR1;NCBP2;GTF2H4
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.5524891181611167,-1.8875800328928398,0.002105263157894737,0.0037052142892652264,0.531,5/28,20.78%,HMGB1;CYCS;HTRA2;FADD;BAK1
gsea,positive regulation of histone modification (GO:0031058),-0.6288928005599648,-1.886809471025512,0.0,0.0037366397586009333,0.539,10/17,26.78%,BRCA1;RUVBL2;UBE2N;PAXIP1;SART3;FMR1;BRD7;RPS6KA5;TADA2A;AKAP8
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.5780138329048876,-1.8844299042879198,0.0057692307692307696,0.0038354967258133403,0.551,10/24,19.68%,SAE1;TFDP1;YWHAE;GZMB;E2F1;TFDP2;HTRA2;NMT1;SREBF2;CSNK2A2
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.5069695340987235,-1.881753623846306,0.0,0.003910539404492796,0.559,11/42,19.71%,ANP32B;CYCS;RPS27L;HSPD1;BAX;CASP8AP2;HSPE1;AIFM1;TRAF2;PIDD1;FADD
gsea,regulation of viral genome replication (GO:0045069),-0.517197572935799,-1.8806687256779737,0.0,0.003976528991870291,0.564,11/40,18.76%,PPIA;BANF1;PPIH;FAM111A;RAD23A;SRPK1;PPID;DDB1;PPIE;ILF3;TARBP2
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5066721829805412,-1.8791745499042012,0.0037735849056603774,0.004018911536303016,0.568,43/78,31.43%,EXOSC8;EIF4A3;RNPS1;RBM8A;MAGOH;ERI1;THRAP3;GSPT1;MAGOHB;RPS17;RPS2;EIF4G1;EXOSC7;MRTO4;RPL14;EXOSC9;NCBP1;RPS15;EXOSC4;UPF3B;CNOT9;RPS25;CNOT10;DXO;ETF1;EXOSC5;RPL23A;RPL31;RPS6;RPL4;CASC3;EXOSC10;CNOT1;PELO;NCBP2;PARN;XRN1;PATL1;PAN2;SMG6;SMG9;PYM1;RPL5
gsea,regulation of inflammatory response (GO:0050727),0.45198576483388136,1.8776214006830745,0.0,0.022121958544045247,0.566,63/101,30.70%,CCL5;XCL1;TNFAIP3;NFKBIA;CD200;PDCD4;RORA;TNFAIP8L2;JAK2;BCL6;NFKBIZ;IL16;MGST2;TMSB4X;AREL1;NINJ1;DNASE1L3;ETS1;CCR2;SEMA7A;FOXP1;CCN4;CCL1;KLF4;ANXA1;MFHAS1;CASP4;IL1B;SERPINE1;PTGER4;ZBP1;IL17RA;TNF;SIRPA;PTGS2;USP18;HCK;APP;TLR7;BST1;SPATA2;IL2;IL23A;MEFV;CX3CL1;GRN;NLRP3;TLR2;LPL;ABCC1;TNIP1;SELENOS;IL10;PLA2G7;PPARG;MMP9;MAPK13;APOE;PIK3AP1;TNFRSF1A;NR1H3;ACOD1;SBNO2
gsea,protein monoubiquitination (GO:0006513),-0.6123526825848165,-1.8761366279619216,0.001953125,0.004192331986417899,0.578,7/19,17.67%,UHRF1;UBE2T;RAD18;DTL;RNF126;LEO1;FANCL
gsea,mitochondrial transport (GO:0006839),-0.5803128995820813,-1.8760913330090097,0.0,0.004187605760877073,0.578,14/29,22.56%,HSP90AA1;SLC25A5;TIMM17A;TOMM40;TIMM23;TIMM13;PPIF;MTX2;SLC25A13;PITRM1;SPG7;BAK1;COX18;TOMM20
gsea,ERAD pathway (GO:0036503),-0.5007412733120804,-1.8757903971694148,0.001949317738791423,0.0041887063003909555,0.579,17/45,29.18%,HSP90B1;STUB1;GET4;RNF5;DERL2;EDEM1;PSMC6;STT3B;DNAJC10;TMEM129;UBQLN1;NPLOC4;TMUB1;CCDC47;ECPAS;DNAJB12;VCP
gsea,endoplasmic reticulum organization (GO:0007029),-0.5305922302339459,-1.8745793606664611,0.0020920502092050207,0.004230396090765148,0.58,12/33,33.31%,REEP4;GET4;RTN3;LMAN2;LNPK;LMAN1;ATL2;ZBED3;CCDC47;BNIP1;SMPD4;GAK
gsea,receptor signaling pathway via JAK-STAT (GO:0007259),0.635139220419462,1.8735167355598021,0.003929273084479371,0.02221952603217723,0.578,6/18,5.18%,STAT4;JAK2;CLCF1;IFNAR2;STAT1;CCR2
gsea,negative regulation of T cell activation (GO:0050868),0.5944865621318888,1.872973267872052,0.0019305019305019305,0.021514386819326645,0.578,10/24,8.32%,LGALS3;RIPOR2;CD274;PDCD1LG2;LAX1;TNFAIP8L2;IL4I1;CD86;PAG1;SDC4
gsea,positive regulation of protein dephosphorylation (GO:0035307),-0.6736207491336768,-1.8720406576441415,0.004032258064516129,0.004358762774897269,0.59,7/15,13.30%,PPIA;CALM2;CDCA2;PIN1;HSP90AB1;PPP1R7;PTBP1
gsea,positive regulation of transport (GO:0051050),-0.49348902080167434,-1.8697061108519881,0.002127659574468085,0.0044664419861183725,0.598,15/49,25.26%,SPAG5;LYAR;ACTB;BAX;CHCHD10;NUMA1;LMAN2;FMR1;CALR;BAK1;PLAA;C2CD5;IFNG;RAB27A;DYNC1H1
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.5142867680026089,-1.8696144577628901,0.002070393374741201,0.004461263632649755,0.598,14/36,34.25%,PLK1;SUMO2;STUB1;RAD23A;TAF1;USP5;HSPBP1;MDM2;KEAP1;VCP;HSPA1B;AXIN1;TRIB3;HSPA1A
gsea,kidney development (GO:0001822),-0.5966427631034992,-1.868584606404216,0.00625,0.004507919102006385,0.6,2/20,10.27%,CENPF;IFT27
gsea,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.7266820244800426,-1.8661168869665963,0.002028397565922921,0.004631989699965352,0.609,13/17,18.46%,TCP1;NHP2;CCT8;RUVBL2;CCT6A;CCT7;CCT3;CCT2;CCT5;RUVBL1;CCT4;DKC1;NOP10
gsea,sensory perception of sound (GO:0007605),-0.5415740116740418,-1.864869122672045,0.0,0.004678171135199847,0.614,1/28,0.15%,BIRC5
gsea,positive regulation of inflammatory response (GO:0050729),0.5161790880522417,1.8635216963205834,0.003795066413662239,0.023034723270989974,0.616,32/49,25.39%,NFKBIA;C2CD4B;PDCD4;NFKBIZ;IL16;CD81;MGST2;NINJ1;ETS1;CCR2;CCN4;CCL1;IL1B;SERPINE1;PTGER4;IL6ST;ZBP1;C2CD4A;IL17RA;TNF;ADAM8;APP;TLR7;NUPR1;IL2;IL23A;CX3CL1;GRN;TLR2;LPL;ABCC1;TNIP1
gsea,negative regulation of transferase activity (GO:0051348),-0.6265556114268664,-1.8623031874430094,0.00392156862745098,0.0047929024935125355,0.627,4/16,10.24%,FBXO5;HNRNPU;PARK7;PIF1
gsea,negative regulation of transport (GO:0051051),0.6028560414515503,1.8602215152291424,0.007285974499089253,0.023023341072956127,0.632,9/19,15.45%,LGALS3;TRAT1;ITGB3;MCTP1;ABCA7;SYT11;SIRPA;CRYAA;FCGR2B
gsea,calcium-mediated signaling (GO:0019722),0.49188458175221894,1.8596326559837921,0.0018832391713747645,0.022413750934708127,0.633,20/52,17.98%,CCR7;CXCR6;CCR6;CCR8;TNFSF11;CXCR3;P2RX4;CCR2;PRNP;CCR5;CXCR5;PLCG1;MCTP1;ATP1B1;LRRK2;SELP;PPP1R9B;KSR2;VCAM1;CXCR4
gsea,regulation of RNA metabolic process (GO:0051252),-0.5553978995208195,-1.8580172181704222,0.0,0.0050186862126464,0.643,11/28,21.73%,PCBP1;HNRNPF;SNRNP70;FUS;HNRNPH1;MBNL3;PTBP1;RRP1B;HNRNPLL;RBM38;HNRNPH3
gsea,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6122965762029735,-1.8578327127878234,0.0,0.00501543010928276,0.644,17/21,33.98%,NOP9;TBL3;UTP3;HELB;NOL10;UTP6;UTP4;WDR46;DCAF13;HEATR1;BMS1;UTP20;NOP14;RPP40;TSR2;KRI1;RRS1
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),-0.5188075022592917,-1.857460764179916,0.001949317738791423,0.005020729112336661,0.644,15/37,29.18%,HSP90B1;STUB1;RNF5;DERL2;EDEM1;PSMC6;STT3B;DNAJC10;TMEM129;UBQLN1;NPLOC4;TMUB1;ECPAS;DNAJB12;VCP
gsea,RNA stabilization (GO:0043489),-0.6243762928348785,-1.8563324385323248,0.002004008016032064,0.0050885500969083276,0.645,11/19,26.85%,YBX1;HNRNPU;THRAP3;FUS;TAF15;E2F1;DKC1;NSUN2;PARN;LARP1;TRDMT1
gsea,positive regulation of protein catabolic process (GO:0045732),-0.496726093635383,-1.8550508278363234,0.0,0.00515896787045932,0.649,20/41,36.93%,HSP90AA1;FZR1;BARD1;DTL;FAF1;EZR;NEDD4;RDX;VPS35;DDB1;IFNG;VCP;HUWE1;AXIN1;NSF;WWP1;IDE;HACE1;GSK3B;SNX9
gsea,negative regulation of mitochondrion organization (GO:0010823),-0.6017256811679621,-1.8549927722335038,0.001968503937007874,0.005149820764306022,0.649,6/19,12.89%,SLC25A5;TFRC;FXN;PRELID1;AKT1;PPIF
gsea,nucleobase-containing compound catabolic process (GO:0034655),-0.5843002532934141,-1.8535655840486285,0.0019305019305019305,0.0052170531566552375,0.654,13/23,25.32%,HNRNPD;RNASEH2B;NUDT5;RNASEH2A;EXOSC7;NCBP1;NUDT1;MTREX;SND1;RNASEH1;PABPC4;PPP1R8;ENTPD5
gsea,modulation by host of symbiont process (GO:0051851),-0.6041981394853714,-1.8530956806672065,0.006109979633401222,0.005241707850678904,0.655,7/19,11.40%,NUCKS1;HDAC1;SAP30;SMARCA4;TARDBP;SMARCB1;SP1
gsea,protein tetramerization (GO:0051262),-0.5367051331090776,-1.850274820816178,0.00202020202020202,0.005387436547675466,0.663,18/30,36.28%,TK1;SHMT2;SHMT1;CPSF6;FARSB;APIP;ALDOA;ALDH9A1;CBY1;FARSA;GLS;ACACA;THG1L;SOD2;CRYZ;GBP5;GOLGA2;CTH
gsea,monocarboxylic acid metabolic process (GO:0032787),-0.4587385114186434,-1.8499561974190462,0.0,0.005392015305201603,0.665,24/61,35.04%,LDHA;ME2;VDAC1;PDZD11;GOT2;MTHFD1L;GATM;SLC16A3;BSG;DLAT;MECR;MSMO1;GRHPR;SCPEP1;ALKBH7;PDHX;ACSF2;THEM4;AASDHPPT;DLD;GNPAT;GBA2;CKM;CPT1A
gsea,cellular component disassembly (GO:0022411),0.5693587260549124,1.849073875921463,0.001984126984126984,0.024021328639626607,0.658,10/23,12.37%,CTSS;CAPG;GSN;FURIN;TIMP2;FLOT1;CTSL;CD44;PRSS2;ADAM8
gsea,sensory perception of mechanical stimulus (GO:0050954),-0.5414281494215207,-1.8478710813217738,0.0,0.0054695805842779254,0.672,8/27,35.92%,BIRC5;TIMM13;CCDC50;GSDME;TIMM8B;TIMM10;ALDH7A1;TBL1X
gsea,regulation of endothelial cell apoptotic process (GO:2000351),0.5731442916261321,1.846000639457181,0.0,0.02405610308698142,0.667,13/26,17.29%,TNFAIP3;CD160;PDCD4;ICAM1;PLCG1;ITGA4;SERPINE1;NFE2L2;CD40LG;TNF;CD40;NDNF;THBS1
gsea,negative regulation of kinase activity (GO:0033673),-0.515332504882362,-1.8451610580903681,0.0,0.005628156846183141,0.68,10/31,23.53%,PPIA;HNRNPU;PARK7;AKT1;CEP85;PRKRIP1;TARBP2;PDPK1;RB1;PRDX3
gsea,proteolysis (GO:0006508),-0.41053510988746683,-1.8433030015875,0.0,0.005755400133774248,0.687,36/104,30.84%,FAM111A;GZMB;PSMB5;METAP2;PSMC4;PSMA6;CASP3;PSMD6;THOP1;LONP1;CLPP;LAP3;HTRA2;CPNE1;SPCS3;PITRM1;SPG7;MIPEP;RNPEP;TYSND1;MDM2;PARL;UFSP2;UBA3;DESI1;ST14;LRP8;ZMPSTE24;CASP7;ERAP1;ADAM17;SENP1;CLPX;YME1L1;TASP1;DPP3
gsea,positive regulation of multicellular organismal process (GO:0051240),-0.3904378680886302,-1.8427730220158711,0.0,0.0057732689126401004,0.688,29/149,26.07%,FBXO5;EZH2;FABP5;MIF;GAPDH;ENO1;CFL1;NME2;TFRC;C1QBP;RIF1;NUMA1;PAXIP1;ACADL;GATM;CEBPB;PLAC8;ROCK1;GLMN;ALMS1;ETV4;KMT5C;MTOR;PIK3CG;VAMP8;ZBED3;IFNG;DYNC1H1;HSF1
gsea,glucose metabolic process (GO:0006006),-0.5537367509366821,-1.842537332084111,0.0,0.005774346168740233,0.69,15/32,28.00%,TPI1;MDH2;GAPDH;SLC25A10;ENO1;PGK1;PGAM1;GOT2;PCK2;ALDOA;SLC25A13;ENO3;SLC25A1;ATF4;PGM1
gsea,positive regulation of cell-matrix adhesion (GO:0001954),0.5899414851658487,1.8423617152545286,0.004106776180698152,0.02430726974970015,0.679,6/21,7.90%,CCR7;UTRN;S100A10;NRP1;MAP4K4;JUP
gsea,positive regulation of mitotic cell cycle (GO:0045931),-0.6052642492862523,-1.8416323768480414,0.0,0.0057921196800229885,0.69,4/18,10.94%,CCNB1;CDC25B;ASNS;EIF4E
gsea,pyruvate metabolic process (GO:0006090),-0.613461831774915,-1.8398294355044655,0.007827788649706457,0.005870958242777964,0.694,14/30,17.15%,LDHA;TPI1;GAPDH;PKM;ENO1;ME2;PGK1;PGAM1;VDAC1;PCK2;ALDOA;SLC16A3;BSG;DLAT
gsea,cholesterol metabolic process (GO:0008203),-0.5396325524940228,-1.8385191140546422,0.004016064257028112,0.0059328810379764545,0.698,23/35,35.23%,LBR;FDFT1;FDX1;FDPS;HMGCS1;HMGCR;SQLE;IDI1;INSIG1;MT3;MSMO1;HSD17B7;PMVK;CLN6;ACAT2;ACLY;MVK;NSDHL;DHCR24;SOAT1;SCAP;GBA2;DHCR7
gsea,cellular response to molecule of bacterial origin (GO:0071219),-0.48377667276224745,-1.837098944511253,0.0020242914979757085,0.006055504190243741,0.708,5/57,22.97%,HMGB2;HMGB1;VIM;CACTIN;PLAA
gsea,negative regulation of protein kinase activity (GO:0006469),-0.4846474107532308,-1.8331952945777656,0.0,0.006299322250700732,0.717,12/42,24.69%,PPIA;CDKN1A;NPM1;PARK7;CORO1C;AKT1;CEP85;PRKRIP1;TARBP2;PDPK1;RB1;IFNG
gsea,regulation of endopeptidase activity (GO:0052548),-0.5402598825422034,-1.8331893919132305,0.00808080808080808,0.0062884425922366555,0.717,10/25,25.33%,GAPDH;HDAC1;PSMA3;SERPINB9;PRELID1;AKT1;PSME3;SERPINE2;PSME2;BIRC3
gsea,IRE1-mediated unfolded protein response (GO:0036498),-0.5555859618218106,-1.831276016753471,0.001968503937007874,0.0064015548246684675,0.721,12/26,28.94%,HDGF;DNAJB11;PDIA6;MYDGF;EDEM1;DCTN1;SHC1;DDX11;SRPRB;ADD1;HYOU1;LMNA
gsea,protein transmembrane import into intracellular organelle (GO:0044743),-0.6384378670720496,-1.831000576365658,0.00823045267489712,0.006412535063035705,0.723,11/18,25.49%,HSPD1;TIMM50;TIMM17A;TOMM40;TIMM23;GRPEL1;AIFM1;PEX7;CHCHD4;TOMM20;DNAJC15
gsea,protein autoubiquitination (GO:0051865),-0.5882542577223439,-1.829708281632553,0.001968503937007874,0.006486614313957688,0.726,12/22,27.63%,UHRF1;BRCA1;UBE2T;RAD18;STUB1;TRAF2;TRIM37;MDM2;RNF8;NFX1;CUL3;DDB2
gsea,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.5935860885578415,-1.8274404880378268,0.0021598272138228943,0.006604285311243689,0.732,5/18,12.98%,EIF5A;UBB;BAX;SFPQ;BCLAF1
gsea,positive regulation of interleukin-8 production (GO:0032757),-0.5451336919879048,-1.827156211527601,0.0042643923240938165,0.006614862003032712,0.732,2/26,8.45%,HMGB1;PARK7
gsea,negative regulation of peptidase activity (GO:0010466),-0.6008779585690278,-1.8263493036154967,0.004123711340206186,0.006649981522337906,0.733,5/18,13.80%,GAPDH;SERPINB9;PARK7;AKT1;SERPINE2
gsea,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.6232793527149794,-1.8253031518255185,0.003976143141153081,0.006684981179802468,0.734,13/16,29.90%,UBB;COPS3;PARP1;COPS4;COPS5;GPS1;DDB1;RAD23B;COPS7A;CUL4B;DDB2;COPS7B;COPS2
gsea,regulation of proteolysis (GO:0030162),-0.5941522627175333,-1.8250944011299293,0.00392156862745098,0.006676314489827513,0.734,10/20,25.60%,PLK1;STUB1;AKT1;HDAC2;SERPINE2;FADD;PARL;BAK1;CLN6;HDAC6
gsea,regulation of cellular senescence (GO:2000772),-0.5775686848192616,-1.8250570121934822,0.0,0.0066649602134842695,0.734,10/21,27.62%,FBXO5;YBX1;RBL1;CDKN2A;CGAS;RSL1D1;EEF1E1;TERF2;HMGA1;CDK6
gsea,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.6094698258436437,-1.8247122978623556,0.0020161290322580645,0.006672631654805228,0.734,7/18,14.09%,CDC6;TFDP1;MTBP;EIF4G1;AKT1;RDX;LSM11
gsea,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.587581510602896,-1.8244667131994734,0.0019342359767891683,0.006682984945756461,0.734,12/21,29.16%,RPA3;UBB;RPA2;RPA1;PARP1;DDB1;CHD1L;RAD23B;CUL4B;GTF2H4;DDB2;GTF2H3
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.48531761743086915,1.8215352610828344,0.0018181818181818182,0.029577861112159206,0.746,27/53,17.98%,CCR7;CXCR6;CCR6;CCR8;CXCR3;S1PR4;GNA15;PTGER2;GPR18;P2RX4;CCR2;F2RL1;CCR5;CXCR5;TRPM1;CCL1;TBXA2R;CIB2;PTGER4;F2RL2;CALCA;F2R;LPAR3;GPR55;GLP1R;CXCL13;CXCR4
gsea,gluconeogenesis (GO:0006094),-0.6326896441913833,-1.8180306109495084,0.011695906432748537,0.0071150137410744465,0.747,15/22,28.00%,TPI1;MDH2;GAPDH;SLC25A10;ENO1;PGK1;PGAM1;GOT2;PCK2;ALDOA;SLC25A13;ENO3;SLC25A1;ATF4;PGM1
gsea,cellular response to topologically incorrect protein (GO:0035967),-0.5644424958630057,-1.8150971849072992,0.003992015968063872,0.007318891645498872,0.753,12/23,31.14%,STUB1;BAX;HSPA8;HSPA14;HSPA9;OPTN;BAK1;HSPA13;HDAC6;HSF1;DNAJB12;HSPA1B
gsea,positive regulation of T cell differentiation (GO:0045582),0.5938233509258881,1.8147275418031508,0.005802707930367505,0.030899505940207947,0.762,10/18,13.73%,VSIR;TESPA1;BCL6;DUSP10;ZBTB1;IL4I1;TNFSF9;LEF1;ADAM8;SOX4
gsea,organic hydroxy compound biosynthetic process (GO:1901617),-0.5975728127333045,-1.8109628112952483,0.003937007874015748,0.007575965043146291,0.763,11/20,28.64%,PSAT1;LBR;PARK7;HMGCR;SQLE;SC5D;INSIG1;MSMO1;PMVK;OSBP;OSBPL9
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5627969390668917,-1.8101900104500892,0.005928853754940711,0.0076250721487699435,0.766,9/21,32.24%,ARL6IP1;YWHAE;CDKN2D;AKT1;MT3;PCID2;USP47;DDX3X;DHCR24
gsea,hexose biosynthetic process (GO:0019319),-0.6133174300101749,-1.8092590801658976,0.004,0.007684754586236906,0.767,15/24,28.00%,TPI1;MDH2;GAPDH;SLC25A10;ENO1;PGK1;PGAM1;GOT2;PCK2;ALDOA;SLC25A13;ENO3;SLC25A1;ATF4;PGM1
gsea,response to gamma radiation (GO:0010332),-0.5709461690168669,-1.8087717429906018,0.00398406374501992,0.007709389022003386,0.767,12/19,36.05%,FANCD2;TMEM109;HRAS;ATR;XRCC5;MDM2;XRCC6;HSF1;MEN1;PRKAA1;TLK2;WRN
gsea,sprouting angiogenesis (GO:0002040),-0.5576983710546192,-1.807759199316338,0.004319654427645789,0.00781690015831944,0.775,4/25,18.11%,E2F8;E2F7;AKT1;VEGFB
gsea,response to amyloid-beta (GO:1904645),0.5927579987402263,1.8072940149938437,0.005597014925373134,0.03239504301895648,0.778,12/22,25.37%,ICAM1;PRNP;RAMP3;CASP4;ITGA4;ADRB2;APP;FCGR2B;VCAM1;LRP1;CACNA2D1;ABCC1
gsea,positive regulation of response to stimulus (GO:0048584),-0.5132075365388556,-1.8071920325833748,0.00808080808080808,0.00784924611256401,0.777,12/28,27.85%,NSMCE4A;ANKLE1;DHX9;NSMCE1;CDKN2A;CGAS;BCLAF1;FMR1;EEF1E1;TAF9;HMGA1;FXR2
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),-0.527139242364633,-1.8031013468697172,0.006198347107438017,0.00814820095586021,0.791,25/34,38.29%,NDUFAB1;NDUFA5;NDUFV1;NDUFA12;NDUFAF2;AIFM1;SAMM50;COX18;CHCHD4;TIMMDC1;COX17;NUBPL;ACAD9;NDUFS1;TIMM21;NDUFAF7;NDUFAF5;NDUFAF6;FOXRED1;ECSIT;SDHAF3;SCO1;BCS1L;COX19;OMA1
gsea,regulation of type I interferon production (GO:0032479),-0.4539103719853256,-1.801107500524293,0.0,0.008302372208206715,0.797,18/54,27.22%,POLA1;PIN1;G3BP1;GAPDH;POLR3K;POLR2F;DHX9;POLR2L;CGAS;IRF8;POLR3H;XRCC5;POLR2E;POLR2H;XRCC6;DDX41;NPLOC4;NFKB2
gsea,brain development (GO:0007420),-0.4580057503958159,-1.8007027851501929,0.0,0.00832045746239281,0.797,16/54,35.88%,CENPF;PHGDH;TUBGCP2;CDK5RAP2;UTP3;SETD1A;PBX2;DDIT4;BPTF;SMG9;PTPN11;ABCB6;CIC;SPATA5;ROGDI;EOMES
gsea,ribosomal small subunit biogenesis (GO:0042274),-0.6067920666013888,-1.7999760897658716,0.011811023622047244,0.008362367528825028,0.799,18/25,33.08%,RPS27L;SNU13;NPM1;RPS17;EMG1;RPS15;MRPS7;RPS25;NOL11;UTP4;RPS6;DDX52;NOP14;TSR3;WDR3;RIOK2;ERAL1;LTV1
gsea,amino acid transmembrane transport (GO:0003333),-0.6052644928946345,-1.7997934643155749,0.0037735849056603774,0.00835114906553428,0.799,4/17,20.47%,SLC7A5;SFXN1;SLC25A13;SLC7A1
gsea,rRNA modification (GO:0000154),-0.6307363152745592,-1.7988784629981298,0.003929273084479371,0.008382289184294275,0.802,11/17,28.04%,NHP2;FBL;GAR1;BUD23;DKC1;FTSJ3;NOP10;TFB1M;DIMT1;METTL5;TSR3
gsea,homotypic cell-cell adhesion (GO:0034109),-0.5923535286674264,-1.7981984462279363,0.0020876826722338203,0.008423889231022032,0.805,8/20,23.64%,PPIA;CSRP1;ACTG1;ACTB;MYH9;PLEK;FLNA;PIK3CG
gsea,ncRNA metabolic process (GO:0034660),-0.5875042718092703,-1.7980079146070254,0.00196078431372549,0.008436352023784443,0.806,14/19,38.52%,RAN;KHSRP;DGCR8;ZCCHC8;TARBP2;PARN;XPO5;DROSHA;DTD1;NIFK;DTD2;AGO2;TDRKH;DICER1
gsea,positive regulation of neurogenesis (GO:0050769),-0.5232407386380568,-1.7967652060247066,0.0,0.008548790389307368,0.81,6/28,24.98%,NAP1L1;ARHGDIA;METRN;CAPRIN1;IFNG;SS18L2
gsea,chaperone-mediated protein complex assembly (GO:0051131),-0.6721328759482991,-1.7958223146557581,0.005859375,0.008629326638539018,0.813,9/15,13.60%,HSP90AA1;PTGES3;HSPD1;PFDN6;HSP90AB1;PSMG2;CCT2;HSPA4;LONP1
gsea,transcription by RNA polymerase I (GO:0006360),-0.5593836574886143,-1.7951537690222674,0.003683241252302026,0.008657130940663036,0.815,19/25,40.06%,POLR2F;TCOF1;POLR2L;TAF1;POLR2E;POLR2H;TBP;GTF2H4;GTF2H3;TAF1D;TAF1B;GTF2H2;GTF2H1;RRN3;UBTF;POLR1A;ERCC3;POLR1E;POLR1C
gsea,protein localization to organelle (GO:0033365),-0.4471734734243686,-1.794061203842618,0.0,0.008742463673958931,0.818,26/61,34.33%,YBX1;RPA2;RPA1;GET4;YWHAE;DHX9;SSB;MTCH2;DDX1;CNTLN;VPS35;CALR;OPTN;MDM2;BICD2;ARL1;PACSIN2;CCDC47;BANP;LMNA;DDX3X;GCC2;IFT140;GAK;SNX10;GBP5
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.49293544761428165,-1.7938398248951077,0.004,0.008759532653173483,0.818,11/38,25.60%,HSP90AA1;MIF;HSP90AB1;TFRC;PARK7;EIF4G1;AKT1;CNOT9;HAX1;IFNG;HDAC6
gsea,regulation of protein modification process (GO:0031399),-0.5101921003069604,-1.7927824206766172,0.0,0.008841808684927538,0.82,9/31,27.72%,HPF1;PIN1;CORO1C;PHIP;MT3;PUM3;IFNG;RABL3;CCAR2
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.5956615499308494,-1.790844762740331,0.011928429423459244,0.008961322577446891,0.824,15/19,35.07%,NDUFAB1;NDUFA5;NDUFV1;NDUFA12;NDUFAF2;TIMMDC1;NUBPL;ACAD9;NDUFS1;TIMM21;NDUFAF7;NDUFAF5;NDUFAF6;FOXRED1;ECSIT
gsea,NADH dehydrogenase complex assembly (GO:0010257),-0.5956615499308494,-1.790844762740331,0.011928429423459244,0.008961322577446891,0.824,15/19,35.07%,NDUFAB1;NDUFA5;NDUFV1;NDUFA12;NDUFAF2;TIMMDC1;NUBPL;ACAD9;NDUFS1;TIMM21;NDUFAF7;NDUFAF5;NDUFAF6;FOXRED1;ECSIT
gsea,negative regulation of GTPase activity (GO:0034260),-0.6116185162035943,-1.7899975863983362,0.0038314176245210726,0.008996109124679626,0.824,6/16,23.16%,RCC2;TMED2;HRAS;RDX;RRP1B;ARL2
gsea,cellular response to chemical stress (GO:0062197),-0.44160630460950456,-1.7888226877996662,0.0,0.009111183149193474,0.826,25/60,34.45%,PPIA;CYCS;PRDX1;EIF2S1;PARK7;PARP1;GSR;LONP1;VKORC1L1;HTRA2;MT3;TXNRD1;SETX;PRDX3;ATF4;FANCC;KEAP1;PYCR2;DDX3X;PNPT1;PYCR1;HSPA1B;SOD2;HSPA1A;PRKAA1
gsea,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.5668012858171441,-1.7878476052367367,0.0057251908396946565,0.009181865068609105,0.829,18/23,40.06%,POLR2F;POLR2L;TAF1;POLR2E;POLR2H;TBP;GTF2H4;GTF2H3;TAF1D;TAF1B;GTF2H2;GTF2H1;RRN3;UBTF;POLR1A;ERCC3;POLR1E;POLR1C
gsea,mRNA catabolic process (GO:0006402),-0.5399024690733741,-1.7867484404087357,0.00196078431372549,0.00926007374960189,0.829,15/25,34.25%,LSM2;THRAP3;MRTO4;EXOSC9;EXOSC4;CNOT10;DXO;METTL16;EXOSC10;XRN1;PNPT1;HSPA1B;SUPV3L1;NBAS;HSPA1A
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),0.6131842383693074,1.7863275286780316,0.0039447731755424065,0.03881741385390406,0.837,8/18,12.23%,PDCD4;ZC3H12A;HIF1A;PER1;IL17RA;TNF;PLD4;SIRPA
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.595191005836999,-1.7859490359313923,0.0,0.009317381799450863,0.831,13/17,35.55%,UCHL5;HSP90AB1;PARK7;TAF1;CSNK2A2;TAF9;GIPC1;USP7;CCAR2;BAG5;RPL5;MAP1A;TLK2
gsea,renal system development (GO:0072001),-0.621265167643964,-1.784516360167136,0.0,0.009418311082681891,0.835,2/15,10.27%,CENPF;IFT27
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.5694272992419109,-1.784065652474583,0.005870841487279843,0.00943658955781212,0.836,10/19,32.32%,RAD23A;XPO1;TAF1;CSNK2A2;RAD23B;GLMN;DESI1;AXIN1;RPL5;UFL1
gsea,signal transduction by p53 class mediator (GO:0072331),-0.5757402392100796,-1.782848450787889,0.007952286282306162,0.00954470828825969,0.839,9/18,25.44%,HINT1;E2F7;PAXIP1;ATRX;MYBBP1A;NBN;USP10;RRP8;MDM4
gsea,metal ion transport (GO:0030001),0.5079636226256473,1.7806743622747818,0.001968503937007874,0.04003323344364764,0.848,13/34,12.03%,TPT1;CCL5;ATP2A3;ATP2B2;CCR5;NIPAL3;RAMP3;RAMP1;SLC30A1;SLC41A1;PSEN2;RYR1;ITPR1
gsea,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.6087767121297424,-1.7790170629575173,0.007766990291262136,0.009898162948674927,0.848,14/17,37.30%,RPA3;RPA2;RPA1;PARP1;DDB1;CHD1L;CUL4B;GTF2H4;DDB2;GTF2H3;GTF2H2;GTF2H1;CUL4A;ERCC3
gsea,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.6087767121297424,-1.7790170629575173,0.007766990291262136,0.009898162948674927,0.848,14/17,37.30%,RPA3;RPA2;RPA1;PARP1;DDB1;CHD1L;CUL4B;GTF2H4;DDB2;GTF2H3;GTF2H2;GTF2H1;CUL4A;ERCC3
gsea,regulation of intracellular transport (GO:0032386),-0.5587582985571715,-1.7780417627368919,0.007766990291262136,0.00999479933313814,0.851,7/21,17.96%,SPAG5;AAAS;NUMA1;LCP1;NUP214;ATPSCKMT;NEFH
gsea,cellular response to alcohol (GO:0097306),-0.564729518627406,-1.7780045721070983,0.005905511811023622,0.009983937462524515,0.851,7/21,27.16%,RAD51;BRCA1;BLM;SPIDR;MAP4K1;LARP1;CTNNA1
gsea,substantia nigra development (GO:0021762),-0.6043483421521563,-1.775988400518944,0.007858546168958742,0.010148926438947598,0.854,6/15,27.27%,CALM2;YWHAE;ACTB;RAD1;CCDC14;GNB4
gsea,negative regulation of cell population proliferation (GO:0008285),-0.3654185881115459,-1.7751074274776204,0.0,0.010188733803884131,0.854,50/163,37.84%,RBBP4;E2F7;CDKN3;CTCF;CDC6;TFDP1;TINF2;NUP62;CDKN2C;NME1;CDKN1A;NPM1;CDKN2D;CDKN2A;PBRM1;E2F1;HRAS;PHB;PDS5B;SMYD2;PTPN6;E2F3;BRD7;CHERP;EEF1E1;GLMN;ING5;UTP20;IFNG;TESC;MDM4;RUNX3;DNAJA3;HMGA1;CDK6;LMNA;GTPBP4;MEN1;GSDME;HSPA1B;HGS;SOD2;KLF11;BAP1;HSPA1A;CDC73;CELF1;THAP12;ARID2;PINX1
gsea,cellular response to unfolded protein (GO:0034620),-0.5925842827215604,-1.7749669663714263,0.018711018711018712,0.010185235293579899,0.856,8/20,20.89%,HSPD1;BAX;HSPA8;HSPA14;HSPA9;OPTN;BAK1;HSPA13
gsea,sterol biosynthetic process (GO:0016126),-0.5854763906158927,-1.7742807311376394,0.017509727626459144,0.010232466434562477,0.858,19/24,35.23%,LBR;FDFT1;FDPS;HMGCS1;HMGCR;SQLE;IDI1;SC5D;INSIG1;MSMO1;HSD17B7;PMVK;ACAT2;ACLY;MVK;NSDHL;DHCR24;PRKAG2;DHCR7
gsea,platelet aggregation (GO:0070527),-0.6073065761074068,-1.7711488139748683,0.004016064257028112,0.010512483440604358,0.861,8/17,23.64%,PPIA;CSRP1;ACTG1;ACTB;MYH9;PLEK;FLNA;PIK3CG
gsea,positive regulation of cell growth (GO:0030307),-0.45984504360073997,-1.7708005061351741,0.0019880715705765406,0.010526184590182595,0.862,20/47,34.38%,HDGFL2;FXN;EIF4G1;DERL2;AKT1;EXOSC9;NCBP1;EIF4G2;EXOSC4;EXOSC2;PLAA;ADAM17;DDX49;UNC13A;USP47;DDX3X;DNPH1;RUFY3;SUPV3L1;GOLGA4
gsea,regulation of T cell activation (GO:0050863),0.549541763538264,1.7696228454454705,0.004032258064516129,0.04315844939482457,0.874,13/24,14.36%,LGALS3;CCL5;TNFSF11;CRTAM;TNFSF8;LAX1;TNFAIP8L2;CCR2;IL4I1;PAG1;TNFSF9;SIRPA;CD4
gsea,positive regulation of protein metabolic process (GO:0051247),-0.4524966918572822,-1.7651084272770283,0.004008016032064128,0.011074911080322805,0.878,10/49,17.18%,UHRF1;FZR1;BARD1;PRMT1;DTL;EIF4G1;AKT1;NEDD4;DDB1;ROCK2
gsea,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5793746527726825,-1.7638887577090498,0.003838771593090211,0.011190998934642045,0.88,7/17,23.47%,MED30;PAXIP1;MED4;BCLAF1;MED14;SETX;SUB1
gsea,nitrogen compound transport (GO:0071705),-0.4378884335753415,-1.7634138942001651,0.0,0.011211114703985227,0.881,17/59,38.24%,CENPF;NDC1;HSP90B1;HIKESHI;SLC7A5;SLC7A1;MYH9;CEP290;SLC19A2;ABCB6;SCAMP4;SLC16A10;SLC7A3;SLC52A2;SLC38A1;SLC1A4;SLC12A2
gsea,positive regulation of tumor necrosis factor production (GO:0032760),-0.48869684497279836,-1.7629485173985595,0.010101010101010102,0.011241215229805344,0.883,7/39,24.69%,HMGB1;MIF;DHX9;FRMD8;FADD;SPN;IFNG
gsea,organic substance transport (GO:0071702),-0.44378642338583923,-1.7618962423111835,0.0,0.011374051704908085,0.884,12/50,34.36%,CENPF;NDC1;HSP90B1;HIKESHI;MYH9;CEP290;SLC19A1;SLC19A2;PEX3;ABCB6;SCAMP4;TAP2
gsea,snRNA processing (GO:0016180),-0.6112109253533113,-1.760763502479018,0.009433962264150943,0.011463901575392052,0.884,12/15,35.10%,INTS11;TOE1;INTS10;INTS1;INTS3;INTS5;INTS7;INTS8;INTS14;INTS4;INTS6;INTS9
gsea,plasma membrane invagination (GO:0099024),-0.6080045736201075,-1.7607518659889518,0.006134969325153374,0.011445961197339795,0.884,4/17,23.03%,AURKB;ELMO1;MYH9;SH3BP1
gsea,negative regulation of protein-containing complex assembly (GO:0031333),-0.520921401342428,-1.7598977303213332,0.008146639511201629,0.011500469681048049,0.885,12/26,36.40%,HMGB1;KIF14;PARK7;AIDA;HDAC6;TFIP11;HSF1;DDX3X;CPTP;SVIP;GSK3B;TRAF3IP1
gsea,regulation of protein metabolic process (GO:0051246),-0.5290525354495101,-1.7595136751301999,0.012048192771084338,0.011509944729610448,0.886,10/25,20.66%,FAM83D;HSP90AB1;FAF1;ZDHHC2;CHEK2;VPS35;ROCK2;ODC1;MDM2;PARL
gsea,positive regulation of RNA metabolic process (GO:0051254),-0.5145580189708456,-1.753999478981062,0.003968253968253968,0.012109171097316719,0.894,20/28,34.39%,U2AF2;HRAS;ZC3H18;POLR2A;DXO;BUD23;WDR75;HNRNPLL;UTP15;WDR43;SETX;HEATR1;DIMT1;GRSF1;PNPT1;RIOK2;ZPR1;SUPV3L1;HSPA1A;DYRK1A
gsea,phospholipid biosynthetic process (GO:0008654),-0.5248862440109536,-1.749471469463462,0.008064516129032258,0.012520184377817349,0.905,16/25,35.66%,DPAGT1;FDPS;AGPAT5;IDI1;CPNE1;DHDDS;CRLS1;PCYT2;MBOAT1;FAR1;AGK;FADS1;AGPAT4;GNPAT;LPCAT1;DOLPP1
gsea,cholesterol biosynthetic process (GO:0006695),-0.5991603304106181,-1.748564740532247,0.015873015873015872,0.012592532638234798,0.906,17/22,32.24%,LBR;FDFT1;FDPS;HMGCS1;HMGCR;SQLE;IDI1;SC5D;INSIG1;MSMO1;HSD17B7;PMVK;ACAT2;ACLY;MVK;NSDHL;DHCR24
gsea,cellular response to oxidative stress (GO:0034599),-0.41909476212049546,-1.7479792621441412,0.0020408163265306124,0.01266465656296103,0.906,32/70,38.78%,PPIA;CYCS;PRDX1;EIF2S1;PARK7;PARP1;GSR;AKT1;LONP1;VKORC1L1;HTRA2;MT3;TXNRD1;SETX;PRDX3;TPM1;ATF4;ERCC6L2;FANCC;CAMKK2;KEAP1;PYCR2;PNPT1;PYCR1;HSPA1B;SOD2;HSPA1A;PRKAA1;TXNRD2;CHUK;ETV5;BRF2
gsea,regulation of microtubule-based process (GO:0032886),-0.5605724947674496,-1.7471080223918782,0.008456659619450317,0.01273903031170437,0.906,8/21,25.60%,AURKA;MEMO1;CLASP2;ROCK1;DIAPH1;CLASP1;BICD2;HDAC6
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.4380253711792156,-1.7466298238026963,0.0,0.012776134725107604,0.907,32/65,39.80%,KDELR2;DYNLL2;ZW10;LMAN2;TMED2;CNIH4;LMAN1;CAPZA2;DCTN1;ACTR1A;ERGIC1;MIA2;BCAP29;COPG1;ARCN1;ATL2;TMED1;DYNC1H1;CUL3;HYOU1;SPTBN1;SEC24D;COPB2;NSF;COPA;COPG2;GOLGA2;DYNC1I2;CD55;GBF1;DYNC1LI2;TRAPPC12
gsea,monocarboxylic acid biosynthetic process (GO:0072330),-0.533645169615964,-1.7465691539569752,0.00411522633744856,0.012758883952637539,0.907,7/23,28.69%,NDUFAB1;PARK7;GATM;OSBP;ACACA;OSBPL9;ACLY
gsea,regulation of TOR signaling (GO:0032006),-0.481559446592874,-1.7463088396820197,0.004,0.012763841514567283,0.907,18/35,43.19%,FAM83D;PIH1D1;SEH1L;TBC1D7;TNFAIP8L1;TTI1;DYRK3;DDIT4;DEPDC5;TBCK;PRKAA1;TELO2;MLST8;ITFG2;NPRL3;TSC2;SIRT1;MAPKAPK5
gsea,histone H3 acetylation (GO:0043966),-0.5200630318249195,-1.7452501609105966,0.007476635514018692,0.012859726074901327,0.91,13/26,26.70%,BRCA2;POLE3;SGF29;WDR5;TAF5;KAT7;TAF6L;TAF9;ING5;JADE1;BRPF1;TADA2A;TADA3
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),-0.5192158237329738,-1.7444957322224188,0.006097560975609756,0.012940591320169791,0.911,7/25,20.66%,BRCA1;FOXM1;CDKN1A;COQ7;EIF6;MT3;PARL
gsea,negative regulation of Ras protein signal transduction (GO:0046580),-0.5494228691443044,-1.7434452583514584,0.002074688796680498,0.013060414258906859,0.915,4/22,26.23%,STMN1;KCTD13;TNFAIP1;CUL3
gsea,regulation of ion transmembrane transporter activity (GO:0032412),-0.5595666389649187,-1.7433017063485547,0.00425531914893617,0.013042860231197205,0.915,5/20,12.89%,YWHAE;STK39;PHB2;NEDD4;PPIF
gsea,DNA methylation (GO:0006306),-0.588410701239829,-1.7425074813487644,0.006097560975609756,0.013103531587768216,0.916,6/17,26.01%,DNMT1;HELLS;ATRX;EHMT2;METTL4;DMAP1
gsea,erythrocyte differentiation (GO:0030218),-0.5288435199715726,-1.7421745861155258,0.010351966873706004,0.013115234965708347,0.917,5/24,11.83%,SLC25A5;LYAR;ID2;CASP3;HSPA9
gsea,negative regulation of hydrolase activity (GO:0051346),-0.5060994923753375,-1.741194290643531,0.006036217303822937,0.01320970687236382,0.917,10/29,25.53%,RCC2;PPP1R35;TMED2;HRAS;RDX;RRP1B;EGLN1;URI1;ARL2;TERF2
gsea,aggrephagy (GO:0035973),-0.5965858407878712,-1.7387227287459446,0.0038910505836575876,0.013495996366816122,0.92,9/15,25.60%,UBB;PCNT;DYNLL2;PARK7;UBE2N;VIM;UBQLN1;DYNC1H1;HDAC6
gsea,regulation of lipid storage (GO:0010883),0.6301018074621532,1.7386373216032949,0.009242144177449169,0.05534940812188946,0.928,6/15,11.67%,NFKBIA;NFKB1;ZC3H12A;IKBKE;ITGB3;TNF
gsea,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.4974577950487769,-1.7379406422424584,0.004032258064516129,0.013579890398285518,0.921,13/31,28.40%,RPS27L;BRCA1;TMEM109;BAX;E2F1;CHEK2;HTRA2;PHLDA3;BAK1;MSH2;MSH6;DDIT4;AEN
gsea,peptidyl-asparagine modification (GO:0018196),-0.6242780127767915,-1.737934054439979,0.008048289738430584,0.01353873921526041,0.921,8/15,20.86%,DDOST;RPN2;ALG8;RPN1;LMAN1;MAGT1;STT3B;STT3A
gsea,protein N-linked glycosylation via asparagine (GO:0018279),-0.6242780127767915,-1.737934054439979,0.008048289738430584,0.01353873921526041,0.921,8/15,20.86%,DDOST;RPN2;ALG8;RPN1;LMAN1;MAGT1;STT3B;STT3A
gsea,snRNA metabolic process (GO:0016073),-0.6040415922804994,-1.7365542383136796,0.011406844106463879,0.013677778724552416,0.922,12/15,35.10%,INTS11;MTREX;ZCCHC8;INTS10;INTS1;INTS3;INTS5;INTS7;INTS8;INTS4;INTS6;INTS9
gsea,protein homotetramerization (GO:0051289),-0.536328037922837,-1.7361367679038213,0.014141414141414142,0.013710211009891598,0.922,15/23,36.28%,TK1;SHMT2;SHMT1;APIP;ALDOA;ALDH9A1;CBY1;GLS;ACACA;THG1L;SOD2;CRYZ;GBP5;GOLGA2;CTH
gsea,skin development (GO:0043588),-0.4948516327688951,-1.7356480135480856,0.0,0.013737726051038193,0.924,4/31,22.85%,STMN1;CASP3;CLIC4;ST14
gsea,organelle disassembly (GO:1903008),-0.5431016666891347,-1.734353314767401,0.0038910505836575876,0.01384937085976815,0.927,9/21,29.50%,CDK1;DENR;VRK1;EIF2D;KIF5B;DYRK3;PELO;VCP;KLC1
gsea,negative regulation of MAPK cascade (GO:0043409),-0.4527425874642328,-1.7340341395858936,0.0021645021645021645,0.013864581599027993,0.927,7/46,13.45%,PPIA;FOXM1;PIN1;EZR;RGS2;PEBP1;PHB
gsea,positive regulation of microtubule polymerization (GO:0031116),-0.6026121415163008,-1.7337946619995352,0.01026694045174538,0.013891740910876424,0.929,11/15,34.25%,CKAP5;NUMA1;CDK5RAP2;DRG1;DCTN1;CLASP1;PSRC1;ARL2;CLIP1;HSPA1B;HSPA1A
gsea,negative regulation of catabolic process (GO:0009895),-0.5460457884655064,-1.733646968106292,0.002070393374741201,0.013899656756548348,0.929,13/23,36.50%,MAD2L1;PIN1;SF3B3;PHB;AZIN1;HMGCR;FLNA;MDM4;BANP;PFKFB1;PRKAA1;PDE3B;TIGAR
gsea,negative regulation of developmental process (GO:0051093),-0.4835208758030434,-1.7335651074310465,0.0,0.013886023890885122,0.929,11/36,29.55%,ANP32B;SUZ12;FOXM1;MIF;TFRC;SINHCAF;ROCK2;ROCK1;SFMBT1;CDK6;HUWE1
gsea,positive regulation of type I interferon production (GO:0032481),-0.44312930377472576,-1.733024271732906,0.003861003861003861,0.013903476989152955,0.929,21/54,33.66%,HSP90AA1;G3BP1;HSPD1;GAPDH;POLR3K;POLR2F;DHX9;POLR2L;CGAS;POLR3H;XRCC5;POLR2E;POLR2H;XRCC6;DDX41;NFKB2;DDX3X;PTPN11;SETD2;PRKDC;POLR3G
gsea,regulation of erythrocyte differentiation (GO:0045646),-0.5294852627486757,-1.73233409880828,0.008350730688935281,0.013990029318128382,0.929,3/23,11.83%,HMGB2;PRMT1;HSPA9
gsea,protein-containing complex assembly (GO:0065003),-0.37144495223882734,-1.7308036796908894,0.0,0.014171562663381328,0.931,63/134,39.24%,KNTC1;BLM;PPIH;STOML2;HDAC1;CDC123;DHX9;ZW10;CHCHD10;PDZD11;TUBGCP2;SMARCA4;TMED2;RUVBL1;ASH2L;FANCA;LMAN1;CAPZA2;TRAF2;PPID;SAMM50;KPNA3;LPXN;LEO1;ST13;FADD;SPG7;MDM2;PPP6R3;MDM4;TSPAN4;HSF1;CUL3;RBBP5;SLC2A1;FANCC;CUL1;TRAPPC9;DNAJB12;MEN1;SEC24D;AXIN1;TUBGCP4;CAND1;NSF;GEMIN5;PYGO2;SEC23IP;CDC73;ANKRD28;TRRAP;NIFK;GOLGA2;GSK3B;PICALM;SNX9;OPA1;PPP6R1;MCU;ANO6;MDN1;AFDN;WDCP
gsea,secondary alcohol biosynthetic process (GO:1902653),-0.5947254791415804,-1.7306091515188868,0.017716535433070866,0.014179003209974585,0.932,16/21,32.24%,LBR;FDFT1;FDPS;HMGCS1;HMGCR;SQLE;IDI1;INSIG1;MSMO1;HSD17B7;PMVK;ACAT2;ACLY;MVK;NSDHL;DHCR24
gsea,rRNA methylation (GO:0031167),-0.5838737968560295,-1.729135052266629,0.006036217303822937,0.01434784679088151,0.933,9/18,24.60%,FBL;EMG1;BUD23;FTSJ3;TFB1M;METTL16;NSUN5;DIMT1;METTL5
gsea,cellular response to amyloid-beta (GO:1904646),0.5944678301258877,1.7277953359955622,0.011538461538461539,0.059719615285245053,0.934,11/19,25.37%,ICAM1;PRNP;CASP4;ITGA4;ADRB2;APP;FCGR2B;VCAM1;LRP1;CACNA2D1;ABCC1
gsea,carbohydrate catabolic process (GO:0016052),-0.6489469037228095,-1.727008847659059,0.015503875968992248,0.014620485944602038,0.935,7/20,8.27%,LDHA;TPI1;GAPDH;PKM;ENO1;PGK1;PGAM1
gsea,lymphocyte chemotaxis (GO:0048247),0.560534606735543,1.7252389921450144,0.0073937153419593345,0.05968374655071564,0.937,14/23,29.13%,CCL5;XCL1;GPR183;CCL1;CCL4;ADAM8;CXCL13;CCL2;CX3CL1;PIK3CD;CH25H;CCL8;CCL7;CXCL16
gsea,maturation of 5.8S rRNA (GO:0000460),-0.6286548026232656,-1.724716044544856,0.011363636363636364,0.014923086529183475,0.937,12/15,33.60%,EIF6;MTREX;EXOSC4;FTSJ3;MPHOSPH6;EXOSC10;RPF1;PES1;LAS1L;WDR12;MAK16;PRKDC
gsea,negative regulation of interleukin-6 production (GO:0032715),0.5851757717291016,1.7216186706857044,0.009784735812133072,0.06001522599662725,0.942,7/18,12.23%,TNFAIP3;CD200;ZC3H12A;SLAMF1;SYT11;TNF;SIRPA
gsea,regulation of protein phosphorylation (GO:0001932),-0.37948905519280085,-1.720969099840694,0.0,0.015425677798400554,0.941,32/126,31.32%,PPIA;ECT2;HSP90AA1;PIN1;NPM1;TFRC;PARK7;CORO1C;TARDBP;AKT1;CDK2AP1;HRAS;FMR1;MYDGF;PPP2R5D;PHIP;CACTIN;ROCK2;CEBPB;VEGFB;DNAJC10;MT3;ZBED3;IFNG;ATF4;AKAP8;CAMKK2;FXR2;ADAM17;MEN1;XDH;AXIN1
gsea,defense response to bacterium (GO:0042742),-0.4683085479049065,-1.7193633744176973,0.002070393374741201,0.015620000790034208,0.943,8/42,30.25%,HMGB2;CEBPB;SHC1;OPTN;SPN;DROSHA;ADAM17;GBP7
gsea,mitochondrial gene expression (GO:0140053),-0.5280989488544787,-1.719296074405232,0.010968921389396709,0.015604031618505414,0.943,19/27,36.71%,MRPL51;MRPL12;MRPS12;MRPS28;MRPS7;MRPL2;TFAM;MRPS18A;MRPL16;MRPS18B;MRPS2;PTCD3;QRSL1;MRPL47;GATC;IARS2;POLRMT;NOA1;RARS2
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.44891507455287327,-1.7180276653373385,0.006085192697768763,0.01575281403734238,0.945,9/47,17.22%,HSP90AA1;MIF;HSP90AB1;TFRC;PARK7;EIF4G1;AKT1;CNOT9;HAX1
gsea,ribosomal large subunit biogenesis (GO:0042273),-0.5562091247099921,-1.7176039556702207,0.011904761904761904,0.015771938450465515,0.946,29/43,32.20%,SNU13;NHP2;NPM1;MRPL20;EIF6;MRTO4;RPL14;EBNA1BP2;GTF3A;NOC2L;BRIX1;RSL1D1;RPL23A;WDR74;RPF2;MRPL1;NVL;NIP7;BOP1;NOP16;RPF1;PES1;LAS1L;WDR12;SDAD1;NLE1;RPL5;RSL24D1;MAK16
gsea,positive regulation of lymphocyte proliferation (GO:0050671),0.4764917187231271,1.715463409889419,0.012474012474012475,0.061652307994646355,0.946,24/37,20.80%,CCL5;BCL2;CD274;PDCD1LG2;GPR183;IRS2;CD81;CLCF1;CD38;CD86;VAV3;ANXA1;TNFRSF13C;TNFSF13B;IL1B;IL6ST;CD40LG;CD40;AIF1;VCAM1;BST1;CD70;IL2;IL23A
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),0.48419578364834204,1.7140493343891163,0.0035087719298245615,0.06113724978699898,0.947,24/42,25.16%,SLA;NTRK3;JAK2;STYK1;KIT;CD7;IL6ST;FLT1;FES;AXL;LIF;HCK;CD4;MTSS1;NEDD9;SYK;CASS4;RET;CSF1;GFRA2;CLNK;LYN;RAPGEF1;BLNK
gsea,plasma membrane bounded cell projection assembly (GO:0120031),-0.3739299143473202,-1.7119317223659731,0.0,0.016560498630301023,0.953,52/119,41.29%,PLK4;PCNT;DYNLL2;CEP83;TMEM107;SCLT1;KIF24;EMP3;CENPJ;EZR;CEP89;EXOC4;POC1B;WDR90;CFAP298;TMEM237;HYLS1;SSX2IP;SRGAP2;PCM1;OFD1;TMEM138;EHD4;FLNA;HDAC6;CEP290;CEP162;IFT74;ACTR2;CEP164;IFT46;RP2;CCDC66;ARFIP2;IFT140;RAP2C;SNX10;NEK1;PDE6D;TRAF3IP1;DYNC2H1;TCTN3;IQCB1;AHI1;RAB23;GBF1;ANO6;CEP41;ARL13B;IFT88;CEP250;CYFIP1
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5244621054317005,-1.710745173123498,0.013806706114398421,0.016709566708809832,0.953,2/22,3.01%,KIF20B;UBB
gsea,peptide biosynthetic process (GO:0043043),-0.5162684081974729,-1.7088788096022194,0.019230769230769232,0.016965798821594158,0.953,33/65,23.57%,MRPL18;MRPL51;MRPL42;MRPL28;GSPT1;RPS17;MRPL13;RPS2;EIF4G1;MRPS12;MRPL55;MRPL35;RPL14;ABCF1;COPS5;SRBD1;RPS15;FARSB;MRPS5;MRPS7;RPS25;MRPS18A;MRPL37;RPL23A;MRPL11;RPL31;RRBP1;RPS6;RPL4;MRPS18B;DHPS;MRPL3;PABPC4
gsea,regulation of protein-containing complex assembly (GO:0043254),-0.4049456518021683,-1.7062878085217703,0.003992015968063872,0.017352082175587053,0.955,31/67,38.56%,HJURP;HSP90AA1;PIH1D1;TFRC;CDT1;BAX;FAF1;PARK7;HSPA8;SPIDR;TRAF2;HCFC1;NCLN;SLF1;AIDA;BAK1;RB1;IFNG;HDAC6;TFIP11;HSF1;SLF2;VCP;DDX3X;PTPN11;BIK;SVIP;GSK3B;TRAF3IP1;GNL3L;ATF7IP
gsea,positive regulation of cytoskeleton organization (GO:0051495),-0.43989018934713703,-1.7056154146183449,0.00398406374501992,0.01742470780001565,0.955,13/41,30.43%,PLK4;SPAG5;NUP62;GPSM2;PFN1;NUMA1;HRAS;HAX1;PRKCE;PLEK;DYNC1H1;PDXP;SYNPO2
gsea,establishment of protein localization to mitochondrion (GO:0072655),-0.5681777960926715,-1.7038093895682636,0.020366598778004074,0.01769275036113447,0.957,18/25,32.81%,HSPD1;TIMM50;TIMM17A;TOMM40;TIMM23;AKT1;TIMM13;GRPEL1;AIFM1;PITRM1;RALA;CHCHD4;TOMM20;DNAJC15;TIMM21;TIMM8B;TIMM10;HK1
gsea,lipid biosynthetic process (GO:0008610),-0.4672712188582755,-1.7034955036843542,0.01383399209486166,0.017722809268830197,0.957,23/37,41.94%,NDUFAB1;FDFT1;PDSS1;AGPAT5;HMGCR;AGPS;PCYT2;ACSL5;MBOAT1;ACACA;ACLY;MVK;FADS1;MCAT;AGPAT4;PRKAA1;GNPAT;LPCAT1;DOLPP1;GPAT4;LSS;CBR4;FDXR
gsea,selective autophagy (GO:0061912),-0.49085765654982666,-1.7032689174779834,0.00984251968503937,0.017743492225256435,0.957,10/29,25.60%,UBB;PCNT;DYNLL2;PARK7;PHB2;UBE2N;VIM;UBQLN1;DYNC1H1;HDAC6
gsea,cellular response to organonitrogen compound (GO:0071417),-0.46699119708799497,-1.7018658077763549,0.0020161290322580645,0.017896285169293542,0.959,11/38,28.38%,BRCA1;HSP90B1;IPO5;ACTB;TAF1;EZR;DIAPH1;MTOR;LARP1;CTNNA1;PDXP
gsea,calcium ion transmembrane import into cytosol (GO:0097553),0.5996385849746426,1.7009799456266992,0.009784735812133072,0.06652592032748478,0.958,7/17,15.05%,CCR7;XCL1;TRPV2;ITPR2;RYR1;ITPR1;F2R
gsea,RNA modification (GO:0009451),-0.47344585280098583,-1.700879342668982,0.005813953488372093,0.01800464241041231,0.959,24/42,38.31%,SSB;TRMT6;ELP5;NSUN2;FTSJ3;NOP10;RBM15;TFB1M;NSUN5;CTU2;FTSJ1;WDR4;PARN;TRDMT1;TSR3;THG1L;METTL1;NAT10;ADAT2;TRUB1;THUMPD1;RBM15B;METTL3;NOP2
gsea,transcription by RNA polymerase III (GO:0006383),-0.5495667843386828,-1.6991086994843183,0.011673151750972763,0.01821904083399845,0.959,11/19,34.19%,POLR3K;POLR2L;GTF3A;GTF3C2;POLR3H;GTF3C5;TBP;IVNS1ABP;ZC3H8;POLR3G;GTF3C1
gsea,positive regulation of interleukin-6 production (GO:0032755),-0.4765693059970721,-1.6988584563972549,0.008016032064128256,0.01822734353867123,0.959,3/41,7.33%,HMGB1;HSPD1;DHX9
gsea,negative regulation of protein modification process (GO:0031400),-0.4322341264209024,-1.6978813874882197,0.006160164271047228,0.01835319709035753,0.961,21/46,40.95%,PPIA;TINF2;DBI;PARK7;CORO1C;XRCC1;TARDBP;CACTIN;DNAJC10;PPP1R8;ZBED3;MEN1;XDH;CRTAP;PRKDC;PRKAA1;GSK3B;TRAF3IP1;PAQR3;IBTK;CDYL
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.4581121831609099,-1.6964837793587686,0.01002004008016032,0.018522427215562857,0.963,18/38,31.90%,PPIA;DDIAS;ENO1;CDKN2D;PARK7;YBX3;AKT1;PPIF;NOC2L;HTRA2;URI1;MDM2;HYOU1;CCAR2;BAG5;DDX3X;SOD2;HERPUD1
gsea,alpha-amino acid metabolic process (GO:1901605),-0.5470797624889343,-1.696132688658099,0.009541984732824428,0.018534855062442002,0.963,12/21,34.53%,MTHFD1;OAT;ASNS;GOT2;SLC25A13;ALDH18A1;GLS;KYAT3;PYCR2;PYCR1;DDAH2;GPT2
gsea,cellular iron ion homeostasis (GO:0006879),-0.5282213847258792,-1.6945449446439884,0.012320328542094456,0.01878597414123879,0.964,11/24,33.80%,NUBP1;TFRC;FXN;GLRX3;ATP6V0A2;ABCB7;CUL1;CCDC115;CAND1;ABCB6;CYB561A3
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4690037618377958,-1.693915656685626,0.012244897959183673,0.018889674533255286,0.964,7/41,24.69%,HMGB1;MIF;DHX9;FRMD8;FADD;SPN;IFNG
gsea,negative regulation of organelle assembly (GO:1902116),-0.5229276482225652,-1.6906202196683628,0.014141414141414142,0.019359297655266967,0.965,8/22,20.23%,BRCA1;CCP110;MDM1;CDK5RAP2;ODF2L;TRIM37;RBM14;TBC1D7
gsea,termination of RNA polymerase I transcription (GO:0006363),-0.5451410635054993,-1.6905519982958226,0.00922509225092251,0.019347601148108545,0.965,16/22,40.06%,POLR2F;POLR2L;POLR2E;POLR2H;TBP;GTF2H4;GTF2H3;TAF1D;TAF1B;GTF2H2;GTF2H1;UBTF;POLR1A;ERCC3;POLR1E;POLR1C
gsea,regulation of osteoblast differentiation (GO:0045667),-0.4643934556124796,-1.6900785506221738,0.004301075268817204,0.019390714088039288,0.966,14/36,52.10%,FBXO5;ATF4;CDK6;MEN1;MEF2C;LTF;ACVR1;SMOC1;WNT4;YAP1;RIOX1;PTCH1;NOTCH1;FFAR4
gsea,positive regulation of cell differentiation (GO:0045597),-0.38856841858926194,-1.6900596306580193,0.0,0.01936305258434736,0.966,14/96,22.88%,FBXO5;EZH2;ECT2;PA2G4;HSP90AB1;ID2;AKT1;TCF3;SIN3A;CEBPB;CPNE1;CREB1;MTOR;MMD
gsea,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.548728778333621,-1.6862111249244707,0.0149812734082397,0.019938565406297876,0.967,12/18,39.39%,HNRNPA2B1;SRRT;DGCR8;TARBP2;MRPL44;DROSHA;PUM2;PUS10;METTL3;AGO2;DICER1;SPOUT1
gsea,intraciliary transport involved in cilium assembly (GO:0035735),-0.5217983554646525,-1.682781634323328,0.013779527559055118,0.020412446750464483,0.969,15/22,41.85%,DYNLL2;IFT27;SSX2IP;TNPO1;PCM1;IFT74;IFT46;IFT140;TRAF3IP1;DYNC2H1;TTC21B;IFT22;IFT88;IFT57;KIFAP3
gsea,steroid biosynthetic process (GO:0006694),-0.5238918644366222,-1.682459845798637,0.022684310018903593,0.020435647232045634,0.969,10/23,28.64%,LBR;FDFT1;HMGCR;SQLE;SC5D;INSIG1;MSMO1;PMVK;OSBP;OSBPL9
gsea,regulation of neuron death (GO:1901214),-0.4385775711304936,-1.6819863505501174,0.007889546351084813,0.0204859756696706,0.97,19/43,39.72%,UBB;KIF14;EIF2S1;PARK7;EIF4G1;AKT1;NAE1;TRAF2;VPS35;HTRA2;SIGMAR1;IFNG;DDIT4;DHCR24;GSK3B;PICALM;DAXX;MEF2C;MAP3K5
gsea,sterol metabolic process (GO:0016125),-0.512621689458373,-1.6792397977742064,0.009784735812133072,0.020850709903316573,0.97,15/26,35.23%,LBR;FDX1;HMGCR;SQLE;SC5D;INSIG1;MSMO1;PMVK;CLN6;NSDHL;SOAT1;SCAP;GBA2;PRKAG2;DHCR7
gsea,ribosome assembly (GO:0042255),-0.5513640969578499,-1.6792301655768704,0.01768172888015717,0.020823477830135793,0.97,24/32,38.91%,RPS27L;NPM1;C1QBP;MRPL20;EIF6;RPS15;MRPS7;BRIX1;MRPL22;RPL23A;RPF2;BOP1;MRPS2;DDX3X;NLE1;RPL5;RSL24D1;ERAL1;RRS1;DHX29;PWP2;RRP7A;NOP2;MDN1
gsea,cellular amino acid catabolic process (GO:0009063),-0.4397871401413091,-1.6790400407327735,0.0022123893805309734,0.020812118501726044,0.97,21/47,38.10%,SHMT2;BCKDK;SHMT1;GOT2;CARNMT1;DLST;BLMH;BCAT1;GSTZ1;BCAT2;GCSH;GLDC;OGDH;GLS;GCDH;BCKDHB;DLD;ALDH7A1;IVD;GOT1;HIBADH
gsea,negative regulation of neuron apoptotic process (GO:0043524),-0.46276320745699545,-1.6784811152168182,0.00398406374501992,0.02089993917598908,0.97,9/32,33.15%,SET;KIF14;NONO;PARK7;MT3;MSH2;SOD2;ZPR1;BHLHB9
gsea,positive regulation of chemokine production (GO:0032722),-0.5110652633382519,-1.6771399447008655,0.018145161290322582,0.02109777172731152,0.971,4/28,29.89%,HMGB1;IFNG;ADAM17;DDX3X
gsea,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5682409664055634,-1.6765531875274216,0.02178217821782178,0.02118269658056384,0.971,6/15,24.35%,BRCA1;RUVBL2;PAXIP1;BRD7;RPS6KA5;TADA2A
gsea,positive regulation of mitochondrion organization (GO:0010822),-0.4665584742876557,-1.6757021877754643,0.005905511811023622,0.02128084609010903,0.972,19/32,39.93%,AURKA;BAX;PARK7;CHCHD10;PPIF;VPS35;HTRA2;RALA;ZDHHC6;BAK1;CAMKK2;BBC3;BIK;GSK3B;MCU;HTT;HIP1R;FAM162A;DDHD1
gsea,negative regulation of viral process (GO:0048525),-0.4611680848899618,-1.6752620169683585,0.01160541586073501,0.021338387305151883,0.972,7/38,21.99%,PPIA;BANF1;FAM111A;TRIM28;SRPK1;ILF3;LARP7
gsea,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.4756757285326489,-1.6737196347264678,0.014957264957264958,0.0215501605578988,0.973,4/31,11.89%,HMGB1;AKT1;SP1;MAP2K3
gsea,regulation of endothelial cell proliferation (GO:0001936),-0.4594620231993836,-1.6695597576178938,0.008849557522123894,0.02227303126122749,0.976,7/39,30.37%,HMGB2;AKT1;MYDGF;VEGFB;EGFL7;NRAS;XDH
gsea,cellular response to lipopolysaccharide (GO:0071222),-0.4323226894537273,-1.6673744200547669,0.008368200836820083,0.022585548900993433,0.976,7/62,22.97%,HMGB2;HMGB1;VIM;MTDH;CACTIN;PRKCE;PLAA
gsea,apoptotic process (GO:0006915),-0.35888921002405144,-1.665555834558233,0.0,0.022870456156863166,0.977,57/126,41.12%,PPIA;CIT;MELK;ESPL1;TRAIP;HSPD1;GAPDH;GZMB;BAX;VDAC1;PARP1;CASP3;AKT1;MCM2;CHEK1;BCLAF1;AIFM1;NAE1;ELMO1;PIDD1;FADD;PRKCE;MDM2;BAK1;MTOR;JADE1;AHCYL1;IFNG;CASP7;TNFAIP1;DDX41;DDIT4;NDUFS1;STK3;BBC3;THOC1;NSG1;RELT;BNIP1;DHCR24;MRPS30;MAP3K7;BIK;TAOK2;PAK4;TCHP;BCL2L13;PLSCR1;ERCC3;HK2;FAM162A;PRF1;IFT57;APAF1;ATN1;FEM1B;IFIT2
gsea,positive regulation of cell adhesion (GO:0045785),0.4730994626117385,1.6641974484141535,0.010040160642570281,0.08822863380108338,0.98,17/35,20.23%,CCR7;CCL5;TNFRSF18;PRKCA;JAK2;CITED2;ADGRG1;SMAD7;PRSS2;PDGFB;TNF;TGM2;ADAM8;LIF;NDNF;SYK;RET
gsea,regulation of T cell proliferation (GO:0042129),0.4700095433458621,1.6641754622001297,0.01937984496124031,0.08644489044509093,0.98,19/36,20.80%,LGALS3;CCL5;CD274;TNFSF8;PDCD1LG2;IL4I1;CD86;ANXA1;SDC4;TNFRSF13C;IL1B;TNFSF9;IL6ST;CD40LG;AIF1;VCAM1;FOXP3;CD70;IL23A
gsea,glycolytic process (GO:0006096),-0.6690371900581118,-1.661240004692389,0.019342359767891684,0.023690823049409455,0.983,7/17,8.27%,LDHA;TPI1;GAPDH;PKM;ENO1;PGK1;PGAM1
gsea,protein targeting (GO:0006605),-0.4354738788303482,-1.6608361990779676,0.002074688796680498,0.023726756061996687,0.984,26/47,41.20%,TIMM17A;TOMM40;TIMM23;ZDHHC2;TIMM13;EDEM1;KATNB1;SPCS3;PITRM1;ZDHHC6;SRPRB;GIPC1;TOMM20;ZDHHC12;TIMM8B;TIMM10;ZFAND2A;ZDHHC15;TIMM44;TAOK2;AP4E1;ICMT;TRAK1;ZDHHC21;AP4M1;PRKCI
gsea,positive regulation of interleukin-1 production (GO:0032732),-0.5265290367670058,-1.6597908210754135,0.01639344262295082,0.023902382250054182,0.984,1/21,0.41%,HMGB1
gsea,negative regulation of protein ubiquitination (GO:0031397),-0.48563594518131237,-1.659592538062728,0.021739130434782608,0.023902468422339212,0.984,14/28,38.27%,FBXO5;U2AF2;PARK7;TAF1;AKT1;IVNS1ABP;NXN;BAG5;GTPBP4;HSPA1B;UFL1;HSPA1A;PINX1;GNL3L
gsea,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.555791584067386,-1.6591881296637763,0.023965141612200435,0.023951235729353502,0.984,2/18,4.43%,TTK;PIN1
gsea,activation of protein kinase B activity (GO:0032148),-0.5626283868328157,-1.6567232739004127,0.017057569296375266,0.024424136127613676,0.984,7/16,22.90%,PPIA;PARK7;AKT1;MT3;PDPK1;MTOR;PRR5
gsea,negative regulation of macromolecule metabolic process (GO:0010605),-0.3783333406702526,-1.6543459815481234,0.0,0.024844976599658217,0.984,38/97,38.52%,DNMT1;AURKA;MIF;RBL1;HDAC1;HSP90AB1;PARK7;TAF1;ID2;SLC7A5;TARDBP;HRAS;ROCK2;CPNE1;SETDB2;FLOT2;OPTN;RB1;SETDB1;SUB1;IFNG;TLE5;TERF2;LDLR;RBL2;WDR54;HINFP;YY1;XDH;TNRC6A;PTRH2;HAVCR2;PRKAA1;CELF1;PICALM;AGO2;CCL3;DICER1
gsea,positive regulation of biomineral tissue development (GO:0070169),-0.5621438715921847,-1.6531509489744993,0.014373716632443531,0.025039885532773767,0.984,1/17,0.56%,FBXO5
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.35680525925304096,-1.6513138218964563,0.0,0.025339886231770824,0.985,43/126,41.20%,PPIA;UBB;TFDP1;NPM1;TFRC;DHX9;PARK7;PSMA6;PHB2;TAF1;UBE2N;SMARCA4;AKT1;SMARCB1;COPS5;TRAF2;TCF3;TRIM37;MTDH;PIDD1;FLOT2;RPS6KA5;RHEBL1;PRDX3;LRP8;HSF1;BUD31;NFKB2;STK3;HSPA1B;TAB1;ERC1;MAP3K7;HSPA1A;SRF;MBTPS2;CHUK;FZD4;LTF;PPRC1;RIPK3;PRKCB;PRKCI
gsea,response to cytokine (GO:0034097),0.4000644971264298,1.6487817648288972,0.001941747572815534,0.09544371428308623,0.986,41/84,24.56%,CCR7;GCH1;AFF3;REL;BCL2;CD274;PRKCA;JAK2;TIMP2;IFNAR2;STAT1;NFAT5;SP100;BCL2L1;IFITM2;TRIM56;IKBKE;IFITM1;ISG15;XAF1;SIGIRR;ANXA1;IL1B;IL6ST;SHFL;IL18R1;IFITM3;SELP;SMAD3;LEF1;PID1;CD40;APP;TRIM21;KYNU;HDAC4;CXCR4;IRAK3;MEFV;PTPN13;MAPKAPK3
gsea,cell junction organization (GO:0034330),-0.5043125723317416,-1.646841978916895,0.02012072434607646,0.026140107822252,0.987,6/24,26.35%,PIN1;ACTG1;ACTB;SH3BP1;FLNA;PPFIA1
gsea,organelle transport along microtubule (GO:0072384),-0.5596766427238419,-1.6406870293203206,0.017241379310344827,0.027436294401965988,0.989,12/16,39.31%,UBB;NDE1;KIF5B;COPG1;BICD2;RHOT2;LRPPRC;COPG2;ARHGAP21;HTT;TMEM201;TRAK1
gsea,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.5299879090224182,-1.6379967819887036,0.0297029702970297,0.027948735939536062,0.99,9/19,26.83%,AUNIP;SMCHD1;RIF1;MRNIP;KMT5C;WRAP53;TFIP11;HSF1;ACTR2
gsea,positive regulation of T cell activation (GO:0050870),0.4653194232420364,1.6347403795129265,0.018480492813141684,0.10433235170315631,0.987,20/33,21.41%,CCR7;CCL5;TNFSF11;CD274;PDCD1LG2;CD81;ZBTB1;CCR2;CD86;ANXA1;TNFRSF13C;IL1B;IL6ST;CD40LG;SIRPA;AIF1;VCAM1;CD70;IL23A;CCL2
gsea,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5523894519489666,-1.6334554255448785,0.026052104208416832,0.028836202399324735,0.991,7/16,32.32%,BRCA1;CNOT9;UFSP2;CNOT1;AXIN1;CARM1;UFL1
gsea,positive regulation of protein binding (GO:0032092),-0.4576213132413613,-1.6332434366569415,0.015968063872255488,0.028822981342655412,0.991,12/32,38.41%,RAN;PIN1;TAF1;PPP2CB;NVL;ADD1;STK3;MEN1;TRIB3;IDE;GSK3B;HIP1R
gsea,cell-matrix adhesion (GO:0007160),0.4573562206765454,1.6328044705042677,0.015904572564612324,0.10377801140515344,0.988,22/37,24.31%,ACTN1;ITGB1;DLC1;PTPRK;ITGA1;ITGB3;ITGB8;CD44;ITGB7;ITGA4;VCL;PEAK1;VCAM1;ITGA7;FN1;BCAM;SORBS1;CD63;ACTN2;MADCAM1;ITGA3;L1CAM
gsea,maturation of LSU-rRNA (GO:0000470),-0.5584836900877748,-1.631306778928401,0.040229885057471264,0.02921138751055181,0.991,15/24,27.76%,SNU13;NHP2;ZNHIT3;EIF6;RSL1D1;FTSJ3;RPF2;MRPL1;RPL7L1;BOP1;RPF1;DDX18;PES1;LAS1L;WDR12
gsea,positive regulation of interleukin-10 production (GO:0032733),-0.5516899635644733,-1.6304402008388792,0.015748031496062992,0.029367698134419244,0.991,2/17,5.32%,HMGB1;HSPD1
gsea,regulation of monocyte chemotaxis (GO:0090025),-0.5940744039613615,-1.630244889502267,0.016563146997929608,0.02936686668595419,0.991,1/16,0.41%,HMGB1
gsea,regulation of androgen receptor signaling pathway (GO:0060765),-0.5502609921881537,-1.628404172523345,0.023483365949119372,0.029748600238645152,0.991,7/16,25.60%,HDAC1;PARK7;SMARCA4;PHB;NCOR2;SAFB2;HDAC6
gsea,glycolytic process through glucose-6-phosphate (GO:0061620),-0.6411601336333962,-1.6282346167010107,0.04271844660194175,0.029762448409669556,0.991,11/17,24.93%,TPI1;GAPDH;PKM;ENO1;PGK1;PGAM1;PFKP;ALDOA;ENO3;PFKL;FOXK2
gsea,regulation of mitochondrial membrane potential (GO:0051881),-0.4947598093319516,-1.6278062038541052,0.014462809917355372,0.029810943053271997,0.991,12/23,30.78%,UBB;STOML2;BAX;PARK7;PRELID1;AKT1;BAK1;PPA2;PRDX3;NDUFS1;VCP;PYCR1
gsea,glucose catabolic process to pyruvate (GO:0061718),-0.6601684617524716,-1.6271500321741172,0.033203125,0.02986213899092858,0.991,11/16,24.93%,TPI1;GAPDH;PKM;ENO1;PGK1;PGAM1;PFKP;ALDOA;ENO3;PFKL;FOXK2
gsea,canonical glycolysis (GO:0061621),-0.6601684617524716,-1.6271500321741172,0.033203125,0.02986213899092858,0.991,11/16,24.93%,TPI1;GAPDH;PKM;ENO1;PGK1;PGAM1;PFKP;ALDOA;ENO3;PFKL;FOXK2
gsea,regulation of neurotransmitter receptor activity (GO:0099601),0.5872580546614128,1.6255339345403004,0.016917293233082706,0.10721493651746529,0.99,9/16,23.58%,CNIH2;DLGAP4;NETO1;NEFL;APP;DLG2;PRRT1;ACTN2;DAPK1
gsea,canonical Wnt signaling pathway (GO:0060070),0.46896200081580397,1.6237132346079395,0.018115942028985508,0.10666595027826482,0.991,19/34,29.28%,TCF7;NR4A2;FRAT2;LRRK2;BCL9L;LEF1;LRP6;WNT1;SCYL2;WNT2B;WNT10A;FZD6;WNT11;RARG;FZD7;DIXDC1;CTNNB1;TCF7L2;DVL3
gsea,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.49682893351058255,-1.6236975135104406,0.016,0.030629237691649706,0.991,2/23,22.80%,EZH2;MTOR
gsea,neurogenesis (GO:0022008),-0.5290528751187746,-1.6223420734729606,0.022,0.030924246722649706,0.992,12/19,39.31%,CIT;WDR62;CDK5RAP2;THOC2;METTL14;CDK6;RYK;ROGDI;CHAC1;METTL3;BTBD6;TRAK1
gsea,vesicle cytoskeletal trafficking (GO:0099518),-0.5204477367640198,-1.6219874772968772,0.022357723577235773,0.030968695671244748,0.992,4/20,20.18%,ACTN4;NDE1;MYO5A;KIF5B
gsea,protein deacetylation (GO:0006476),-0.46719655865638127,-1.6209475107335376,0.028846153846153848,0.03117644381042542,0.993,20/29,43.05%,HDAC1;HDAC2;PHB;MTA1;SIN3A;MORF4L2;RBM14;MTA2;FLNA;HDAC6;SIRT6;TBL1XR1;TBL1X;TRERF1;PRDM5;MIER3;SIRT3;BRMS1L;MIER2;SIRT1
gsea,cellular response to chemokine (GO:1990869),0.5050539326732691,1.6203423845550016,0.020676691729323307,0.10756979069570478,0.992,15/31,22.37%,CCL5;XCL1;RIPOR2;ZC3H12A;DUSP1;SH2B3;CCR2;CCL1;CCL4;LRCH1;CXCL9;CXCL13;CXCL2;CCL2;CX3CL1
gsea,negative regulation of protein phosphorylation (GO:0001933),-0.37442732299325365,-1.6202286671620765,0.002070393374741201,0.031312770681182704,0.993,33/78,43.61%,PPIA;CALM2;PARK7;EIF4G1;CORO1C;TARDBP;AKT1;CEP85;PTPN6;PRKRIP1;CACTIN;TARBP2;DNAJC10;PDPK1;RB1;ZBED3;DDIT4;MEN1;XDH;DUSP19;TAB1;TRIB3;PRKDC;PRKAG2;TRAF3IP1;PAQR3;SNX25;IBTK;DVL1;GPD1L;SPRED1;TSC2;RACK1
gsea,intrinsic apoptotic signaling pathway (GO:0097193),-0.40335970105753566,-1.6175448747010364,0.009708737864077669,0.0318819156022599,0.994,27/56,36.68%,HINT1;BRCA1;CDKN1A;C1QBP;BAX;E2F1;CHEK2;AIFM1;TRAF2;MYBBP1A;CEBPB;HTRA2;DNAJC10;BAK1;MSH6;RRP8;ATF4;CUL3;QRICH1;CUL1;BBC3;DDX3X;TRIB3;PRKDC;CHAC1;CUL4A;CUL5
gsea,regulation of cellular protein metabolic process (GO:0032268),-0.4604453073337811,-1.6166432955582233,0.01417004048582996,0.032042630521865303,0.994,7/33,14.71%,UHRF1;TCOF1;NOLC1;EIF4G1;EIF4E;AKT1;VPS35
gsea,regulation of protein targeting to mitochondrion (GO:1903214),-0.5529002527969643,-1.6136761849866812,0.033073929961089495,0.03277823454510179,0.995,8/16,20.87%,SAE1;LMAN1;HAX1;HTRA2;SREBF2;CSNK2A2;PARL;BAG4
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.41538054338389974,1.6118760673338348,0.01383399209486166,0.11244951083443946,0.994,36/55,30.03%,CCL5;TNFRSF18;RIPK2;JAK2;CD81;CLCF1;NRP1;ITGB3;PRNP;PECAM1;CD44;KIT;CSF2;IL6ST;PDGFB;TNF;CD40;PARP14;LIF;ENPP2;PIBF1;NEDD9;ITGA5;CASS4;IL2;SOCS3;IL23A;BANK1;LYN;PARP9;IL3;TEC;CD80;CSF1R;PTPRJ;TNFRSF1A
gsea,regulation of epithelial cell proliferation (GO:0050678),-0.4490837745648378,-1.6118090475797282,0.018145161290322582,0.03315090891346171,0.995,6/37,14.07%,UHRF1;TINF2;NME1;NME2;HRAS;SRSF6
gsea,interferon-gamma-mediated signaling pathway (GO:0060333),0.4942027015881485,1.6117758102889352,0.026530612244897958,0.11059976993450818,0.994,20/30,16.44%,JAK2;IRF7;ICAM1;STAT1;SP100;IRF4;CAMK2D;GBP2;CD44;TRIM25;IRF1;IFNGR2;TRIM5;IRF9;HCK;OAS3;IRF5;PTAFR;VCAM1;TRIM21
gsea,regulation of actin filament bundle assembly (GO:0032231),-0.5195762547148004,-1.6110052642226613,0.03180914512922465,0.03330501981918324,0.995,7/19,22.38%,PFN1;ACTG1;RDX;ROCK2;ROCK1;ALMS1;PLEK
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.44193691859364065,-1.6091445838539329,0.014583333333333334,0.033731382659898224,0.996,9/36,27.71%,HSP90AA1;HSP90AB1;ACTG1;ACTB;ELMO1;PRKCE;MYO10;ACTR2;ELMO2
gsea,tRNA modification (GO:0006400),-0.4303246695772817,-1.6089516540967357,0.017509727626459144,0.033733268903518986,0.996,22/45,36.26%,SSB;TRMT6;ELP5;NSUN2;PUSL1;TYW1;CTU2;FTSJ1;WDR4;TRDMT1;TRMO;THG1L;GTPBP3;TRMT10A;METTL1;PUS1;ADAT2;TRUB1;PUS10;THUMPD1;MTO1;TYW3
gsea,regulation of macrophage activation (GO:0043030),-0.5527366694267255,-1.6079429843724338,0.028985507246376812,0.03395822404978031,0.996,2/16,5.32%,MIF;HSPD1
gsea,cellular defense response (GO:0006968),0.5052886187190959,1.6078514455974107,0.011928429423459244,0.1120008286530161,0.994,10/25,19.95%,CCR6;ITGB1;TRAT1;TYROBP;CCR5;LGALS3BP;NCF1;ADORA2A;CXCL9;NCR1
gsea,anion transmembrane transport (GO:0098656),-0.45200889236539976,-1.6076165307703958,0.009652509652509652,0.03402345479679815,0.996,13/31,34.84%,SLC25A5;SLC25A10;SLC7A5;SFXN1;SLC25A13;SLC7A1;SLC25A1;SLC19A1;SLC35A3;SLC35A1;SLC35B1;LRRC8B;SLC7A3
gsea,regulation of amyloid-beta formation (GO:1902003),-0.4998253753331365,-1.6073915890853214,0.02850877192982456,0.03404189719751211,0.996,7/21,24.69%,PIN1;RTN3;CASP3;SP1;ROCK2;ROCK1;IFNG
gsea,regulation of stress fiber assembly (GO:0051492),-0.42947430458850727,-1.6069819391100857,0.016701461377870562,0.03407933538985403,0.996,10/41,26.35%,STMN1;PFN1;ACTG1;ROCK2;CLASP2;ROCK1;CLASP1;ALMS1;TPM1;PPFIA1
gsea,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.5131171101263177,-1.6069186257143475,0.03680981595092025,0.03407229581256729,0.996,9/20,28.40%,HINT1;RPS27L;TMEM109;MYBBP1A;PHLDA3;MSH2;RRP8;DDIT4;AEN
gsea,Fc-gamma receptor signaling pathway (GO:0038094),-0.4395654041085617,-1.6040673668202547,0.014767932489451477,0.03471741348229028,0.997,9/37,27.71%,HSP90AA1;HSP90AB1;ACTG1;ACTB;ELMO1;PRKCE;MYO10;ACTR2;ELMO2
gsea,regulation of protein polymerization (GO:0032271),-0.5148581246986833,-1.6023176026760848,0.023076923076923078,0.03512687465122248,0.997,7/18,35.40%,HSP90AA1;PFN1;HAX1;ARL2;PRUNE1;GBA2;MAP2
gsea,myeloid leukocyte differentiation (GO:0002573),-0.4296920652249534,-1.6012129087046807,0.013944223107569721,0.035366863283266416,0.997,9/39,25.06%,DEK;CDK4;CDKN1A;CDK2;E2F1;PARP1;MYH9;IFNG;THOC5
gsea,T cell differentiation (GO:0030217),0.5076304945183512,1.6003658590049985,0.025390625,0.11670418438293295,0.995,10/21,22.88%,TCF7;ZFP36L1;ANXA1;SPI1;KIT;SOX4;CD4;DLL4;IL2;MR1
gsea,heme biosynthetic process (GO:0006783),-0.5528878629031813,-1.6001879548741802,0.03815261044176707,0.03554263653752397,0.997,8/15,33.76%,FXN;HMBS;ALAD;CPOX;PGRMC1;COX10;ABCB6;COX15
gsea,porphyrin-containing compound biosynthetic process (GO:0006779),-0.5528878629031813,-1.6001879548741802,0.03815261044176707,0.03554263653752397,0.997,8/15,33.76%,FXN;HMBS;ALAD;CPOX;PGRMC1;COX10;ABCB6;COX15
gsea,regulation of cell differentiation (GO:0045595),-0.3885988684594147,-1.6000066178451866,0.001941747572815534,0.035540021945551614,0.997,17/63,27.62%,ANP32B;PA2G4;SUZ12;HSP90AB1;ID2;CDK5RAP2;SINHCAF;PTBP1;NSUN2;CEBPB;CLASP2;FLOT2;ROCK1;CLASP1;ATF4;RUNX3;CDK6
gsea,cellular protein catabolic process (GO:0044257),-0.4532405700767197,-1.5963382551279794,0.025440313111545987,0.03640637643281016,0.997,15/29,38.59%,GZMB;RNF5;PSMA6;CHEK2;LONP1;CLPP;CLTC;HTRA2;MDM2;TCIRG1;CLPX;YME1L1;IDE;AP2B1;AP2A2
gsea,regulation of stress-activated MAPK cascade (GO:0032872),-0.5006605968850777,-1.5956129527227516,0.013916500994035786,0.03657829424804593,0.997,3/22,12.67%,PPIA;FOXM1;COPS5
gsea,positive regulation of protein secretion (GO:0050714),-0.42774577154764953,-1.5950108377204069,0.016985138004246284,0.03665996094602138,0.997,3/38,14.88%,PPIA;EZR;PPID
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4839426710802476,1.5897316953792329,0.023575638506876228,0.12375389663946192,0.996,18/25,31.17%,HIF1A;JUN;ETS1;NR3C1;KLF4;SPI1;FOXO3;REST;PDGFB;TNF;SMAD3;FGF2;TGFB2;IL10;PPARG;FOS;FOSL1;APLN
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5044197250562612,-1.5882761294797918,0.06420233463035019,0.03840579047673622,0.998,20/49,21.85%,EIF4A3;RNPS1;RBM8A;MAGOH;GSPT1;MAGOHB;RPS17;RPS2;EIF4G1;RPL14;NCBP1;RPS15;UPF3B;RPS25;ETF1;RPL23A;RPL31;RPS6;RPL4;CASC3
gsea,positive regulation of defense response (GO:0031349),0.4300848593578061,1.5881322006254823,0.02091254752851711,0.1231252945387568,0.996,28/52,25.39%,CCL5;NFKBIA;PDCD4;NFKBIZ;IL16;MGST2;NINJ1;ETS1;CCR2;CCN4;CCL1;IL1B;SERPINE1;PTGER4;ZBP1;IL17RA;TNF;ADAM8;APP;TLR7;IL2;IL23A;CX3CL1;GRN;TLR2;LPL;ABCC1;TNIP1
gsea,regulation of protein autophosphorylation (GO:0031952),-0.4984596915697511,-1.586658144971508,0.021611001964636542,0.03878897446075204,0.998,7/19,35.21%,CALM2;RAD50;PPP2R5D;NBN;DDX3X;RAP2C;TAOK2
gsea,response to estrogen (GO:0043627),-0.5202321153409328,-1.5861935732823937,0.027196652719665274,0.03886328315269149,0.998,4/17,12.41%,BRCA1;SERPINB9;PELP1;ASH2L
gsea,protein ADP-ribosylation (GO:0006471),-0.5451553181572524,-1.585873553978212,0.03696098562628337,0.038908312916559495,0.998,3/16,10.47%,HPF1;PARP2;PARP1
gsea,positive regulation of response to external stimulus (GO:0032103),0.4216718280884227,1.585686999587646,0.01717557251908397,0.12320242608499156,0.996,39/66,25.39%,CCL5;NFKBIA;PDCD4;PRKCA;NFKBIZ;IL16;MGST2;NINJ1;ETS1;CCR2;F2RL1;CCN4;CCL1;DHX58;IL1B;SERPINE1;PTGER4;ZBP1;IL17RA;PDGFB;TNF;ADAM8;DDX60;CD180;APP;TLR7;AIF1;SCIMP;THBS1;LY86;IL2;IL23A;CX3CL1;GRN;TLR2;LPL;ABCC1;PPM1F;TNIP1
gsea,carboxylic acid metabolic process (GO:0019752),-0.5223384891442424,-1.5838249535673397,0.024742268041237112,0.03941591717283881,0.998,6/17,26.77%,MIF;CARNMT1;GSTO1;GRHPR;LIAS;SLC2A1
gsea,positive regulation of nitric oxide metabolic process (GO:1904407),-0.5247359461965032,-1.5833468922400449,0.034623217922606926,0.03949326788752937,0.998,3/18,11.06%,HSP90AA1;HSP90AB1;AKT1
gsea,regulation of cell death (GO:0010941),-0.4183743260128793,-1.5825480548232684,0.012145748987854251,0.03965526665832781,0.998,17/41,36.12%,UBB;RAD18;TMEM109;FAF1;PARK7;EIF4G1;PHB;SRSF6;VPS35;MT3;SRGAP2;HSPA1B;ACER3;DHCR24;HSPA1A;NOA1;CELF1
gsea,histone H3-K4 methylation (GO:0051568),-0.5394646856402485,-1.580195128292847,0.0390625,0.040298410012292986,0.998,7/16,29.75%,DPY30;PAXIP1;ASH2L;WDR5;SETD1A;RBBP5;MEN1
gsea,unsaturated fatty acid metabolic process (GO:0033559),0.5310158351071108,1.5755454511949298,0.03018867924528302,0.12991807955402818,0.998,4/16,12.18%,EPHX1;PNPLA8;DECR2;ACOX1
gsea,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5302362054500196,-1.5750218906936744,0.04742268041237113,0.0417428368330336,0.999,3/17,11.06%,HSP90AA1;HSP90AB1;AKT1
gsea,primary neural tube formation (GO:0014020),-0.5319909575735395,-1.5696444797075737,0.021484375,0.04322053352504668,0.999,3/17,11.55%,STIL;MTHFD1;MTHFD1L
gsea,tube closure (GO:0060606),-0.5319909575735395,-1.5696444797075737,0.021484375,0.04322053352504668,0.999,3/17,11.55%,STIL;MTHFD1;MTHFD1L
gsea,positive regulation of intracellular signal transduction (GO:1902533),-0.3139792429369553,-1.5696143371851992,0.00408997955010225,0.04317313327167856,0.999,56/233,32.61%,HMGB1;ECT2;HSP90AA1;MIF;ACTN4;NUP62;GAPDH;HSP90AB1;TFRC;C1QBP;BAX;PARK7;PHB2;UBE2N;MAZ;CGAS;EEF1D;DDX1;NEDD4;PPP5C;HRAS;BCLAF1;RPS15;PHB;TRAF2;MYDGF;PTPN6;SEH1L;MTDH;ROCK2;HAX1;SLC20A1;SHC1;CPNE1;USP15;FADD;ROCK1;TMEM101;PDPK1;PTP4A3;FLNA;PIK3CG;DDX21;BIRC3;PUM2;LGALS1;RYK;BBC3;DDX3X;GSDME;PTPN11;CC2D1A;DUSP19;THEM4;TRIB3;MAP3K7
gsea,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.516180405224004,1.5684608574752703,0.03872053872053872,0.13485081351451148,0.999,12/24,21.11%,GNA15;GPR18;F2RL1;F2RL2;CALCA;TGM2;HOMER1;F2R;GPR55;P2RY6;ACTN2;C3AR1
gsea,regulation of regulatory T cell differentiation (GO:0045589),0.5317172131999051,1.5668207934398268,0.03571428571428571,0.13418538928624746,0.999,10/17,19.66%,VSIR;TNFRSF18;BCL6;DUSP10;IL4I1;CTLA4;IRF1;IL2RA;FOXP3;IL2
gsea,ion transport (GO:0006811),-0.43454329247655765,-1.5659881786013332,0.015748031496062992,0.04421011044680007,0.999,5/39,17.81%,PLP2;SLC25A10;VDAC2;VDAC1;SLC20A1
gsea,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.49850810974456644,1.5654804374108466,0.024761904761904763,0.1334463556379172,0.999,12/25,22.37%,TNFAIP3;VSIR;CD274;ZC3H12A;RARA;SLAMF1;SYT11;SIRPA;CD33;CIDEA;IRAK3;CX3CL1
gsea,response to lipopolysaccharide (GO:0032496),-0.3829950842444725,-1.5649471600333051,0.022540983606557378,0.04451431263230192,0.999,20/76,48.28%,HMGB2;HMGB1;HNRNPA0;VIM;CACTIN;PLAA;PRDX3;LIAS;ADAM17;MAPKAPK2;CDC73;CTR9;SCARB1;MEF2C;TNFSF4;NOS1;RELA;DAB2IP;GFI1;CTSG
gsea,histone lysine demethylation (GO:0070076),0.51145327197949,1.5636719766591345,0.03522504892367906,0.13341295164086064,0.999,9/20,22.96%,KDM5B;KDM7A;KDM2B;KDM4D;JMJD1C;KDM1B;KDM4B;KDM5D;KDM6B
gsea,morphogenesis of an epithelium (GO:0002009),-0.5390065011710041,-1.562949018708509,0.03375527426160337,0.04504509044330243,0.999,3/15,11.31%,ACTG1;ACTB;TIMELESS
gsea,response to lipid (GO:0033993),-0.4094834961903381,-1.561629166183462,0.017241379310344827,0.0454108589216751,0.999,10/46,31.00%,HMGB2;CDKN2D;HNRNPA0;PCK2;ASXL1;PRDX3;LIAS;SPP1;ADAM17;MAPKAPK2
gsea,organophosphate biosynthetic process (GO:0090407),-0.5060872004573995,-1.5596250510147733,0.029880478087649404,0.045955476849561375,0.999,13/19,35.60%,TPI1;TKT;AGPAT5;GK;PCYT2;PPIP5K1;MBOAT1;GPHN;FADS1;AGPAT4;GNPAT;LPCAT1;IPMK
gsea,post-Golgi vesicle-mediated transport (GO:0006892),-0.4326419831355306,-1.558315808378615,0.024896265560165973,0.04630690595583951,0.999,19/36,42.88%,AP1M1;HSPA8;EXOC4;MYO5A;CLTC;VAMP8;AP1G2;KIF16B;RP2;HGS;EPS15;CORO7;KLHL20;AP1G1;AP4E1;GBF1;AP4M1;LLGL1;VAMP7
gsea,protein transport (GO:0015031),-0.3320685029421573,-1.5581949471561705,0.006060606060606061,0.046288596998357676,0.999,50/144,39.03%,CENPF;NDC1;HSP90B1;NPM1;TFRC;HIKESHI;ADPRH;CANX;IFT27;TMED2;PDIA4;TBC1D10B;VPS35;EIF2D;CLTC;MIA2;OPTN;MYH9;COPG1;ARCN1;ARL1;TMED1;HDAC6;CEP290;AP3D1;SIL1;ATP6V0A2;TCIRG1;SPTBN1;RABL3;SNX27;GCC2;ARFIP2;COPB2;NSF;TBCK;COPA;HERC2;COPG2;SCAMP4;GGA3;GOLGA4;SEC23IP;SCFD2;SNX9;TBC1D5;RAB23;IFT22;VPS33A;SGSM3
gsea,RNA polyadenylation (GO:0043631),-0.5410441979866402,-1.5572478532724805,0.043560606060606064,0.04647773893836202,0.999,10/15,35.03%,CPSF2;CPSF1;LEO1;SYMPK;CPSF3;AHCYL1;GRSF1;PNPT1;CSTF3;CDC73
gsea,mRNA polyadenylation (GO:0006378),-0.5410441979866402,-1.5572478532724805,0.043560606060606064,0.04647773893836202,0.999,10/15,35.03%,CPSF2;CPSF1;LEO1;SYMPK;CPSF3;AHCYL1;GRSF1;PNPT1;CSTF3;CDC73
gsea,negative regulation of inflammatory response (GO:0050728),0.3905112164141763,1.5566172093051698,0.019963702359346643,0.1378038949788917,0.999,45/73,32.83%,TNFAIP3;CD200;RORA;TNFAIP8L2;FURIN;PTGER2;PLK2;RAMP3;RAMP1;PLCG1;KLF4;MFHAS1;PTGER4;CALCB;CALCA;SIRPA;ADORA2A;ADRB2;HCK;ADM;GLP1R;SYK;CYSLTR2;CYSLTR1;MEFV;CALCRL;GRN;NLRP3;LYN;SLAMF8;SELENOS;IL10;ADCY6;PPARG;RLN3;APOE;TNFRSF1A;NR1H3;ACOD1;PLCG2;CD200R1;SCT;ADORA2B;GHSR;HTR7
gsea,cellular transition metal ion homeostasis (GO:0046916),-0.43490136228909637,-1.5557464032994752,0.026,0.04688964921438058,0.999,17/36,37.96%,NUBP1;TFRC;FXN;GLRX3;MT3;SLC31A1;ATP6V0A2;ABCB7;CUL1;ANKRD9;CCDC115;CAND1;ABCB6;CYB561A3;SLC39A4;SLC39A10;COX19
gsea,positive regulation of macromolecule metabolic process (GO:0010604),-0.32753813913845736,-1.5553196625950874,0.0,0.04696192912742422,0.999,58/164,39.46%,DNMT1;BRCA1;CTCF;TRIM28;ACTG1;TFRC;SERPINB9;PARK7;HMGN5;ID2;MAZ;E2F1;AKT1;SP1;EZR;FAM98B;PHB;RDX;FMR1;FUBP1;VPS35;HCFC1;ROCK2;PPHLN1;GABPA;MT3;SETDB2;ROCK1;MTOR;SETDB1;IFNG;TESC;RAB27A;TERF2;ATF4;TADA3;HINFP;SCRIB;DDX3X;UBR5;TNRC6A;HSPA1B;RPL5;HGS;ZPR1;NSF;HSPA1A;PRKAA1;CELF1;PLSCR1;GSK3B;TBC1D5;AHI1;AGO2;CCL3;ATF7IP;AFDN;MEF2C
gsea,regulation of blood vessel endothelial cell migration (GO:0043535),-0.4385223607064753,-1.5545962534273774,0.029748283752860413,0.04711502121632855,0.999,7/35,28.23%,HMGB1;AKT1;SP1;MAP2K3;PDPK1;SH3BP1;ADAM17
gsea,negative regulation of neuron death (GO:1901215),-0.40450345818586647,-1.5540354718869323,0.032388663967611336,0.04724345786959762,0.999,11/43,25.84%,SET;KIF14;PARK7;EIF4G1;AKT1;TRAF2;VPS35;HTRA2;MT3;MSH2;ATF4
gsea,regulation of signal transduction (GO:0009966),-0.3670882687036016,-1.5535557566916747,0.009881422924901186,0.047341273301913324,0.999,21/72,43.05%,PPIA;NUCKS1;NUP62;RGS2;RGS16;NCLN;TMEM237;SREBF2;GRK2;AXIN1;POFUT1;UBTF;RGS12;PLSCR1;NCAM1;CD55;LLGL1;TSC2;ACVR1;CREBBP;SIRT1
gsea,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.5363864186733573,-1.5532400182287127,0.041015625,0.047394462998769794,0.999,13/16,37.30%,UBB;PARP1;DDB1;CHD1L;RAD23B;CUL4B;GTF2H4;DDB2;GTF2H3;GTF2H2;GTF2H1;CUL4A;ERCC3
gsea,global genome nucleotide-excision repair (GO:0070911),-0.5232192729803937,-1.5505548360541712,0.039761431411530816,0.04829166572908595,0.999,13/18,37.30%,UBB;PARP1;DDB1;CHD1L;RAD23B;CUL4B;GTF2H4;DDB2;GTF2H3;GTF2H2;GTF2H1;CUL4A;ERCC3
gsea,response to organonitrogen compound (GO:0010243),-0.521462140757192,-1.5472195082270628,0.028513238289205704,0.049319409327659845,0.999,7/17,29.18%,DHFR;RNF5;KAT7;MTOR;CCDC47;DNAJB12;VCP
gsea,regulation of MAPK cascade (GO:0043408),-0.36346607415832044,-1.546003051612633,0.007952286282306162,0.04967336009838275,0.999,18/70,35.67%,HMGB1;FAM83D;HRAS;PEBP1;APIP;MYDGF;PTPN6;ROCK2;SHC1;ROCK1;LBH;WDR54;RYK;STK3;GSDME;DUSP19;TAOK2;PAK4
gsea,regulation of protein localization (GO:0032880),-0.4391555632750276,-1.5456944714605783,0.022684310018903593,0.04973138106543283,0.999,13/30,40.74%,HSP90AA1;HSP90AB1;BORA;PARP1;RSL1D1;MMD;CEP290;USP8;UFL1;MAP2;PICALM;AFDN;DVL1
gsea,gene silencing by miRNA (GO:0035195),-0.5161768229873395,-1.5450975437006542,0.05172413793103448,0.049885475304706384,0.999,7/17,30.80%,RAN;EIF6;TARBP2;CNOT1;XPO5;PUM2;TNRC6A
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),0.41117982812906956,1.5450706002699863,0.01694915254237288,0.14689922518265033,0.999,34/52,29.23%,CCR7;CXCR6;CCR6;CCR8;CXCR3;S1PR4;PTGER2;ATP2B2;CCR2;F2RL1;CCR5;CXCR5;CCL1;TBXA2R;CIB2;PTGER4;CALCB;RYR1;CALCA;SMAD3;F2R;LPAR3;GLP1R;CXCL13;CXCR4;CYSLTR1;C3AR1;ITPR3;CLN3;CCR1;CCR4;SLC8A1;CCR3;ATP1A2
gsea,cellular response to organic cyclic compound (GO:0071407),-0.3829198597545616,-1.5447960092077495,0.011695906432748537,0.04992907071249337,0.999,19/63,28.38%,RAD51;BRCA1;BLM;HSP90B1;ACTB;RUVBL2;TAF1;CASP3;EZR;SPIDR;ROCK2;INSIG1;DIAPH1;URI1;CASP7;LARP1;CTNNA1;SPP1;PDXP
gsea,regulation of Ras protein signal transduction (GO:0046578),-0.4046704584958255,-1.5444994527576494,0.00819672131147541,0.04996455882682155,0.999,11/45,28.73%,KIF14;FOXM1;NUP62;ARHGDIA;LRRC59;RDX;SHC1;SH3BP1;SHOC2;RABL3;MYO9B
gsea,negative regulation of endopeptidase activity (GO:0010951),-0.4996428895675762,-1.54414526327949,0.05,0.05001393751980331,0.999,6/18,24.08%,GAPDH;SERPINB9;AKT1;SERPINE2;MT3;PCID2
gsea,regulation of myeloid cell differentiation (GO:0045637),-0.4113368774290316,-1.5422164882761624,0.020964360587002098,0.050541884804664025,0.999,14/42,30.80%,DPY30;PRMT1;HDAC1;EIF6;HSPA9;ASH2L;WDR5;SIN3A;LEO1;RBM15;SETD1A;RBBP5;CDK6;TNRC6A
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),-0.3986001495183044,-1.5407207798832354,0.03373015873015873,0.051008753636276806,0.999,21/43,38.40%,SLC25A5;PIH1D1;FXN;PARK7;PRELID1;MAZ;AKT1;PSME3;PPIF;NOC2L;PHIP;CSNK2A2;URI1;RB1;BIRC6;DDX3X;HERPUD1;HSPA1A;CAAP1;OPA1;HTT
gsea,regulation of Rho protein signal transduction (GO:0035023),-0.4111823733608245,-1.5400821876680235,0.027777777777777776,0.051170053644935196,0.999,7/39,28.73%,STMN1;ARHGDIA;KCTD13;NET1;TNFAIP1;CUL3;MYO9B
gsea,regulation of kinase activity (GO:0043549),-0.43411992323182513,-1.5399307747134134,0.022727272727272728,0.05115807408601999,0.999,11/32,28.22%,ECT2;HNRNPU;RAD50;RBL1;NBN;RB1;VAC14;PRDX3;RBL2;CAMKK2;RYK
gsea,positive regulation of phosphorylation (GO:0042327),-0.34901306766274154,-1.5390056953906985,0.002173913043478261,0.051400158045333814,0.999,28/107,31.32%,PPIA;HSP90AA1;PTGES3;MIF;PIN1;RAD50;TFRC;AKT1;CDK2AP1;HRAS;FMR1;MYDGF;ROCK2;VEGFB;KCTD20;MT3;GLMN;NBN;VAC14;IFNG;ENTPD5;DSCAM;CAMKK2;FXR2;RYK;ADAM17;PFKFB1;AXIN1
gsea,regulation of interleukin-8 production (GO:0032677),-0.4236384601833677,-1.5373097825494315,0.021739130434782608,0.05197068257957203,0.999,4/36,19.71%,HMGB1;PARK7;CACTIN;FADD
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",-0.42358919381568705,-1.5371711131125865,0.02,0.051947856848314315,0.999,16/35,39.02%,RNF126;LMAN1;TBC1D10B;SNX5;VPS35;DCTN1;CLTC;VPS52;ARL1;ANKFY1;GCC2;ERC1;TBC1D5;HEATR5A;GBF1;VPS50
gsea,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5077086279270765,1.5369558436347412,0.04038461538461539,0.15284056170551777,0.999,7/19,15.32%,EMB;ITGB1;PECAM1;PVR;CEACAM1;CDH1;MPZL2
gsea,histone monoubiquitination (GO:0010390),-0.5453391808946564,-1.5361525391917905,0.044145873320537425,0.052186087257127214,0.999,6/15,21.68%,UHRF1;RNF168;DDB1;TRIM37;LEO1;CUL4B
gsea,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.5179569680938207,-1.5350889071136704,0.049281314168377825,0.05246520005980533,0.999,8/15,31.77%,PPIA;PARK7;AKT1;HTRA2;ATF4;BAG5;PYCR1;SOD2
gsea,neurotransmitter transport (GO:0006836),-0.46749758550590226,-1.5350794501979663,0.03495145631067961,0.05240240059573706,0.999,6/24,28.34%,SLC29A1;HSPA8;PDZD11;GLS;PPFIA1;UNC13A
gsea,protein lipidation (GO:0006497),-0.44496056840093,-1.5327828255152323,0.0392156862745098,0.05312773832615684,0.999,18/27,48.35%,PIGF;ZDHHC2;ZDHHC16;ZDHHC6;PIGU;PIGA;ZDHHC12;PIGQ;ZDHHC15;ZDHHC13;ZDHHC21;ATG7;PGAP2;PIGN;PIGV;PIGG;HHAT;ZDHHC8
gsea,neuron projection extension (GO:1990138),-0.4912307429753169,-1.5292466556251039,0.045174537987679675,0.05433136677169752,0.999,4/20,19.24%,HSP90AA1;HSP90AB1;PPP3CB;CPNE1
gsea,glycosaminoglycan catabolic process (GO:0006027),-0.49241009404556013,-1.5255505738499502,0.04752851711026616,0.0555418598100198,0.999,2/19,12.76%,HMMR;ARSB
gsea,positive regulation of kinase activity (GO:0033674),-0.4039381923734732,-1.5255286319715768,0.028688524590163935,0.055477551958077534,0.999,16/41,38.25%,CENPE;CDKN1A;RAD50;MAP2K3;MRNIP;XRCC5;NBN;XRCC6;MMD;VAC14;RYK;DUSP19;PRKAG2;TIGAR;SNX9;DAXX
gsea,lipid transport (GO:0006869),-0.4012867130557938,-1.5254326628419899,0.028397565922920892,0.05544868708854625,0.999,18/43,47.31%,FABP5;PRELID3B;PRELID1;GOT2;PITPNB;LDLR;OSBP;SLC25A17;CPTP;PEX3;SCARB1;PRELID2;NME4;NCOA1;ACSL1;PLEKHA8;STARD5;ABCC4
gsea,glutamine family amino acid metabolic process (GO:0009064),-0.52160918766073,-1.5248049919928952,0.05168986083499006,0.05561959723680725,0.999,11/17,39.74%,OAT;GOT2;CAD;ALDH18A1;GLS;PYCR2;PYCR1;DDAH2;GOT1;NIT2;FPGS
gsea,positive regulation of cellular catabolic process (GO:0031331),-0.36188780444686264,-1.5235352477794268,0.0,0.05603256958347948,0.999,25/73,36.93%,HMGB1;HSP90AA1;FAF1;KHSRP;EZR;ZC3H18;RDX;VPS35;DXO;MTDH;OPTN;ROCK1;CNOT1;IFNG;ENTPD5;ATF6;GRSF1;PNPT1;PFKFB1;UFL1;SUPV3L1;PRKAA1;SVIP;GSK3B;SNX9
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4221850222111423,1.5235051603486858,0.035398230088495575,0.16528013616435588,0.999,27/41,32.83%,FURIN;PTGER2;PLK2;CD81;RAMP3;RAMP1;PLCG1;PTGER4;CALCB;CALCA;ADORA2A;ADRB2;HCK;ADM;GLP1R;SYK;CYSLTR2;CYSLTR1;CALCRL;LYN;IL10;ADCY6;RLN3;PLCG2;SCT;ADORA2B;HTR7
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4968204772481736,1.5227414125699308,0.053742802303262956,0.16387282490099897,0.999,6/18,5.54%,TNFAIP3;RORA;ZC3H12A;STAT1;TNIP3;PER1
gsea,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.46772797130310795,1.5224606669095166,0.047524752475247525,0.1618879891519638,0.999,17/24,31.17%,HIF1A;JUN;ETS1;NR3C1;KLF4;SPI1;FOXO3;PDGFB;TNF;SMAD3;FGF2;TGFB2;IL10;PPARG;FOS;FOSL1;APLN
gsea,regulation of supramolecular fiber organization (GO:1902903),-0.5185725337014997,-1.5223713648531263,0.029469548133595286,0.056413282649802804,0.999,7/15,35.40%,PARK7;HSPA8;ARL2;PRUNE1;MAP1A;GBA2;MAP2
gsea,negative regulation of neuron projection development (GO:0010977),-0.5001761417486015,-1.5221869389847915,0.06458333333333334,0.056400972647508325,0.999,7/19,33.31%,FKBP4;ARHGDIA;HDAC2;MT3;BAG5;RUFY3;GAK
gsea,tRNA aminoacylation (GO:0043039),-0.5044176871847355,-1.5194259537644759,0.04222648752399232,0.05737454984916958,0.999,16/19,39.09%,PPA1;AIMP2;FARSB;EEF1E1;DARS2;FARSA;SARS2;PPA2;QRSL1;GATC;IARS2;MARS2;RARS2;YARS2;FARS2;GATB
gsea,endoderm formation (GO:0001706),0.5423342621353678,1.516257449675238,0.0421455938697318,0.16610683762095224,0.999,10/16,25.81%,DUSP4;DUSP2;DUSP1;ITGA4;ITGA7;FN1;ITGA5;INHBA;MMP14;COL7A1
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.48278249459069245,-1.5157483888323127,0.04771784232365145,0.058731055686846056,0.999,7/21,24.98%,C1QBP;P4HB;TRIOBP;CAPRIN1;CALR;FLNA;SS18L2
gsea,negative regulation of lymphocyte proliferation (GO:0050672),0.4900867145097584,1.5136092129191299,0.05860113421550094,0.1664832371684106,0.999,18/23,29.40%,CD274;PDCD1LG2;TYROBP;IL4I1;CTLA4;CD86;LST1;TNFRSF13B;SDC4;CD300A;FCGR2B;FOXP3;LYN;TNFRSF21;DLG5;IL10;CD80;GPNMB
gsea,regulation of activated T cell proliferation (GO:0046006),-0.5193986841374673,-1.512925250667306,0.05084745762711865,0.05974801928348291,0.999,3/16,29.47%,HMGB1;FADD;SCRIB
gsea,cellular response to hydrogen peroxide (GO:0070301),-0.45518421557857935,-1.51219209122593,0.05029013539651837,0.05997825368248555,0.999,8/24,25.60%,ECT2;FXN;PARK7;PPIF;SETX;NET1;SIGMAR1;HDAC6
gsea,regulation of B cell proliferation (GO:0030888),0.43290907587210864,1.511445293464846,0.04133858267716536,0.1666868611967016,0.999,23/31,28.90%,BCL2;GPR183;IRS2;CD81;CLCF1;CD38;TYROBP;CTLA4;TNFRSF13B;VAV3;TNFRSF13C;TNFSF13B;AHR;CD300A;CD40;IKZF3;FCGR2B;BST1;IL2;LYN;TNFRSF21;IL10;TNFRSF4
gsea,response to metal ion (GO:0010038),-0.43565464143887583,-1.510641282420102,0.028513238289205704,0.06043283892406644,0.999,9/29,26.79%,CALM2;FXN;NEDD4;PPP5C;PPP2CB;SLC25A13;MT3;AHCYL1;GPHN
gsea,negative regulation of cell-matrix adhesion (GO:0001953),-0.5108006276481548,-1.5092827045487467,0.05219206680584551,0.06089987782463928,0.999,4/16,18.04%,CDKN2A;RCC2;CORO1C;CLASP2
gsea,positive regulation of proteolysis (GO:0045862),-0.4190101397078757,-1.5081642989688997,0.016129032258064516,0.06125553751797499,0.999,8/32,24.69%,PLK1;STUB1;HDAC2;WDR48;FADD;BAK1;CLN6;IFNG
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.39168867355415277,-1.505845835426685,0.022540983606557378,0.06208557047017569,0.999,18/45,43.44%,PLK1;IPO5;CDKN2A;AKT1;RGS2;PKIG;IPO7;RB1;PRKAR2A;MEN1;SMPD1;PRKAR2B;UCHL1;PAQR3;PIK3CB;SIRT1;HYAL2;TFAP4
gsea,cellular response to oxygen-containing compound (GO:1901701),-0.3296901492295918,-1.5056523340894863,0.014198782961460446,0.06207426172254098,0.999,30/137,29.18%,HMGB2;HMGB1;HSP90B1;IPO5;ACTB;RUVBL2;CDK2;SHMT1;TAF1;AKT1;EZR;VIM;CACTIN;ROCK2;HTRA2;INSIG1;MT3;SETX;CREB1;MTOR;PLAA;PRDX3;GUCY1B1;TESC;TPM1;ERCC6L2;CAMKK2;MTR;PDXP;VCP
gsea,neural tube closure (GO:0001843),-0.4830973541907395,-1.505314741492888,0.037549407114624504,0.06213043163986756,0.999,3/20,11.55%,STIL;MTHFD1;MTHFD1L
gsea,acyl-CoA metabolic process (GO:0006637),-0.5108604504841288,-1.50493292115313,0.05228758169934641,0.062186466207995776,0.999,8/15,32.14%,DBI;HMGCS1;DLST;SUCLG2;OGDH;ACACA;ACSF2;THEM4
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.5019488165296382,-1.5037201966049272,0.04276985743380855,0.06262302965149773,0.999,6/16,31.47%,PPIA;FOXM1;EZR;AIDA;MEN1;DUSP19
gsea,ephrin receptor signaling pathway (GO:0048013),-0.43805367501223824,-1.5033678050053236,0.04216867469879518,0.06270330049004742,0.999,10/28,38.59%,ACTG1;ACTB;HRAS;ROCK2;ROCK1;SIPA1L1;ACTR2;PTPN11;AP2B1;AP2A2
gsea,natural killer cell activation (GO:0030101),-0.5086297756785628,-1.5024583843267774,0.06172839506172839,0.06298092520286701,0.999,6/15,29.10%,PRDX1;ULBP1;KAT7;RABL3;TOX;SNX27
gsea,platelet degranulation (GO:0002576),-0.38216684412230884,-1.5011204572285402,0.02702702702702703,0.06341688131404177,0.999,14/57,28.80%,TAGLN2;TUBA4A;ACTN4;MANF;FAM3C;ALDOA;PCYOX1L;VEGFB;CYB5R1;OLA1;PLEK;FLNA;NHLRC2;SCCPDH
gsea,hippo signaling (GO:0035329),-0.5109827221895806,-1.5007480347566176,0.06444906444906445,0.0635054797054589,0.999,2/15,10.69%,YWHAE;CASP3
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.4212496970226136,-1.4982945285849785,0.03655913978494624,0.06432006348650375,0.999,13/30,43.56%,UBB;PIN1;STUB1;STRAP;PDPK1;ADAM17;HSPA1A;PRDM16;MTMR4;SNX25;SPRED1;SIRT1;SKIL
gsea,regulation of endocytosis (GO:0030100),0.43152956641235524,1.497216124555151,0.028089887640449437,0.17951518626009014,0.999,14/30,26.67%,LGALS3;PACSIN1;FLOT1;MCTP1;ABCA7;SYT11;RUFY2;STON1;RAB4A;LRP1;DAB2;STON2;PACSIN3;HIP1
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4063303536975839,-1.4966319569833713,0.037815126050420166,0.06497236478561258,0.999,9/38,27.71%,HSP90AA1;HSP90AB1;ACTG1;ACTB;ELMO1;PRKCE;MYO10;ACTR2;ELMO2
gsea,positive regulation of interleukin-1 beta production (GO:0032731),0.49856821087615194,1.495857447426792,0.057803468208092484,0.17876362196017814,0.999,10/19,27.50%,RIPK2;JAK2;TYROBP;F2RL1;MALT1;TNF;APP;NLRP3;LPL;TMEM106A
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),0.40068338869647746,1.495586269271574,0.028513238289205704,0.17679849341242185,0.999,27/50,26.27%,XCL1;ZFP36L1;ITGB1;FURIN;RPS27A;OVOL2;PRKCZ;JUN;PTPRK;LRRC32;ENG;NR3C1;SMAD7;TGFBR3;SMAD3;NLK;ARHGEF18;NRROS;TWSG1;CLEC3B;GCNT2;ACVRL1;SMAD5;WNT10A;TGFB2;SKI;TGFB3
gsea,regulation of cytoskeleton organization (GO:0051493),-0.3814019037077897,-1.492834607108305,0.01991150442477876,0.06652678301953856,0.999,25/52,46.99%,IQGAP3;CORO1A;EZR;IQGAP2;ROCK2;CLIC4;ROCK1;DIAPH1;CLASP1;MTOR;BICD2;SH3BP1;PRKAA1;TAOK2;MLST8;GSK3B;TRAF3IP1;HIP1R;TRIM36;RHOF;RHOQ;CCDC88A;BAIAP2;ARHGAP35;RHOB
gsea,histone deacetylation (GO:0016575),-0.43968046523976645,-1.4923700664249269,0.03732809430255403,0.06666647449259987,0.999,19/28,43.05%,HDAC1;SFPQ;HDAC2;PHB;MTA1;SIN3A;MORF4L2;RBM14;MTA2;HDAC6;SIRT6;TBL1XR1;TBL1X;TRERF1;PRDM5;MIER3;BRMS1L;MIER2;SIRT1
gsea,glial cell development (GO:0021782),-0.5030239852347405,-1.4889857960641075,0.05731225296442688,0.06800786288116181,0.999,7/15,36.01%,EIF2B1;MT3;NSUN5;EIF2B5;EIF2B3;CDK6;EIF2B4
gsea,regulated exocytosis (GO:0045055),-0.36448101100274427,-1.4887138910073199,0.032467532467532464,0.0680143828677088,0.999,16/70,28.80%,TAGLN2;TUBA4A;ACTN4;MANF;FAM3C;ALDOA;PCYOX1L;PPP3CB;VEGFB;MYH9;CYB5R1;OLA1;PLEK;FLNA;NHLRC2;SCCPDH
gsea,regulation of actin cytoskeleton organization (GO:0032956),-0.38637000029146984,-1.4869574826483725,0.03260869565217391,0.06866032051870334,0.999,9/45,23.03%,IQGAP3;ARHGDIA;CORO1A;EZR;IQGAP2;ROCK2;ROCK1;MTOR;SH3BP1
gsea,tRNA aminoacylation for protein translation (GO:0006418),-0.4685232740958862,-1.4847217447114343,0.05827067669172932,0.06943738808216916,0.999,17/22,41.66%,PPA1;AIMP2;FARSB;EEF1E1;DARS2;FARSA;SARS2;PPA2;CARS2;TARS2;IARS2;MARS2;RARS2;YARS2;FARS2;VARS2;HARS2
gsea,negative regulation of cell junction assembly (GO:1901889),-0.5282701921103937,-1.483916211284187,0.061855670103092786,0.06974506017909533,0.999,5/15,19.92%,RCC2;CORO1C;ROCK2;CLASP2;ROCK1
gsea,phosphate-containing compound metabolic process (GO:0006796),-0.33763045187009527,-1.4837454949244802,0.010121457489878543,0.06974571206437236,0.999,44/97,42.84%,PGP;NUDT5;BCKDK;PGK1;PPA1;PFKP;AKT1;NUDT4;GPD2;PSPH;ALDOA;PPP3CB;SLC20A1;GK;PPA2;MTOR;PLAA;ISYNA1;INPP5B;PIK3CG;PFKL;GDE1;PPIP5K1;FRA10AC1;PDXP;PFKFB1;AGK;PI4KA;HK1;DUSP12;CERKL;IPMK;PXYLP1;TIGAR;AGPAT1;HK2;HDHD2;PLCH1;G6PC3;NUDT11;PIK3CB;NUDT10;STAT3;DUSP5
gsea,macrophage activation (GO:0042116),0.5291389899695154,1.4825175348286586,0.06274509803921569,0.1891689300792753,0.999,13/18,31.34%,JAK2;FOXP1;ITGAM;TNF;APP;AIF1;C1QA;SYK;CD93;CX3CL1;TMEM106A;SBNO2;PLCG2
gsea,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.455970041236092,-1.481527062791116,0.06746031746031746,0.07068492526878417,0.999,5/22,12.89%,BAX;FXN;PRELID1;AKT1;PPIF
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.39653019874682327,-1.478808327734172,0.049523809523809526,0.07177470510946045,0.999,16/39,34.89%,UBB;STUB1;GZMB;PRPF19;PSMA6;LONP1;DDB1;CLPP;MDM2;CUL4B;HDAC6;VCP;CLPX;YME1L1;USP9X;IDE
gsea,iron ion homeostasis (GO:0055072),-0.44535752653484634,-1.4787460425035928,0.0498960498960499,0.07170890515254486,0.999,12/26,36.91%,NUBP1;TFRC;FXN;GLRX3;ATP6V0A2;ABCB7;CUL1;CCDC115;CAND1;ABCB6;CYB561A3;PICALM
gsea,positive regulation of TOR signaling (GO:0032008),-0.48562768440444626,-1.4779136288298225,0.06813627254509018,0.07194622733979772,0.999,2/16,15.31%,PIH1D1;SEH1L
gsea,response to calcium ion (GO:0051592),-0.39473019335627374,-1.4759856472131383,0.04411764705882353,0.07269423405454543,0.999,15/41,40.58%,CALM2;ECT2;NEDD4;PPIF;CLIC4;SLC25A13;CPNE1;AHCYL1;ADD1;SMPD1;PRKAA1;RASGRP2;CPNE2;MEF2C;TRPC1
gsea,regulation of interleukin-10 production (GO:0032653),-0.44902911169233406,-1.475971051997529,0.05148514851485148,0.07261256664476219,0.999,4/25,42.43%,HMGB1;HSPD1;TNFSF4;STAT3
gsea,response to molecule of bacterial origin (GO:0002237),-0.44528774083054967,-1.4745682448108735,0.07676348547717843,0.07317051963980933,0.999,6/30,31.00%,HMGB2;HNRNPA0;PRDX3;LIAS;ADAM17;MAPKAPK2
gsea,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.47320902414902777,-1.4737512977006608,0.07036247334754797,0.0734668230980966,0.999,4/20,31.77%,DNMT1;CDKN1A;TPM1;SOD2
gsea,positive regulation of cell junction assembly (GO:1901890),0.5124612073570338,1.4718720536818413,0.056112224448897796,0.19947143968226227,1.0,9/15,30.95%,S100A10;FLOT1;NRP1;MAP4K4;CLSTN1;PPM1F;DLG5;PTPRJ;COL16A1
gsea,positive regulation of stress fiber assembly (GO:0051496),0.45544503771205985,1.4716654916927923,0.05,0.1973105764257865,1.0,11/22,26.27%,EVL;RHOC;S100A10;NRP1;LIMK1;PFN2;PAK1;WNT11;ARHGEF10L;PPM1F;TGFB3
gsea,response to hydrogen peroxide (GO:0042542),-0.4235788655396155,-1.471438463677209,0.057692307692307696,0.0744452622274933,0.999,9/28,28.75%,ECT2;FXN;PARK7;PPIF;SETX;NET1;PRDX3;HDAC6;APTX
gsea,negative regulation of tumor necrosis factor production (GO:0032720),0.477956164523444,1.4705925621483686,0.054409005628517824,0.19628051969698143,1.0,13/23,27.66%,TNFAIP3;VSIR;ZC3H12A;RARA;SLAMF1;SYT11;SIRPA;CD33;CIDEA;IRAK3;CX3CL1;SELENOS;IL10
gsea,actin filament bundle assembly (GO:0051017),-0.4714381200901563,-1.4699443942449848,0.05919661733615222,0.07503461697056116,0.999,6/20,33.42%,HSP90B1;EZR;LCP1;ADD1;PDXP;PLS1
gsea,protein processing (GO:0016485),-0.3875193062176515,-1.4683311318712007,0.033203125,0.07564499145718967,0.999,14/43,30.31%,FAM111A;STOML2;METAP2;FXN;PIDD1;HTRA2;SPCS3;PITRM1;SPG7;TYSND1;PARL;ZMPSTE24;ADAM17;YME1L1
gsea,regulation of nitric-oxide synthase activity (GO:0050999),-0.45969587327823136,-1.4665633384157302,0.0482897384305835,0.07635274501236598,0.999,8/20,41.33%,HSP90AA1;DHFR;AKT1;TERF2;DDAH2;SCARB1;ZDHHC21;PIK3CB
gsea,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.503313107827381,1.465684429742858,0.05394990366088632,0.1996318970573227,1.0,9/17,27.35%,KLF4;TBXA2R;ANXA1;PTGS2;THBS1;DLL4;FGF2;HDAC9;HDAC5
gsea,regulation of cellular metabolic process (GO:0031323),-0.4704482386117725,-1.464381115469745,0.04878048780487805,0.07721712257322119,0.999,10/19,28.69%,FOXM1;STUB1;COQ7;EIF6;VPS35;NCOR2;PARL;KIF16B;ACACA;ACLY
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.4218836409722112,-1.4619048693765335,0.05263157894736842,0.07825431603202947,0.999,11/32,43.06%,TTK;HSP90AB1;NUP93;NUMA1;GIPC1;ADAM17;MEN1;FBXL15;ACVR1;CREBBP;UBE2O
gsea,negative regulation of T cell proliferation (GO:0042130),0.4938208934541987,1.4598246864900821,0.06274509803921569,0.20430727438744478,1.0,13/18,29.40%,CRTAM;CD274;PDCD1LG2;IL4I1;CD86;PRNP;SDC4;FOXP3;TNFRSF21;DLG5;IL10;CD80;GPNMB
gsea,carboxylic acid transmembrane transport (GO:1905039),-0.47748402551908553,-1.4594227826339048,0.0682261208576998,0.07933739798079065,1.0,2/18,10.77%,SLC25A10;SLC7A5
gsea,protein glycosylation (GO:0006486),-0.34422694547822463,-1.4580492261704354,0.036,0.07988913045129256,1.0,27/72,39.31%,DDOST;RPN2;ALG8;MOGS;RPN1;DPAGT1;ALG6;MAGT1;GALNT1;STT3B;STT3A;ALG3;PMM1;ENTPD5;ST3GAL4;POMT1;ST3GAL5;EOGT;GALNT7;ALG9;MPI;POFUT1;PLOD2;DOLPP1;GOLGA2;B4GAT1;TRAK1
gsea,regulation of actin cytoskeleton reorganization (GO:2000249),-0.49111775281129844,-1.4577119262151688,0.06832298136645963,0.07995769778523755,1.0,4/17,17.22%,ARHGDIA;IQGAP2;HRAS;HAX1
gsea,regulation of macroautophagy (GO:0016241),-0.37610180515893044,-1.452864411824433,0.037267080745341616,0.08211062077916377,1.0,18/45,37.08%,GAPDH;CASP3;AKT1;NEDD4;EXOC4;SNX5;VPS35;SCOC;MTOR;UBQLN1;HDAC6;LARP1;ATP6V0A2;MAP3K7;PRKAA1;PRKAG2;MLST8;UCHL1
gsea,regulation of nitric oxide biosynthetic process (GO:0045428),-0.4451092101315932,-1.45234589292541,0.04684317718940937,0.08228370681281418,1.0,6/25,24.69%,HSP90AA1;HSP90AB1;KHSRP;AKT1;ROCK2;IFNG
gsea,ERBB2 signaling pathway (GO:0038128),-0.4961579474151284,-1.4512418562331544,0.09980430528375733,0.08272789810671291,1.0,6/15,36.68%,HSP90AA1;STUB1;SHC1;PTPN12;GRB7;CUL5
gsea,leukocyte cell-cell adhesion (GO:0007159),0.5097493825191891,1.4482215088744883,0.07763401109057301,0.21670861317920218,1.0,10/15,18.73%,CCL5;ITGB1;ICAM1;NT5E;PECAM1;ITGA4;CD40LG;SELP;VCAM1;SYK
gsea,cellular glucose homeostasis (GO:0001678),-0.449436983833147,-1.4481664360693929,0.06395348837209303,0.08418388244186452,1.0,9/21,44.22%,NUCKS1;PCK2;FOXK2;HK1;PRKAA1;HK2;SIRT1;RACK1;ERN1
gsea,positive regulation of cellular component organization (GO:0051130),-0.3520296084050508,-1.4458876061846864,0.03824091778202677,0.08524769517680773,1.0,23/59,38.27%,CDC20;PIH1D1;TFRC;CDT1;BAX;FAF1;PARK7;LMAN1;SPIDR;DCTN1;SLF1;BAK1;RB1;IFNG;ADD1;SLF2;ABCB7;VCP;SMPD1;BIK;GSK3B;ATP10A;GNL3L
gsea,positive regulation of protein polymerization (GO:0032273),-0.4062725902963615,-1.44379856587743,0.056133056133056136,0.0861912588195872,1.0,11/32,28.06%,HSP90AA1;PFN1;NUMA1;CDK5RAP2;DRG1;DCTN1;PRKCE;CLASP1;PSRC1;ARL2;CLIP1
gsea,cell chemotaxis (GO:0060326),-0.4172057698655593,-1.4425642609643727,0.05555555555555555,0.08673370193189141,1.0,30/30,99.93%,HMGB2;CCRL2;ELMO2;BCAR1;NR4A1;RAB13;CCR9;VEGFA;CCL25;CX3CR1;CCR3;CCR4;HBEGF;CCR1;ABCC1;CX3CL1;EGR3;CXCR4;LEF1;PDGFB;KIT;CXCR5;CCR5;CCR2;NRP1;CXCR3;CCR8;CCR6;CXCR6;CCR7
gsea,protein destabilization (GO:0031648),-0.4735666027468457,-1.4422573075955585,0.07468879668049792,0.0868029532436184,1.0,11/18,43.05%,PLK1;RAD23A;MDM2;KDM8;CUL3;GGA3;CDC73;HTT;BTRC;CREBBP;SIRT1
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3994488624605433,1.4393716986752172,0.059782608695652176,0.2257658980012779,1.0,28/42,32.83%,FURIN;PTGER2;PLK2;RAMP3;RAMP1;PLCG1;PTGER4;CALCB;CALCA;ADORA2A;ADRB2;HCK;ADM;FCGR2B;GLP1R;SYK;CYSLTR2;CYSLTR1;CALCRL;LYN;SELENOS;IL10;ADCY6;RLN3;PLCG2;SCT;ADORA2B;HTR7
gsea,extrinsic apoptotic signaling pathway (GO:0097191),-0.3998855127793509,-1.438798379734119,0.05128205128205128,0.08835779028510997,1.0,11/35,24.69%,SIVA1;BAX;CASP8AP2;CASP3;TRAF2;DELE1;FADD;BAK1;DDX47;PDPK1;IFNG
gsea,sensory perception of light stimulus (GO:0050953),-0.42171929113558815,-1.4379538129709992,0.04670912951167728,0.08865403893581214,1.0,11/27,37.43%,OAT;RGS16;OPA3;CRYBG3;RABGGTB;ATF6;RP2;EYA3;CRYZ;MYO9A;OPA1
gsea,regulation of insulin secretion (GO:0050796),0.40040510833678883,1.4356541421948876,0.05232558139534884,0.228601746772778,1.0,22/38,32.88%,CCL5;PRKCA;IRS2;ITPR2;IL1B;REST;TNF;ITPR1;SOX4;GLP1R;CACNA2D2;ITPR3;SIRT4;DPP4;TCF7L2;CLOCK;NOS2;KCNG2;ADRA2A;CACNA1A;RAPGEF4;MIDN
gsea,cellular response to lipid (GO:0071396),-0.33613689551409587,-1.4355751298078314,0.037578288100208766,0.08968528923236688,1.0,31/100,49.67%,HMGB2;HMGB1;RUVBL2;VIM;CACTIN;ROCK2;HTRA2;INSIG1;URI1;MAP4K1;SETX;CREB1;PLAA;TESC;SPP1;CDC73;CTR9;CCDC62;MEF2C;FZD4;TNFSF4;ATP1A1;ADNP2;MED1;RELA;DAB2IP;ATM;GFI1;CTSG;PTK2B;SPHK2
gsea,regulation of chemokine production (GO:0032642),0.46196367784297027,1.4353034144738253,0.07061068702290077,0.2265709647049076,1.0,11/21,24.26%,HIF1A;F2RL1;FOXP1;SIGIRR;AIRE;TNF;APP;TLR7;AIF1;TLR2;LPL
gsea,blood vessel morphogenesis (GO:0048514),0.4634286842233608,1.4351814898489772,0.05928853754940711,0.22416353745584686,1.0,11/19,20.39%,NRP1;ENG;ITGB8;SMAD7;TGFBR3;FLT1;RASA1;ADM;RASIP1;SYK;CUL7
gsea,cytosolic transport (GO:0016482),-0.3629548645989022,-1.4327035653504645,0.03937007874015748,0.09112729790487678,1.0,23/53,39.02%,RNF126;TBC1D10B;SNX5;VPS35;DCTN1;CLTC;VPS52;ARL1;EEA1;HOOK1;KIF16B;ANKFY1;GCC2;ERC1;EPS15;CORO7;GAK;KLHL20;AP1G1;TBC1D5;HEATR5A;GBF1;VPS50
gsea,glycerophospholipid metabolic process (GO:0006650),-0.39995167273880144,-1.432275511885024,0.05858585858585859,0.09124225653554607,1.0,12/36,32.16%,PGP;PIGF;CPNE1;PIGA;CRLS1;PLEK;GDE1;PIGQ;FAR1;PDXP;AGK;SMPD4
gsea,negative regulation of cellular biosynthetic process (GO:0031327),-0.42056768153779617,-1.4305910813301992,0.06451612903225806,0.09199892442265843,1.0,8/28,32.42%,BRCA1;PGP;KHSRP;ACADL;ROCK2;PLEK;CLK2;TRIB3
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.33676222703829284,-1.4270917676223402,0.03550295857988166,0.09365925347736984,1.0,27/77,42.43%,PPIA;UBB;NPM1;TFRC;DHX9;PSMA6;UBE2N;TRAF2;TRIM37;MTDH;PIDD1;FLOT2;RPS6KA5;RHEBL1;PRDX3;NFKB2;HSPA1B;TAB1;ERC1;MAP3K7;HSPA1A;CHUK;LTF;RIPK3;PRKCB;PRKCI;STAT3
gsea,positive regulation of secretion by cell (GO:1903532),-0.39298692851407513,-1.4262756168651771,0.052083333333333336,0.09402386395018214,1.0,6/35,25.16%,PPIA;EZR;PPID;CLASP2;CLASP1;RAB27A
gsea,regulation of autophagy (GO:0010506),-0.31121754528018863,-1.4262502763326086,0.007905138339920948,0.0939278024496552,1.0,43/112,37.08%,HMGB1;GAPDH;VDAC1;EIF4G1;CASP3;EIF4E;AKT1;NEDD4;EXOC4;EIF4G2;SNX5;VPS35;MTDH;HAX1;HTRA2;SREBF2;MT3;OPTN;CSNK2A2;ROCK1;MTOR;USP10;UBQLN1;IFNG;FOXK2;EIF4G3;HDAC6;ATP6V0A2;ATF6;KEAP1;DEPDC5;UFL1;TRIB3;CPTP;PRKAA1;SVIP;PRKAG2;MTMR4;TLK2;GOLGA2;MLST8;GSK3B;UCHL1
gsea,muscle contraction (GO:0006936),-0.39493444936237826,-1.426061363068423,0.055776892430278883,0.09393725788610818,1.0,9/38,28.53%,TPM3;TPM4;SMTN;ALDOA;VIM;ROCK2;ROCK1;TPM1;MYLPF
gsea,response to endoplasmic reticulum stress (GO:0034976),-0.353220384479959,-1.4206308642344097,0.038535645472061654,0.09679196768491546,1.0,32/61,39.76%,HSP90B1;BAX;EIF2S1;RNF5;P4HB;PDIA4;PDIA3;AIFM1;TRAF2;ATP2A2;CEBPB;DNAJC10;BAK1;EIF2B5;UBQLN1;ATF4;CCDC47;HYOU1;QRICH1;ATF6;DNAJB12;VCP;BBC3;GORASP2;HERPUD1;UFL1;TRIB3;CHAC1;GSK3B;MBTPS2;MAP3K5;TMEM33
gsea,mRNA modification (GO:0016556),-0.47702038280988346,-1.4189657433526812,0.09861932938856016,0.09755168699475344,1.0,11/18,37.11%,TRMT6;DKC1;VIRMA;NSUN2;METTL14;METTL16;CMTR1;PUS1;ZC3H13;TRUB1;METTL3
gsea,regulation of cellular amide metabolic process (GO:0034248),-0.43108649585351716,-1.4186207247145144,0.08932038834951456,0.09763842588143092,1.0,13/24,43.19%,PGAM1;TCOF1;NOLC1;EIF4E;ROCK1;PUM3;GEMIN5;EIF2B4;TIGAR;PICALM;METAP1;CYFIP1;MAPKAPK5
gsea,phospholipid metabolic process (GO:0006644),-0.4081098095285913,-1.4169968386192,0.05510204081632653,0.09840631250820421,1.0,14/29,38.19%,PGP;FDFT1;AGPAT5;PLAA;PCYT2;GDE1;MBOAT1;PDXP;SMPD1;FADS1;AGPAT4;GNPAT;LPCAT1;AGPAT1
gsea,cellular response to reactive oxygen species (GO:0034614),-0.3859629229377497,-1.4152584791002274,0.0496031746031746,0.09922481565194596,1.0,12/36,27.32%,ECT2;FXN;PARK7;AKT1;PPIF;SETX;NET1;PRDX3;TPM1;HDAC6;ERCC6L2;CAMKK2
gsea,response to retinoic acid (GO:0032526),-0.4220421174656279,-1.4146607612503508,0.08091286307053942,0.09943559635148806,1.0,6/24,24.89%,CDKN2D;ASXL1;HTRA2;SETX;CREB1;TESC
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.377283727387185,-1.4135450983060025,0.050955414012738856,0.09996831048287588,1.0,15/39,43.56%,UBB;PIN1;STUB1;STRAP;PDPK1;ADAM17;HSPA1A;PRDM16;TRIM33;MTMR4;SNX25;SPRED1;ACVR1;SIRT1;SKIL
gsea,regulation of cell motility (GO:2000145),-0.35648799685796406,-1.4131842726573627,0.04554455445544554,0.10007522834051849,1.0,14/54,28.94%,KIF14;PIN1;RCC2;AKT1;MEMO1;SERPINE2;ROCK2;ROCK1;DIAPH1;KIF2A;FLNA;SLK;CDK6;LMNA
gsea,regulation of defense response to virus by host (GO:0050691),-0.47444944282846546,-1.4114641601415236,0.10848126232741617,0.10094747614007729,1.0,5/16,18.76%,HSP90AA1;DHX9;CGAS;SIN3A;TARBP2
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.4948974680032989,-1.41062983355601,0.08032128514056225,0.10121281696319001,1.0,8/15,32.32%,PARK7;CALR;UFSP2;SAFB2;HDAC6;AXIN1;CARM1;UFL1
gsea,secondary alcohol metabolic process (GO:1902652),-0.4670227499624695,-1.408558119079847,0.08113590263691683,0.10228982736528607,1.0,8/18,34.71%,IDH3A;FDX1;SQLE;CLN6;NSDHL;SOAT1;SCAP;GBA2
gsea,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4815122186842623,1.4084076453923888,0.10150375939849623,0.25862151944943573,1.0,11/19,24.45%,TNFAIP3;GRAMD4;F2RL1;MFHAS1;CD300A;PTPRS;RAB7B;CD300LF;IRAK3;CD14;LYN
gsea,negative regulation of cytokine production (GO:0001818),0.3406650379408769,1.4066492114827234,0.040293040293040296,0.25849683122234796,1.0,59/89,32.81%,CCR7;XCL1;TNFAIP3;VSIR;CD200;CD274;PDCD4;PDCD1LG2;ZC3H12A;TMSB4X;RARA;ZFP36;TYROBP;SLAMF1;IKBKE;F2RL1;PRNP;ISG15;SIGIRR;KLF4;TRIM25;DHX58;ANXA1;PTGER4;SYT11;ZFPM1;TNF;AXL;SIRPA;LEF1;CD33;CEACAM1;FCGR2B;TWSG1;ANXA4;THBS1;PIBF1;FN1;FOXP3;CIDEA;IRAK3;IL23A;MEFV;INHBA;LGALS7;CX3CL1;DDX58;HDAC9;MAVS;TNFRSF21;DDIT3;SELENOS;IL10;GPNMB;ACOD1;TRIB2;CD200R1;ARRB1;GHSR
gsea,positive regulation of endothelial cell migration (GO:0010595),-0.3697435370705656,-1.406367733765589,0.04329004329004329,0.10337337829430848,1.0,9/47,28.23%,HMGB1;AKT1;SP1;MAP2K3;CALR;ROCK2;PDPK1;PIK3CG;ADAM17
gsea,carboxylic acid transport (GO:0046942),-0.43175732514215703,-1.4057402309067757,0.0673076923076923,0.10358501734672725,1.0,4/26,20.47%,SLC25A10;SLC7A5;SLC16A3;SLC7A1
gsea,neuron differentiation (GO:0030182),-0.3610651520338804,-1.4056981257471592,0.05241090146750524,0.10349774344212473,1.0,21/54,45.33%,PIN1;MANF;TDP2;ID2;CASP3;MYEF2;THOC2;RUNX3;PBX2;DDIT4;RYK;SRF;ERCC3;MEF2C;FZD4;PBX3;PBX4;ADNP2;EPOP;WNT4;ERCC2
gsea,apoptotic mitochondrial changes (GO:0008637),-0.4418782976122605,-1.4054872555865396,0.07630522088353414,0.10350884319881486,1.0,13/21,38.22%,HSPD1;TIMM50;BAX;VPS35;BAK1;CCAR2;NDUFS1;BBC3;SOD2;THEM4;BIK;GGCT;HK2
gsea,regulation of neuron apoptotic process (GO:0043523),-0.3713673386890918,-1.4037864541827765,0.06557377049180328,0.10438649206759834,1.0,14/43,41.20%,SET;KIF14;BAX;PARK7;NAE1;MT3;MSH2;SIGMAR1;ATF4;SOD2;BHLHB9;CCL3;MEF2C;PRKCI
gsea,epithelial cell migration (GO:0010631),-0.4563984382251819,-1.4036044589746812,0.07758620689655173,0.10435026803787158,1.0,5/19,23.38%,ANLN;LPXN;ROCK1;GIPC1;PTP4A3
gsea,regulation of interferon-gamma production (GO:0032649),0.37934016450684627,1.401835214565474,0.07370517928286853,0.262931222366299,1.0,30/46,25.54%,CCR7;SLAMF6;XCL1;VSIR;CRTAM;CD274;PDE4B;PDCD1LG2;ZC3H12A;RARA;CCR2;CD226;F2RL1;PRNP;ISG15;TXK;IL1B;IL12RB2;ZFPM1;IL18R1;AXL;SIRPA;EBI3;TLR7;FOXP3;IL23A;INHBA;LGALS7;CD14;DDIT3
gsea,regulation of GTPase activity (GO:0043087),-0.31429331455855036,-1.4000554097505715,0.02584493041749503,0.1062889286079879,1.0,32/104,40.37%,EZH2;ECT2;ARHGAP11A;PIN1;RCC2;TMED2;HRAS;RGS16;RDX;TBC1D10B;RRP1B;ADAP1;SRGAP2;TBC1D7;SH3BP1;ARL2;NET1;DOCK11;SIPA1L1;PKP4;DOCK8;RAP1GDS1;GSK3B;RASGRP2;PICALM;SNX9;CCL3;RAB3GAP1;AFDN;SGSM3;RSU1;CHN2
gsea,negative regulation of B cell activation (GO:0050869),0.5045305013133142,1.3982574837338761,0.11754068716094032,0.2655374472295587,1.0,12/15,27.66%,TNFAIP3;PARP3;TYROBP;CTLA4;TNFRSF13B;CD300A;FCGR2B;BANK1;INHBA;LYN;TNFRSF21;IL10
gsea,innate immune response (GO:0045087),-0.3277856035325646,-1.3966441610234404,0.05485232067510549,0.10820728213848158,1.0,26/107,41.46%,HMGB1;SHMT2;TRIM28;SERINC3;PHB2;TRIM59;CORO1A;SKP2;SRPK1;CAPZA2;PHB;PPP1R14B;CLPB;ATAD3A;PIK3CG;DDX3X;SETD2;ANKHD1;SMPD1;TTC4;TRIM35;CHUK;TKFC;LTF;ANKRD17;PML
gsea,positive regulation of interleukin-12 production (GO:0032735),-0.47790732153569415,-1.394610826229082,0.09430255402750491,0.10931900528073427,1.0,3/17,24.69%,HMGB1;HSPD1;IFNG
gsea,regulation of interleukin-12 production (GO:0032655),-0.4318024687844012,-1.393877847652333,0.08298755186721991,0.10958068116780657,1.0,5/26,24.69%,HMGB1;HSPD1;C1QBP;MAST2;IFNG
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.35611928230922496,-1.3935892978508357,0.06187624750499002,0.109615061572805,1.0,18/46,43.56%,UBB;PIN1;STUB1;HSP90AB1;STRAP;GIPC1;PDPK1;ADAM17;MEN1;HSPA1A;PRDM16;TRIM33;MTMR4;SNX25;SPRED1;CREBBP;SIRT1;SKIL
gsea,protein targeting to membrane (GO:0006612),-0.3917049414238113,-1.392798668354039,0.06485355648535565,0.10994306159075765,1.0,14/31,42.80%,ARL6IP1;SSR2;ZDHHC2;ZDHHC6;ZDHHC12;SIL1;SLC25A17;PEX3;ZDHHC15;TAOK2;ICMT;ZDHHC21;PRKCI;VPS37C
gsea,regulation of smoothened signaling pathway (GO:0008589),-0.4409500403034138,-1.3891984757972582,0.08210526315789474,0.11207297626331027,1.0,9/21,43.61%,UCHL5;TEDC1;TEDC2;TUBD1;VCP;PDCL;BTRC;CREBBP;RACK1
gsea,positive regulation of cell migration (GO:0030335),-0.30294503878647294,-1.3883045203840902,0.02412280701754386,0.11250698667184066,1.0,32/134,37.86%,FBXO5;KIF20B;GTSE1;ACTN4;PFN1;ACTG1;C1QBP;ARHGEF39;CCAR1;MAZ;HRAS;RDX;ELP5;ROCK2;CLASP2;SUN2;PRKCE;CLASP1;MTOR;PLAA;IFNG;HDAC6;ELP6;ADAM17;SYNE2;SEMA4A;SOD2;RUFY3;GRB7;CARMIL2;AGO2;CCL3
gsea,positive regulation of immunoglobulin production (GO:0002639),-0.46114188338012574,-1.3856909853523254,0.10204081632653061,0.11396457040129807,1.0,6/18,22.64%,TFRC;PHB2;RIF1;PAXIP1;PHB;KMT5C
gsea,negative regulation of interferon-gamma production (GO:0032689),-0.45679227365606045,-1.3845556298421096,0.08050847457627118,0.11446775764090855,1.0,2/19,7.38%,HMGB1;C1QBP
gsea,regulation of cilium assembly (GO:1902017),-0.3945085452362726,-1.3842311731459251,0.06589147286821706,0.11454051634459583,1.0,17/29,46.71%,CCP110;TBC1D10B;ODF2L;TBC1D7;IFT140;TCHP;TBC1D5;CEP120;HTT;KCTD17;CEP97;SGSM3;IFT88;SDCCAG8;CCDC88A;ARHGAP35;YAP1
gsea,protein localization to membrane (GO:0072657),-0.3164141809303501,-1.383989262727608,0.029013539651837523,0.11456390290965443,1.0,26/90,33.31%,NDC1;PDZD11;NUP155;TMED2;EZR;ZDHHC2;RDX;NUP54;MYO5A;BSG;ROCK2;CLASP2;SYNE3;FLOT2;ROCK1;FGF13;EHD4;FLNA;C2CD5;TESC;AP3D1;SPTBN1;SCRIB;HGS;ZDHHC15;GAK
gsea,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.4412587692885951,-1.3830537508406358,0.07991803278688525,0.1150103477829717,1.0,8/21,45.10%,NUP62;AKT1;CNOT9;ADAM17;HIP1R;CBL;CCDC88A;BTC
gsea,cellular response to decreased oxygen levels (GO:0036294),-0.3622516366435175,-1.3805159396893516,0.07196969696969698,0.11638878879873635,1.0,19/45,39.05%,SUV39H1;STUB1;SUV39H2;PGK1;P4HB;HP1BP3;MT3;EGLN1;MDM2;MTOR;UBQLN1;MDM4;HYOU1;LMNA;TBL2;EPAS1;TIGAR;NDRG1;FAM162A
gsea,regulation of defense response (GO:0031347),0.3591459587174481,1.3797753834413655,0.06976744186046512,0.29146394505262024,1.0,25/46,31.60%,XCL1;JAK2;BCL6;SAMHD1;TMSB4X;AREL1;CCR2;SEMA7A;FOXP1;DHX58;IRF1;ANXA1;CASP4;ZBP1;PTGS2;USP18;HCK;FCGR2B;BST1;SPATA2;GRN;APOE;PIK3AP1;SBNO2;CASP12
gsea,positive regulation of interferon-gamma production (GO:0032729),0.4199989817061804,1.379371686799316,0.09016393442622951,0.2890338754135354,1.0,16/26,23.60%,SLAMF6;CRTAM;PDE4B;CCR2;CD226;F2RL1;ISG15;TXK;IL1B;IL12RB2;ZFPM1;IL18R1;EBI3;TLR7;IL23A;CD14
gsea,RNA phosphodiester bond hydrolysis (GO:0090501),-0.4472221779482782,-1.3789561944955073,0.11156186612576065,0.1172421729471175,1.0,9/19,34.37%,RPP30;NHP2;TOE1;CPSF3;RNASEH1;PARN;XRN1;CSTF3;POP1
gsea,visual perception (GO:0007601),-0.4031277108125397,-1.3769657080588058,0.0815450643776824,0.1184051651053398,1.0,11/28,37.43%,OAT;RGS16;OPA3;CRYBG3;RABGGTB;ATF6;RP2;EYA3;CRYZ;MYO9A;OPA1
gsea,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.47126972632966313,-1.374487916435143,0.12317327766179541,0.11981032662758197,1.0,8/16,34.89%,CANX;IFI30;PDIA3;CALR;ERAP1;SEC24D;TAP2;IDE
gsea,negative regulation of epithelial cell apoptotic process (GO:1904036),0.46502316358952817,1.3729981244092768,0.10150375939849623,0.2957822571128621,1.0,9/17,28.89%,TNFAIP3;ICAM1;SERPINE1;NFE2L2;NDNF;NUPR1;TNIP2;IL10;TCF7L2
gsea,ribosomal large subunit assembly (GO:0000027),-0.4916569130304344,-1.3729563221218124,0.13813229571984437,0.12066939574741396,1.0,12/17,38.91%,MRPL20;BRIX1;RPL23A;RPF2;BOP1;NLE1;RPL5;RSL24D1;RRS1;DHX30;NOP2;MDN1
gsea,regulation of epidermal cell differentiation (GO:0045604),0.4696888972429331,1.3717344033852448,0.11422845691382766,0.29475551992842247,1.0,9/16,29.05%,ZFP36L1;CTSL;ZFP36;AQP3;SULT2B1;KLF7;KDF1;ERRFI1;RUNX1
gsea,clathrin-dependent endocytosis (GO:0072583),-0.45524212721177004,-1.3706728918629294,0.0945179584120983,0.12205680836917787,1.0,7/15,38.59%,CLTB;CANX;CLTC;GAK;PICALM;AP2B1;AP2A2
gsea,positive regulation of actin filament polymerization (GO:0030838),0.41747959139294877,1.370258778364061,0.09125475285171103,0.2940454333152807,1.0,8/23,18.68%,CCR7;EVL;GSN;FCHSD2;CDC42EP3;PFN2;HCK;SCIN
gsea,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.41951792532771903,1.3691202339835558,0.10097087378640776,0.2929493218960368,1.0,11/24,17.29%,LGALS3;TNFAIP3;FAS;ICAM1;SP100;BCL2L1;TMBIM1;SERPINE1;TNFSF10;PMAIP1;THBS1
gsea,regulation of insulin receptor signaling pathway (GO:0046626),-0.43252611932801754,-1.3684491290989467,0.10609037328094302,0.12345861741013643,1.0,11/20,48.91%,NUCKS1;SNX5;PTPN11;GKAP1;GRB7;PRKCB;TSC2;SIRT1;SOCS1;SIK2;PIP4K2B
gsea,response to growth factor (GO:0070848),-0.44414567740234434,-1.3653323003547333,0.10159362549800798,0.12533248582890297,1.0,6/18,25.60%,AKT1;HTRA2;SHC1;URI1;TBC1D7;HDAC6
gsea,cellular response to interferon-gamma (GO:0071346),0.3817734865766787,1.3651572628124768,0.0777988614800759,0.29632369283295107,1.0,37/57,30.25%,CCL5;XCL1;JAK2;IRF7;ICAM1;STAT1;SP100;IRF4;CAMK2D;GBP2;CD44;GBP6;CCL1;TRIM25;IRF1;IFNGR2;TRIM5;CCL4;SIRPA;IRF9;HCK;OAS3;IRF5;PTAFR;AIF1;VCAM1;TRIM21;CCL2;CX3CL1;DAPK1;TRIM8;TLR2;GBP4;CCL8;CCL7;ACOD1;IRF2
gsea,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4706949503330168,-1.3643069426181398,0.12804878048780488,0.1258914860247384,1.0,8/15,38.25%,HSP90AA1;HSP90AB1;UBQLN1;HSPA1B;HSPA1A;EPAS1;DCUN1D1;DAXX
gsea,regulation of interleukin-2 production (GO:0032663),0.4107525464266389,1.3641356924116892,0.10578842315369262,0.29500020985794356,1.0,17/27,31.34%,XCL1;TNFAIP3;PDE4B;ZFP36;IRF4;CCR2;CD86;PRNP;MALT1;ANXA1;IL1B;CARD11;CD4;FOXP3;CD80;RUNX1;PLCG2
gsea,negative regulation of cell differentiation (GO:0045596),-0.3115855544736155,-1.362295812239834,0.06198347107438017,0.12703970102007356,1.0,37/82,49.32%,ANP32B;SUZ12;HNRNPU;ID2;E2F1;SINHCAF;PTBP1;ASXL1;CALR;LEO1;ANKRD26;METTL14;RB1;IFNG;MYB;CDK6;MEN1;XDH;PTPN11;TRIB3;CDC73;CTR9;IQCB1;SPRED1;SIRT1;MED1;DAB2IP;EIF2AK4;YAP1;GATA3;TSKU;RIOX1;SOX8;NEPRO;USF3;PTCH1;PTK2B
gsea,steroid metabolic process (GO:0008202),-0.4487674862152744,-1.3608181394273062,0.10331384015594541,0.12787838542137192,1.0,10/19,44.10%,FDFT1;FDX1;MSMO1;PIAS4;HSD17B7;DHCR24;GBA2;LSS;FDXR;HSD17B10
gsea,synapse organization (GO:0050808),-0.37025560894984944,-1.3557412323369522,0.08955223880597014,0.13105105407966489,1.0,9/40,28.34%,PIN1;CHCHD10;NEDD4;DCTN1;PPFIA1;GPHN;DSCAM;RYK;UNC13A
gsea,calcium ion transmembrane transport (GO:0070588),-0.3897529271370219,-1.3556340504708058,0.07531380753138076,0.13097830685593845,1.0,15/33,41.96%,STOML2;PHB2;PMPCA;PHB;LETM1;ATP2A2;SPG7;PARL;PMPCB;YME1L1;SLC24A5;MCU;ANO6;TRPC1;AFG3L2
gsea,positive regulation of cellular component biogenesis (GO:0044089),-0.34014347041370707,-1.354925031361978,0.08187134502923976,0.13131895796528992,1.0,20/50,38.27%,PFN1;PIH1D1;TFRC;CDT1;BAX;FAF1;PARK7;SPIDR;SLF1;BAK1;PLEK;IFNG;SLX4;SLF2;VCP;SYNPO2;HGS;BIK;GSK3B;GNL3L
gsea,non-motile cilium assembly (GO:1905515),-0.4291441037951031,-1.3532530253356883,0.1277445109780439,0.13235146853166563,1.0,12/19,43.71%,TMEM107;CEP89;DCTN1;PCM1;C2CD3;CEP290;RPGRIP1L;ARL13B;IFT88;IFT57;CEP250;GORAB
gsea,axon guidance (GO:0007411),0.33106595711935904,1.3480606690425052,0.0821917808219178,0.3178618315756683,1.0,33/68,37.64%,EMB;EVL;PRKCA;PIK3R1;IRS2;SEMA4C;NRP1;PLXNC1;SEMA7A;SCN1B;PLCG1;GRB10;SEMA6D;DAG1;CXCR4;LAMC2;KLF7;SEMA4B;RET;ALCAM;PLXNB2;GFRA2;L1CAM;PIK3CD;EFNB2;NRP2;FEZ1;UNC5A;USP33;LGR6;PALLD;PTPRM;PLXNA1
gsea,glycosaminoglycan biosynthetic process (GO:0006024),0.3790156536118151,1.3474893309674212,0.1067193675889328,0.3158211100966144,1.0,15/34,21.85%,CHST2;ST3GAL1;CHST15;SDC4;IL1B;DSEL;UST;HS6ST1;SDC1;ABCC5;DSE;CHPF2;GCNT2;CHSY1;HEXA
gsea,cortical cytoskeleton organization (GO:0030865),-0.43418586181309626,-1.3474436353655954,0.12240663900414937,0.13613361351623943,1.0,6/20,22.38%,EZR;LCP1;ROCK2;FMNL3;ROCK1;PLEK
gsea,cellular response to virus (GO:0098586),-0.43954086464128406,-1.3462989801899088,0.12448132780082988,0.13673990533541105,1.0,5/19,18.20%,HSP90AA1;EIF5A;BAX;FMR1;RRP1B
gsea,BMP signaling pathway (GO:0030509),0.4254719493391593,1.344070796070895,0.11992263056092843,0.3184679388831979,1.0,13/21,26.27%,PDCD4;ENG;SMAD7;TGFBR3;SMAD3;HFE;BMP7;ACVRL1;RUNX2;SMAD5;RGMB;TGFB2;TGFB3
gsea,cellular response to growth factor stimulus (GO:0071363),0.3318100274898813,1.3426605371979956,0.08761904761904762,0.31770560261964553,1.0,35/73,35.59%,EEF1A1;CCL5;XCL1;ZFP36L1;NTRK3;OVOL2;ZFP36;NRP1;NR3C1;CD44;SMAD7;PLCG1;KLF4;ANXA1;CPNE3;FLT1;PDGFB;SMAD3;NDNF;SPRY2;CLEC3B;EGR3;BMP7;DLL4;ACVRL1;RUNX2;KIDINS220;CCL2;WNT10A;DUSP3;RAPGEF1;CTNNB1;VSTM2A;LGMN;RAPGEF2
gsea,activation of GTPase activity (GO:0090630),-0.34789392368379435,-1.3391539542336717,0.0755939524838013,0.1417504355633411,1.0,12/50,41.38%,ECT2;RANGAP1;ADPRH;CORO1C;TBC1D10B;TBC1D7;SIPA1L1;SCRIB;TBCK;TBC1D5;SGSM3;BCR
gsea,regulation of actin filament-based process (GO:0032970),-0.3655445376084713,-1.3385625005062998,0.10154525386313466,0.14206046048765572,1.0,17/36,46.99%,IQGAP3;CORO1A;EZR;IQGAP2;ROCK2;ROCK1;MTOR;SH3BP1;TAOK2;MLST8;HIP1R;RHOF;RHOQ;CCDC88A;BAIAP2;ARHGAP35;RHOB
gsea,cellular response to BMP stimulus (GO:0071773),0.4206609756295947,1.3382901128634457,0.11877394636015326,0.3220745848719584,1.0,13/22,26.27%,PDCD4;ENG;SMAD7;TGFBR3;SMAD3;HFE;BMP7;ACVRL1;RUNX2;SMAD5;RGMB;TGFB2;TGFB3
gsea,response to interferon-gamma (GO:0034341),0.39854532758907313,1.3375588902924311,0.11654135338345864,0.3203416880670668,1.0,28/46,30.22%,GCH1;CCL5;XCL1;STAT1;SP100;IFITM2;IFITM1;GBP2;GBP6;CCL1;CCL4;SHFL;IFITM3;SIRPA;CD40;AIF1;TRIM21;KYNU;MEFV;CCL2;CX3CL1;DAPK1;TLR2;GBP4;CCL8;CCL7;CXCL16;ACOD1
gsea,regulation of keratinocyte differentiation (GO:0045616),-0.4549182252309715,-1.3373117761118358,0.11823647294589178,0.1428594162582446,1.0,6/16,22.47%,NME2;NUMA1;SRSF6;ROCK2;ROCK1;ETV4
gsea,lysosome organization (GO:0007040),-0.42302981395813233,-1.336538972166277,0.1120162932790224,0.1432774106304483,1.0,6/21,26.84%,CORO1A;ARSB;MTOR;GNPTAB;CLN6;HOOK1
gsea,JNK cascade (GO:0007254),-0.43109497981275413,-1.3347934153119476,0.13163064833005894,0.14446075530607366,1.0,3/18,13.94%,UBB;UBE2N;GPS1
gsea,positive regulation of lipid biosynthetic process (GO:0046889),-0.456263565142372,-1.334069872936279,0.12224448897795591,0.14487271259776155,1.0,7/15,38.62%,AKT1;MID1IP1;CREB1;MTOR;LDLR;LPGAT1;SCARB1
gsea,positive regulation of protein localization to membrane (GO:1905477),-0.33447585496047344,-1.330191134943942,0.08958333333333333,0.14755023879028956,1.0,17/47,34.06%,TFDP1;YWHAE;GZMB;E2F1;AKT1;HRAS;TFDP2;NMT1;KIF5B;PRKCE;PDPK1;C2CD5;IFNG;SPTBN1;BBC3;PLS1;CNPY4
gsea,protein secretion (GO:0009306),-0.42060613598005697,-1.3296904244410312,0.11377245508982035,0.1477649275700453,1.0,5/21,21.42%,PARK7;CANX;PDIA4;MIA2;COPG1
gsea,phospholipid transport (GO:0015914),-0.39828815847553123,-1.3291753618816822,0.11020408163265306,0.1479552613755889,1.0,10/25,39.37%,PRELID3B;PRELID1;PITPNB;ATP8B4;LDLR;ATP11C;CPTP;ATP10A;SCARB1;PRELID2
gsea,purine ribonucleotide biosynthetic process (GO:0009152),-0.45489723708357954,-1.328718117703495,0.12375249500998003,0.14810938281713498,1.0,6/15,29.20%,IMPDH2;ADSL;GMPS;GUCY1B1;DCAKD;PANK4
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.37142937235904383,-1.3279714027433176,0.11222444889779559,0.14848629938945607,1.0,13/33,38.92%,METAP2;RGS2;RGS16;PHB;ROCK2;NMT1;ROCK1;PLEK;FNTB;NMT2;RGS12;METAP1;RPGRIP1L
gsea,positive regulation of T cell proliferation (GO:0042102),-0.3843100723005831,-1.3272545632596462,0.13163064833005894,0.1488964415742856,1.0,4/30,20.47%,HMGB1;TFRC;FADD;SLC7A1
gsea,transport across blood-brain barrier (GO:0150104),-0.35903894823031435,-1.3264942951091538,0.08761904761904762,0.14927681773234255,1.0,13/42,39.52%,FABP5;SLC29A1;TFRC;SLC7A5;SLC7A1;SLC2A1;SLC4A8;SLC19A1;SLC7A3;SLC38A1;SLC1A4;SLC12A2;SLC6A9
gsea,negative regulation of BMP signaling pathway (GO:0030514),0.4509367277025489,1.3261073462550614,0.1252371916508539,0.3365945691044785,1.0,10/16,30.74%,CRIM1;SMAD7;HTRA3;WNT1;HIPK2;SMAD5;RBPMS2;SKI;PPARG;BAMBI
gsea,protein acylation (GO:0043543),-0.4027144068127064,-1.3232117916469706,0.11960784313725491,0.15172770709802863,1.0,14/24,43.49%,ZDHHC2;NAA10;ZDHHC16;ZDHHC6;ING5;ZDHHC12;NAT10;ZDHHC15;KAT2A;ZDHHC13;ZDHHC21;KAT6A;CREBBP;KAT2B
gsea,fat cell differentiation (GO:0045444),0.3995911442200819,1.3216875138642505,0.12754158964879853,0.341096536951831,1.0,13/27,31.68%,NR4A3;NR4A2;SDF4;FOXO1;KLF4;EGR2;PID1;TMEM120B;MAFB;ATF5;PPARG;TCF7L2;EP300
gsea,fatty acid biosynthetic process (GO:0006633),-0.3942759285429635,-1.3209268435924104,0.1101871101871102,0.15323041559938805,1.0,8/26,36.85%,NDUFAB1;HACD2;LIAS;ACACA;ACLY;FADS1;MCAT;HACD3
gsea,protein localization to cell periphery (GO:1990778),-0.3207744786534288,-1.3151959064908436,0.08893280632411067,0.157527067460868,1.0,17/64,27.26%,PDZD11;TMED2;EZR;ZDHHC2;RDX;MYO5A;BSG;ROCK2;CLASP2;FLOT2;ROCK1;FGF13;EHD4;FLNA;C2CD5;TESC;SPTBN1
gsea,receptor-mediated endocytosis (GO:0006898),-0.3321742769105548,-1.3150973925342122,0.09745762711864407,0.15743635397563688,1.0,26/68,38.62%,HSP90AA1;HSP90B1;TFRC;CLTB;CANX;NEDD4;CALR;M6PR;CLTC;HSPH1;AP1G2;RABEPK;LDLR;HYOU1;GRK2;PDLIM7;EPS15;GAK;AP1G1;PICALM;SNX9;AP2B1;AP4E1;HIP1R;AP2A2;SCARB1
gsea,macroautophagy (GO:0016236),-0.3429950967297849,-1.3149307170985627,0.09823182711198428,0.15739824163968627,1.0,27/44,48.91%,DYNLL2;TOMM40;VDAC1;VPS16;CSNK2A2;TOMM20;MTMR14;PLAA;EI24;VAMP8;UBQLN1;TCIRG1;VCP;HGS;STAM2;PRKAA1;PRKAG2;TBC1D5;VPS33A;ATG7;VPS37C;VAMP7;TOMM5;MFN1;STAM;MFN2;PIP4K2B
gsea,regulation of T cell differentiation (GO:0045580),0.40563163707765626,1.3145672810073323,0.14428857715430862,0.350353412468813,1.0,11/23,29.05%,TCF7;CRTAM;TNFRSF18;ZBTB1;CCR2;CTLA4;IL2RA;FOXP3;IL2;XBP1;RUNX1
gsea,cellular response to hormone stimulus (GO:0032870),0.3592234981268348,1.3132197917415651,0.11313131313131314,0.3495461583181798,1.0,20/39,34.71%,CTSS;ZFP36L1;NR4A3;RARA;AR;CTSL;NR3C1;RAMP3;RAMP1;ARID5A;CTSH;KLF9;MGARP;NCOA4;GAS2L1;SOCS2;XBP1;ATP1A2;ADRA2A;LMO2
gsea,cellular response to cytokine stimulus (GO:0071345),-0.2827697894814984,-1.3124058046344236,0.05785123966942149,0.15922130168635246,1.0,61/236,47.17%,BIRC5;HSP90AA1;UBB;BRCA1;HNRNPU;HSP90B1;CDKN1A;PLP2;GAPDH;STK39;DHX9;HSPA8;SHMT1;YBX3;CDC34;SYNCRIP;CASP3;KHSRP;AKT1;PHB;PTPN6;RBMX;TXLNA;IRF8;VIM;GBP3;CACTIN;HAX1;HTRA2;SHC1;PTPN7;POU2F1;BAG4;USP10;LRP8;OXSR1;GSDME;GBP7;PNPT1;PTPN11;SMPD4;PTPN12;GBP5;DOCK8;GSK3B;CHUK;CCL3;SLC12A2;PIK3CB;PTPN9;STAT3;CBL;SIRT1;HYAL2;IL12RB1;RELA;DAB2IP;ARHGEF2;INPPL1;SOCS1;GATA3
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.40250194358702984,1.311660181316599,0.1396761133603239,0.3494104382425209,1.0,10/23,27.20%,ITPKB;CISH;PIK3R1;SOCS5;PIK3R2;SOCS3;SOCS2;TTC7B;SOCS6;PIK3CD
gsea,regulation of interleukin-6 production (GO:0032675),-0.33695594412036467,-1.3087033062745619,0.10699588477366255,0.16197851007026368,1.0,16/58,52.92%,HMGB1;HSPD1;DHX9;PTPN6;IFNG;MAPKAPK2;PTPN11;TNFSF4;STAT3;HYAL2;NLRC3;IL33;ARHGEF2;SPHK2;IFIH1;GAS6
gsea,positive regulation of Ras protein signal transduction (GO:0046579),0.3804786894985875,1.3082365799964655,0.14313346228239845,0.35216171263262147,1.0,19/32,32.68%,JAK2;IRS2;ARHGEF3;GPR18;RASGEF1A;ADGRG1;MAP4K4;F2RL1;F2RL2;F2R;GPR55;ERBIN;EPOR;LYN;RAPGEF1;RASGRP1;GPR174;ARRB1;GPR65
gsea,positive regulation of GTPase activity (GO:0043547),-0.29350730340030873,-1.3080919151866834,0.04791666666666667,0.16235198826126004,1.0,32/110,41.38%,EZH2;ECT2;ARHGAP11A;RANGAP1;PIN1;ADPRH;CORO1C;HRAS;RGS16;TBC1D10B;SRGAP2;TBC1D7;SH3BP1;NET1;DOCK11;SIPA1L1;SCRIB;PKP4;TBCK;DOCK8;RAP1GDS1;GSK3B;RASGRP2;PICALM;SNX9;TBC1D5;CCL3;RAB3GAP1;AFDN;SGSM3;RSU1;BCR
gsea,response to interleukin-1 (GO:0070555),0.39037526854835175,1.307879849383103,0.13931297709923665,0.34976319222333313,1.0,22/39,30.22%,CCL5;XCL1;NFKB1;PRKCA;ZC3H12A;HIF1A;GBP2;CCL1;ANXA1;IL1B;CCL4;SIRPA;CD40;APP;HDAC4;IRAK3;CCL2;CX3CL1;CCL8;CCL7;MAPK13;ACOD1
gsea,regulation of mitochondrion organization (GO:0010821),-0.40048080033053624,-1.30404976926034,0.13663366336633664,0.16562870352010445,1.0,9/24,25.60%,VDAC1;VPS35;HAX1;HTRA2;SREBF2;CSNK2A2;PARL;RHOT2;HDAC6
gsea,endosome organization (GO:0007032),-0.3904107447348322,-1.302137441914129,0.14092664092664092,0.1669023185854918,1.0,10/24,44.39%,CORO1C;PI4K2B;RAB27A;EEA1;HOOK1;USP8;SNX10;TMEM9;WASHC5;HOOK3
gsea,hemopoiesis (GO:0030097),-0.33976966208882486,-1.2997047396880956,0.10344827586206896,0.1688267564267586,1.0,10/46,28.85%,MELK;ASH2L;GLRX5;PLEK;PRDX3;ATF4;RUNX3;PRRC2C;ARMC6;TOX
gsea,negative regulation of immune response (GO:0050777),0.3411851735422076,1.297212755051343,0.10727272727272727,0.3652191655371693,1.0,37/58,32.83%,LGALS3;TNFAIP3;FURIN;PTGER2;PLK2;CCR2;RAMP3;RAMP1;PLCG1;DHX58;SPI1;PTGER4;CALCB;CALCA;CD300A;ADORA2A;ADRB2;HCK;ADM;FCGR2B;TRIM21;GLP1R;FOXP3;SYK;CYSLTR2;CYSLTR1;IRAK3;CALCRL;LYN;IL10;ADCY6;RLN3;ACOD1;PLCG2;SCT;ADORA2B;HTR7
gsea,lymphocyte proliferation (GO:0046651),-0.4345957928157095,-1.2946821000322497,0.13592233009708737,0.17272405579124325,1.0,4/16,23.64%,HELLS;HSPD1;PPP3CB;PIK3CG
gsea,icosanoid metabolic process (GO:0006690),0.44480696304272005,1.2927548680814898,0.15173674588665448,0.3703356216394656,1.0,7/16,29.03%,EPHX1;PNPLA8;ALOX5AP;PTGS2;GPX1;ABCC1;PLA2G4A
gsea,positive regulation of axonogenesis (GO:0050772),-0.4317328519897259,-1.2877649566832514,0.14785992217898833,0.1782359567008602,1.0,4/16,34.38%,ARHGDIA;METRN;RUFY3;GOLGA4
gsea,positive regulation of B cell proliferation (GO:0030890),0.4074344270907276,1.2846563328383236,0.16024340770791076,0.3815544283277098,1.0,12/20,19.66%,BCL2;GPR183;IRS2;CD81;CLCF1;CD38;VAV3;TNFRSF13C;TNFSF13B;CD40;BST1;IL2
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.32726187906080245,1.2831203853919702,0.13108614232209737,0.38103521990489947,1.0,30/49,36.12%,CCL5;NTRK3;JAK2;PIK3R1;IRS2;PIK3IP1;F2RL1;KIT;NCF1;DIPK2A;FLT1;PDGFB;TNF;SELP;CEACAM1;F2R;FN1;FGF2;IER3;PDGFA;EPOR;LYN;PTPN13;TGFB2;PIK3CD;PIK3AP1;TWIST1;IGF1;OSM;PIK3R5
gsea,glucose homeostasis (GO:0042593),-0.3691015765166614,-1.2831177331747827,0.1413934426229508,0.18202646527947294,1.0,10/29,43.05%,NUCKS1;PARK7;RPS6;FOXK2;HK1;PRKAA1;MCU;HK2;STAT3;SIRT1
gsea,regulation of focal adhesion assembly (GO:0051893),-0.3649093571861647,-1.281471311657845,0.142570281124498,0.183219362649908,1.0,9/32,32.25%,ACTG1;RCC2;CORO1C;ROCK2;CLASP2;ROCK1;CLASP1;SLK;DUSP22
gsea,positive regulation of cytokine production involved in immune response (GO:0002720),0.45255012288108176,1.2811997816006995,0.1693548387096774,0.3812089010480246,1.0,7/15,16.92%,XCL1;CD160;CD226;F2RL1;MALT1;KIT;SCIMP
gsea,cellular response to amino acid starvation (GO:0034198),0.34539881340278783,1.278759412223363,0.13295880149812733,0.3824470276635071,1.0,35/35,94.84%,DAPL1;SESN3;DAP;FAS;CASTOR1;IMPACT;SESN1;RNF152;SLC38A9;EIF2AK2;RPTOR;RRAGB;ATP6V0E2;WDR24;ATP6V1G3;SESN2;MIOS;ATF2;MAPK8;EIF2AK4;EIF2AK3;NPRL3;TFEB;MAP3K5;ITFG2;MLST8;DEPDC5;TCIRG1;ATF4;GCN1;MTOR;CEBPB;SEH1L;EIF2S1;CDKN1A
gsea,ERBB signaling pathway (GO:0038127),-0.3618642364883554,-1.2780933474962,0.1446028513238289,0.18592049798056365,1.0,12/34,36.68%,HSP90AA1;STUB1;AKT1;SHC1;RPS6KA5;PDPK1;KIF16B;ADAM17;PTPN11;PTPN12;GRB7;CUL5
gsea,nervous system development (GO:0007399),-0.2745804299611072,-1.2746401169010515,0.07042253521126761,0.18875455009804543,1.0,55/137,44.89%,ECT2;STIL;ACTL6A;WDR62;LRCH4;CDK5RAP2;PRPS1;PPP2R5D;IGSF8;NAB1;HMGCR;DCTN1;UTP11;CHERP;THOC6;SREBF2;NRGN;SPG7;SDHA;FGF13;GMFB;SLC2A1;DSCAM;RYK;MTR;ANKLE2;SMPD1;BPNT1;WWP1;DPYSL2;DYRK1A;GBA2;ROGDI;CHAC1;DHX30;FARP1;BTBD6;NAB2;AHI1;IGF2BP3;ARNT2;TRAK1;MEF2C;GSS;ELP3;RPS6KA6;APAF1;DVL1;ATN1;STAT3;RAPGEF5;ATXN3;BTD;CHD7;ATXN1
gsea,regulation of axonogenesis (GO:0050770),-0.4403753494268122,-1.2719857414192368,0.16634050880626222,0.1908956028626976,1.0,5/15,36.38%,ARHGDIA;METRN;SIPA1L1;RUFY3;GSK3B
gsea,calcium ion homeostasis (GO:0055074),0.36106822166826646,1.269930512194836,0.12939001848428835,0.39564392082668964,1.0,20/38,32.87%,TPT1;CCL5;ATP2A3;ATP2B2;CCR2;CCL1;STIM2;ATP1B1;CIB2;SLC30A1;ATP13A2;CALCB;FAM20A;CD40;TMTC2;CCR1;SLC8A1;CCL8;CCL7;SELENON
gsea,determination of heart left/right asymmetry (GO:0061371),-0.4383750284128774,-1.2697970131059237,0.18480492813141683,0.19245334133932995,1.0,7/15,39.46%,STIL;SETDB2;TBX21;EOMES;SRF;AHI1;MEF2C
gsea,heart looping (GO:0001947),-0.4383750284128774,-1.2697970131059237,0.18480492813141683,0.19245334133932995,1.0,7/15,39.46%,STIL;SETDB2;TBX21;EOMES;SRF;AHI1;MEF2C
gsea,regulation of apoptotic signaling pathway (GO:2001233),-0.4078782152845233,-1.2685078612079428,0.1646090534979424,0.1934400816641131,1.0,6/18,29.00%,PPIA;MAZ;CSNK2A2;ING5;RB1;PTPMT1
gsea,protein K63-linked deubiquitination (GO:0070536),-0.4229795645954335,-1.2681611821666916,0.19881889763779528,0.19359273862396267,1.0,6/17,29.97%,SHMT2;PSMD14;BRCC3;ABRAXAS1;USP7;USP8
gsea,regulation of filopodium assembly (GO:0051489),0.4251648079468273,1.2671969428590726,0.16767676767676767,0.39737520521933484,1.0,9/18,31.25%,CCR7;RIPOR2;PIK3R1;NRP1;ARAP1;FSCN1;TGFB3;PALM;FNBP1L
gsea,positive regulation of catabolic process (GO:0009896),-0.3823310746371106,-1.2665101229928157,0.16033755274261605,0.19484003030307812,1.0,13/27,36.38%,FZR1;BARD1;DTL;NEDD4;DDB1;VCP;HUWE1;AXIN1;NSF;WWP1;IDE;HACE1;GSK3B
gsea,regulation of smooth muscle cell proliferation (GO:0048660),0.38845258208179784,1.2661606025337149,0.1534195933456562,0.3962369173182866,1.0,16/27,28.89%,CCL5;TNFAIP3;NR4A3;TRIB1;STAT1;FOXP1;CCN4;PDGFB;TNF;AIF1;THBS1;CX3CL1;RBPMS2;PPARG;CTNNB1;TCF7L2
gsea,cellular response to retinoic acid (GO:0071300),-0.4240794539411813,-1.264859672551947,0.16702819956616052,0.19620737420710552,1.0,4/17,24.89%,HTRA2;SETX;CREB1;TESC
gsea,regulation of viral entry into host cell (GO:0046596),0.42888382537597386,1.264850862899347,0.18147448015122875,0.3953379981314527,1.0,9/16,16.44%,GSN;IFITM2;IFITM1;TRIM25;TRIM5;IFITM3;TRIM14;CD4;TRIM21
gsea,positive regulation of metabolic process (GO:0009893),-0.31780686080803533,-1.2624063274800976,0.11555555555555555,0.19829040571692225,1.0,20/54,38.29%,FABP5;ACADL;GATM;CEBPB;PLAC8;PIGA;ALMS1;IFNG;DYNC1H1;HSF1;ACACA;ACLY;SIRT6;EHMT1;HADH;PRDM16;EPAS1;CPT2;AGPAT1;OMA1
gsea,actin filament organization (GO:0007015),-0.2978266178992497,-1.262078246350187,0.11428571428571428,0.1984175631303264,1.0,43/81,49.34%,TPM3;TPM4;CORO1C;GAS2L3;CORO1A;TRIOBP;LCP1;MYO5A;ALDOA;ELMO1;MPRIP;FLII;SH3BP1;FLNA;ZBED3;SVIL;TPM1;GAS2;ELMO2;RUFY3;CORO7;PLS1;CARMIL2;ERMN;DSTN;NEBL;MCU;HIP1R;MYO1G;BCAR1;RHOF;ABI2;ARHGEF2;BAIAP2;NEB;INPPL1;RHOB;SPIRE1;ENAH;FHOD1;PLS3;LMOD3;VIL1
gsea,regulation of angiogenesis (GO:0045765),0.30057716025716397,1.2610551475991723,0.11003861003861004,0.39942425148970584,1.0,55/95,38.05%,TNFAIP3;CD160;PRKCA;ITGAX;ITGB1;ZC3H12A;HIF1A;STAT1;GTF2I;SP100;NINJ1;ETS1;CCR2;ITGB8;PLCG1;KLF4;JUP;IL1B;SERPINE1;CTSH;FLT1;ECM1;CEACAM1;HHEX;CD40;SERPINF1;PIK3R6;TNFSF12;HIPK2;THBS1;SPRY2;CXCL13;FGF2;GRN;GLUL;TGFB2;AGO1;PIK3CD;STAB1;XBP1;CCR3;PPARG;CTNNB1;RUNX1;GPNMB;PGF;TWIST1;FOXO4;ADGRA2;AMOT;ANGPTL4;PF4;PTPRM;ANXA3;FOXJ2
gsea,regulation of sprouting angiogenesis (GO:1903670),-0.4061525809785942,-1.2610394760997716,0.19542619542619544,0.19919540673399722,1.0,3/20,22.77%,PKM;E2F2;PDPK1
gsea,neutrophil chemotaxis (GO:0030593),0.39699164143074617,1.2606367408800045,0.19455252918287938,0.3970881437220938,1.0,18/31,29.47%,LGALS3;CCL5;XCL1;JAML;PDE4B;CCL1;CCL4;CXCL9;CXCL13;SYK;CXCL2;CCL2;CX3CL1;TGFB2;PIK3CD;CCL8;CCL7;PIKFYVE
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.34295946158555596,1.2602937877876434,0.14602587800369685,0.3945500005584617,1.0,24/36,36.12%,CCL5;NTRK3;JAK2;PIK3R1;IRS2;F2RL1;KIT;NCF1;FLT1;PDGFB;TNF;SELP;F2R;FN1;FGF2;PDGFA;EPOR;LYN;TGFB2;PIK3CD;PIK3AP1;IGF1;OSM;PIK3R5
gsea,positive regulation of ion transport (GO:0043270),0.4225641063144635,1.2572272390675323,0.1958568738229755,0.3971272055457345,1.0,13/22,26.29%,CCL5;ORAI1;P2RX4;SCN1B;STIM2;CCL4;CRACR2A;SCN4B;F2R;ACTN2;PKP2;CNKSR3;CCR1
gsea,long-chain fatty acid transport (GO:0015909),-0.4274683933386656,-1.2566286321673754,0.1888412017167382,0.20319166827954852,1.0,6/17,37.00%,FABP5;MID1IP1;ACACA;PRKAG2;CPT1A;CPT2
gsea,glycolipid biosynthetic process (GO:0009247),-0.39904270021756294,-1.2557325701879476,0.2065439672801636,0.20382613373253775,1.0,7/18,31.80%,PIGF;PIGU;PIGA;ST3GAL4;PIGQ;SCCPDH;ST3GAL5
gsea,regulation of cardiac muscle contraction (GO:0055117),-0.43920982527768243,-1.2552617861672224,0.16910229645093947,0.20409364690158277,1.0,4/16,23.64%,CALM2;RGS2;ATP2A2;PIK3CG
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.32644445627978025,1.25518159997489,0.13872832369942195,0.39787786557840915,1.0,44/69,32.59%,CCR7;CCL5;XCL1;TNFSF11;NTRK3;PRKCA;GPR183;PRKCZ;ICAM1;NRP1;SLAMF1;SEMA7A;F2RL1;RAMP3;CD44;CCL1;MFHAS1;ABCA7;CCL4;MTURN;PDGFB;TNF;GLIPR2;CD4;F2R;APP;GPR55;SCIMP;SPRY2;P2RY6;GCNT2;CCL2;CX3CL1;FGF2;PDGFA;CCR1;CCL8;CCL7;GPNMB;CSF1R;APOE;RASGRP1;CD36;ARRB1
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3650363282509168,1.2546691106233971,0.1619047619047619,0.39579497513623985,1.0,20/31,31.17%,SPRY1;CRIM1;SMAD7;CREB3L1;HTRA3;HHEX;WNT1;HIPK2;SHISA2;THBS1;SPRY2;SPRY4;SULF2;SMAD5;FGF2;RBPMS2;SKI;PPARG;BAMBI;APLN
gsea,regulation of complement activation (GO:0030449),-0.4981041981804296,-1.254534995099372,0.20292887029288703,0.2046172835549991,1.0,3/16,13.45%,C1QBP;PHB2;PHB
gsea,neuron projection morphogenesis (GO:0048812),-0.31995334526260427,-1.2510582457301869,0.14225941422594143,0.20775490033436128,1.0,22/53,46.21%,KIF20B;UBB;ACTB;NEFH;CPNE1;ROCK1;SRGAP2;RYK;MAP1A;TAOK2;MAP2;FARP1;DICER1;ABITRAM;DVL1;AFG3L2;LLGL1;DOCK7;CTNND2;DAB2IP;EIF2AK4;BAIAP2
gsea,chemokine-mediated signaling pathway (GO:0070098),0.4071984620939262,1.2500311725972986,0.19557195571955718,0.4010798798596475,1.0,14/26,28.69%,CCL5;XCL1;SH2B3;CCR2;CCL1;CCL4;CXCL9;CXCL13;CXCL2;CCL2;CX3CL1;CCR1;CCL8;CCL7
gsea,embryonic heart tube morphogenesis (GO:0003143),-0.42483646114219475,-1.2495140592015739,0.18480492813141683,0.20898466963576395,1.0,9/16,44.76%,STIL;SETDB2;TBX21;EOMES;SRF;AHI1;MEF2C;ACVR1;MKKS
gsea,positive regulation of fat cell differentiation (GO:0045600),-0.3775050727593151,-1.2471103884251653,0.1955193482688391,0.2109730043516709,1.0,7/23,35.65%,HNRNPU;ID2;AKT1;CEBPB;CREB1;CARM1;METRNL
gsea,peptidyl-lysine trimethylation (GO:0018023),-0.4210599665220286,-1.2469357148582745,0.2099236641221374,0.2109204816974132,1.0,10/17,42.42%,SUV39H1;SUV39H2;ATPSCKMT;KMT5C;SETD1A;SETD2;CTR9;SETD1B;EEF2KMT;SMYD5
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.2979978575520546,-1.2441243706180845,0.11764705882352941,0.2134282099433533,1.0,28/97,56.45%,HMGB1;FAM83D;MIF;PIN1;PHB2;EZR;HRAS;PHB;APIP;PTPN6;SHC1;MT3;PTPN11;CCL3;RPS6KA6;HTR2A;SPRED1;PRKD2;DAB2IP;PTK2B;CCL17;GAREM1;NOTCH1;FFAR4;GAS6;FBXW7;NPNT;SPRED2
gsea,Golgi to plasma membrane transport (GO:0006893),-0.40688384059210675,-1.244031326623587,0.18016194331983806,0.21331277774521656,1.0,9/18,42.15%,EXOC4;OPTN;SPTBN1;GCC2;NSF;GGA3;GOLGA4;LLGL1;GGA2
gsea,granulocyte chemotaxis (GO:0071621),0.38810972437108404,1.2432223962126816,0.20156555772994128,0.4107681225628554,1.0,19/32,29.47%,LGALS3;CCL5;XCL1;JAML;PDE4B;CCL1;ANXA1;CCL4;CXCL9;CXCL13;SYK;CXCL2;CCL2;CX3CL1;TGFB2;PIK3CD;CCL8;CCL7;PIKFYVE
gsea,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.42052502087470345,-1.2414270847017703,0.1947261663286004,0.2156381393161652,1.0,6/16,29.89%,BAX;CASP8AP2;DELE1;FADD;DDX47;DDX3X
gsea,regulation of ion transport (GO:0043269),0.4274495030594962,1.2406923932215135,0.1950286806883365,0.4125800456116645,1.0,7/16,20.73%,P2RX4;PER1;ITGB3;CLDN10;SYT11;HFE;KCNJ8
gsea,response to amino acid starvation (GO:1990928),0.3347884921591777,1.2396477121530802,0.15370018975332067,0.41144021663351665,1.0,36/36,94.84%,DAPL1;SESN3;DAP;FAS;CASTOR1;IMPACT;SESN1;RNF152;SLC38A9;EIF2AK2;RPTOR;RRAGB;ATP6V0E2;WDR24;ATP6V1G3;SESN2;MIOS;ATF2;MAPK8;EIF2AK4;EIF2AK3;NPRL3;TFEB;MAP3K5;ITFG2;MLST8;DEPDC5;TCIRG1;LARP1;ATF4;GCN1;MTOR;CEBPB;SEH1L;EIF2S1;CDKN1A
gsea,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3759054451843823,-1.2384948384285994,0.1752136752136752,0.2182214869722449,1.0,4/26,13.45%,DNMT1;ID2;AKT1;PHB
gsea,neutrophil migration (GO:1990266),0.38627080136375747,1.2380402684557992,0.20817120622568094,0.41162777647276794,1.0,19/32,29.47%,LGALS3;CCL5;XCL1;JAML;PDE4B;PECAM1;CCL1;CCL4;CXCL9;CXCL13;SYK;CXCL2;CCL2;CX3CL1;TGFB2;PIK3CD;CCL8;CCL7;PIKFYVE
gsea,positive regulation of ossification (GO:0045778),0.44122296686354906,1.2379090359462472,0.19848771266540643,0.4088731663403706,1.0,8/16,28.30%,GPM6B;CCN1;ISG15;BMP7;TGFB2;TGFB3;TMEM119;SLC8A1
gsea,positive regulation of JNK cascade (GO:0046330),-0.33272762996328553,-1.2344368150319605,0.17177914110429449,0.22190649473280027,1.0,11/39,49.32%,HMGB1;HRAS;TRAF2;AXIN1;DUSP19;DUSP22;TAOK2;MAP3K5;TRAF3;DAB2IP;PTK2B
gsea,positive regulation of supramolecular fiber organization (GO:1902905),-0.32029387616032207,-1.2337053078261564,0.158004158004158,0.22244083587458485,1.0,16/45,30.43%,PFN1;NUMA1;CDK5RAP2;DRG1;DCTN1;KATNB1;PRKCE;CLASP1;PLEK;RB1;PSRC1;ARL2;COLGALT1;CLIP1;PDXP;SYNPO2
gsea,regulation of actin filament polymerization (GO:0030833),0.35173103602748323,1.2321578348095112,0.16,0.4164945242849542,1.0,13/30,36.49%,CCR7;EVL;SSH2;SSH1;FCHSD2;CDC42EP3;PFN2;HCK;RASA1;CDC42EP1;CDC42EP2;NCKAP1;NCK2
gsea,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4160911589831452,-1.2313319504429603,0.1821705426356589,0.2245717229097091,1.0,7/17,28.69%,HSD17B12;HACD2;SLC25A1;ACSL5;ACACA;GCDH;ACLY
gsea,response to interferon-beta (GO:0035456),0.440657101584292,1.230792414171431,0.2219959266802444,0.41595004184138157,1.0,9/15,12.00%,IFNAR2;STAT1;IFITM2;IKBKE;IFITM1;XAF1;IRF1;SHFL;IFITM3
gsea,regulation of epithelial cell migration (GO:0010632),-0.36322240321810373,-1.2302984683420841,0.17219917012448133,0.2254045646050412,1.0,8/28,25.60%,PFN1;CORO1C;ARSB;CLASP2;PRKCE;CLASP1;IFNG;HDAC6
gsea,Rho protein signal transduction (GO:0007266),-0.3726971860535102,-1.2294708190857244,0.16216216216216217,0.2260067842469326,1.0,6/24,32.98%,CFL1;ARHGDIA;ROCK2;ROCK1;MYO9B;ARHGDIG
gsea,regulation of cardiac conduction (GO:1903779),0.39697252010952655,1.2286203004099392,0.1702127659574468,0.4170725979621684,1.0,15/23,32.07%,ATP2A3;ATP2B2;ITPR2;ATP1B1;RYR1;TMEM65;FXYD1;ITPR1;FXYD2;FXYD7;ITPR3;SLC8A1;ATP1A2;ASPH;NPPC
gsea,COPII-coated vesicle budding (GO:0090114),-0.3664700511579759,-1.2263560780678304,0.18421052631578946,0.22883149322918075,1.0,13/25,37.99%,TMED2;SEC23B;LMAN1;PPP6R3;CUL3;TRAPPC9;SEC24D;NSF;SCAP;SEC23IP;ANKRD28;GOLGA2;PPP6R1
gsea,spermatid development (GO:0007286),-0.4197645015951087,-1.2263538163396315,0.18259023354564755,0.2286042735631202,1.0,6/15,44.76%,CEP57;RNF8;YTHDC2;SPINK2;CDYL;MKKS
gsea,actin polymerization or depolymerization (GO:0008154),-0.3534030703313509,-1.22418069648287,0.1592356687898089,0.23051740526971082,1.0,16/29,52.37%,DIAPH3;CFL1;DIAPH1;FLII;SVIL;CORO7;DSTN;CFL2;WASHC5;ABI2;SPIRE1;ENAH;VIL1;MICAL2;SPIRE2;MICAL1
gsea,import into cell (GO:0098657),-0.40323160728098617,-1.2237910230122284,0.20866141732283464,0.23064953878783656,1.0,4/18,27.44%,SLC29A1;SLC7A5;SLC7A1;SLC19A1
gsea,glutathione metabolic process (GO:0006749),-0.39898756635513355,-1.2229870417743367,0.20641282565130262,0.23127571860252652,1.0,7/17,39.64%,PARK7;GSR;GSTZ1;MMACHC;CHAC1;GGCT;GSS
gsea,myeloid cell differentiation (GO:0030099),-0.36052159489666624,-1.222685165637467,0.2015810276679842,0.23133258570455503,1.0,11/26,49.71%,SLC25A5;CASP3;HSPA9;PRDX3;DYRK3;UFL1;KAT8;KAT6A;NCOA6;IKZF1;CDKN2B
gsea,positive regulation of organelle organization (GO:0010638),-0.39927753387498227,-1.2223225714499915,0.20866141732283464,0.2314409266300549,1.0,8/17,40.63%,LNPK;LMAN1;HTRA2;C2CD5;GSK3B;RAB3GAP1;FYCO1;ANXA2
gsea,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.4009534949639905,-1.2213381057508959,0.20235756385068762,0.23216587763937943,1.0,4/18,22.77%,CALM2;GSTO1;DIAPH1;PDPK1
gsea,axon development (GO:0061564),-0.36271883973609403,-1.2204431036905836,0.218,0.23279283473945026,1.0,13/24,46.24%,DHFR;ACTB;NEFH;RYK;MTR;ZPR1;MAP1A;TAOK2;AFG3L2;LLGL1;DOCK7;BAIAP2;ARHGAP35
gsea,heart morphogenesis (GO:0003007),0.42817594161440464,1.2196225698900374,0.21176470588235294,0.43054566656563564,1.0,10/15,28.77%,DLC1;ENG;TGFBR3;ZFPM1;OLFM1;ACVRL1;TTN;TGFB2;ALPK2;TBX2
gsea,cytoplasmic translation (GO:0002181),-0.4528349543368441,-1.2145238196140031,0.3,0.2387064744220348,1.0,17/35,26.27%,EIF4A1;GSPT1;RPS17;RPS2;RPL14;RPS15;DRG1;RPS25;ETF1;RPL23A;RPL31;RPS6;RPL4;FTSJ1;DRG2;RPL22L1;EIF2B3
gsea,O-glycan processing (GO:0016266),0.3742785501282686,1.2071559101510871,0.21115537848605578,0.45149412253019017,1.0,10/22,37.83%,GALNT14;GALNT6;GALNT10;ST6GAL1;ST3GAL1;B3GNT5;MUC20;XXYLT1;MUC1;GCNT1
gsea,positive regulation of interferon-beta production (GO:0032728),-0.35873203365774975,-1.202980436146123,0.2076923076923077,0.2506760258918516,1.0,10/24,52.16%,HSP90AA1;DHX9;DDX3X;PTPN11;POLR3G;POLR3F;POLR3D;POLR3B;POLR3A;IFIH1
gsea,inflammatory response (GO:0006954),0.32087185215421943,1.2017880784230275,0.1717557251908397,0.4587875492701785,1.0,62/95,30.03%,CCR7;CCL5;XCL1;REL;RIPK2;NFKB1;PTGER2;GPR68;CCR2;CCR5;CD44;CCL1;TBXA2R;ANXA1;MFHAS1;KIT;IL1B;PTGER4;CCL4;CD40LG;IL2RA;TNF;ADAM8;ADORA2A;CYBB;CD40;ADM;NFAM1;F2R;FCGR2B;LY75;NRROS;AIF1;CXCL9;THBS1;HDAC4;IL1RN;CXCL13;CXCR4;ADGRE5;CXCL2;C3AR1;MEFV;CCL2;CX3CL1;NLRP3;CD14;TLR2;HDAC9;BLNK;CCR1;PIK3CD;HDAC5;OLR1;CCR3;CCL8;CCL7;TNFRSF4;FOS;CSF1R;NOS2;TNFRSF1A
gsea,response to insulin (GO:0032868),-0.3103888735028466,-1.2009355610899701,0.19161676646706588,0.2527181351582664,1.0,19/44,45.65%,PKM;EIF6;PARP1;PCK2;AKT1;MYO5A;INSIG1;PDPK1;C2CD5;ZBED3;TRIB3;PRKDC;PDE3B;GOT1;PRKCI;SIRT1;KAT2B;RHOQ;LPIN2
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.30211676007862,-1.20067527791075,0.15547024952015356,0.25271944478414193,1.0,14/52,40.21%,HMGB1;PRMT1;HRAS;TRAF2;MAP3K4;MID1;XDH;AXIN1;DUSP19;DUSP22;TAOK2;MAP3K5;RELL1;TRAF3
gsea,regulation of p38MAPK cascade (GO:1900744),0.3713882656057785,1.1999528840441236,0.21893491124260356,0.45935221576450636,1.0,13/23,30.41%,ZC3H12A;GADD45B;DUSP10;DUSP1;PER1;MFHAS1;SPI1;NCF1;IL1B;GADD45A;GADD45G;PHLPP1;RASGRP1
gsea,negative regulation of viral genome replication (GO:0045071),-0.3585234611406695,-1.1995526478674656,0.20710059171597633,0.2536684466005332,1.0,5/28,23.22%,BANF1;FAM111A;SRPK1;ILF3;SETDB1
gsea,regulation of tumor necrosis factor production (GO:0032680),-0.2995176968013964,-1.1971908156194335,0.19480519480519481,0.2560020838693693,1.0,19/65,46.07%,HMGB1;MIF;DHX9;PTPN6;FRMD8;CACTIN;FADD;SPN;IFNG;MAPKAPK2;PTPN11;HAVCR2;CCL3;DICER1;LTF;STAT3;NLRC3;IL33;ARHGEF2
gsea,positive regulation of B cell activation (GO:0050871),-0.33773376322667753,-1.1959575912207385,0.1975806451612903,0.2570481536295708,1.0,9/33,42.09%,MIF;TFRC;RIF1;PAXIP1;KMT5C;PPP2R3C;MEF2C;TNFSF4;IL21
gsea,negative regulation of cell projection organization (GO:0031345),-0.4024188378806638,-1.1958985488223062,0.22245322245322247,0.25686158794486413,1.0,10/18,49.23%,FKBP4;HDAC2;MT3;BAG5;GAK;PAQR3;PTPN9;TSKU;GFI1;DENND5A
gsea,response to tumor necrosis factor (GO:0034612),0.32082440266741624,1.193018177838002,0.2018867924528302,0.4700819332482115,1.0,52/52,96.94%,GCH1;AFF3;CCL5;XCL1;ZFP36L1;JAK2;ZC3H12A;ZFP36;GBP2;CCL1;NFE2L2;CCL4;PID1;CD40;ERBIN;CCL2;CX3CL1;TNFRSF21;CCL8;CCL7;CXCL16;ACOD1;NUB1;CCL25;ZFP36L2;CCL22;SPHK1;ADAM9;RIPK1;NPNT;TANK;CCL17;GATA3;ARHGEF2;DAB2IP;RELA;HYAL2;SIRT1;CCL3;CHUK;SMPD1;SMPD4;GSDME;YTHDC2;BAG4;CACTIN;GBP3;AKT1;CASP3;YBX3;DHX9;BRCA1
gsea,positive regulation of immune response (GO:0050778),0.3340791798135591,1.1914022883652253,0.22666666666666666,0.46985781698932255,1.0,17/35,27.72%,CCR7;CCL5;CD81;CD226;F2RL1;ITGAM;IL6ST;RSAD2;ADAM8;FCGR2B;IL2;IL23A;GRN;NLRP3;TGFB2;IL10;XBP1
gsea,cytoskeleton organization (GO:0007010),-0.2914942228332937,-1.1890245545768048,0.18105263157894738,0.2641772596607179,1.0,27/60,46.99%,DIAPH3;CFL1;PRPF40A;PHIP;MAST2;SYNE3;FMNL3;DIAPH1;ARHGAP10;PACSIN2;TPM1;KLHL20;DPYSL2;ZMYM3;PAK4;SPRYD3;PPP2R3C;CCL3;LARP4;PDZD8;MAST3;PRKCI;STRIP1;ZMYM4;RHOF;ABI2;RHOB
gsea,positive regulation of autophagy (GO:0010508),-0.29892954393818916,-1.1883897307885782,0.1799163179916318,0.2645573862238275,1.0,22/50,44.00%,HMGB1;PARK7;PHB2;MTDH;OPTN;ROCK1;SCOC;IFNG;LARP1;CAMKK2;ATF6;UFL1;MAP3K7;PRKAA1;SVIP;GSK3B;HTT;TFEB;PIK3CB;TSC2;SIRT1;BNIP3
gsea,positive regulation of monooxygenase activity (GO:0032770),-0.3882957141586355,-1.1872267293828558,0.23541666666666666,0.2656353226924064,1.0,8/17,41.33%,DHFR;PARK7;AKT1;IFNG;TERF2;SCARB1;POR;PIK3CB
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),0.3288188735836023,1.1870983491382756,0.21150278293135436,0.47535707874242694,1.0,42/42,94.22%,TPT1;CCL5;ATP2A3;ATP2B2;CCR2;CCL1;STIM2;ATP1B1;SLC30A1;ATP13A2;SLC41A1;CALCB;CD40;SLC39A13;CCR1;SLC8A1;CCL8;CCL7;TNNI3;SLC39A14;PTH1R;ATP2B4;STC2;SLC39A7;SLC39A6;EDN1;SLC11A1;TMEM203;DRD4;HTR2A;RMDN3;CCL3;SLC39A10;SLC39A4;SLC24A5;ATP13A1;MT3;ATP13A3;CHERP;ATP2A2;CALR;STOML2
gsea,glycolipid metabolic process (GO:0006664),0.3611429133781937,1.185264372007897,0.232,0.47591161821686945,1.0,11/22,37.19%,GM2A;ST6GALNAC3;CERK;B3GNT5;PGAP1;NEU1;ST6GALNAC6;HEXA;NAGA;PGAP3;ABCA2
gsea,epidermal cell differentiation (GO:0009913),-0.3875538807947706,-1.1847621343585202,0.20486815415821502,0.268265826663421,1.0,5/18,22.85%,HDAC1;CASP3;HDAC2;CLIC4;ST14
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3269829710029587,-1.1818684935192905,0.22332015810276679,0.2711928410552247,1.0,13/34,46.21%,HSP90AA1;ELMO1;ROCK2;VEGFB;ROCK1;ELMO2;MAPKAPK2;CYFIP1;PIK3CB;BCAR1;PRKD2;DAB2IP;BAIAP2
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3428974550060392,-1.1790360669215205,0.24266144814090018,0.2741695706078765,1.0,12/27,31.90%,BAX;P4HB;PPIF;NOC2L;BCLAF1;URI1;UBQLN1;PTPMT1;BBC3;DDX3X;GSDME;HERPUD1
gsea,embryonic organ development (GO:0048568),-0.36990692775857015,-1.1776590076375197,0.2349137931034483,0.2754841164690479,1.0,7/21,47.17%,STIL;ATF4;PBX2;ERCC3;PBX3;PBX4;GATA3
gsea,regulation of interleukin-17 production (GO:0032660),0.3945966122221044,1.1770379633843748,0.23943661971830985,0.48942391626077547,1.0,9/18,26.88%,SLAMF6;VSIR;PRNP;CCL1;FOXP3;IL2;IL23A;DDIT3;LY9
gsea,cellular response to interleukin-6 (GO:0071354),0.3978225613099363,1.1769336753040693,0.2413127413127413,0.4863618910960173,1.0,7/16,20.35%,NFKB1;JAK2;STAT1;SPI1;IL6ST;PID1;SOCS3
gsea,positive regulation of cytokine production (GO:0001819),-0.2523993780790769,-1.1762698809002654,0.16767676767676767,0.2768403914331765,1.0,71/179,52.16%,HMGB1;BRCA1;MIF;G3BP1;HSPD1;GAPDH;STOML2;POLR3K;POLR2F;DHX9;PARK7;POLR2L;CGAS;SLC7A5;PHB;TRAF2;POLR3H;XRCC5;POLR2E;ROCK2;CEBPB;POLR2H;FADD;GLMN;XRCC6;PIK3CG;IFNG;ATF4;DDX41;NFKB2;SPTBN1;ADAM17;SCRIB;PTPN11;HSPA1B;MAP3K7;KAT2A;PRKDC;POLR3G;HAVCR2;HSPA1A;GBP5;POLR3F;AGPAT1;LACC1;POLR1C;TNFSF4;POLR3D;IL21;STAT3;CREBBP;HYAL2;EIF2AK3;POLR3GL;IL12RB1;RELA;PRKD2;IL33;ARHGEF2;GATA3;CADM1;POLR3B;RGCC;SPHK2;HMOX1;HPSE;POLR3A;F3;FCER1G;SLC11A1;IFIH1
gsea,T cell activation (GO:0042110),0.3263751443794599,1.1758502340521666,0.23155737704918034,0.4853761211364313,1.0,35/35,94.70%,CCR7;CRTAM;JAML;TNFSF14;IRF4;F2RL1;CD44;KIT;CD7;SOX4;CD4;FOXP3;TREML2;DLL4;IL2;PIK3CD;DPP4;TNFRSF4;RASGRP1;NCK2;CD74;JAG2;GATA3;KIF13B;EIF2AK4;CHD7;NLRC3;TNFSF4;ADA;SCRIB;PIK3CG;PPP3CB;LCP1;DDOST;HSPD1
gsea,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.39724351331367724,-1.175189810322288,0.26452905811623245,0.2778681266073882,1.0,8/17,37.11%,HSP90AB1;PTPN6;CACTIN;TTLL12;FADD;ABCE1;PTPN11;METTL3
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2761001303531749,-1.1747794146549582,0.19887429643527205,0.2780499744282925,1.0,26/76,40.77%,ECT2;NUP62;GAPDH;TFRC;UBE2N;EEF1D;DDX1;PPP5C;TRAF2;MTDH;SLC20A1;FADD;TMEM101;FLNA;DDX21;BIRC3;LGALS1;CC2D1A;MAP3K7;MAP3K3;TSPAN6;CHUK;LTF;ZDHHC13;ANKRD17;PRKCB
gsea,positive regulation of MAP kinase activity (GO:0043406),-0.3338594218999197,-1.1745987027104403,0.24843423799582465,0.2779993954529282,1.0,7/31,32.61%,EZH2;HRAS;TRAF2;PIK3CG;MAP3K4;DUSP19;MAP3K7
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),-0.308277105951058,-1.17183224878609,0.2214765100671141,0.28095650602313166,1.0,15/45,38.29%,FABP5;ACADL;GATM;CEBPB;PLAC8;ALMS1;DYNC1H1;HSF1;SIRT6;EHMT1;HADH;PRDM16;EPAS1;CPT2;OMA1
gsea,response to glucose (GO:0009749),-0.3663793168794883,-1.1716471889135789,0.2681318681318681,0.2808874046461015,1.0,10/22,44.22%,PCK2;EIF2B1;PFKL;EIF2B5;ZBED3;EIF2B3;PRKAA1;EIF2B4;RACK1;ERN1
gsea,lytic vacuole organization (GO:0080171),-0.384077883348963,-1.170379963774052,0.24536082474226803,0.28204460397537956,1.0,5/19,26.84%,ARSB;MTOR;GNPTAB;CLN6;HOOK1
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.30505150892266136,-1.1689116681045657,0.22690763052208834,0.28353917986063626,1.0,19/41,46.46%,ANLN;PFN1;CCP110;HRAS;FMR1;RALA;DOCK11;ACTR2;CARMIL2;CEP120;HTT;KCTD17;DEF8;CYFIP1;RHOQ;CCDC88A;ABI2;ARHGAP35;FAM98A
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),0.3190891217982518,1.1682693195020744,0.23586744639376217,0.4980491357813115,1.0,24/39,30.74%,ITGB1;FURIN;RPS27A;PRKCZ;JUN;PTPRK;LRRC32;ENG;SMAD7;TGFBR3;SMAD3;NLK;ARHGEF18;EID2;NRROS;TWSG1;GCNT2;ACVRL1;SMAD5;TGFB2;SKI;TGFB3;FOS;BAMBI
gsea,glycosphingolipid metabolic process (GO:0006687),0.3788575376231932,1.1682466168505548,0.2583170254403131,0.4948343641107206,1.0,7/17,21.85%,GM2A;ST8SIA1;ST6GALNAC3;CERK;NEU1;ST6GALNAC6;HEXA
gsea,cartilage development (GO:0051216),0.4002118551958465,1.1677769433481622,0.25553319919517103,0.4927062506741858,1.0,9/16,29.05%,CREB3L2;ITGB8;CD44;SULF2;RUNX2;WNT2B;FGF2;SNX19;RUNX1
gsea,positive regulation of wound healing (GO:0090303),-0.3853580865047032,-1.1664478029939243,0.23440860215053763,0.2860739130059326,1.0,6/18,31.97%,ACTG1;HRAS;PRKCE;MTOR;ST3GAL4;ENPP4
gsea,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4043855314713607,1.1647338814551325,0.25769230769230766,0.4958816127222291,1.0,12/16,34.59%,FURIN;TIMP2;IL1B;TNF;ADAM8;PTPN3;PACSIN3;IL10;APOE;ADRA2A;SH3D19;TIMP1
gsea,fatty acid beta-oxidation (GO:0006635),-0.33740117543956316,-1.164073321542198,0.2332657200811359,0.2885157807489668,1.0,14/28,40.13%,ETFB;ACADL;MECR;ECHDC2;ACAT2;GCDH;SLC25A17;ETFDH;MCAT;HADH;IVD;CPT2;ECHDC1;ECI1
gsea,negative regulation of epithelial cell proliferation (GO:0050680),-0.32997368319278,-1.163602854069617,0.22792607802874743,0.28877511896306834,1.0,15/34,50.35%,TINF2;BRCA2;RUNX3;CDK6;XDH;WDR77;CDC73;NLRC3;MED1;DAB2IP;GATA3;RGCC;VASH1;CDKN2B;SPARC
gsea,inorganic cation import across plasma membrane (GO:0098659),0.36953334962130446,1.163147382847492,0.2342857142857143,0.49595611363320186,1.0,11/25,29.23%,TRPV2;ATP1B1;SLC9A9;SLC12A6;SLC12A7;FXYD2;KCNJ8;CACNA2D1;SLC12A3;SLC8A1;ATP1A2
gsea,protein localization to plasma membrane (GO:0072659),-0.28425412938044686,-1.1630468824005225,0.22941176470588234,0.28913419238315036,1.0,31/64,52.92%,TMED2;EZR;ZDHHC2;RDX;MYO5A;BSG;ROCK2;CLASP2;FLOT2;ROCK1;FGF13;EHD4;FLNA;C2CD5;TESC;SPTBN1;GORASP2;GAK;AFDN;RAP2A;FAM126B;CCDC88A;PACS2;TSPAN15;PTCH1;SLMAP;NKD2;PLEKHF1;RAMP2;MYADM;GAS6
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2579700089246424,-1.159580198991912,0.19245283018867926,0.29294445367792,1.0,45/105,49.75%,ECT2;NUP62;GAPDH;TFRC;UBE2N;EEF1D;TRIM59;DDX1;PPP5C;TRAF2;MTDH;CACTIN;PIDD1;SLC20A1;CPNE1;OPTN;FADD;TMEM101;PDPK1;USP10;FLNA;DDX21;BIRC3;LGALS1;CC2D1A;UFL1;MAP3K7;MAP3K3;TSPAN6;CHUK;LTF;TRAF3;ZDHHC13;ANKRD17;PRKCB;SIRT1;NLRC3;TNFRSF10B;RELA;DAB2IP;BIRC2;BST2;TAB3;SPHK2;HMOX1
gsea,regulation of protein secretion (GO:0050708),-0.2921702104495079,-1.1593487289970221,0.1978021978021978,0.2929595211339585,1.0,19/58,53.62%,PPIA;EZR;PPID;HMGCR;PPP3CB;IFNG;SLC2A1;HADH;SLC12A2;STXBP5;RHBDF2;LLGL1;MYH10;DRD4;EXPH5;MYO18A;SYTL4;APBB1;UNC13B
gsea,cellular response to epidermal growth factor stimulus (GO:0071364),0.3894573883898492,1.1583950398643341,0.25884543761638734,0.5024946814731301,1.0,17/17,96.49%,EEF1A1;ZFP36L1;ZFP36;PLCG1;DUSP3;ZFP36L2;STAT5B;GAREM1;VIL1;DAB2IP;MED1;PTPN12;DUSP22;ZPR1;PTPN11;PDPK1;KNSTRN
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.31168290071525295,1.158290253227698,0.22857142857142856,0.49950235777309976,1.0,27/41,36.29%,RIPK2;JAK2;PRKCZ;CD81;NRP1;ITGB3;PRNP;PECAM1;CD44;PDGFB;LIF;APP;ENPP2;BST1;ITGA5;IL23A;BANK1;PDGFA;IL3;TEC;RAP2B;CD80;PTPRJ;PLCG2;IGF1;OSM;DMTN
gsea,negative regulation of MAP kinase activity (GO:0043407),0.3403733679358264,1.1551153043459925,0.26407766990291265,0.5026770585922693,1.0,16/28,29.92%,SPRY1;PDCD4;DUSP10;DUSP1;SH2B3;IL1B;CD300A;MAPK8IP1;SPRY2;BMP7;SPRY4;IRAK3;DUSP7;LYN;APOE;PTPRJ
gsea,negative regulation of protein secretion (GO:0050709),0.40949819863581044,1.1536928059701945,0.25,0.502408087051703,1.0,12/16,32.88%,CD200;IL1B;REST;RSAD2;F2R;RAB11FIP1;RHBDF1;SIRT4;APOE;NR1H3;ADRA2A;MIDN
gsea,positive regulation of phagocytosis (GO:0050766),-0.359789298533778,-1.1535036417744786,0.2924731182795699,0.2995728038491545,1.0,6/27,28.10%,LYAR;LMAN2;CALR;IFNG;RAB27A;DOCK2
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.396934542943637,1.1511960949616467,0.29457364341085274,0.504556578557359,1.0,12/21,18.73%,SLC5A3;ZC3H12A;TYROBP;F2RL1;CBR1;ITGAM;GADD45A;PDGFB;DCXR;PID1;THBS1;SYK
gsea,regulation of chemotaxis (GO:0050920),0.41103276161937463,1.1510642450019926,0.30019120458891013,0.5016585218853493,1.0,12/15,27.76%,GPR183;P2RX4;F2RL1;ZSWIM6;ZSWIM8;PDGFB;AIF1;THBS1;CXCR4;DUSP3;PPM1F;EFNB2
gsea,organonitrogen compound catabolic process (GO:1901565),-0.3398904381289812,-1.149442303968877,0.25748502994011974,0.30410123818945606,1.0,18/29,49.12%,BCKDK;UCHL3;MTOR;CLN6;TXN2;ERAP1;CLPX;NAGK;IDE;ADO;CTH;TRIM24;NPL;PDXDC1;PRSS16;NPEPPS;GNPDA1;PLA2G6
gsea,peptide metabolic process (GO:0006518),-0.3288696531098356,-1.147908581376098,0.23613963039014374,0.3057715924113241,1.0,13/30,44.14%,GSR;THOP1;CARNMT1;SPCS3;MIPEP;PARL;GSTZ1;ERAP1;MMACHC;IDE;NLN;CPD;AEBP1
gsea,regulation of bone mineralization (GO:0030500),0.36626068937907375,1.1472219511086172,0.26204238921001927,0.5063317550410312,1.0,13/23,31.96%,GPM6B;CCN1;S1PR1;ISG15;ECM1;BCOR;BMP7;TXLNG;TGFB3;CCR1;TMEM119;SLC8A1;TWIST1
gsea,cell junction assembly (GO:0034329),-0.34722551613035035,-1.1466957377000735,0.27839643652561247,0.3070229319837124,1.0,9/26,36.90%,ACTG1;ACTB;SH3BP1;FLNA;DSCAM;RYK;PKP4;MYO9A;FARP1
gsea,posttranscriptional regulation of gene expression (GO:0010608),-0.3264340350826427,-1.1454558949350564,0.23968565815324164,0.30820960938889036,1.0,16/32,43.19%,TCOF1;NOLC1;EIF4E;METTL16;PUM3;LARP1;PUM2;NANOS1;GEMIN5;ZC3H10;EIF2B4;METAP1;LARP4;SPOUT1;CYFIP1;MAPKAPK5
gsea,regulation of cell adhesion (GO:0030155),0.2872662628299741,1.1442383778018759,0.2515463917525773,0.5092849994226291,1.0,60/60,96.91%,CCR7;CCL5;CXCR3;TNFRSF18;RIPOR2;C2CD4B;PRKCA;CYTH1;DUSP1;ADGRG1;PLXNC1;PRSS2;C2CD4A;TNF;TGFBI;FES;TGM2;ADAM8;RASA1;CXCR4;ACVRL1;RET;PLXNB2;LYN;PTPRJ;PLAU;FUT7;PLXNA1;ABL1;FBLN1;VEGFA;DLL1;TFE3;MINK1;PLXND1;MYADM;MIA3;PTK2B;ATM;PRKD2;ATXN3;RSU1;PPP1CB;PDE3B;ARHGDIG;PKP4;PTPN11;DSCAM;TPM1;TESC;PIK3CG;SPN;ROCK1;ROCK2;LPXN;ZDHHC2;P4HB;C1QBP;ARHGDIA;KIF14
gsea,regulation of cell migration (GO:0030334),-0.2367709444734068,-1.1436125502877765,0.1896551724137931,0.3101399551249551,1.0,66/185,52.84%,KIF14;GTSE1;MIF;ACTN4;ACTG1;RCC2;ARHGEF39;CORO1C;CCAR1;MAZ;AKT1;SINHCAF;ARSB;HRAS;RDX;SERPINE2;ELP5;ROCK2;CLIC4;SUN2;ROCK1;SRGAP2;KIF2A;FLNA;SLK;TPM1;ELP6;ADAM17;LMNA;GTPBP4;SYNE2;SEMA4A;SOD2;DUSP22;RUFY3;RAP2C;GRB7;CARMIL2;HACE1;ARID2;CCL3;AFDN;ELP3;RAP2A;STAT3;ACVR1;LMO4;RACK1;BCAR1;TBCCD1;ATM;RHOB;ABI3;CD151;BST2;PTK2B;VIL1;NF2;MIA3;LIMCH1;F3;NOTCH1;RIPOR1;EDN1;AMOTL1;MYADM
gsea,cell-cell junction assembly (GO:0007043),0.35941987524032915,1.1435444007889035,0.27599243856332706,0.5075862757697245,1.0,12/21,29.20%,RHOC;CD9;PRKCA;PKP3;SMAD7;JUP;VCL;FSCN1;PKP2;LIM2;CTNNB1;TJP1
gsea,regulation of interferon-alpha production (GO:0032647),-0.37509472308981506,-1.1430806117507677,0.26614481409001955,0.31048909872048697,1.0,7/18,43.37%,HSPD1;DHX9;DDX3X;SETD2;HAVCR2;CHUK;NLRC3
gsea,TOR signaling (GO:0031929),-0.36223279939603836,-1.1429807208909903,0.2875,0.31029002566819264,1.0,13/18,47.17%,AKT1;RPS6;MTOR;PRR5;RHEBL1;LARP1;TIPRL;EIF4EBP1;MLST8;NPRL3;FNIP1;CCDC88A;GATA3
gsea,cellular metal ion homeostasis (GO:0006875),0.31696994659581373,1.1417144261695702,0.24202626641651032,0.5083836467392159,1.0,41/41,94.22%,TPT1;CCL5;ATP2A3;ATP2B2;CCR2;CCL1;STIM2;ATP1B1;SLC30A1;ATP13A2;SLC41A1;CALCB;CD40;CCR1;SLC8A1;CCL8;CCL7;ATP1A2;TNNI3;ATP1A3;PTH1R;ATP2B4;STC2;SLC9A1;EDN1;TMEM203;DRD4;ATP1A1;HTR2A;RMDN3;SLC12A2;CCL3;SLC24A5;ATP13A1;MT3;ATP13A3;CHERP;ATP2A2;LETM1;CALR;STOML2
gsea,negative regulation of cellular metabolic process (GO:0031324),-0.37545491698390676,-1.1411290059447152,0.2822085889570552,0.3122545757388395,1.0,6/17,30.26%,BRCA1;TRAP1;MT3;OPTN;WDR54;AATF
gsea,sensory organ development (GO:0007423),-0.3629049606768374,-1.1410539537973496,0.27521008403361347,0.3120325044218001,1.0,12/23,47.17%,SMCHD1;ZDHHC16;PBX2;ATF6;SMG9;AHI1;PBX3;HIPK1;PBX4;SMOC1;CHD7;GATA3
gsea,zymogen activation (GO:0031638),0.40517397823636536,1.1390099320887428,0.30364372469635625,0.5109651868992262,1.0,10/15,35.18%,VSIR;RIPK2;FURIN;CTSL;CTSH;MMP14;PERP;ASPH;LGMN;PLAU
gsea,positive regulation of actin filament bundle assembly (GO:0032233),0.33190958974008083,1.1389506681272772,0.2982107355864811,0.5080219666626182,1.0,17/28,37.96%,EVL;RHOC;SYNPO;S100A10;NRP1;LIMK1;PFN2;PAK1;CX3CL1;WNT11;ARHGEF10L;PPM1F;TGFB3;GPR65;ARHGEF5;SORBS3;ABL1
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3141061176201417,1.138777038718322,0.2514395393474088,0.5053430735282204,1.0,22/38,36.10%,TNFAIP3;NFKBIA;CD200;DAP;ZC3H12A;TMSB4X;KLF4;SPI1;PRMT2;MTURN;TRIM21;ANXA4;FOXP3;BMP7;ERBIN;IRAK3;NLRP3;DDIT3;IL10;ACOD1;ARRB1;PARP10
gsea,negative regulation of response to external stimulus (GO:0032102),0.2993562684451052,1.1365871312694753,0.2476894639556377,0.5068484415207072,1.0,29/47,36.63%,TNFAIP3;RORA;TNFAIP8L2;TRIB1;KLK8;SIGIRR;KLF4;DHX58;MFHAS1;INPP5F;SERPINE1;PTGER4;SIRPA;PTPRS;TRIM21;IRAK3;MEFV;FGF2;NLRP3;DUSP3;SELENOS;IL10;PPARG;APOE;TNFRSF1A;NR1H3;ACOD1;GHSR;FEM1A
gsea,response to peptide hormone (GO:0043434),-0.33565321579020624,-1.1360153718471808,0.2891566265060241,0.3180730322090314,1.0,9/26,26.27%,EIF6;AKT1;EIF2B1;ROCK2;ROCK1;CREB1;EIF2B5;ZBED3;EIF2B3
gsea,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3673770313330418,1.135556063089694,0.2837301587301587,0.505947438940536,1.0,18/18,92.64%,ZFP36L1;CD160;PIK3R1;PIK3R2;PIK3CD;IGF1;PIK3R5;PIK3C2A;PLEKHA1;NF1;EDN1;PIK3CA;GATA3;HTR2A;PIK3CB;PIK3CG;AKT1;C1QBP
gsea,tRNA methylation (GO:0030488),-0.33692788079172575,-1.134598976812452,0.27514231499051234,0.3195160171956602,1.0,17/27,51.28%,NSUN2;FTSJ1;TRDMT1;TRMO;GTPBP3;TRMT10A;METTL1;MTO1;TYW3;DALRD3;TRMT61A;TRMT5;HSD17B10;THADA;TRMT44;LCMT2;NSUN6
gsea,positive regulation of phospholipase C activity (GO:0010863),0.39078134456711067,1.1331553650120383,0.27906976744186046,0.5077004617156978,1.0,12/17,22.48%,NTRK3;S1PR4;GNA15;CD86;PLCG1;TXK;KIT;FLT1;PLCB2;GPR55;P2RY6;FGF2
gsea,cellular response to peptide hormone stimulus (GO:0071375),0.2916080133474529,1.1318275194466345,0.2524850894632207,0.5074488998766918,1.0,49/49,93.64%,TBC1D4;ZFP36L1;NR4A3;NR4A2;NFKB1;PIK3R1;IRS2;FOXO1;MGARP;CEACAM1;SLC25A33;CYSLTR2;PIK3R2;SORBS1;LPIN1;DENND4C;HDAC9;SELENOS;CPEB2;HDAC5;XBP1;ADCY6;PPARG;OTOP1;SLC39A14;ENPP1;TSHR;RAB13;CAPN10;NR4A1;LPIN2;RELA;RHOQ;KAT2B;PRKCI;GOT1;PDE3B;PRKAR2B;PRKDC;TRIB3;PRKAR2A;C2CD5;PDPK1;INSIG1;MYO5A;AKT1;PCK2;PARP1;PKM
gsea,positive regulation of mononuclear cell migration (GO:0071677),-0.3691066094644156,-1.1269535248941907,0.30019880715705766,0.3290061289435605,1.0,7/21,53.76%,HMGB1;C1QBP;CALR;ANO6;CXCL10;GAS6;MOSPD2
gsea,regulation of transport (GO:0051049),-0.3807650155168261,-1.1263148388090112,0.2911392405063291,0.3295259254902615,1.0,6/17,46.18%,ACTG1;ACTB;YRDC;GAPVD1;ICA1;DNAJA1
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),-0.30729855168407316,-1.1254136892992712,0.27586206896551724,0.33041447093415394,1.0,11/37,51.37%,EZH2;CLASP2;CLASP1;MTOR;SPRED1;DAB2IP;GATA3;RGCC;USF3;EPHA3;LOXL2
gsea,regulation of dendrite morphogenesis (GO:0048814),-0.38611274415587726,-1.1234335668720448,0.28937007874015747,0.33264036188115903,1.0,6/15,42.33%,NEDD4;CAPRIN1;SS18L2;GSK3B;FBXW8;RAP2A
gsea,cellular response to peptide (GO:1901653),0.3359624718180207,1.122330977446039,0.2729044834307992,0.5236190502168954,1.0,18/28,35.44%,ZFP36L1;RIPK2;ICAM1;PRNP;CASP4;ITGA4;ADRB2;APP;FCGR2B;VCAM1;LRP1;CACNA2D1;ABCC1;XBP1;CD36;CACNA1A;LGMN;IGF1
gsea,amino acid transport (GO:0006865),-0.35876804377211285,-1.1203345262226327,0.2892249527410208,0.3363519657478085,1.0,9/20,47.80%,SLC7A5;SLC7A1;SLC16A10;SLC7A3;SLC38A1;SLC1A4;SLC3A1;SLC3A2;SLC1A5
gsea,organic acid transport (GO:0015849),-0.3060741736854284,-1.118451962147684,0.28435114503816794,0.33850795572450265,1.0,20/38,49.79%,SLC25A10;GOT2;SLC7A1;SLC19A1;SLC25A17;SLC16A10;SLC7A3;SLC38A1;SLC1A4;ABCG2;SLC3A1;NCOA1;ACSL1;SLC3A2;STARD5;ABCC4;SLC16A1;SLC1A5;SLC25A14;NCOA2
gsea,regulation of immune effector process (GO:0002697),-0.44154568317046605,-1.1177642851720944,0.34439834024896265,0.33906830822901224,1.0,2/16,8.79%,C1QBP;PHB2
gsea,chemical homeostasis (GO:0048878),0.3370088927398743,1.1155582628356877,0.3004115226337449,0.5347356636299488,1.0,15/26,31.76%,IRS2;PNPLA8;ABCB4;ATP13A2;SLC4A7;ACOX1;KLHL3;ABHD4;TLCD2;TLCD1;ZBTB20;PPARG;VGF;NR1H3;ADCK1
gsea,positive regulation of protein localization to cell periphery (GO:1904377),-0.3165825678933689,-1.1140065230573613,0.3018867924528302,0.34364620242273136,1.0,11/30,34.06%,GPSM2;NUMA1;AKT1;EPB41L2;KIF5B;PRKCE;PDPK1;IFNG;SPTBN1;PLS1;CNPY4
gsea,cellular response to calcium ion (GO:0071277),-0.3292638487701023,-1.1126459605079477,0.2938689217758985,0.34510276544611496,1.0,10/25,39.46%,ECT2;PPIF;CLIC4;CPNE1;ADD1;SMPD1;PRKAA1;RASGRP2;CPNE2;MEF2C
gsea,positive regulation of protein kinase B signaling (GO:0051897),-0.2664919476656885,-1.110675230178336,0.2766798418972332,0.347483900478735,1.0,25/68,53.28%,HSP90AA1;HSP90AB1;C1QBP;PARK7;MAZ;PHB;MYDGF;MTDH;HAX1;CPNE1;PDPK1;PIK3CG;PTPN11;THEM4;TRIB3;CCL3;STRN;PIK3CB;BTC;GATA3;HPSE;PIK3CA;F3;GAS6;FLT3
gsea,establishment of protein localization to membrane (GO:0090150),-0.32236594255348305,-1.110071934310582,0.3097165991902834,0.34791732709685735,1.0,14/28,42.80%,ZDHHC2;SYNE3;ZDHHC6;COX18;ZDHHC12;GORASP2;ZDHHC15;TAOK2;ICMT;RAB3GAP1;AFDN;ZDHHC21;PRKCI;VPS37C
gsea,positive regulation of signaling receptor activity (GO:2000273),-0.330892833997519,-1.1096303231888733,0.3012295081967213,0.3481635852433681,1.0,8/27,28.23%,HDAC1;PARK7;TAF1;HDAC2;IFNG;HDAC6;BUD31;ADAM17
gsea,regulation of cation channel activity (GO:2001257),-0.3250649065337384,-1.1070059424904242,0.29764453961456105,0.35136812431507514,1.0,29/29,99.49%,CALM2;FGF13;MEF2C;NOS1;PTK2B;SLMAP;GRIN1;NLGN2;MINK1;KCNAB1;JPH3;JPH4;SELENON;SHANK1;MMP9;CACNB3;DAPK1;ACTN2;PRRT1;DLG2;APP;HOMER1;NEFL;NETO1;CAMK2D;ITGB1;CNIH2;AHNAK;CTSS
gsea,vesicle organization (GO:0016050),-0.32915392720367864,-1.1034554917223307,0.3213572854291417,0.35587605906346703,1.0,16/26,54.21%,CORO1A;PI4K2B;HOOK1;USP8;EPS15;SNX10;WASHC5;HOOK3;ZFYVE16;HOOK2;SNX11;ARFGEF2;ALS2;PLEKHF1;CAV2;EXOC8
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3038226932448106,-1.1007695677838276,0.3145631067961165,0.3592636040982414,1.0,17/38,47.19%,NUP62;RNF126;AKT1;CNOT9;WDR54;HGS;STAM2;EPS15;EPS15L1;PTPN12;HIP1R;RHBDF2;CBL;CCDC88A;BTC;DAB2IP;STAM
gsea,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.36562983787353176,1.1005982265581484,0.32432432432432434,0.5621949738681713,1.0,10/19,27.66%,CCL5;JAK2;SH2B3;KIT;TNF;NLK;F2R;IL10RA;SOCS3;IL10
gsea,cell-substrate junction assembly (GO:0007044),0.36024672778237127,1.1003949113246372,0.31275720164609055,0.5594802888541585,1.0,11/19,29.19%,ACTN1;DLC1;PTPRK;ITGA6;PEAK1;FN1;LAMC2;SORBS1;ACTN2;COL17A1;DST
gsea,cotranslational protein targeting to membrane (GO:0006613),-0.40578657045845234,-1.0995802084734287,0.38049713193116635,0.3605662506960802,1.0,15/32,31.43%,ARL6IP1;RPS17;RPS2;RPL14;SSR2;RPS15;RPS25;RPL23A;RPL31;RPS6;RPL4;SRP68;SIL1;SRP72;RPL5
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.30095414913782714,-1.0977297599444826,0.33064516129032256,0.36264471403895276,1.0,19/38,49.30%,UBB;AKT1;PRDX4;TRAF2;ROCK2;ROCK1;IRAK1BP1;BIRC3;TAB1;ERC1;MAP3K7;BCL3;CHUK;NLRC3;RELA;DAB2IP;BIRC2;TAB3;RELB
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2706724881368218,1.0969458599943114,0.29740518962075846,0.5638845615793289,1.0,70/70,92.13%,XCL1;TNFAIP3;NFKBIA;CD200;ID3;DAP;ZC3H12A;TRIB1;SP100;TMSB4X;PRNP;SMAD7;SIGIRR;KLF4;SPI1;PRMT2;BHLHE40;MTURN;TRIM21;ADGRG3;ANXA4;HDAC4;FOXP3;BMP7;ERBIN;NUPR1;IRAK3;FZD6;NLRP3;NFKBIE;PIM1;DDIT3;TCF7L2;TNFRSF4;ACOD1;ARRB1;PARP10;SFRP4;GAS6;PTCH1;GFI1;EIF2AK4;DAB2IP;ID1;NLRC3;SIRT1;BTRC;TNFSF4;TRAF3;CHUK;EOMES;LRRC14;HAVCR2;UFL1;MEN1;KEAP1;USP7;FLNA;SETD6;RB1;TAF3;EGLN1;CACTIN;TRIM37;HDAC2;PAXIP1;ID2;TAF1;PHB2;CDKN2A
gsea,positive regulation of cell motility (GO:2000147),0.25389446597476084,1.0922955996645762,0.2951127819548872,0.5706230504628971,1.0,104/104,96.68%,CCR7;CCL5;VSIR;RHOC;NTRK3;PRKCA;ITGAX;ITGB1;MGAT5;CCN1;SEMA4C;MAP4K4;SEMA7A;F2RL1;PECAM1;KIT;SPOCK2;IL1B;CPNE3;CTSH;ITGA6;FLT1;PDGFB;LEF1;F2R;AIF1;SEMA6D;PAK1;COL1A1;THBS1;SPRY2;NEDD9;LAMC2;GCNT2;CASS4;SEMA4B;RET;MYO1C;CSF1;GRN;DAB2;WNT11;MMP14;PDGFA;HSPA5;PPM1F;CCR1;TIAM1;HBEGF;PIK3CD;XBP1;MMP9;CCL7;CXCL16;TJP1;GPNMB;CSF1R;ADRA2A;TWIST1;PLAU;IGF1;FAM110C;LGR6;PLET1;FGR;VEGFA;SMIM22;SPHK1;ADAM9;CAVIN1;MYADM;EDN1;RIPOR1;NOTCH1;F3;VIL1;PTK2B;CD151;ATM;BCAR1;RACK1;ACVR1;STAT3;ELP3;CCL3;CARMIL2;GRB7;RUFY3;SOD2;SEMA4A;SYNE2;ADAM17;ELP6;SUN2;ROCK2;ELP5;RDX;HRAS;MAZ;CCAR1;ARHGEF39;ACTG1;ACTN4;GTSE1
gsea,positive regulation of vasculature development (GO:1904018),0.28757621350340323,1.0888515012146662,0.312015503875969,0.5748545918914858,1.0,51/51,96.94%,PRKCA;ITGAX;ITGB1;ZC3H12A;HIF1A;NINJ1;ETS1;ITGB8;PLCG1;JUP;IL1B;SERPINE1;CTSH;FLT1;ECM1;CD40;PIK3R6;TNFSF12;HIPK2;THBS1;FGF2;GRN;PIK3CD;XBP1;CCR3;RUNX1;PGF;TWIST1;ANGPTL4;ANXA3;VEGFA;SPHK1;VASH2;HSPB1;RAMP2;F3;HMOX1;RHOB;PRKD2;SIRT1;HIPK1;PRKCB;HK2;AGO2;PAK4;PDPK1;VEGFB;MTDH;MYDGF;SP1;BRCA1
gsea,dephosphorylation (GO:0016311),-0.26127977108915174,-1.0868127614885845,0.31749049429657794,0.37762179233899434,1.0,30/65,43.67%,PPM1G;TIMM50;PGP;PPP5C;PSPH;PPP2CB;PTPN6;PPP2R5D;PPP3CB;PTPN7;FRA10AC1;CTDP1;CTDSP1;PDXP;PDP1;UBLCP1;TAB1;DUSP12;PTPN12;MTMR4;PXYLP1;PPP1CB;PPP4R1;HDHD2;SBF1;PTPN9;BTRC;PPM1M;DUSP5;ACP6
gsea,cellular response to amino acid stimulus (GO:0071230),0.36993237112245275,1.0863419047165004,0.3087378640776699,0.5770629767492829,1.0,15/15,93.31%,SESN3;CASTOR1;SESN1;XBP1;SLC38A9;RPTOR;RRAGB;UBR1;GLRA1;SH3BP4;CAPN2;SESN2;KLHL22;MTOR;IPO5
gsea,response to organic cyclic compound (GO:0014070),-0.331092325673983,-1.0858740814522019,0.3238512035010941,0.37854978092319236,1.0,7/26,47.25%,DHFR;CDKN2D;GLDC;SPP1;CCL3;STAT3;DRD4
gsea,positive regulation of leukocyte chemotaxis (GO:0002690),-0.34043636748604283,-1.0850865550623534,0.3319838056680162,0.37927137805636907,1.0,6/27,38.72%,HMGB1;C1QBP;CALR;VEGFB;ADAM17;ANO6
gsea,regulation of phagocytosis (GO:0050764),-0.3315570079097045,-1.0806959816170916,0.3400900900900901,0.38500106108709414,1.0,8/28,38.62%,LYAR;LMAN2;CALR;IFNG;RAB27A;DOCK2;PLSCR1;SCARB1
gsea,positive regulation of epithelial cell migration (GO:0010634),-0.2780146223696494,-1.0791717227366653,0.30851063829787234,0.38675001361240213,1.0,20/53,50.35%,PFN1;AKT1;CALR;ROCK2;CLASP2;PRKCE;CLASP1;MTOR;PIK3CG;IFNG;HDAC6;SCARB1;PIK3CB;BCAR1;PRKD2;RHOB;GATA3;PTK2B;VIL1;SPARC
gsea,cellular response to organic substance (GO:0071310),0.273427964386889,1.0782982690996312,0.32745098039215687,0.5911967599139667,1.0,56/56,91.57%,CCR7;CCL5;NFAT5;RAMP3;RAMP1;SIGIRR;KLF4;IL1B;CPNE3;LRRK2;PDGFB;TNF;IL18R1;SMAD3;LEF1;PID1;CLEC3B;CXCR4;ACVRL1;CCL2;SOCS2;PTPN13;TIPARP;CTNNB1;CSF1R;PTPN5;ADRA2A;NCOA3;CASP1;SPHK1;STAT5B;PTPN23;NDOR1;MAPK8;FLT3;RAMP2;NCOA2;MAPK7;NCOA1;RACK1;ACVR1;STAT3;NOS1;PTPN9;CCL3;PTPN12;PTPN11;HDAC6;URI1;PTPN7;SHC1;HTRA2;HAX1;PTPN6;KHSRP;PARK7
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),0.35136270746706755,1.0781663266776584,0.36174242424242425,0.5882277182900233,1.0,13/23,29.61%,JAK2;TXK;KIT;FLT1;PDGFB;FES;HCK;PIBF1;SYK;BTK;LYN;TEC;CSF1R
gsea,defense response to symbiont (GO:0140546),0.27109208732765544,1.0778887922221922,0.31952662721893493,0.5856026447834217,1.0,64/64,94.98%,BCL2;RTP4;SAMHD1;IRF7;IFI27;IFNAR2;STAT1;ISG20;BCL2L1;IFITM2;TRIM56;F2RL1;RNASEL;IFITM1;IFIT1;ISG15;IRF1;TRIM5;SHFL;ZBP1;RSAD2;IFITM3;RNASE6;CD40;PMAIP1;OAS3;TLR7;IFIT3;MAP3K14;DDX58;TLR2;MAVS;ACOD1;IRF2;STAT2;EIF2AK2;LYST;IFIH1;BST2;NDUFAF4;MOV10;RELA;BNIP3;IL21;IFIT2;AGBL5;RIPK3;ATG7;PRF1;PLSCR1;TTC4;SETD2;DDIT4;FLNA;NCBP3;ABCE1;FADD;MLKL;EXOSC5;EXOSC4;SKP2;CGAS;SERINC3;G3BP1
gsea,regulation of protein kinase B signaling (GO:0051896),-0.2475776807334934,-1.0763080863249506,0.31237322515212984,0.390388029589847,1.0,33/84,53.28%,HSP90AA1;HSP90AB1;C1QBP;PARK7;MAZ;AKT1;PHB;MYDGF;MTDH;HAX1;CPNE1;PHLDA3;PDPK1;PIK3CG;XDH;PTPN11;THEM4;TRIB3;CCL3;STRN;PIK3CB;TSC2;SIRT1;HYAL2;RACK1;PHLPP2;BTC;GATA3;HPSE;PIK3CA;F3;GAS6;FLT3
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3297526424405246,-1.074609769231103,0.3731958762886598,0.39169618827720704,1.0,11/22,37.99%,TMED2;LMAN1;PPP6R3;CUL3;TRAPPC9;SEC24D;NSF;SEC23IP;ANKRD28;GOLGA2;PPP6R1
gsea,vesicle coating (GO:0006901),-0.3297526424405246,-1.074609769231103,0.3731958762886598,0.39169618827720704,1.0,11/22,37.99%,TMED2;LMAN1;PPP6R3;CUL3;TRAPPC9;SEC24D;NSF;SEC23IP;ANKRD28;GOLGA2;PPP6R1
gsea,COPII vesicle coating (GO:0048208),-0.3297526424405246,-1.074609769231103,0.3731958762886598,0.39169618827720704,1.0,11/22,37.99%,TMED2;LMAN1;PPP6R3;CUL3;TRAPPC9;SEC24D;NSF;SEC23IP;ANKRD28;GOLGA2;PPP6R1
gsea,regulation of JNK cascade (GO:0046328),0.2759483986257128,1.0731816772844296,0.35040983606557374,0.5925493851540377,1.0,52/52,99.61%,CCR7;PINK1;GADD45B;DUSP10;TRAF1;SLAMF1;MAP4K4;PER1;F2RL1;RASSF2;MFHAS1;TGFBR3;NCF1;IL1B;SH3RF1;GADD45A;MTURN;SIRPA;GADD45G;MAPK8IP1;APP;FCGR2B;UNC5CL;HIPK2;PHLPP1;TRAF4;TAOK1;LTBR;DUSP3;FZD7;TRAF5;RASGRP1;FKTN;MAP3K11;RIPK1;MINK1;PJA2;PTK2B;DAB2IP;RAP2A;TRAF3;MAP3K5;TAOK2;DUSP22;DUSP19;AXIN1;MEN1;AIDA;TRAF2;HRAS;COPS5;HMGB1
gsea,gonad development (GO:0008406),-0.37470182039813005,-1.07300770780951,0.350210970464135,0.3936654905101927,1.0,8/16,48.11%,NUP107;MSH2;BIK;UTF1;MKKS;WNT4;GATA3;SOX8
gsea,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3576201475866463,-1.0709892296001502,0.3553398058252427,0.3962162815242764,1.0,5/17,40.21%,UBB;FADD;BIRC3;CHUK;TRAF3
gsea,regulation of peptide hormone secretion (GO:0090276),0.32518927812912307,1.0693103875931358,0.36363636363636365,0.5976090744318523,1.0,17/27,32.02%,CCL5;PRKCA;ITPR2;IL1B;TNF;ITPR1;HFE;GLP1R;CACNA2D2;ITPR3;DPP4;CLOCK;NOS2;KCNG2;ADRA2A;CACNA1A;RAPGEF4
gsea,regulation of fat cell differentiation (GO:0045598),-0.2804989542269208,-1.0652613129156832,0.336734693877551,0.40403010750031587,1.0,10/38,33.30%,ID2;E2F1;AKT1;ASXL1;ANKRD26;CEBPB;CREB1;CARM1;TRIB3;FTO
gsea,positive regulation of p38MAPK cascade (GO:1900745),0.36092803008929897,1.065061747813063,0.3824091778202677,0.6034663360488804,1.0,16/16,95.30%,ZC3H12A;GADD45B;MFHAS1;SPI1;NCF1;IL1B;GADD45A;GADD45G;VEGFA;SPHK1;MINK1;PJA2;RELL1;XDH;MAP3K4;PRMT1
gsea,cell-cell junction organization (GO:0045216),0.30882049301111136,1.064618727113992,0.3577981651376147,0.6012111057254617,1.0,16/30,32.30%,PKP3;F2RL1;JUP;SMAD3;PVR;CDH1;F2R;FSCN1;PKP2;LIM2;TGFB2;TGFB3;NECTIN2;TJP1;CSF1R;DSG2
gsea,substrate adhesion-dependent cell spreading (GO:0034446),-0.3667745736499946,-1.0634627470422515,0.3861788617886179,0.40619998786105627,1.0,4/15,30.79%,KIF14;LPXN;SRGAP2;MEGF9
gsea,positive regulation of signal transduction (GO:0009967),-0.2320358787314799,-1.0629212513646695,0.32264957264957267,0.4066301475747987,1.0,43/119,49.32%,UCHL5;DEPDC1B;TEDC1;PIH1D1;BAX;SMARCA4;SMARCB1;PHB;SNX5;ASXL1;VPS35;PHIP;TEDC2;BMP2K;MT3;BAK1;ING5;FLNA;TUBD1;LANCL2;PTPN11;GKAP1;CDC73;PDCL;AGPAT1;HTT;TRIM44;PRKCB;POGLUT1;PRKCI;STAT3;CREBBP;SIRT1;KAT2B;ERN1;ZMIZ1;PRKD2;DAB2IP;KLF2;YAP1;GATA3;NEPRO;PTK2B
gsea,negative regulation of type I interferon production (GO:0032480),0.32835720365341087,1.0627445310237098,0.36242884250474383,0.6021605075584018,1.0,22/22,95.59%,TNFAIP3;REL;IKBKE;ISG15;TRIM25;DHX58;SIRPA;PTPRS;DDX58;MAVS;IL10;ACOD1;IFIH1;UBE2L6;RELB;NLRC3;TRAF3IP1;HAVCR2;YY1;NPLOC4;CACTIN;PIN1
gsea,cellular response to insulin stimulus (GO:0032869),-0.25770829740128653,-1.062011374403937,0.3409090909090909,0.4076290133514719,1.0,27/61,46.21%,PKM;PARP1;PCK2;AKT1;MYO5A;PHIP;SHC1;INSIG1;AP3S1;PDPK1;C2CD5;ATP6V0A2;TCIRG1;TRIB3;PRKDC;GRB7;IDE;NAMPT;PDE3B;GSK3B;GOT1;PRKCI;KAT2B;BCAR1;RHOQ;LPIN2;BAIAP2
gsea,bone development (GO:0060348),0.3541832149441491,1.0617561956730586,0.3691683569979716,0.6011889045442603,1.0,9/16,26.21%,RPL13;PTGER4;TGM2;LRP6;WNT1;P3H1;SULF2;SH3PXD2B;SKI
gsea,beta-catenin-TCF complex assembly (GO:1904837),-0.32155256983748437,-1.0608612464563176,0.38414634146341464,0.4089030099518375,1.0,10/23,35.99%,HDAC1;SMARCA4;RUVBL1;ASH2L;LEO1;RBBP5;MEN1;PYGO2;CDC73;TRRAP
gsea,regulation of response to external stimulus (GO:0032101),0.26056684836519833,1.06023273099268,0.36511156186612576,0.6013399958524885,1.0,64/64,93.35%,XCL1;JAK2;BCL6;SAMHD1;TMSB4X;AREL1;P2RX4;CCR2;SEMA7A;F2RL1;FOXP1;DHX58;IRF1;ANXA1;CASP4;TRIM5;ZBP1;PTGS2;USP18;HCK;F2R;FCGR2B;BST1;SPATA2;CXCR4;GNAT1;CX3CL1;GRN;EFNB2;PIK3AP1;SBNO2;CASP12;CD36;ADGRA2;SAG;APPL2;CASP1;FGR;ALOX5;ELMOD2;PDE6A;BIRC2;RELA;AKNA;TNFSF4;TRAF3;TKFC;LACC1;METAP1;CD55;CELF1;NMT2;UFL1;FNTB;ERAP1;BIRC3;ZMPSTE24;LRP8;SETD6;NMT1;PSMA6;PARK7;METAP2;USP14
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.28839758092511225,1.0565662557189317,0.342911877394636,0.605974440191375,1.0,41/41,96.94%,LGALS3;TNFAIP3;BCL2;FAS;ICAM1;BCL2L1;AR;TMBIM1;IL1B;SH3RF1;SERPINE1;CSF2;ITGA6;TNF;TNFSF10;THBS1;GPX1;TCF7L2;IGF1;PF4;RIPK1;HMOX1;MAPK7;ARHGEF2;RELA;TNFRSF10B;ACVR1;HTT;GSK3B;HSPA1A;HSPA1B;EYA3;DDX3X;BIRC6;FADD;PHIP;TRAF2;PSME3;AKT1;PARK7;BRCA1
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3352542225701393,1.0563376920697736,0.3712121212121212,0.6032772108043547,1.0,21/21,95.59%,DUSP4;SPRY1;CAMK2N1;DUSP10;SIRPA;DUSP6;SPRY2;CNKSR3;LYN;DUSP3;TNIP1;SPRED3;TLR4;FBLN1;SPRED2;DAB2IP;SPRED1;RPS6KA6;PHB;EZR;PIN1
gsea,circulatory system development (GO:0072359),-0.27036470868558793,-1.0548307813000668,0.35625,0.4173161053425985,1.0,18/52,44.76%,CDKN1A;MTHFD1;ID2;CACYBP;ZDHHC16;SMYD4;NXN;SMG9;PTPN11;PDLIM7;KAT2A;SRF;MEF2C;TSC2;ACVR1;KAT2B;DVL2;MKKS
gsea,phosphatidylcholine metabolic process (GO:0046470),-0.3041029100877648,-1.054812846696407,0.35789473684210527,0.41696308826941797,1.0,12/30,49.12%,DBI;CSNK2A2;PLA2G12A;STARD7;PCYT1A;MBOAT1;LPCAT1;GPAT4;CHPT1;LPIN2;MBOAT2;PLA2G6
gsea,stem cell differentiation (GO:0048863),-0.345814002708986,-1.0530753147347185,0.39250493096646943,0.41906392069757087,1.0,8/17,44.33%,PSMD11;MTF2;SETD6;METTL5;SETD2;UFL1;MEF2C;EPOP
gsea,negative regulation of intracellular signal transduction (GO:1902532),-0.23516131381038408,-1.0529077039028916,0.34854771784232363,0.4189292140267932,1.0,42/102,45.66%,CIT;CDC34;TRIM59;AKT1;MAP2K3;PPIF;NOC2L;PEBP1;CACTIN;CPNE1;PHLDA3;URI1;TBC1D7;MDM2;TNFAIP8L1;PLEK;SH3BP1;USP10;DDIT4;DDX3X;XDH;DEPDC5;HERPUD1;THEM4;TRIB3;PRKAA1;PDE3B;TSPAN6;PIK3CB;GPD1L;NPRL3;SPRED1;TSC2;SIRT1;HYAL2;MAPKAPK5;NLRC3;RACK1;FNIP1;PHLPP2;RELA;DAB2IP
gsea,epidermal growth factor receptor signaling pathway (GO:0007173),-0.3201264015178743,-1.05179651146626,0.3671399594320487,0.4201897079076176,1.0,15/26,51.27%,AKT1;SHC1;RPS6KA5;PDPK1;KIF16B;ADAM17;PTPN11;GRB7;CBL;BCAR1;BTC;PTK2B;VIL1;GAREM1;PIK3CA
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3062867630643728,-1.0514745557170886,0.3584158415841584,0.42027456645816164,1.0,16/27,46.21%,ACTB;NEFH;RB1;RYK;MAP1A;TAOK2;MAP2;FARP1;MEF2C;ABITRAM;DVL1;UNK;AFG3L2;LLGL1;DOCK7;BAIAP2
gsea,regulation of interleukin-4 production (GO:0032673),0.3446309576340705,1.0495698405271152,0.3768939393939394,0.6148766785737891,1.0,11/17,25.54%,PRKCZ;RARA;IRF4;CD86;ZFPM1;CD40LG;LEF1;FOXP3;SYK;NLRP3;DDIT3
gsea,actin filament bundle organization (GO:0061572),-0.33395001495159166,-1.0443547889365508,0.39112050739957716,0.43035712473173315,1.0,4/19,33.42%,EZR;LCP1;ADD1;PLS1
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),0.29028361025995564,1.0428737115728905,0.37074148296593185,0.6259339931571505,1.0,38/38,95.73%,NFKBIA;PDCD4;TNFSF14;ZC3H12A;NFAT5;TMSB4X;CD86;RASSF2;C1QTNF4;SPI1;IL1B;TERF2IP;TNF;APP;TLR7;ADGRG3;BMP7;IL23A;NLRP3;CD14;TLR2;EIF2AK2;EP300;TLR4;SPHK1;HDAC7;RELA;NLRC3;TRIM44;TSPAN6;BCL3;DDX3X;PTP4A3;CPNE1;PHB;EZR;PHB2;ACTN4
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.27111934716938735,1.042382247165514,0.3817097415506958,0.6238624844867641,1.0,31/50,31.81%,PDCD4;ITGB1;FURIN;RPS27A;PRKCZ;JUN;PTPRK;LRRC32;ENG;SMAD7;TGFBR3;SMAD3;NLK;ARHGEF18;HFE;EID2;NRROS;TWSG1;BMP7;GCNT2;ACVRL1;RUNX2;SMAD5;INHBA;RGMB;TGFB2;SKI;TGFB3;FOS;BAMBI;SLC33A1
gsea,branched-chain amino acid catabolic process (GO:0009083),-0.367780477001054,-1.041289197214046,0.3709981167608286,0.4341066013400764,1.0,9/15,45.88%,BCKDK;BCAT1;BCAT2;BCKDHB;DLD;IVD;HIBADH;HSD17B10;HIBCH
gsea,branched-chain amino acid metabolic process (GO:0009081),-0.367780477001054,-1.041289197214046,0.3709981167608286,0.4341066013400764,1.0,9/15,45.88%,BCKDK;BCAT1;BCAT2;BCKDHB;DLD;IVD;HIBADH;HSD17B10;HIBCH
gsea,phosphatidylinositol-mediated signaling (GO:0048015),0.296565701628986,1.0412802157021683,0.3895582329317269,0.6230309704374931,1.0,30/30,92.64%,ZFP36L1;CD160;PIK3R1;IRS2;INPP5F;PLCB2;PITPNM2;PTAFR;PIK3R2;PIK3CD;CSF1R;PLCB4;IGF1;PIK3R5;PIK3C2A;PLEKHA1;PI4KB;NF1;PLCL1;EDN1;PIK3CA;GATA3;HTR2A;PIK3CB;PLCH1;PI4KA;PIK3CG;EZR;AKT1;C1QBP
gsea,defense response to virus (GO:0051607),-0.2564444758163262,-1.0378061004866335,0.3883089770354906,0.4390823811721582,1.0,30/70,48.98%,G3BP1;SERINC3;PHB2;CGAS;SKP2;PHB;EXOSC4;EXOSC5;CLPB;MLKL;FADD;ATAD3A;ABCE1;NCBP3;FLNA;DDIT4;SETD2;TTC4;PLSCR1;PRF1;ATG7;RIPK3;AGBL5;IFIT2;IL21;BNIP3;RELA;MOV10;NDUFAF4;BST2
gsea,response to peptide (GO:1901652),0.3334901490279332,1.0369374464677856,0.37425742574257426,0.6292492252645678,1.0,13/20,36.11%,STAT4;STAT1;PRNP;RAMP3;ANXA1;IRF5;ERBIN;STAT5A;MMP9;STAT2;CACNA1A;CACNA1B;STAT6
gsea,mRNA destabilization (GO:0061157),-0.3234417372739289,-1.035435635831059,0.41353383458646614,0.4423490348944529,1.0,14/22,46.68%,TARDBP;KHSRP;ROCK2;METTL14;ROCK1;METTL16;CNOT1;FTO;CELF1;METTL3;GIGYF2;DIS3L2;PLEKHN1;MOV10
gsea,regulation of hydrolase activity (GO:0051336),-0.30575231068215764,-1.034023759913072,0.4,0.4440815905952342,1.0,10/27,45.66%,RDX;TBC1D10B;TDG;ADAP1;SIPA1L1;WRN;RAB3GAP1;CHN2;NOS1;DAB2IP
gsea,positive regulation of MAPK cascade (GO:0043410),0.24414641386309027,1.033444999343144,0.3731060606060606,0.6338064011119817,1.0,110/110,99.61%,CCR7;CCL5;XCL1;TNFSF11;NTRK3;PRKCA;GPR183;PRKCZ;ICAM1;SEMA4C;NRP1;SLAMF1;SEMA7A;F2RL1;RAMP3;CD44;CCL1;MFHAS1;KIT;TRIM5;LRRK2;ABCA7;CCL4;MTURN;FLT1;PDGFB;TNF;ADAM8;GLIPR2;CD40;ADRB2;LIF;CD4;PIK3R6;F2R;APP;GPR55;SCIMP;DHX33;SPRY2;WWC1;P2RY6;GCNT2;RET;TAOK1;CCL2;CX3CL1;FGF2;PDGFA;TGFB2;CCR1;TMEM106A;CCL8;CCL7;GPNMB;CSF1R;APOE;PTPRJ;RASGRP1;ADRA2A;BCAR3;PLCG2;EIF2AK2;CD36;ARRB1;KSR1;IGF1;OSM;RAPGEF2;PIK3R5;CCL25;JCAD;C5AR1;NOTCH2;CD74;CCL22;VEGFA;NPNT;FBXW7;CAV2;FLT3;GAS6;EDN1;FFAR4;NOTCH1;GAREM1;CCL17;PTK2B;DAB2IP;PRKD2;HTR2A;CCL3;TAOK2;DUSP19;PTPN11;GSDME;MID1;RYK;PIK3CG;ROCK1;MT3;SHC1;ROCK2;MYDGF;PHB;HRAS;PHB2;MIF;EZH2;HMGB1
gsea,cation transmembrane transport (GO:0098655),-0.35601953760926164,-1.0313797809850112,0.4,0.44773105743872377,1.0,8/15,46.82%,SLC7A5;SFXN1;SLC7A1;SLC7A3;SLC6A9;SFXN2;SLC25A19;SLC3A2
gsea,positive regulation of angiogenesis (GO:0045766),0.26091450942389993,1.0310901179390255,0.3860640301318267,0.635788738520326,1.0,60/60,96.94%,PRKCA;ITGAX;ITGB1;ZC3H12A;HIF1A;S100A1;NINJ1;ETS1;ITGB8;PLCG1;KLF4;JUP;IL1B;SERPINE1;CTSH;FLT1;ECM1;CD40;PIK3R6;TNFSF12;HIPK2;THBS1;ITGA5;FGF2;GRN;PIK3CD;XBP1;CCR3;RUNX1;TJP1;PGF;TWIST1;ANGPTL4;ANXA3;FOXC2;VEGFA;SPHK1;DLL1;VASH2;HSPB1;SMAD1;RAMP2;F3;HMOX1;RHOB;PRKD2;SIRT1;HIPK1;PRKCB;HK2;AGO2;PAK4;SIRT6;PDPK1;VEGFB;MTDH;MYDGF;SP1;PKM;BRCA1
gsea,regulation of heart contraction (GO:0008016),-0.28776305205065233,-1.0307266209998933,0.40043763676148797,0.44845635335305684,1.0,9/36,49.98%,CALM2;ATP2A2;CELF2;AHCYL1;TPM1;TRPC1;NOS1;ATP1A1;FXYD3
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.31324374319245835,-1.0304697622650283,0.41141732283464566,0.4484331710057745,1.0,7/24,45.23%,ACTN4;PHB2;PHB;PTP4A3;DDX3X;TRIM44;RELA
gsea,regulation of endothelial cell migration (GO:0010594),0.28013722924659223,1.0292126411922629,0.40693430656934304,0.6368501897158457,1.0,43/43,88.97%,PRKCA;ZC3H12A;SP100;ETS1;NRP1;ITGB3;FOXP1;DNAJA4;CEACAM1;THBS1;DLL4;ACVRL1;FGF2;RIN2;GRN;GLUL;PIK3CD;NRP2;APOE;PTPRM;ANXA3;ABL1;FOXC2;VEGFA;BCAS3;PRCP;NF1;EDN1;SPARC;VASH1;PTK2B;GATA3;RHOB;DAB2IP;PRKD2;BCAR1;PIK3CB;SCARB1;PIK3CG;SH3BP1;ROCK2;CALR;AKT1
gsea,protein dephosphorylation (GO:0006470),-0.24474575882883542,-1.0266424266034966,0.40576923076923077,0.4539670840069519,1.0,29/63,42.84%,PPM1G;TIMM50;PGP;PPP5C;PPP2CB;PTPN6;RPRD1B;PPP2R5D;PPP3CB;PTPN7;CTDP1;CTDSP1;PDXP;PDP1;EYA3;PTPN11;UBLCP1;TAB1;DUSP22;DUSP12;PTPN12;MTMR4;PPP1CB;PPP4R1;SBF1;PTPN9;BTRC;PPM1M;DUSP5
gsea,inorganic cation transmembrane transport (GO:0098662),0.2572593993136644,1.0255161902693246,0.4196078431372549,0.6417187460705207,1.0,37/71,39.20%,ORAI1;ATP2A3;P2RX4;TRPV2;SCN1B;TRPM1;HVCN1;ATP1B1;SLC30A1;SLC41A1;SLC9A9;MCOLN2;TRPA1;KCNK10;SCN4B;SLC39A13;SLC39A1;KCNN4;KCNJ8;SLC6A11;KCNC1;SLC12A3;KCNK7;CACNA2D4;SLC8A1;ATP1A2;KCNG2;CACNA1A;ABCB8;ATP6V0E2;SLC6A12;OTOP1;SLC39A14;KCNJ14;SLC6A13;ATP1A3;KCNAB1
gsea,peptidyl-tyrosine dephosphorylation (GO:0035335),0.32917962813122015,1.0215298261826267,0.437984496124031,0.6474499121954432,1.0,19/19,94.30%,DUSP4;DUSP2;DUSP10;DUSP1;DUSP16;DUSP6;PTPRS;DUSP7;PTPN13;DUSP3;PTPRJ;DUSP18;DUSP5;PTPN9;PTPN12;DUSP22;PTPN11;PTPN6;PGP
gsea,negative regulation of protein kinase B signaling (GO:0051898),-0.3290111402927626,-1.0213839888230087,0.4251012145748988,0.46166763707729,1.0,11/18,45.07%,AKT1;PHLDA3;XDH;THEM4;TRIB3;PIK3CB;TSC2;SIRT1;HYAL2;RACK1;PHLPP2
gsea,B cell activation (GO:0042113),-0.26775894347097157,-1.0207801757883053,0.41318681318681316,0.4622463641400684,1.0,12/45,40.77%,SLC25A5;HSPD1;PHB2;PHB;TCF3;DCAF1;MSH2;KLF6;RABL3;ADAM17;MEF2C;PRKCB
gsea,positive regulation of biosynthetic process (GO:0009891),-0.3185232668992442,-1.019109888044043,0.44970414201183434,0.46455258907500785,1.0,6/22,25.16%,AKT1;HDAC2;VIM;CREB1;MTOR;RAB27A
gsea,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.322742133931849,-1.0174180289242956,0.4432773109243697,0.46675021743630446,1.0,9/21,50.10%,STK39;NEDD4;PRKCE;FGF13;GLRX;GPD1L;HECW2;FXYD3;SLMAP
gsea,ameboidal-type cell migration (GO:0001667),-0.3201259341304066,-1.0158965175436032,0.416,0.4687925594229076,1.0,8/21,43.42%,CORO1C;AKT1;CENPV;SRGAP2;SEMA4A;NANOS1;PHACTR4;PDXDC1
gsea,stress-activated MAPK cascade (GO:0051403),-0.28919080553926146,-1.01394137244807,0.43418467583497056,0.47134022222779337,1.0,12/30,42.10%,UBB;UBE2N;MAP2K3;GPS1;CUL1;TAB1;MAP3K7;TAOK2;CHUK;MAP3K5;MAP3K20;BTRC
gsea,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3650673252005041,1.0131536973532347,0.4194831013916501,0.6624368116958972,1.0,15/15,94.84%,TNFAIP3;PDCD4;TRIB1;AIF1;TGFB3;IL10;PPARG;APLN;HMOX1;MFN2;MEF2C;SOD2;TPM1;IFNG;CDKN1A
gsea,positive regulation of synaptic transmission (GO:0050806),0.32578130785818726,1.011420157582423,0.4202020202020202,0.6630134518932398,1.0,12/20,34.73%,PRKCZ;PLK2;FLOT1;ARC;CCR2;TNF;APP;CLSTN1;BAIAP3;CCL2;HAP1;LGMN
gsea,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.33160768657881534,-1.0099121125110069,0.4174757281553398,0.4771913391461434,1.0,5/18,40.21%,UBB;FADD;BIRC3;CHUK;TRAF3
gsea,modulation of chemical synaptic transmission (GO:0050804),0.28168844998220965,1.0086303990069203,0.43833017077798864,0.6661562626104395,1.0,35/35,86.06%,ITGB1;DLGAP4;ARC;KCNMB4;MCTP1;IL1B;TMEM108;LRRK2;TNF;HOMER1;APP;CLSTN1;BAIAP3;SYN1;CLN3;ATP1A2;CACNA1A;MCTP2;CACNA1B;IQSEC2;CX3CR1;ABR;NLGN2;NPTX1;DGKI;BCR;MEF2C;SLC12A2;USP46;UNC13A;SLC4A8;LRP8;KCTD13;PSMC5;FMR1
gsea,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.32172314575860705,-1.0076673341568885,0.45294117647058824,0.48040317507538116,1.0,8/18,46.07%,BRCA1;PARK7;TRAF2;FADD;DDX3X;GSK3B;TNFRSF10B;ARHGEF2
gsea,negative regulation of fat cell differentiation (GO:0045599),-0.3133106223371582,-1.0070348787733443,0.45875251509054327,0.4809581091933184,1.0,7/20,47.17%,E2F1;ASXL1;ANKRD26;TRIB3;SIRT1;YAP1;GATA3
gsea,regulation of neuron projection development (GO:0010975),-0.2472450353774106,-1.0067532154395826,0.4503171247357294,0.4809785086925183,1.0,30/62,49.85%,FKBP4;CFL1;AKT1;ARSB;HDAC2;MT3;SETX;MBOAT1;SIPA1L1;TOX;BAG5;RUFY3;ZDHHC15;GAK;GSK3B;RTN4IP1;PAQR3;PRKCI;PTPN9;CCDC88A;DAB2IP;ABI2;ARHGAP35;KIF13B;TSKU;GFI1;ABI3;DENND5A;PTK2B;CAMK2G
gsea,hematopoietic progenitor cell differentiation (GO:0002244),-0.3423812029202872,-1.0065211862278116,0.4575569358178054,0.48086013667012195,1.0,5/16,32.32%,MLF1;PLEK;PRRC2C;ARMC6;UFL1
gsea,protein localization to Golgi apparatus (GO:0034067),-0.3454109664107431,-1.004266313491767,0.43172690763052207,0.48401165953968783,1.0,9/15,38.58%,OPTN;BICD2;ARL1;GCC2;ZDHHC15;GAK;GBP5;PAQR3;GBF1
gsea,regulation of BMP signaling pathway (GO:0030510),0.3067158267239771,1.0042104246606052,0.45540796963946867,0.6725356600281166,1.0,16/26,30.74%,CCN1;CRIM1;ENG;SMAD7;HTRA3;WNT1;TWSG1;HIPK2;ACVRL1;SMAD5;ITGA3;RBPMS2;SKI;FST;PPARG;BAMBI
gsea,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.321131129012376,1.0040906046082363,0.4462809917355372,0.6695899485780554,1.0,13/21,36.35%,ZFP36L1;TNFSF11;PRKCA;TNF;FES;LEF1;LIF;CD4;IL23A;CSF1;CCR1;RUNX1;PF4
gsea,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.331679408151065,-1.0040062698515544,0.4601226993865031,0.48401464016070433,1.0,7/17,47.70%,TRAF2;HTRA2;FADD;WWOX;PML;HYAL2;BID
gsea,positive regulation of cell-substrate adhesion (GO:0010811),0.28553521073338795,1.0036928913218914,0.4538606403013183,0.6673002166051963,1.0,33/33,92.64%,CCR7;UTRN;S100A10;JAK2;NRP1;JUP;PDGFB;NDNF;NEDD9;FN1;CASS4;CSF1;CX3CL1;PPM1F;CD36;DOCK5;DMTN;CCL25;DOCK1;ABL1;FBLN2;NPNT;MYADM;PTK2B;RSU1;GSK3B;CDK6;FLNA;ARL2;CALR;TRIOBP;P4HB;C1QBP
gsea,positive regulation of macroautophagy (GO:0016239),-0.2909640476976299,-1.0031568470630752,0.43286573146292584,0.484981730039387,1.0,12/26,44.00%,SLC25A5;VDAC1;OPTN;SCOC;LARP1;MAP3K7;HTT;RAB3GAP1;FYCO1;TSC2;SIRT1;BNIP3
gsea,heart development (GO:0007507),-0.25072357808672374,-1.0018638752155435,0.460446247464503,0.4866978591249246,1.0,18/57,44.76%,CDKN1A;MTHFD1;ID2;CACYBP;ZDHHC16;SMYD4;SMG9;PTPN11;PDLIM7;KAT2A;SRF;MEF2C;TSC2;ACVR1;KAT2B;DVL2;CHD7;MKKS
gsea,cellular response to mechanical stimulus (GO:0071260),0.29713921258212633,1.0011325083280915,0.4482758620689655,0.669679006199645,1.0,25/25,90.76%,NFKB1;FAS;TNFSF14;IRF1;IL1B;PTGER4;GADD45A;CD40;TLR7;MAP3K14;LTBR;TNFRSF1A;PIEZO1;TLR4;CASP1;SLC9A1;MAPK8;HABP4;MAP3K1;TNFRSF10B;BNIP3;BAK1;FADD;CHEK1;CASP8AP2
gsea,cellular protein localization (GO:0034613),-0.21568545332896386,-0.9994179476639149,0.4505050505050505,0.4902570847807527,1.0,61/131,51.81%,NPM1;PRPF19;ADPRH;IFT27;TMED2;CNTLN;TBC1D10B;VPS35;EIF2D;CLTC;COX18;PIGU;ARCN1;BICD2;FLNA;ARL1;TMED1;HDAC6;AP3D1;SIL1;RABL3;SNX27;ARFIP2;HGS;COPB2;NSF;TBCK;ZDHHC15;COPA;HERC2;GGA3;MESD;SEC23IP;SCFD2;SNX9;TBC1D5;AHI1;RAB23;IFT22;VPS33A;SGSM3;CEP68;DNAJC27;AP4M1;CEP250;GGA2;RAP2A;AP3B1;ID1;ARHGEF2;COG7;PACS2;MFN2;USO1;TM9SF4;BICD1;STX2;STXBP3;TBC1D25;RPGR;ITSN1
gsea,negative regulation of autophagy (GO:0010507),0.2783615184151772,0.9991220533045546,0.4665314401622718,0.6709206287511402,1.0,35/35,94.62%,DAPL1;PINK1;BCL2;DAP;LRRK2;LZTS1;USP36;IL10RA;RASIP1;NUPR1;TBC1D14;SMCR8;IL10;ZKSCAN3;WDR6;KDM4A;MET;PIK3CA;TAB3;TSC1;KLHL22;STAT3;ATG7;GOLGA2;TLK2;CPTP;EIF4G3;FOXK2;MTOR;MT3;EIF4G2;AKT1;EIF4E;EIF4G1;SNRNP70
gsea,acylglycerol metabolic process (GO:0006639),0.33780276341305276,0.9968902000333798,0.4594594594594595,0.6727227349367991,1.0,9/15,33.14%,DGKA;DGKD;APOBR;DGKE;LPL;DGKG;LMF1;APOE;AWAT2
gsea,polyol metabolic process (GO:0019751),0.31393801917696046,0.9964444942350639,0.4444444444444444,0.670591081156463,1.0,21/21,88.43%,ITPKB;INPP4B;SLC5A3;PLCG1;PLD4;PLCB2;PLCG2;PLCB4;IP6K2;SYNJ1;PPIP5K2;INPPL1;IPPK;NUDT10;NUDT11;PLCH1;IPMK;PPIP5K1;INPP5B;ISYNA1;NUDT4
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),0.26934221247218265,0.9962784268267665,0.47443762781186094,0.6678083847563313,1.0,45/45,93.34%,TNFAIP3;JAK2;TRAF1;IFNAR2;STAT1;RNASEL;SIGIRR;IFNGR2;ZBP1;TNF;AXL;USP18;ELF1;SPATA2;SYK;IRAK3;SOCS3;IL3;RUNX1;TNFRSF1A;AGPAT2;MADD;CLIP3;LIFR;SPPL2B;CD74;SPHK1;RIPK1;IKBKG;GAS6;BIRC2;SOCS1;RACK1;HIPK1;TRIM44;AGPAT1;CHUK;PTPN11;BIRC3;IFNG;ABCE1;FADD;PTPN6;TRAF2;HSP90AB1
gsea,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3116969331445023,-0.9955024340181227,0.45401174168297453,0.49609300357775254,1.0,15/21,45.66%,BAX;AIFM1;TRAF2;CEBPB;DNAJC10;BAK1;ATF4;QRICH1;BBC3;TRIB3;CHAC1;MAP3K5;ERN1;TNFRSF10B;DAB2IP
gsea,lymphocyte differentiation (GO:0030098),-0.2669718748012314,-0.9949701431841037,0.45610278372591007,0.4964564729353448,1.0,9/42,28.85%,SLC25A5;TCF3;DCAF1;KAT7;MSH2;KLF6;RABL3;ADAM17;TOX
gsea,cellular calcium ion homeostasis (GO:0006874),0.25659731351027254,0.9923744084175736,0.4582560296846011,0.6734380038856714,1.0,57/57,94.68%,TPT1;CCL5;BCL2;ATP2A3;ATP2B2;CCR2;CAMK2D;CCL1;STIM2;MICU3;ATP1B1;SLC30A1;ATP13A2;CALCB;RYR1;CALCA;CD40;CLN3;CCR1;SLC8A1;CCL8;CCL7;MCUB;CDH23;TNNI3;PTH1R;ATP2B4;STC2;PLN;CAV2;EDN1;PACS2;TMEM203;DRD4;SLC35G1;HTR2A;AFG3L2;PML;TRPC1;PDZD8;RMDN3;KCTD17;MCU;CCL3;HERPUD1;SLC24A5;CCDC47;ATP13A1;BAK1;ATP13A3;CHERP;ATP2A2;LETM1;CALR;BAX;STOML2;YWHAE
gsea,response to steroid hormone (GO:0048545),0.334383501274562,0.9909704608696895,0.4605009633911368,0.6732447620303246,1.0,9/17,30.14%,AR;NR3C1;PAQR7;MGARP;THBS1;TGFB2;TGFB3;ATP1A2;NR1H3
gsea,sterol homeostasis (GO:0055092),-0.30704621280371674,-0.9902279663217457,0.453416149068323,0.5036403976516276,1.0,7/23,43.05%,TMEM97;CNBP;INSIG1;LDLR;SOAT1;SCARB1;SIRT1
gsea,positive regulation of protein localization to plasma membrane (GO:1903078),0.27949331842470265,0.9889407102405554,0.47591522157996147,0.6745934384859428,1.0,31/31,88.97%,LGALS3;ITGB1;PIK3R1;ACSL3;RAMP3;TNF;SORBS1;LRP1;ITGA3;CLN3;CLIP3;ATP2B4;RANGRF;ZDHHC5;NKD2;EPHA3;AKAP5;ZDHHC8;RACK1;CNST;PTPN9;PRKCI;CNPY4;PLS1;SPTBN1;IFNG;PDPK1;PRKCE;KIF5B;ZDHHC2;AKT1
gsea,cellular response to nutrient levels (GO:0031669),-0.27942028696464216,-0.9885529787364271,0.49166666666666664,0.5058518226138806,1.0,15/30,49.71%,HSPA8;EIF4G1;EHMT2;SREBF2;MTOR;FADS1;PRKAA1;WRN;TFEB;ATG7;SIRT1;FNIP1;TSC1;KLF10;CDKN2B
gsea,integrin-mediated signaling pathway (GO:0007229),0.27786736466480016,0.9870762033188497,0.4819047619047619,0.6756818004194305,1.0,23/36,37.96%,ITGB1;NRP1;SEMA7A;ITGB3;ISG15;ITGB8;TXK;ITGB7;CD40LG;CEACAM1;HCK;NEDD9;FN1;ITGA5;SYK;ERBIN;DAB2;MADCAM1;TEC;DST;COL16A1;DOCK1;ABL1
gsea,stress-activated protein kinase signaling cascade (GO:0031098),-0.3262312502289436,-0.9847379574660424,0.4528301886792453,0.5116785194923478,1.0,9/17,42.10%,UBB;KAT7;CUL1;MAP3K7;TAOK2;CHUK;MAP3K5;MAP3K20;BTRC
gsea,embryonic limb morphogenesis (GO:0030326),-0.33245400515722845,-0.984350656495505,0.4386694386694387,0.5119166860536982,1.0,6/16,49.21%,HDAC1;HDAC2;MAP3K20;OSR2;CREBBP;PTCH1
gsea,cholesterol homeostasis (GO:0042632),-0.3114680001861079,-0.9829163854717096,0.4718162839248434,0.5138315044521793,1.0,7/22,43.05%,TMEM97;CNBP;INSIG1;LDLR;SOAT1;SCARB1;SIRT1
gsea,negative regulation of cellular catabolic process (GO:0031330),0.27384847762136316,0.9820853151941121,0.4691848906560636,0.6832356671790235,1.0,35/35,90.77%,DAPL1;BCL2;DAP;TIMP2;PTPN3;IL10RA;RASIP1;MFSD2A;NUPR1;TBC1D14;IL10;ZKSCAN3;RGP1;TIMP1;WDR6;KDM4A;MET;TAB3;DAB2IP;KLHL22;STAT3;NRDE2;CST3;GOLGA2;TLK2;CPTP;EIF4G3;FOXK2;MTOR;ROCK1;MT3;EIF4G2;AKT1;EIF4E;EIF4G1
gsea,regulation of cytokine production (GO:0001817),0.24557756562376815,0.9809530844490811,0.4582560296846011,0.6826600673809482,1.0,70/70,96.82%,CCR7;CRTAM;BCL6;IRF7;FLOT1;CCR2;TRIM56;PER1;FOXP1;CCN4;ISG15;TXK;ANXA1;PTGER4;SYT11;ZBP1;TNF;PLD4;SIRPA;NFAM1;FCGR2B;TWSG1;TRIM21;FOXP3;CIDEA;BATF;BTNL9;DDX58;LYN;HDAC9;DTX4;PIK3CD;IL10;GPNMB;NOS2;IGF2BP2;ADRA2A;EIF2AK2;HILPDA;AGPAT2;CCDC88B;FGR;ALOX5;IFIH1;SLC11A1;FFAR4;BTN1A1;RGCC;CADM1;GATA3;IL33;IL21;ASB1;TNFSF4;RIPK3;TRAF3;LTF;IGF2BP3;AGPAT1;KAT2A;MAPKAPK2;IFNG;PIK3CG;GLMN;RPS6KA5;MAST2;IRF8;GAPDH;MIF;POLA1
gsea,regulation of wound healing (GO:0061041),-0.3247473253895606,-0.9809055070097211,0.5,0.5167329058678718,1.0,4/18,20.41%,ACTG1;HRAS;SRSF6;PRKCE
gsea,regulation of cellular component movement (GO:0051270),-0.3006599587576778,-0.9795241764022313,0.48841698841698844,0.5184942884295064,1.0,8/24,28.23%,ACTN4;MEMO1;ROCK2;ROCK1;DIAPH1;HDAC6;CDK6;ADAM17
gsea,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.33610072564782645,-0.9741012828533827,0.48412698412698413,0.5269239496662497,1.0,7/16,49.67%,PHB2;SLC7A5;PHB;LACC1;TNFSF4;IL21;SPHK2
gsea,B cell receptor signaling pathway (GO:0050853),0.31595005076075394,0.9718216939495827,0.4880294659300184,0.6993705314104365,1.0,14/22,31.34%,BCL2;CD38;CTLA4;VAV3;NFAM1;CD79A;CD79B;SYK;BTK;SH2B2;BLNK;TEC;PIK3CD;PLCG2
gsea,glycoprotein metabolic process (GO:0009100),-0.2834952376872137,-0.9716578562253492,0.49693251533742333,0.5304562826070726,1.0,10/25,52.67%,PARK7;GANAB;STT3B;PRKCSH;ST3GAL4;AGA;MAN1B1;FBXO44;HPSE;FUT8
gsea,protein targeting to ER (GO:0045047),-0.3478484016640286,-0.9691127142174264,0.4866412213740458,0.5341088019930752,1.0,16/34,32.86%,RPS17;RPS2;RPL14;RPS15;RPS25;EDEM1;RPL23A;RPL31;SPCS3;RPS6;RPL4;SRPRB;SRP68;SRP72;RPL5;ZFAND2A
gsea,negative regulation of cellular component organization (GO:0051129),-0.25355118262210957,-0.9687981718951317,0.4791666666666667,0.5341442712943917,1.0,18/40,36.40%,HSPA8;RTEL1;RDX;XRCC5;DNAJB1;AIDA;TERF2;HDAC6;TFIP11;HSF1;DDX3X;HSPA1B;SACS;HSPA1A;SVIP;CARMIL2;GSK3B;TRAF3IP1
gsea,oligosaccharide metabolic process (GO:0009311),0.30278768132608,0.9671764101926009,0.4921259842519685,0.7061840591187428,1.0,11/20,38.75%,ST8SIA1;ST8SIA4;ST6GALNAC3;NEU1;ST6GALNAC6;B4GALNT2;B3GALT5;NAGA;B3GALT4;FUT7;FUT4
gsea,cellular response to starvation (GO:0009267),-0.22907813563661672,-0.9658258355134136,0.47489539748953974,0.5385950611270758,1.0,31/71,45.84%,CDKN1A;EIF2S1;HNRNPA1;ASNS;HSPA8;SEH1L;MYBBP1A;CEBPB;EHMT2;SREBF2;MTOR;GCN1;RRP8;ATF4;TCIRG1;DEPDC5;TBL2;FADS1;PRKAA1;PRKAG2;WRN;MLST8;ITFG2;MAP3K5;TFEB;ATG7;NPRL3;SIRT1;EIF2AK3;FNIP1;EIF2AK4
gsea,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3083951809622656,-0.9655299436402426,0.47904191616766467,0.5385905860371453,1.0,6/20,42.69%,HNRNPK;FMR1;TBC1D5;AHI1;ANXA2;CBL
gsea,fatty acid metabolic process (GO:0006631),-0.24572033498869222,-0.9652053550597374,0.49782608695652175,0.5386205075123518,1.0,23/55,48.76%,NDUFAB1;MECR;MSMO1;ACSL5;ALKBH7;ACACA;ACAD9;ACLY;ACSF2;THEM4;NUDT19;MCAT;GNPAT;CPT1A;CPT2;PON3;CBR4;LPIN2;ACSL1;ACSL4;FASN;LTC4S;MLYCD
gsea,inorganic anion transmembrane transport (GO:0098661),-0.30288080547430507,-0.9630231341619804,0.5323590814196242,0.5417597493839317,1.0,5/22,38.72%,SLC25A10;SLC20A1;SLC4A8;SLC12A2;ANO6
gsea,regulation of innate immune response (GO:0045088),-0.2588526180361396,-0.9596357161067588,0.5220125786163522,0.5469086493164277,1.0,19/38,43.37%,LYAR;HSP90AB1;DHX9;PTPN6;CACTIN;ABCE1;LRP8;AKIRIN2;BIRC3;ERAP1;PTPN11;POLR3G;GBP5;PLSCR1;POLR3F;TKFC;TRAFD1;POLR3D;NLRC3
gsea,mononuclear cell differentiation (GO:1903131),-0.34015670680788923,-0.9591419938340219,0.5301455301455301,0.547239716723502,1.0,3/15,25.06%,IRF8;MYH9;THOC5
gsea,adherens junction organization (GO:0034332),-0.31129661885224624,-0.9580908837795403,0.511340206185567,0.5485596119600554,1.0,8/17,57.34%,ACTB;CTNNA1;AFDN;CADM1;RAMP2;PIP5K1C;NECTIN4;CTNND1
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.273986366903263,-0.9579813425120487,0.516597510373444,0.5482267370905335,1.0,13/28,38.27%,U2AF2;PARK7;AKT1;IVNS1ABP;NXN;BAG5;GTPBP4;HSPA1B;RPL5;UFL1;HSPA1A;PINX1;GNL3L
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.29755764590529377,0.95777165657319,0.4978902953586498,0.7236031425106522,1.0,22/22,92.40%,SPRY1;CBLB;SOCS5;ITGA1;PTPN3;SPRY2;DUSP3;ERRFI1;HBEGF;AREG;PTPRJ;MVP;TGFA;STAM;DAB2IP;BTC;CBL;EPS15L1;EPS15;STAM2;HGS;RNF126
gsea,endocytic recycling (GO:0032456),-0.31678636289967627,-0.9568584330955148,0.5305719921104537,0.5497001675164315,1.0,6/17,39.02%,VPS35;VPS52;EHD4;SNX27;EPS15;VPS50
gsea,lipid homeostasis (GO:0055088),0.27591723305626803,0.9508328419153137,0.5303030303030303,0.7355636230595332,1.0,17/27,31.76%,IRS2;ABCG1;PNPLA8;RCN3;ABCB4;ATP13A2;ACOX1;ABHD4;TLCD2;TLCD1;ZBTB20;XBP1;PPARG;APOE;NR1H3;LIPG;ADCK1
gsea,eye development (GO:0001654),-0.30817760068445904,-0.950511052027064,0.5376344086021505,0.559822687356479,1.0,11/21,47.64%,ZDHHC16;CEP290;PBX2;ATF6;SMG9;RAB3GAP1;PBX3;HIPK1;PBX4;SMOC1;TSKU
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.2697242969175086,0.9499646411294285,0.5283757338551859,0.7342584496722304,1.0,32/32,91.57%,LGALS3;FAS;TRAF1;SP100;AR;SH3RF1;ITGA6;TNF;TNFSF10;TNFSF12;THBS1;LTBR;TCF7L2;MADD;IGF1;RIPK1;TMC8;BID;RELA;TNFRSF10B;HYAL2;ACVR1;PML;FEM1B;HTT;WWOX;BIRC6;FADD;PHIP;TRAF2;PSME3;PARK7
gsea,regulation of glucose import (GO:0046324),0.3179958050368939,0.9491416997910159,0.5301204819277109,0.732902753221644,1.0,9/16,37.45%,PIK3R1;IRS2;C1QTNF12;GRB10;PID1;SORBS1;SELENOS;IGF1;APPL2
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2723270683928545,-0.9478987891160613,0.509090909090909,0.5636717944975014,1.0,13/27,47.70%,BAX;BCLAF1;TRAF2;FADD;ING5;WWOX;BBC3;GSDME;PML;HYAL2;RACK1;DAB2IP;BID
gsea,regulation of interferon-beta production (GO:0032648),-0.2628916162373307,-0.9469402430611984,0.5175097276264592,0.5647423564115976,1.0,15/32,52.16%,HSP90AA1;DHX9;CACTIN;YY1;DDX3X;PTPN11;POLR3G;POLR3F;TRAF3;POLR3D;NLRC3;POLR3B;RELB;POLR3A;IFIH1
gsea,positive regulation of cell projection organization (GO:0031346),-0.24545384950819502,-0.9412605540047346,0.5501022494887525,0.5738261681929234,1.0,15/44,46.24%,ARHGDIA;METRN;ARSB;CAPRIN1;SETX;SS18L2;TOX;CARMIL2;FBXW8;FZD4;DVL1;PRKCI;DVL2;DAB2IP;ARHGAP35
gsea,vascular transport (GO:0010232),-0.2542653931182572,-0.9321389796060449,0.5735567970204841,0.5889168977404639,1.0,16/40,47.80%,SLC29A1;TFRC;SLC7A5;SLC7A1;SLC2A1;SLC4A8;SLC19A1;SLC7A3;SLC38A1;SLC1A4;SLC12A2;SLC6A9;ABCG2;ABCC4;SLC16A1;SLC1A5
gsea,axonogenesis (GO:0007409),-0.21411246140324702,-0.9312810167915739,0.6024590163934426,0.5897892625320627,1.0,34/84,48.45%,HSP90AA1;HSP90AB1;ACTB;EZR;BSG;PPP3CB;NEFH;SHC1;KIF5B;RPS6KA5;SPTBN1;DSCAM;RYK;SEMA4A;PTPN11;PDLIM7;SPG11;USP9X;GRB7;MAP1A;TAOK2;NCAM1;CYFIP1;PIK3CB;AFG3L2;LLGL1;DOK2;DOCK7;BAIAP2;ARHGAP35;MAPK7;GFRA4;GPC1;ENAH
gsea,cation transport (GO:0006812),0.26735076928774043,0.9258601184394861,0.5736434108527132,0.7814678085833131,1.0,20/35,36.20%,SLC9B2;KCNMB4;TRPM1;ATP1B1;SLC41A1;SCN4B;SLC39A1;KCNN4;SGK1;KCNJ8;KCNC1;SLC12A3;CLN3;KCNK7;SLC8A1;ATP1A2;SLC7A8;KCNG2;SLC7A6;PIEZO1
gsea,endothelial cell migration (GO:0043542),-0.3032063588352793,-0.924768287586588,0.5787234042553191,0.6004030995648323,1.0,10/20,56.28%,LPXN;MYH9;GIPC1;PTP4A3;ID1;NR4A1;PIK3CA;LOXL2;PLXND1;RAB13
gsea,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.28973170193529174,-0.9239173469959552,0.5714285714285714,0.6012000662441102,1.0,9/20,46.26%,CEBPB;MT3;GCN1;ATF4;HSF1;ATF6;MBTPS2;KLF2;MAPK7
gsea,regulation of postsynapse organization (GO:0099175),-0.31918522981681274,-0.9224712802971128,0.551948051948052,0.6031549675088169,1.0,7/15,48.75%,CFL1;VPS35;SIPA1L1;ZDHHC15;ABHD17C;ABI2;ABI3
gsea,negative regulation of cell motility (GO:2000146),-0.23503248373920324,-0.9220056955632182,0.6092184368737475,0.6034240225379323,1.0,18/48,51.14%,MIF;PIN1;SINHCAF;CLIC4;SRGAP2;TPM1;GTPBP4;DUSP22;RAP2C;ARID2;AFDN;RAP2A;RHOB;GATA3;BST2;NF2;MIA3;LIMCH1
gsea,positive regulation of neuron death (GO:1901216),-0.27310662112082235,-0.9180608867541165,0.5906313645621182,0.609532717198373,1.0,10/28,39.72%,BAX;EIF2S1;IFNG;ATF4;DDIT4;GSK3B;PICALM;CCL3;DAXX;MAP3K5
gsea,skeletal system development (GO:0001501),-0.2499709862851041,-0.9159238430118188,0.6,0.6127089181446268,1.0,12/40,55.43%,PRDX1;TCOF1;VKORC1;WWOX;DYM;HYAL2;EIF2AK3;CHD7;PLS3;FRZB;SPEF2;XYLT1
gsea,positive regulation of cell death (GO:0010942),-0.2567076058958777,-0.9151769701032592,0.6016597510373444,0.6134844749272567,1.0,13/35,44.00%,EIF2S1;FAF1;EIF4G1;PHB;MT3;IFNG;DDIT4;CELF1;GSK3B;PICALM;DAXX;MAP3K5;BNIP3
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.290263265352952,-0.9132827695273801,0.5836909871244635,0.6162152390888254,1.0,5/22,43.14%,TRAIP;CACTIN;TTLL12;METTL3;OTUD4
gsea,positive regulation of interleukin-2 production (GO:0032743),0.29860663827972456,0.9131162858760394,0.536144578313253,0.8068339718931333,1.0,18/18,94.22%,PDE4B;IRF4;CCR2;CD86;MALT1;ANXA1;IL1B;CARD11;CD4;CD80;RUNX1;PLCG2;PRKD2;MAP3K7;SPTBN1;GLMN;TRAF2;STOML2
gsea,positive regulation of signaling (GO:0023056),0.3140908265371208,0.9115592929433997,0.5728952772073922,0.8068277289279874,1.0,8/15,28.82%,RAMP3;WLS;INPP5F;TNF;HOMER1;CLSTN1;CD80;ECE1
gsea,positive regulation of mRNA catabolic process (GO:0061014),0.26551644102312694,0.9112286022255075,0.5772357723577236,0.8039691861661227,1.0,27/27,88.98%,ZFP36L1;BTG2;ZC3H12A;TOB1;ZFP36;PABPC1;NANOS3;RIDA;PRR5L;EIF4ENIF1;ZFP36L2;UPF1;MOV10;GIGYF2;AGO2;METTL3;CELF1;FTO;NANOS1;TNRC6A;PNPT1;CNOT1;METTL16;ROCK1;METTL14;ROCK2;KHSRP
gsea,regulation of response to biotic stimulus (GO:0002831),0.2946908093287619,0.9108447440686217,0.5714285714285714,0.8013265126083599,1.0,19/19,75.80%,SAMHD1;FOXP1;DHX58;IRF1;TRIM5;FCGR2B;CX3CL1;CD36;APPL2;FGR;ELMOD2;BIRC2;TRAF3;TKFC;CD55;ERAP1;BIRC3;ZMPSTE24;LRP8
gsea,membrane lipid biosynthetic process (GO:0046467),-0.26776331844140955,-0.9094293666197096,0.5486542443064182,0.6222503797123264,1.0,11/25,50.60%,HACD2;ST3GAL4;PRKD3;SCCPDH;ACER3;HACD3;CERS6;PRKD2;SPHK2;ELOVL4;PLPP1
gsea,Wnt signaling pathway (GO:0016055),0.24742109880936003,0.9093106339411632,0.6038461538461538,0.8011431224858178,1.0,45/45,97.02%,TCF7;NR4A2;RPS27A;WLS;LRRK2;CSNK1G1;BCL9L;LEF1;LRP6;WNT1;WNT2B;WNT10A;FZD6;WNT11;RARG;FZD7;DIXDC1;CTNNB1;TCF7L2;DVL3;CPE;PLCG2;WNT3;WNT10B;SFRP4;FZD3;CCDC88C;WNT6;CSNK1E;FRZB;WNT4;DVL2;BTRC;DVL1;FZD4;STRN;GSK3B;AXIN1;DDX3X;CUL1;NXN;RYK;USP34;VPS35;UBB
gsea,regulation of protein localization to plasma membrane (GO:1903076),-0.24260123484904642,-0.9091693035127922,0.5967078189300411,0.6221710145382433,1.0,22/41,52.21%,ACTB;AKT1;ZDHHC2;CLTC;KIF5B;PRKCE;PDPK1;VAMP8;IFNG;PPFIA1;SPTBN1;PLS1;CNPY4;PICALM;PRKCI;PTPN9;RHOQ;ZDHHC8;ABI3;AKAP5;EPHA3;NKD2
gsea,sphingolipid biosynthetic process (GO:0030148),-0.2628081890603786,-0.906968947508576,0.6126315789473684,0.6254372740955852,1.0,13/27,50.60%,HACD2;PRKD3;ACER3;AGK;ST3GAL5;SMPD4;SMPD1;HACD3;CERS6;PRKD2;SPHK2;ELOVL4;PLPP1
gsea,amyloid fibril formation (GO:1990000),-0.28741632497726466,-0.9054391166802954,0.5865800865800865,0.6274354008459312,1.0,11/21,50.38%,UBB;MDM2;USP9X;GGA3;CST3;LTF;RIPK3;GGA2;MFGE8;TSPAN15;UBE2L6
gsea,cell morphogenesis involved in differentiation (GO:0000904),0.26720550552126443,0.9003325347159313,0.6137667304015296,0.8177293481706117,1.0,26/26,96.91%,ACTN1;PIK3R1;NRP1;RILPL2;ITGB3;ITGB7;SPI1;ITGA4;PEAK1;FN1;PARVB;RAB25;ANTXR1;ATRNL1;LAMC1;ABI2;UNK;ARL13B;MEF2C;METTL3;MEGF9;ATF4;RB1;SRGAP2;LPXN;KIF14
gsea,negative regulation of cellular protein localization (GO:1903828),-0.2798915303275193,-0.8927407422459939,0.6110056925996205,0.6484881159731118,1.0,9/21,36.91%,CDT1;SIN3A;ROCK2;NSFL1C;CTNNA1;MAP1A;UBXN2B;GSK3B;PICALM
gsea,insulin receptor signaling pathway (GO:0008286),-0.2556691002218108,-0.8923278923057696,0.6228070175438597,0.6487010798187037,1.0,14/32,46.21%,AKT1;PHIP;SHC1;AP3S1;C2CD5;ATP6V0A2;TCIRG1;GRB7;IDE;NAMPT;GSK3B;BCAR1;RHOQ;BAIAP2
gsea,regulation of osteoclast differentiation (GO:0045670),0.3173035324711107,0.8915075592155923,0.5916030534351145,0.8337277044746898,1.0,10/15,26.29%,TNFSF11;TCTA;TNF;GPR55;GPR137B;MAFB;IL23A;CSF1;PRXL2A;CCR1
gsea,negative regulation of cell migration (GO:0030336),0.22179430258983543,0.890950445471229,0.666,0.8314212525742012,1.0,60/60,96.48%,EVL;DUSP10;TRIB1;CITED2;DLC1;PTPRK;ADGRG1;ENG;IFITM1;SMAD7;MCTP1;SERPINE1;VCL;FOXO3;FUZ;PFN2;CDH1;ZMYND8;DAG1;ACVRL1;LRP1;CX3CL1;FGF2;WNT11;DUSP3;SCAI;DLG5;RAP2B;TCAF1;PTPRJ;MITF;TIMP1;PHLDB2;CD74;SRGAP3;PTPN23;NF1;LIMCH1;MIA3;HMOX1;NF2;BST2;RHOB;DAB2IP;HYAL2;RAP2A;AFDN;ARID2;RAP2C;DUSP22;GTPBP4;TPM1;CLASP1;SRGAP2;CLASP2;CLIC4;CALR;SINHCAF;CORO1C;MIF
gsea,negative regulation of innate immune response (GO:0045824),-0.29510077441939775,-0.8908995783288703,0.5970464135021097,0.6506414099212758,1.0,7/19,43.37%,LYAR;CACTIN;TTLL12;USP15;METTL3;TRAFD1;NLRC3
gsea,regulation of cell-matrix adhesion (GO:0001952),-0.24542442386464325,-0.8897685904352364,0.6161616161616161,0.6520234360662683,1.0,15/36,51.25%,ACTG1;CDKN2A;CORO1C;ROCK2;ROCK1;CLASP1;SLK;CDK6;GSK3B;PIK3CB;TSC1;PTK2B;NF2;LIMCH1;EPHA3
gsea,receptor internalization (GO:0031623),0.2706638300153736,0.8881946848500292,0.6320939334637965,0.8339090222050849,1.0,24/24,92.85%,CD9;ITGB1;CD81;RAMP3;RAMP1;CEACAM1;ADM;SCYL2;SYK;CALCRL;LRP1;CD36;ARRB1;SAG;DNM1;DNM3;RAMP2;FCER1G;PICALM;GTF2H2;GRK2;CLTC;NEDD4;TFRC
gsea,B cell differentiation (GO:0030183),-0.2547131298420695,-0.8874114310544267,0.6442105263157895,0.6555243802563587,1.0,7/30,28.23%,SLC25A5;TCF3;DCAF1;MSH2;KLF6;RABL3;ADAM17
gsea,negative regulation of TOR signaling (GO:0032007),0.268010533099091,0.8858108559160017,0.631163708086785,0.8356324131985082,1.0,23/23,79.80%,SESN3;CASTOR1;TMEM127;SESN1;RNF152;AKT1S1;ARNTL;UBR1;SH3BP4;SESN2;TSC1;ATM;FNIP1;MAPKAPK5;SIRT1;TSC2;NPRL3;ITFG2;PRKAA1;DEPDC5;DDIT4;TNFAIP8L1;TBC1D7
gsea,long-chain fatty acid metabolic process (GO:0001676),0.2619441452399506,0.8832064204628233,0.6397058823529411,0.8378163373851429,1.0,29/29,88.58%,EPHX1;ACSL6;ACSL3;PNPLA8;ACOX1;PTGS2;ACOT1;GPX1;ACOT4;PLA2G4A;PLA2G4B;SLC27A3;SLC27A2;ELOVL2;ALOX5;ELOVL6;HACL1;ABCD1;LTC4S;ACSL4;ACSL1;FADS2;AIG1;CPT2;CPT1A;FADS1;ACAD9;ACSL5;ACADL
gsea,synapse assembly (GO:0007416),-0.30399773833632965,-0.8815781283618647,0.6255230125523012,0.6652116113754355,1.0,6/15,40.74%,FGF13;DSCAM;RYK;FARP1;LGI2;DVL1
gsea,regulation of MAP kinase activity (GO:0043405),0.23156858798624635,0.8803655308101936,0.6622889305816135,0.8404809097047433,1.0,48/48,98.65%,TNFSF11;SPRY1;TRIB1;DUSP1;SH2B3;KIT;IL1B;LRRK2;FLT1;PDGFB;TNF;CD300A;ADAM8;CD40;PIK3R6;SPRY2;BMP7;SPRY4;IRAK3;FGF2;DUSP7;PDGFA;LYN;APOE;PTPRJ;RASGRP1;ADRA2A;TRIB2;KSR1;PIK3R5;VEGFA;NF1;CDK12;FLT3;EDN1;DAB2IP;HYAL2;PIK3CB;PAQR3;UCHL1;TRIB3;SMPD1;HGS;DUSP19;PIK3CG;HRAS;RGS2;EZH2
gsea,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3348756492899975,0.8770497908545954,0.6125461254612546,0.8442269947706079,1.0,9/15,23.74%,TXNIP;P2RX4;NT5E;IL1B;APP;C3AR1;MEFV;NLRP3;C3
gsea,negative regulation of blood vessel morphogenesis (GO:2000181),0.2571737515960937,0.87354155286133,0.6496212121212122,0.8481970878323173,1.0,35/35,91.77%,CD160;STAT1;GTF2I;CCR2;KLF4;HHEX;SERPINF1;THBS1;SPRY2;TGFB2;AGO1;STAB1;PPARG;CTNNB1;FOXO4;AMOT;PF4;PTPRM;FOXJ2;ATP2B4;ALOX5;ATF2;CXCL10;SPARC;VASH1;RGCC;DAB2IP;WNT4;SPRED1;PML;PDE3B;HGS;ROCK1;ROCK2;PGK1
gsea,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.30435101964750755,0.8730218961515145,0.6171428571428571,0.8458873307742807,1.0,16/16,89.93%,JAK2;IRS2;RASGEF1A;TGM2;ERBIN;EPOR;LYN;RAPGEF1;RASGRP1;IGF1;NOTCH2;RASGRF1;NOTCH1;SHOC2;SHC1;LRRC59
gsea,regulation of vesicle-mediated transport (GO:0060627),0.24423727259988293,0.8721208108573095,0.6800766283524904,0.8443402912610937,1.0,35/35,80.19%,PACSIN1;NRP1;INPP5F;LRRK2;FES;HCK;RUFY2;STON1;SYK;RAB4A;STON2;PACSIN3;HIP1;RAB5B;HAP1;RAB3D;SYT7;ABL1;RAB25;FGR;SPHK1;DNAJC13;RAB13;ZFYVE16;RUFY1;TSC2;STXBP5;SCARB1;HIP1R;PICALM;NSF;RINT1;USP7;PACSIN2;RALA
gsea,fatty acid catabolic process (GO:0009062),-0.25152254912660515,-0.8719777953834028,0.6742738589211619,0.681068934955098,1.0,17/31,47.01%,ACADL;MECR;ECHDC2;ACAT2;SLC25A17;NUDT19;MCAT;HADH;CPT2;AIG1;ECHDC1;ECI1;PCCA;HSD17B10;MCEE;LPIN2;PECR
gsea,monocarboxylic acid transport (GO:0015718),0.27315417624115634,0.870468612720206,0.659043659043659,0.8445713393037148,1.0,12/20,38.58%,SLC16A6;ABCB4;SLC16A11;SLCO3A1;CEACAM1;SLC27A1;RXRA;SLC6A11;SLCO2A1;CD36;SLC6A12;SLC6A13
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.25326584406945324,-0.8664888230821745,0.6556016597510373,0.6897350230027604,1.0,11/28,43.61%,TRAIP;TRAF2;CPNE1;FADD;BIRC3;ADAM17;HSPA1B;HSPA1A;CHUK;HIPK1;RACK1
gsea,negative regulation of defense response (GO:0031348),-0.23901025116493874,-0.8655786685004869,0.6796536796536796,0.690644167641684,1.0,13/38,47.50%,LYAR;C1QBP;VPS35;CACTIN;RB1;MVK;METRNL;TRAF3IP1;TRAFD1;NLRC3;MAPK7;GATA3;SMPDL3B
gsea,regulation of Notch signaling pathway (GO:0008593),-0.2361954996248747,-0.863155335320759,0.6855983772819473,0.6941324164755962,1.0,20/38,52.99%,AKT1;BMP2K;SREBF2;EGFL7;POFUT1;CHAC1;METTL3;POGLUT1;PRKCI;LLGL1;STAT3;CREBBP;KAT2B;ZMIZ1;YAP1;TSPAN15;NEPRO;NOTCH1;EPN2;NRARP
gsea,inositol lipid-mediated signaling (GO:0048017),0.2734305197159291,0.8621714196186011,0.6395348837209303,0.8586875958552993,1.0,12/20,38.20%,PIK3R1;IRS2;INPP5F;PLCB2;PITPNM2;PTAFR;PIK3R2;PIK3CD;CSF1R;PLCB4;IGF1;PIK3C2A
gsea,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.30393343095310255,0.861234746615663,0.6479166666666667,0.8571560294687043,1.0,9/15,36.49%,CBLB;SOCS5;NCF1;APP;ERRFI1;HBEGF;AREG;ADRA2A;NCK2
gsea,cellular response to metal ion (GO:0071248),-0.21995891515961016,-0.8569926714556944,0.7145833333333333,0.7038814924559523,1.0,17/48,39.46%,ECT2;AKT1;PPIF;CLIC4;CPNE1;MT3;ADD1;HSF1;SMPD1;PRKAA1;RASGRP2;TIGAR;CPNE2;CHUK;SLC12A2;DAXX;MEF2C
gsea,receptor metabolic process (GO:0043112),0.25192383653647715,0.8541374292354204,0.7108910891089109,0.8685629170770941,1.0,28/28,92.85%,CD9;ITGB1;CD81;RAMP3;RAMP1;ADM;SYK;CALCRL;LRP1;PIK3R4;CD36;LGMN;LMTK2;DNM1;EHD3;DNM3;RAMP2;REP15;ARFGEF2;FCER1G;SNX25;PICALM;GRK2;NSG1;KIF16B;CLTC;NEDD4;TFRC
gsea,aminoglycan biosynthetic process (GO:0006023),0.29770619814543675,0.8506797537044347,0.6901408450704225,0.8721547857586024,1.0,15/15,70.28%,SDC4;HS6ST1;SDC1;GCNT2;HEXA;B3GALT5;SDC3;XYLT1;B3GNT3;GPC1;HS2ST1;B4GAT1;SLC35D2;PXYLP1;B3GALT6
gsea,regulation of cell morphogenesis (GO:0022604),-0.28008110301768185,-0.8443046564973232,0.7297830374753451,0.724877573729958,1.0,11/19,50.35%,CFL1;PHIP;ZMYM3;MYO9A;LARP4;PDZD8;STRIP1;ZMYM4;MOV10;VIL1;SPARC
gsea,negative regulation of endothelial cell proliferation (GO:0001937),0.309723253403761,0.8404892807709717,0.6580406654343808,0.8894166108323657,1.0,7/16,29.72%,STAT1;FLT1;THBS1;DLL4;CCL2;PPARG;APOE
gsea,regulation of protein tyrosine kinase activity (GO:0061097),0.28958479683759625,0.8378374278667533,0.6857142857142857,0.8912310573060593,1.0,10/15,36.49%,SH3BP5;PRNP;PDGFB;APP;NEDD9;CASS4;RAP2B;CSF1R;MVP;NCK2
gsea,fatty acid oxidation (GO:0019395),-0.2560099520996671,-0.8369521694423528,0.7019027484143763,0.7364566500983611,1.0,13/26,47.01%,ACADL;MECR;ADH5;ECHDC2;ACAT2;SLC25A17;MCAT;HADH;CPT2;ECHDC1;ECI1;HSD17B10;PECR
gsea,regulation of humoral immune response (GO:0002920),0.3334854485390027,0.8338102742655438,0.6596558317399618,0.8958518812130113,1.0,10/17,23.74%,CCR7;CD81;CFP;C1QB;FCGR2B;C1QA;C1QC;CXCL13;C3AR1;C3
gsea,protein localization to lysosome (GO:0061462),-0.28182130598941413,-0.831901461277587,0.6927835051546392,0.7438919992973788,1.0,9/15,48.42%,NEDD4;M6PR;GCC2;HGS;GGA3;AP3M1;AP4M1;SNX16;ZFYVE16
gsea,negative regulation of cell-cell adhesion (GO:0022408),-0.25984120086990814,-0.8270502039762552,0.7290836653386454,0.751333844319538,1.0,10/22,52.84%,AKT1;RDX;GTPBP4;AKNA;MAPK7;RGCC;NF2;MIA3;NOTCH1;MYADM
gsea,negative regulation of signal transduction (GO:0009968),0.18762638839161608,0.8240815531118914,0.8103130755064457,0.9116254778445866,1.0,108/108,98.65%,CCL5;TNFAIP3;BCL2;SPRY1;NR4A2;NFATC1;PRKCZ;TRIB1;MGRN1;SOCS5;SLAMF1;TMBIM1;SIGIRR;IL1B;CREB3L1;PTPRE;LRRK2;GRB10;TNF;NLK;RNF157;HHEX;PID1;SHISA2;THBS1;SPRY2;SPRY4;SULF2;DLL4;IRAK3;LRP1;CX3CL1;FGF2;MMP14;LYN;CRY1;TULP3;IL10;TLE1;DKK3;PALM;PTPRJ;APLN;ARRB1;KCTD21;LGMN;CX3CR1;SOX30;RITA1;ENPP1;PTCH2;TAX1BP3;DLL1;DLK2;FBXW7;SFRP4;NRARP;EPN2;NKD2;KANK2;FRZB;PTCH1;PIP4K2B;TSPAN15;TSKU;SMPDL3B;GPC1;GATA3;SOCS1;DAB2IP;HIC1;RACK1;OTUD4;ACVR1;TSC2;BTRC;PIK3CB;PRKCB;LTF;PHACTR4;RPGRIP1L;METTL3;CHAC1;LRRC14;GRB7;PTPN12;SMPD1;HGS;XDH;VCP;NXN;DDIT4;WWOX;CNOT1;EGFL7;RB1;PLEK;CSNK2A2;CBY1;CACTIN;HMGXB4;CALR;ASXL1;RGS2;NEDD4;AKT1;MAZ;EZH2
gsea,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.24767615589500258,0.8232423994744652,0.7392156862745098,0.9095698903436663,1.0,27/27,80.78%,HIF1A;C1QTNF4;TXK;CASP4;ZBP1;AXL;PARP14;CD300LF;CXCR4;CSF1;PARP9;MAVS;TICAM2;AGPAT2;CASP1;CD74;RIPK1;GAS6;EDN1;GFI1;TRIM44;AGPAT1;HSPA1A;HSPA1B;ADAM17;FADD;CPNE1
gsea,potassium ion transmembrane transport (GO:0071805),0.24523227383863094,0.8220830512282524,0.7485714285714286,0.908219245987557,1.0,31/31,75.57%,ATP1B1;SLC9A9;KCNK10;SLC12A6;SLC12A7;FXYD2;KCNN4;KCNJ8;KCNC1;SLC12A3;KCNK7;ATP1A2;KCNG2;ABCB8;KCNJ14;ATP1A3;KCNAB1;KCNJ10;SLC12A4;SLC9A2;SLC9A1;SLC12A5;KCNQ3;KCNK13;KCNK5;SLC9A8;ATP1A1;KCNAB2;SLC12A2;KCNQ5;CCDC51
gsea,glycerophospholipid biosynthetic process (GO:0046474),-0.18904425340777548,-0.821323260765231,0.8113590263691683,0.759847257735573,1.0,40/90,47.52%,TAMM41;AGPAT5;CPNE1;PI4K2B;CSNK2A2;CRLS1;PLA2G12A;MTMR14;STARD7;VAC14;PIK3CG;PCYT1A;PCYT2;SELENOI;FAR1;SACM1L;AGK;PI4KA;MTMR1;AGPAT4;GNPAT;MTMR4;LPCAT1;PLSCR1;PTDSS2;GPAT4;AGPAT1;MTMR12;DDHD1;SBF1;PIK3CB;GPD1L;ACP6;DGKH;CHPT1;LPIN2;RUFY1;INPPL1;PLEKHA8;FIG4
gsea,actin cytoskeleton reorganization (GO:0031532),-0.23535637754611916,-0.8204430072738534,0.7357723577235772,0.7605913354043201,1.0,14/31,57.59%,EZR;RALA;MYH9;PLEK;FLNA;SIPA1L1;MCU;RAP2A;BCAR1;CAPN10;PLEK2;MINK1;ANTXR1;CTTN
gsea,central nervous system development (GO:0007417),-0.18652775272942967,-0.8147776306089676,0.845691382765531,0.7690792694891143,1.0,41/93,49.21%,PHGDH;TUBGCP2;CDK5RAP2;UTP3;THOC6;EIF2B5;SETD1A;PBX2;SLC2A1;DDIT4;BPTF;ANKLE2;SMG9;PTPN11;ZPR1;ABCB6;WWP1;GBA2;CIC;SPATA5;ROGDI;EOMES;DHX30;AHI1;RAB3GAP1;ARNT2;ELP3;RPS6KA6;ATN1;PBX3;STAT3;CHD8;PBX4;BTD;CHD7;ATXN1;DHX37;NCOA6;POMK;SOX8;PTCH1
gsea,negative regulation of multicellular organismal process (GO:0051241),-0.1875891399768881,-0.8142190637541195,0.8631578947368421,0.7692442944143112,1.0,34/88,53.17%,BRCA2;CORO1C;RGS2;SRSF6;CALR;HMGCR;ROCK2;ROCK1;RPS6KA5;RB1;IFNG;ATF4;SFMBT1;ADAM17;WDR77;GSK3B;SRF;MEF2C;RPS6KA6;ASB1;SPRED1;DOCK7;ID1;DAB2IP;GATA3;RGCC;USF3;PTCH1;LOXL2;NOTCH1;FFAR4;SLC11A1;GAS6;PLCL1
gsea,negative regulation of angiogenesis (GO:0016525),0.22638373574218973,0.8136886215425606,0.7925636007827789,0.9206925523412636,1.0,42/42,91.77%,CD160;STAT1;GTF2I;CCR2;KLF4;SERPINE1;CREB3L1;TNF;HHEX;SERPINF1;THBS1;SPRY2;TGFB2;AGO1;STAB1;PPARG;CTNNB1;FOXO4;AMOT;PF4;PTPRM;FOXJ2;ATP2B4;ALOX5;ATF2;EPN2;CXCL10;SPARC;VASH1;RGCC;KLF2;DAB2IP;SPRED1;PML;PIK3CB;SLC12A2;PDE3B;HGS;ROCK1;ROCK2;E2F2;PGK1
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.3090714833163898,-0.8061416148559596,0.6340996168582376,0.7812527556566516,1.0,12/30,31.43%,RPS17;RPS2;RPL14;RPS15;RPS25;RPL23A;RPL31;RPS6;RPL4;SRP68;SRP72;RPL5
gsea,sodium ion transmembrane transport (GO:0035725),0.2702075702075701,0.8060893643664988,0.755859375,0.9314067101149904,1.0,12/21,38.81%,SCN1B;ATP1B1;SLC9A9;SCN4B;FXYD2;SLC6A11;SLC12A3;SLC8A1;ATP1A2;SLC6A12;SLC6A13;ATP1A3
gsea,anterograde axonal transport (GO:0008089),-0.24744960190666773,-0.8059886114513233,0.7304526748971193,0.7808175297556194,1.0,9/21,47.33%,KIF5B;AP3S1;AP3D1;MAP1A;AP3M1;TRAK1;KIF1C;AP3B1;BLOC1S2
gsea,inositol phosphate metabolic process (GO:0043647),0.24843153115611255,0.800120803759346,0.7550200803212851,0.9389405459400347,1.0,21/21,88.43%,ITPKB;INPP4B;PLCG1;PLD4;PLCB2;FGF2;PLCG2;PLCB4;IP6K2;SYNJ1;PPIP5K2;INPPL1;IPPK;NUDT10;NUDT11;PLCH1;IPMK;PPIP5K1;INPP5B;ISYNA1;NUDT4
gsea,phosphatidylcholine biosynthetic process (GO:0006656),-0.26834522047554743,-0.7976772714805132,0.7392197125256673,0.7930333988813649,1.0,7/15,45.65%,CSNK2A2;STARD7;PCYT1A;LPCAT1;GPAT4;CHPT1;LPIN2
gsea,response to reactive oxygen species (GO:0000302),0.24094020466802754,0.792851668262865,0.7757575757575758,0.94819593733009,1.0,24/24,88.97%,HIF1A;PDK2;JUN;PTPRK;NCF1;PLK3;GPX1;MMP9;FOS;APOE;ADAM9;MAPK8;HMOX1;HYAL2;SIRT1;CHUK;TXNRD2;SOD2;APTX;CAMKK2;ERCC6L2;TPM1;PRDX3;AKT1
gsea,autophagosome assembly (GO:0000045),-0.267368769105112,-0.7828625757333655,0.7944664031620553,0.8146999306758004,1.0,8/16,48.08%,ATP2A2;NSFL1C;UBQLN1;UBXN2B;RAB23;ATG7;PACS2;MFN2
gsea,phosphatidylinositol metabolic process (GO:0046488),0.19477813189507245,0.7802344866581185,0.8469184890656064,0.9669637571542781,1.0,53/53,80.65%,INPP4B;PIK3R1;PLA2G4F;PLCG1;INPP5F;PLBD1;PGAP1;PLCB2;PITPNM2;PIK3R6;SLC27A1;SYNJ2;PIK3R2;RAB4A;MTMR3;FGF2;PTPN13;PIK3CD;PLA2G4A;PIKFYVE;CSF1R;PIK3R4;PLCG2;PGAP3;PIK3R5;PIK3C2A;PLEKHA1;SYNJ1;PI4KB;CDIPT;PIP5K1C;LCLAT1;PIK3CA;PIP4K2B;FIG4;PLEKHA8;INPPL1;RUFY1;PIK3CB;SBF1;MTMR12;MTMR4;LPGAT1;MTMR1;PI4KA;SACM1L;PIK3CG;VAC14;INPP5B;MTMR14;PLEK;PLA2G12A;PI4K2B
gsea,positive regulation of immune effector process (GO:0002699),0.24971130567319197,0.777571492636228,0.7775628626692457,0.9676500141965524,1.0,18/18,86.58%,CD81;CCR2;DHX58;IL1B;DDX60;IL2;IL23A;IL10;XBP1;PTPRJ;APPL2;MYO18A;IL12RB1;TNFSF4;ANKRD17;MYB;IFNG;PHB
gsea,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.28128109264857115,0.7768829074264381,0.7366412213740458,0.965082343542014,1.0,15/15,88.97%,BCL2;BCL2L1;IL1B;CSF2;TNF;RET;INHBA;PF4;PPP2R1B;MAPK7;HSPA1A;HSPA1B;EYA3;HTRA2;AKT1
gsea,regulation of cell adhesion mediated by integrin (GO:0033628),-0.26031153340548135,-0.776017993313088,0.7565392354124748,0.8237871563777922,1.0,5/16,37.01%,PIK3CG;TESC;PTPN11;PDE3B;ADA
gsea,sodium ion transport (GO:0006814),0.26958456170623807,0.7754036268674026,0.7890625,0.9639862639374573,1.0,11/18,38.58%,SLC9B2;SCN1B;ATP1B1;SCN4B;SGK1;SLC6A11;SLC12A3;SLC8A1;ATP1A2;SLC6A12;SLC6A13
gsea,gland development (GO:0048732),-0.23391571930021765,-0.7744620980503014,0.7975206611570248,0.825256280629103,1.0,9/25,46.24%,EZR;GFER;PRKCSH;FADD;TG;PHF2;RIPK3;WNT4;ARHGAP35
gsea,cellular response to glucose starvation (GO:0042149),-0.2291039319654869,-0.7724686453723778,0.8089430894308943,0.8273235383701565,1.0,9/26,36.89%,HNRNPA1;ASNS;MYBBP1A;RRP8;ATF4;TBL2;PRKAA1;PRKAG2;ITFG2
gsea,positive regulation of ATP metabolic process (GO:1903580),0.2566736463413183,0.7689362405891441,0.7951582867783985,0.9711035479410768,1.0,18/18,93.61%,PINK1;HIF1A;TMSB4X;PID1;APP;BEND3;NUPR1;ZBTB20;PFKFB3;IGF1;ARNT;SLC4A4;PRKAA1;PFKFB1;VCP;ENTPD5;IFNG;ENO1
gsea,regulation of TORC1 signaling (GO:1903432),0.2516383944440981,0.7662863704465029,0.8271119842829077,0.9717168392283599,1.0,17/17,93.11%,SESN3;CASTOR1;SESN1;GPR137B;RNF152;SMCR8;RRAGB;C9ORF72;SESN2;ATM;KLHL22;ITFG2;TELO2;DEPDC5;DYRK3;SEH1L;PIH1D1
gsea,organonitrogen compound biosynthetic process (GO:1901566),-0.1794341993261267,-0.7662610214840111,0.9200913242009132,0.8351927184435619,1.0,27/70,50.90%,GSTO1;NMRAL1;CSNK2A2;HACD2;TYW1;GSTZ1;STARD7;NANP;PCYT1A;ST3GAL4;GPHN;PRKD3;ACER3;LPCAT1;HACD3;GPAT4;CERS6;ALAS1;CHPT1;TYW5;PRKD2;LPIN2;SLC25A15;SPHK2;ELOVL4;PLPP1;LCMT2
gsea,regulation of protein localization to cell surface (GO:2000008),0.2515812065881988,0.7650215276684068,0.784394250513347,0.9700507266734,1.0,17/17,93.34%,GPM6B;TYROBP;ABCA7;TNF;HFE;ACTN2;CTNNB1;ABCA2;TAX1BP3;RANGRF;TM9SF4;GPD1L;KCNAB2;GBF1;PICALM;MAP1A;HSP90AB1
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.23158139132635458,0.7628543502419816,0.8403361344537815,0.9698459110922774,1.0,23/23,86.26%,CCR7;P2RX4;EVI5;FSCN1;TBC1D1;TBC1D14;TBC1D22B;USP6NL;TBC1D8;DMTN;TBC1D13;RABGAP1;SDCCAG8;IFT88;ABITRAM;SGSM3;TBC1D5;IFT140;FXR2;MYO10;TBC1D10B;FMR1;RDX
gsea,chemical synaptic transmission (GO:0007268),-0.18786201142951567,-0.7613768375882487,0.9244897959183673,0.8410770385709235,1.0,32/68,56.10%,HSPA8;PDZD11;EXOC4;NRGN;GIPC1;PRKAR2A;CAMKK2;UNC13A;NSG1;ERC1;SPG11;PRKAR2B;SLC1A4;DVL1;HTR2A;ATXN3;RAPSN;LIN7A;DRD4;PDE7B;STXBP3;AKAP5;GABRR1;NPTX1;UNC13B;KCNQ3;CAMK1;GRIN1;KCNMB1;NLGN2;MINK1;SLC12A5
gsea,positive regulation of protein tyrosine kinase activity (GO:0061098),0.27364203118154884,0.7609827468400628,0.7941176470588235,0.9691342142072639,1.0,9/15,30.76%,PRNP;NCF1;PDGFB;NEDD9;CASS4;HBEGF;CSF1R;AREG;ADRA2A
gsea,regulation of Wnt signaling pathway (GO:0030111),-0.19651610923182816,-0.7598246071448566,0.8706365503080082,0.8424688794197449,1.0,18/45,52.21%,DEPDC1B;SMARCA4;HMGXB4;TMEM237;CBY1;WWOX;NXN;AXIN1;CDK14;CDC73;BTRC;TSC2;RACK1;CTNND2;HIC1;TSKU;FRZB;NKD2
gsea,negative regulation of proteolysis (GO:0045861),-0.2525013452202774,-0.7586317984657771,0.7925311203319502,0.8434278387942153,1.0,6/17,39.69%,AKT1;SERPINE2;ROCK1;HDAC6;CHAC1;CST3
gsea,regulation of sodium ion transport (GO:0002028),0.25331912750923485,0.7572346510982022,0.8011695906432749,0.9712821907107935,1.0,16/16,88.03%,P2RX4;PER1;SCN1B;SCN4B;PKP2;CNKSR3;WNK1;ATP2B4;NKAIN1;RANGRF;SLMAP;ATP1A1;NOS1;GPD1L;AHCYL1;NEDD4
gsea,membrane protein proteolysis (GO:0033619),0.23645101781407835,0.7570866429925345,0.8385214007782101,0.9678739439705746,1.0,21/21,85.02%,NFKB1;BACE2;NAPSA;CTSH;PSEN2;DAG1;RET;ADAM19;TMPRSS6;SPPL2B;RHBDD1;ADAM9;RELA;AFG3L2;MBTPS2;ADAM17;ERAP1;MYH9;PARL;CLPP;RBMX
gsea,sphingolipid metabolic process (GO:0006665),0.19956133181065172,0.7555447555012829,0.8635477582846004,0.9666273188390244,1.0,42/42,80.31%,GM2A;ST6GALNAC3;CERK;NEU1;ST6GALNAC6;ENPP2;SGPL1;PPM1L;HACD1;HEXA;FA2H;HACD4;TEX2;SGMS1;PLPP2;SAMD8;ALDH3B1;FUT7;ABCA2;ELOVL2;GLA;SPHK1;GALC;ELOVL6;ALDH3A2;PLPP1;ELOVL4;SPHK2;PRKD2;PDXDC1;CERS6;HACD3;GBA2;CERKL;SUMF2;CPTP;SMPD1;SMPD4;AGK;ACER3;PRKD3;HACD2
gsea,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.23331149569038007,-0.7551383801910289,0.8241106719367589,0.8473783333565869,1.0,13/23,51.97%,NEDD4;PHB;SAFB;ARID1A;TADA3;UBR5;TRERF1;DAXX;MED1;ZMIZ1;YAP1;PLPP1;DDX54
gsea,potassium ion transport (GO:0006813),0.24499267220322438,0.7550474578527127,0.8212290502793296,0.9638201690819973,1.0,23/23,75.57%,KCNMB4;SLC9A9;KCNK10;KCNN4;KCNJ8;KCNC1;KCNK7;ATP1A2;KCNG2;ABCB8;KCNJ14;KCNAB1;KCNJ10;SLC9A2;SLC9A1;KCNMB1;KCNQ3;KCNK13;KCNK5;SLC9A8;KCNAB2;KCNQ5;CCDC51
gsea,regulation of cellular catabolic process (GO:0031329),-0.21050537001310096,-0.7549672091437741,0.8556263269639066,0.8468729901738064,1.0,14/34,54.01%,ROCK1;TYSND1;USP10;HDAC6;KEAP1;DEPDC5;TRIB3;MTMR4;KAT8;ATM;PIP4K2B;RAB39B;ABCD1;BOK
gsea,positive regulation of endocytosis (GO:0045807),0.24732321780023625,0.7533926118023242,0.816247582205029,0.9627781284428006,1.0,14/22,37.45%,FLOT1;F2RL1;SERPINE1;SGIP1;AXL;HFE;LRP1;DAB2;C3;CLN3;HIP1;APOE;CLIP3;APPL2
gsea,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.2543248052780433,0.7509909924725613,0.8038461538461539,0.962757852714608,1.0,16/16,91.57%,BCL2L1;CREB3L1;BCL2L11;SYVN1;LRRK2;PMAIP1;DDIT3;SELENOS;XBP1;CREB3;BOK;EIF2AK3;OPA1;HSPA1A;HERPUD1;PARK7
gsea,glycoprotein biosynthetic process (GO:0009101),-0.20034856733098833,-0.7504291974347194,0.8350100603621731,0.8520365663957818,1.0,14/36,52.50%,DDOST;ALG3;ST3GAL4;B3GALT6;ST3GAL5;MPI;GOLGA2;FAM20B;SERP2;COG7;CSGALNACT2;ST3GAL3;B3GNT3;NPC1
gsea,positive regulation of neuron apoptotic process (GO:0043525),-0.26645211210752096,-0.7502691770110839,0.8049792531120332,0.8515104075345595,1.0,5/15,56.69%,BAX;ATF4;CCL3;FBXW7;NF1
gsea,protein-containing complex disassembly (GO:0032984),-0.2353803906228928,-0.7501799980304775,0.8165938864628821,0.8509007725230163,1.0,12/23,43.82%,HSPA8;VPS16;VAMP8;UBQLN1;VCP;PYM1;AXIN1;GSK3B;VPS33A;DVL1;VAMP7;DVL2
gsea,cellular response to ketone (GO:1901655),0.24743689519639187,0.7486704465195378,0.7882599580712788,0.9625991861871946,1.0,18/18,89.50%,PTGER2;AR;NR3C1;PTGER4;AHR;KLF9;NCOA4;ADCY6;ACOD1;NDOR1;SPHK2;TNFSF4;TRERF1;SPP1;LARP1;MAP4K1;ROCK2;PCK2
gsea,hexose metabolic process (GO:0019318),0.2497129124058049,0.7485491483023795,0.7870182555780934,0.9592983761365891,1.0,18/18,89.40%,ALDOC;IRS2;CHST15;GALM;GAA;DCXR;HECTD4;BRAT1;SLC37A4;SORD;OMA1;FUOM;HK1;ADPGK;PGM1;PMM1;ALDOA;GALK1
gsea,striated muscle contraction (GO:0006941),-0.24745740737754346,-0.7457865140776851,0.8393574297188755,0.855864179278419,1.0,7/19,51.27%,ALDOA;RCSD1;TPM1;GRK2;NOS1;LMOD3;PIK3CA
gsea,positive regulation of response to biotic stimulus (GO:0002833),0.23536170508815607,0.7440341195431756,0.831041257367387,0.9623017467940725,1.0,22/22,92.69%,CCL5;PRKCA;DHX58;ADAM8;DDX60;CD180;SCIMP;LY86;GRN;ACOD1;SLC15A4;POLR3B;POLR3D;ANKRD17;POLR3F;PLSCR1;GBP5;POLR3G;PUM2;AKIRIN2;USP15;DHX9
gsea,organic anion transport (GO:0015711),0.22226295210166203,0.7393938957943625,0.8478260869565217,0.9654666468167848,1.0,27/27,77.85%,SLC2A6;SLC4A7;SLCO3A1;SLC25A24;ABCC5;SLC17A9;SLCO2A1;SLC52A3;LRRC8D;MGST1;SLC4A5;SLC4A4;ABCC4;ABCG2;SLC25A19;SLC35C2;SLCO4A1;SLC52A2;SLC4A2;CPTP;SLC35B1;SLC35A1;SLC25A17;SLC35A3;SLC19A1;SLC4A8;CYB5R1
gsea,glycosaminoglycan metabolic process (GO:0030203),0.24035644531250003,0.7367029484596769,0.8148148148148148,0.9657235134024816,1.0,19/19,76.02%,GNS;SDC4;HS6ST1;SDC1;HGSNAT;GCNT2;HEXA;SDC3;XYLT1;HPSE;GPC1;NAGLU;HYAL2;HS2ST1;SLC35D2;PXYLP1;B3GALT6;GUSB;CLN6
gsea,myelination (GO:0042552),0.2383742218967413,0.7366555279300123,0.8326771653543307,0.9623331245536515,1.0,18/18,76.21%,MBP;MARVELD1;CXCR4;MALL;TNFRSF21;SBF2;SKI;PMP22;SOX10;CMTM8;NF1;B4GALT5;FAM126A;ABCD1;GPC1;EIF2B4;ACER3;EIF2B5
gsea,plasma membrane organization (GO:0007009),0.2142246120004888,0.7269134429231797,0.8832116788321168,0.9716471786981852,1.0,28/28,78.65%,PACSIN1;ABCA7;SYT11;PLSCR3;PLSCR4;CXCR4;TLCD2;TLCD1;EHD2;CLN3;PACSIN3;FA2H;MICALL1;SERP1;FNBP1L;SYT7;OSBPL2;ABCD1;SYTL4;STX2;ANO6;SNX9;PLSCR1;NSF;SMPD1;SPTBN1;PACSIN2;MYH9
gsea,positive regulation of neuron projection development (GO:0010976),0.2046890130952482,0.7261794720600993,0.8814531548757171,0.9691158846539804,1.0,31/31,87.26%,PACSIN1;NTRK3;SCN1B;ITGA6;FES;CAMK1D;NDNF;P3H1;BMP7;KIDINS220;RET;PLXNB2;CX3CL1;LYN;RAPGEF1;APOE;EP300;RAPGEF2;CAMK1;EPHA3;PTK2B;ARHGAP35;DAB2IP;PRKCI;BHLHB9;ZDHHC15;TOX;LRP8;SETX;CAPRIN1;ARSB
gsea,negative regulation of secretion by cell (GO:1903531),0.255720369658905,0.7257296448649768,0.8441814595660749,0.9662323693486782,1.0,16/16,83.49%,ANXA1;SLC30A1;SYT11;RSAD2;LIF;RHBDF1;APOE;TNFRSF1A;OSM;CHGA;SYT4;NOTCH1;DRD4;RHBDF2;VAMP8;HMGCR
gsea,diterpenoid metabolic process (GO:0016101),0.24249450817671442,0.7252468246092222,0.8297455968688845,0.9633940176834782,1.0,10/17,33.14%,ADH4;SDC4;SDC1;DHRS3;LRP1;LPL;SDC3;APOE;AKR1B10;AWAT2
gsea,fatty acid derivative biosynthetic process (GO:1901570),-0.24164536145936139,-0.7249266162420719,0.8574257425742574,0.88052737515878,1.0,11/16,51.56%,SLC25A1;ACACA;FAR1;GCDH;ACLY;CBR4;FASN;LTC4S;GGTA1;AACS;PPT2
gsea,wound healing (GO:0042060),0.21427698325388078,0.7229718847211922,0.8928571428571429,0.962817376309144,1.0,30/30,78.65%,JAML;ITGB3;SYT11;SMAD3;PAK1;MACF1;FGF2;PDGFA;TGFB2;FZD7;DST;PLEC;IGF1;SYT7;DSP;EVPL;PRCP;NF1;SLC11A1;SYTL4;MIA3;HPSE;HMOX1;TSKU;SCARB1;SRF;SMPD1;DCBLD2;TPM1;MYH9
gsea,regulation of axon extension (GO:0030516),-0.23006035270704658,-0.722501285850248,0.8528225806451613,0.882552387242827,1.0,6/20,36.38%,SIN3A;MT3;RUFY3;GOLGA4;MAP2;GSK3B
gsea,ceramide metabolic process (GO:0006672),0.24029777886258238,0.7192681173090858,0.8386491557223265,0.9638604545986967,1.0,17/17,76.02%,ST6GALNAC3;CERK;ST6GALNAC6;SGPL1;FA2H;SGMS1;PLPP2;SAMD8;FUT7;ABCA2;PLPP1;CERS6;SMPD1;SMPD4;AGK;ACER3;CLN6
gsea,regulation of toll-like receptor signaling pathway (GO:0034121),0.24731891755098112,0.7176103985950752,0.8512720156555773,0.9625230403949463,1.0,15/15,83.25%,IRF7;FLOT1;IRF1;IRAK3;TLR2;CD36;APPL2;BIRC2;GFI1;SMPDL3B;OTUD4;LRRC14;BIRC3;FLOT2;CACTIN
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),0.23040293040293064,0.7169399533210602,0.8598484848484849,0.9599168779996258,1.0,21/21,77.02%,TLE3;IL18R1;MAP2K6;CIDEA;DDIT3;NR1H3;PCTP;ARRDC3;ARNTL;ABHD6;TLR4;FOXC2;TFE3;WNT10B;PLCL1;NOTCH1;ID1;DOCK7;ADAM17;ATF4;RB1
gsea,negative regulation of metabolic process (GO:0009892),0.23043106606423275,0.7164883934433974,0.861328125,0.9571282422354471,1.0,22/22,77.02%,TLE3;IL1B;IL18R1;MAP2K6;CIDEA;DDIT3;NR1H3;PCTP;ARRDC3;ARNTL;ABHD6;TLR4;FOXC2;TFE3;WNT10B;PLCL1;NOTCH1;ID1;DOCK7;ADAM17;ATF4;RB1
gsea,sulfur compound biosynthetic process (GO:0044272),0.1875777025527341,0.7162762516116097,0.9099616858237548,0.9540776485121654,1.0,43/43,85.46%,MGST2;SLC26A2;CHST2;ST3GAL1;CHST15;DSEL;UST;DSE;GCLC;CHPF2;CHSY1;GSTM1;GSTA4;CHSY3;GSTK1;CHST11;VCAN;CHAC2;B4GALT4;MGST3;CHPF;MGST1;GSTT1;ST3GAL6;B4GALT5;CBS;GSTM5;B3GNT3;ST3GAL3;GGTA1;CSGALNACT2;GSS;B4GAT1;SLC35D2;GGCT;CTH;CHAC1;MAT2A;ST3GAL4;LIAS;GSTZ1;METTL16;GSTO1
gsea,neuron migration (GO:0001764),-0.23589405432187865,-0.7126609531257077,0.8493975903614458,0.8924400717631695,1.0,9/18,43.17%,TUBGCP2;FGF13;DDIT4;TUBB2A;USP9X;CEP85L;MEF2C;ELP3;SDCCAG8
gsea,regulation of cell-cell adhesion (GO:0022407),0.23860797695736796,0.7123118390145752,0.8471337579617835,0.9554487356811201,1.0,17/17,87.88%,CITED2;SMAD7;ADAM8;CEACAM1;WNT1;CDH1;B4GALNT2;DPP4;FUT7;FUT4;MINK1;NF2;AFDN;ADA;GTPBP4;FLOT2;ZDHHC2
gsea,"phagocytosis, engulfment (GO:0006911)",0.2661611623406603,0.710308716516251,0.8071161048689138,0.9544340234827757,1.0,10/15,36.80%,GSN;ARHGAP25;ITGAM;FCGR2B;AIF1;THBS1;MSR1;ARHGAP12;CD36;DOCK1
gsea,negative regulation of catalytic activity (GO:0043086),-0.24141309423975435,-0.7078946412787661,0.8699360341151386,0.8969421736466958,1.0,6/15,43.05%,MT3;HDAC6;CCAR2;CAND1;NOS1;SIRT1
gsea,phosphatidylinositol biosynthetic process (GO:0006661),0.17148551019363023,0.7061322213271792,0.9545454545454546,0.9558623246081358,1.0,65/65,90.17%,ITPKB;INPP4B;CISH;PIK3R1;SOCS5;INPP5F;PITPNM2;PIK3R6;SLC27A1;SYNJ2;PIK3R2;RAB4A;SOCS3;SOCS2;MTMR3;FGF2;TTC7B;PTPN13;SOCS6;PIK3CD;PIGL;PIKFYVE;PIK3R4;PLCG2;IP6K2;PGAP3;PIK3R5;PIK3C2A;PIGC;PLEKHA1;SYNJ1;PI4KB;CDIPT;FAM126A;PIP5K1C;PIGH;PIGB;PIK3CA;SOCS7;PIP4K2B;FIG4;SOCS1;PIGG;PLEKHA8;INPPL1;RUFY1;PIGV;FAM126B;PIGN;PGAP2;PIK3CB;SBF1;MTMR12;MTMR4;MTMR1;PI4KA;SACM1L;PIGQ;PIK3CG;VAC14;MTMR14;PIGA;PIGU;PI4K2B;PIGF
gsea,autophagosome organization (GO:1905037),-0.2430024900115881,-0.7046073463981629,0.8717948717948718,0.8997347582856893,1.0,7/15,47.79%,ATP2A2;NSFL1C;UBQLN1;UBXN2B;RAB23;ATG7;PACS2
gsea,metal ion homeostasis (GO:0055065),-0.24240540772850122,-0.7039377034590267,0.8837675350701403,0.8996587767133928,1.0,4/16,38.24%,LETM1;MT3;CNNM2;SLC12A2
gsea,regulation of receptor-mediated endocytosis (GO:0048259),-0.251401211970173,-0.7020917862865299,0.8606060606060606,0.9008034513286529,1.0,6/15,42.69%,HNRNPK;BMP2K;PICALM;HIP1R;PIK3CB;CBL
gsea,negative regulation of cell adhesion (GO:0007162),0.19842238458295347,0.6918603573161767,0.9102803738317757,0.9676917512883648,1.0,30/30,92.86%,RIPOR2;DUSP1;PLXNC1;SERPINE1;TGFBI;WNT1;CDH1;RASA1;GCNT2;ACVRL1;B4GALNT2;PLXNB2;CX3CL1;FZD7;MUC1;DMTN;PLXNA1;FBLN1;PLXND1;NOTCH1;MIA3;NF2;FZD4;PDE3B;ARHGDIG;GTPBP4;DSCAM;SPN;LPXN;ARHGDIA
gsea,positive regulation of Notch signaling pathway (GO:0045747),0.2139597599254665,0.6906636367708453,0.892578125,0.965504772141663,1.0,23/23,81.52%,MAML2;TSPAN5;IL6ST;WNT1;DLL4;MAML3;TGFB2;EP300;ENHO;AAK1;DLL1;JAG2;EPN2;NOTCH1;NEPRO;YAP1;ZMIZ1;KAT2B;CREBBP;STAT3;PRKCI;POGLUT1;BMP2K
gsea,peptidyl-tyrosine modification (GO:0018212),0.223368889438327,0.6905087283676965,0.8641509433962264,0.9623745379216239,1.0,23/23,85.11%,JAK2;KIT;FLT1;PDGFB;FES;HCK;SYK;BTK;LYN;TEC;CSF1R;ABL1;FGR;FLT3;EPHA3;PTK2B;ABI3;ABI2;TPST1;TTL;DYRK1A;TPST2;PTPN6
gsea,amide biosynthetic process (GO:0043604),-0.23733084513860292,-0.6902325686621841,0.865546218487395,0.9117548272013631,1.0,6/15,37.91%,NMRAL1;NANP;AGK;SMPD4;SMPD1;CERS6
gsea,regulation of JUN kinase activity (GO:0043506),0.21846070314632496,0.6885965050197458,0.8914728682170543,0.961070599402231,1.0,19/19,85.34%,PDCD4;DUSP10;TNF;MAPK8IP1;PAK1;DVL3;HIPK3;ARHGEF5;MAP3K11;EDN1;DNAJA1;DAB2IP;DVL2;MAP3K5;MAP3K7;DUSP19;MAP3K4;AIDA;TRAF2
gsea,blood circulation (GO:0008015),0.22997198395387203,0.6873143788009825,0.8915441176470589,0.9591058272865165,1.0,19/19,82.84%,GUCY1A1;STAT1;ADORA2A;GCLC;DLL4;ACVRL1;C3AR1;GPX1;OLR1;ADCY6;HTR7;TBC1D8;TNNI3;PLN;CXCL10;SCPEP1;GUCY1B1;ROCK1;ROCK2
gsea,phosphatidic acid biosynthetic process (GO:0006654),0.21237994120345444,0.6808466532688963,0.8913857677902621,0.9620874981725976,1.0,23/23,84.50%,DGKA;DGKD;SLC27A1;ABHD4;DGKE;DGKG;PLA2G4A;AGPAT2;PLA2G4B;PLD2;GPD1;LCLAT1;DGKH;ACP6;GPD1L;DDHD1;AGPAT1;GPAT4;LPCAT1;GNPAT;AGPAT4;PLA2G12A;AGPAT5
gsea,axonal transport (GO:0098930),-0.20747062163453095,-0.68012945610654,0.9020833333333333,0.9201468720913818,1.0,8/20,47.33%,DCTN1;AP3S1;DYNC1H1;AP3D1;OPA1;AP3M1;AP3B1;BLOC1S2
gsea,phosphatidic acid metabolic process (GO:0046473),0.20879920102731922,0.6775819920089242,0.9022988505747126,0.961973318989601,1.0,24/24,84.50%,DGKA;DGKD;SLC27A1;ABHD4;DGKE;DGKG;PLA2G4A;AGPAT2;PLA2G4B;PLD2;GPD1;LCLAT1;PLA2G6;DGKH;ACP6;GPD1L;DDHD1;AGPAT1;GPAT4;LPCAT1;GNPAT;AGPAT4;PLA2G12A;AGPAT5
gsea,carbohydrate homeostasis (GO:0033500),0.21562641570787083,0.6733005720614047,0.9195402298850575,0.9626232196568022,1.0,20/20,91.57%,BACE2;PDK2;SOX4;PYGL;KLF7;CRY1;CRY2;PPARG;TCF7L2;VGF;ADRA2A;APPL2;ALOX5;HECTD4;TENT4B;STAT3;MCU;PRKAA1;RPS6;PARK7
gsea,regulation of anatomical structure morphogenesis (GO:0022603),0.16799036303566203,0.6707387163236084,0.9624505928853755,0.9616444281458452,1.0,59/59,93.28%,TNFAIP3;BCL6;SP100;ARC;ETS1;LRRK2;LZTS1;BCL9L;CEACAM1;PID1;PDLIM5;PAK1;TANC2;CXCL13;DAG1;FGF2;FMNL2;CTNNB1;KIF1A;GPNMB;STAT2;TNIK;SH3D19;ADGRA2;PHLDB2;KNDC1;HECW1;DLL1;VASH2;CAMSAP1;NF1;PLXND1;SPARC;HMOX1;VASH1;ABI3;HECW2;KIF13B;ARHGAP35;ABI2;ZMYM4;STRIP1;RAP2A;INF2;POGLUT1;PDZD8;MEF2C;LARP4;GSK3B;ZMYM3;ZDHHC15;RUFY3;SIPA1L1;CLASP1;EGLN1;CLASP2;PHIP;NEDD4;CFL1
gsea,positive regulation of developmental growth (GO:0048639),0.22986822840409954,0.6651040052710406,0.9066390041493776,0.9632023963965568,1.0,15/15,77.06%,SEMA7A;RNF157;LIMK1;MACF1;L1CAM;SHTN1;GHSR;SYT4;MAP3K13;DLL1;CPNE9;GOLGA4;RUFY3;UNC13A;PLAA
gsea,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.20558985445520453,-0.6599048022855536,0.9279661016949152,0.9361853078952677,1.0,11/22,52.80%,MAP2K3;VEGFB;MAPKAPK2;ERN1;RELA;PRKD2;DAB2IP;NR4A1;PIK3CA;NOTCH1;RAMP2
gsea,retinoid metabolic process (GO:0001523),-0.20465134508102095,-0.6560867086471908,0.92,0.9382396252758519,1.0,10/23,56.89%,DHRS13;LRP8;SCPEP1;RDH11;BCO1;GPC1;ALDH1A3;RDH12;UGT1A9;ALDH8A1
gsea,muscle organ development (GO:0007517),-0.2199456253112291,-0.6541759932615527,0.9190871369294605,0.9389256952448369,1.0,7/18,53.31%,SMTN;MEF2C;COL6A3;NEB;COPRS;CXCL10;SPEG
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.21527544661702674,0.651392174454598,0.9190283400809717,0.9707907224635415,1.0,17/17,83.39%,NFATC1;PLCB2;LEF1;NLK;FZD6;WNT11;AGO1;CTNNB1;TCF7L2;PDE6A;FZD3;MOV10;FZD4;AGO2;MAP3K7;TNRC6A;PPP3CB
gsea,positive regulation of innate immune response (GO:0045089),0.22213785368162337,0.649563744571721,0.9120458891013384,0.9689640849274044,1.0,15/15,92.69%,CCL5;SPI1;ZBP1;ADAM8;MAVS;SLC15A4;POLR3B;POLR3D;POLR3F;PLSCR1;GBP5;POLR3G;AKIRIN2;FADD;DHX9
gsea,regulation of autophagosome assembly (GO:2000785),-0.21530365113021216,-0.6485484545732998,0.9321357285429142,0.9422289550945894,1.0,7/18,48.91%,ADPRH;PHF23;TMEM39A;RAB3GAP1;IFT88;NPRL3;PIP4K2B
gsea,regulation of developmental growth (GO:0048638),0.2271307196522251,0.6424625330734244,0.9262948207171314,0.9708642202530907,1.0,9/15,37.96%,LATS2;OLFM1;APP;MFSD2A;STAT5A;APOE;IGF1;NRCAM;ABL1
gsea,regulation of secretion by cell (GO:1903530),-0.20412055933147877,-0.6406797890083138,0.9537815126050421,0.9468676500801497,1.0,8/20,41.97%,FMR1;RALA;VAMP8;NSF;STXBP5;MEF2C;RHBDF2;LLGL1
gsea,lysosome localization (GO:0032418),0.20205103162007088,0.6372213955588142,0.9447731755424064,0.9711635432186739,1.0,20/20,79.84%,NR4A3;KIT;RAB34;PLEKHM2;PLEKHM1;PIK3CD;MAP6;VPS33B;CHGA;SYTL4;MILR1;BLOC1S2;FAM98A;TFEB;DEF8;VPS33A;HDAC6;PIK3CG;MYH9;KIF5B
gsea,negative regulation of ERBB signaling pathway (GO:1901185),-0.20104565754620585,-0.6369245069598127,0.9392789373814042,0.9485677629051356,1.0,10/22,47.19%,RNF126;HGS;STAM2;EPS15;EPS15L1;PTPN12;CBL;BTC;DAB2IP;STAM
gsea,cholesterol transport (GO:0030301),-0.2181507775299189,-0.6350574723855837,0.934640522875817,0.9489973765604267,1.0,9/18,52.93%,STARD4;LDLR;OSBP;SOAT1;SCARB1;STARD5;TSKU;NPC1;OSBPL2
gsea,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.21498117029803407,0.6213575958583317,0.923679060665362,0.9776835861079508,1.0,15/15,80.61%,HIF1A;NFE2L2;RUNX2;SMAD5;XBP1;EP300;CREB3;CHD6;VEGFA;SESN2;SMAD1;NOTCH1;RELA;ATF4;MT3
gsea,protein O-linked glycosylation (GO:0006493),-0.15903867590660467,-0.6202392199658745,0.980544747081712,0.9569909063207102,1.0,26/50,51.71%,SDF2L1;GALNT1;ST3GAL4;POMT1;B3GLCT;EOGT;GALNT7;TMTC4;POFUT1;PLOD2;B4GAT1;MUC6;TRAK1;POGLUT1;POGLUT2;POMT2;FKRP;GALNT3;POGLUT3;POMK;POMGNT1;ST3GAL3;TMTC1;PLOD3;B3GNT3;PGM3
gsea,regulation of dendrite development (GO:0050773),0.20058176317312587,0.6064582970347836,0.949290060851927,0.98217328669525,1.0,18/18,88.03%,PACSIN1;LZTS1;CAMSAP2;CAMK1D;BMP7;MFSD2A;BCL11A;TNIK;KNDC1;HECW1;HECW2;DAB2IP;RAP2A;RTN4IP1;GSK3B;ZDHHC15;LRP8;NEDD4
gsea,visual system development (GO:0150063),-0.2032664754549265,-0.5960386710909721,0.9639830508474576,0.9685854650419965,1.0,8/19,44.48%,ZDHHC16;PBX2;ATF6;SMG9;PBX3;HIPK1;PBX4;SMOC1
gsea,very long-chain fatty acid metabolic process (GO:0000038),0.20560165872600658,0.5944650847753759,0.9621212121212122,0.9844293635746121,1.0,10/16,39.19%,ACSL6;ACOX1;PEX2;HACD1;ACOT1;ACOT4;HACD4;ABCD3;SLC27A2;ELOVL2
gsea,regulation of ossification (GO:0030278),0.1955395369035218,0.5619181118324693,0.979757085020243,0.9930968702447299,1.0,15/15,81.52%,S1PR1;ECM1;LRP6;TXLNG;CHSY1;TGFB2;TWIST1;ENPP1;ZBTB16;KREMEN2;NOTCH1;ACVR1;MEF2C;PTPN11;BMP2K
gsea,negative regulation of macroautophagy (GO:0016242),0.1955620376848038,0.5603813776487127,0.9782608695652174,0.9903852259621998,1.0,15/15,88.97%,PINK1;LRRK2;LZTS1;USP36;NUPR1;SMCR8;FEZ1;PIK3CA;TSC1;TSC2;UBQLN4;TMEM39A;PHF23;MTOR;AKT1
gsea,phospholipid translocation (GO:0045332),0.1877745241581258,0.5504547467546658,0.982421875,0.9901176614041207,1.0,15/15,81.26%,ABCB4;ABCA7;PLSCR3;PLSCR4;MFSD2A;ATP8A1;ABCC1;ATP8B2;ABCA1;ATP11A;ANO6;ATP10A;PLSCR1;ATP11C;ATP8B4
gsea,chloride transport (GO:0006821),0.17499084137257295,0.5364913713804099,0.9849906191369606,0.9903487776543362,1.0,22/22,82.55%,FXYD1;SLC12A6;TTYH3;SLC12A7;SLC12A3;GABRB1;ANO7;CLIC5;GLRA1;CLCN6;SLC12A4;SLC12A5;GABRR1;TTYH1;FXYD3;ANO10;ANO8;PACC1;ANO6;SLC12A2;SLC4A8;CLIC4
gsea,regulation of cell-substrate adhesion (GO:0010810),-0.1588556783379208,-0.5150584850614166,0.9958762886597938,0.9916611598826051,1.0,12/23,56.69%,CORO1C;ARL2;FZD4;RSU1;PIK3CB;ATXN3;TSC1;NOTCH1;MYADM;NPNT;MINK1;NF1
gsea,anterograde trans-synaptic signaling (GO:0098916),0.14027968316132167,0.5143417347488587,1.0,0.9913484420231296,1.0,49/49,87.43%,SLC1A2;MBP;KCNMB4;LRP6;HOMER1;CHRNE;SLC12A6;LPAR3;DLG2;SLC12A7;SYN1;CACNB3;GABRB1;PMP22;MYCBPAP;PENK;PNOC;CACNA1A;HTR7;HAP1;RPS6KA3;CACNA1B;NPY;GLRA1;SLC12A4;APBA3;SLC12A5;MINK1;NLGN2;KCNMB1;GRIN1;CAMK1;KCNQ3;UNC13B;NPTX1;GABRR1;AKAP5;PDE7B;DRD4;RAPSN;ATXN3;HTR2A;PRKAR2B;SPG11;CAMKK2;PRKAR2A;GIPC1;NRGN;EXOC4
gsea,collagen fibril organization (GO:0030199),-0.14613794222139503,-0.507325907084207,0.9957446808510638,0.9920439155540047,1.0,13/32,58.80%,P4HB;COLGALT1;CRTAP;PLOD2;COL6A3;COL4A4;CD151;PLOD3;LOXL2;NF1;ITGB4;P4HA1;ADAMTS14
